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Abstract 
Human adenoviruses (Ads) are DNA viruses believed to hold potential as gene therapy vectors. 
However, Ad vectors often express residual late structural proteins, which stimulate immune 
responses resulting in rapid clearance of the vector. Therefore a greater understanding of the 
mechanisms controlling Ad late gene expression is required. During the late phase of adenovirus 
5 (Ad5) infection it was previously shown that a nuclear compartment involved in RNA 
metabolism known as the Cajal body (CB) is disassembled from 1-6 punctate domains per cell 
into numerous microfoci. Furthermore, the marker protein of CBs, p80 coilin, was suggested to 
play a role in the expression of Ad late phase proteins. However, the exact function of coilin in 
Ad late protein expression is unknown. The aim of this investigation was to determine the roles 
of coilin and additional CB proteins during Ad infection. 
Immunofluorescence microscopy was utilised to investigate the redistribution of key CB 
proteins following Ad5 infection of A549 cells. Whilst coilin was redistributed from CBs into 
microfoci, another CB protein, termed survival of motor neuron (SMN), was redistributed from 
CBs into the nucleoplasm. To assess the roles of coilin and SMN during Ad5 infection, coilin 
was depleted in A549 cells by RNA interference (RNAi). Cells were infected with Ad5 and the 
virus yield, Ad proteins levels and Ad mRNA levels were assessed. Depletion of coilin reduced 
the virus yield and decreased the synthesis of Ad early, intermediate and late phase proteins. 
Although Ad mRNA expression was mostly unaffected, nuclear export of Ad mRNAs was 
abrogated in coilin-depleted cells. This indicated that coilin plays a role in Ad mRNA transport. 
Similar to coilin, SMN depletion significantly reduced the virus yield. However, in contrast to 
coilin, SMN depletion resulted in significant decreases in the levels of Ad capsid proteins, 
whilst non-structural proteins were either increased or unaffected. SMN depletion was found to 
reduce early gene transcription and altered alternative splicing patterns of Ad mRNAs. This 
suggested that SMN plays a role in Ad transcription and mRNA splicing. 
This investigation uncovered the involvement of two CB proteins in two very distinct roles 
during Ad infection. This is the first report suggesting a role for CBs in mRNA export. Further 
study is now required to identify the exact function of coilin in Ad mRNA export. Furthermore, 
investigation of a role for coilin in cellular mRNA export and mRNA export during infection 
with other viruses is also warranted. Although SMN was known to play a role in cellular mRNA 
splicing, this is the first report indicating that SMN may be involved in splicing of virus 
mRNAs. Additional work is required to define the precise function of SMN in transcription and 
mRNA splicing during Ad infection and during infection with other virus species.  
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1.1  Introduction 
Viruses are infectious agents able to replicate only within the cells of a host organism. 
Following entry to the host cell, there is a stepwise dismantling of the virus capsid in order to 
release the viral genome for replication and gene transcription. Following protein translation, 
virus genomes are packaged into newly-assembled capsids to form progeny virions which are 
then released to infect neighbouring cells. However, due to their limited genome coding 
capacity, viruses are not able to encode all the proteins required for their replication. As a result, 
viruses have developed mechanisms of hijacking host cellular proteins in order to complete their 
life cycles. 
A prime cellular target of many viruses is the host cell nucleus, as it contains proteins required 
for RNA and DNA polymerisation and processing as well as factors required for the maturation 
and release of new virus particles (reviewed in Greco, 2009; Zakaryan and Stamminger, 2011). 
The nucleus is the site for numerous cellular processes including DNA replication, RNA 
transcription and ribosome assembly. In order to efficiently co-ordinate its many functions, the 
nucleus is subdivided into specialised domains which include the nucleolus, promyelocytic 
leukaemia nuclear bodies (PML-NBs) and Cajal Bodies (CBs). The nucleolus is primarily 
involved in the biogenesis and assembly of ribosomes, CBs are involved in RNA metabolism 
whilst PML-NBs have been implicated in diverse roles including transcriptional regulation, 
apoptosis and immune surveillance. During virus infection, nuclear substructures are disrupted 
and rearranged in order to facilitate virus replication (reviewed in Tavalai and Stamminger, 
2008; Greco, 2009; Boulon et al., 2010). Most DNA viruses (with the exception of poxviruses) 
replicate within the host cell nucleus, with key life cycle stages including DNA replication, 
mRNA transcription and virus assembly occurring in this compartment. Although RNA viruses 
replicate in the cytoplasm, they can also interact with the nucleus in order to promote genome 
replication and mRNA transport (reviewed in Hiscox, 2007; Hiscox et al., 2010). 
Considering their role in immune surveillance, it is unsurprising that multiple viruses including 
adenovirus (Ad), herpes simplex virus 1 (HSV-1) and varicella zoster virus (VZV) reorganise 
and/or degrade PML-NB components in order to subvert immune responses (Ullman and 
Hearing, 2008; El Mchichi et al., 2010; Boutell et al., 2011; Cuchet et al., 2011; Jiang et al., 
2011a; Wang et al., 2011). Some viruses also interfere with the transcriptional regulatory 
functions of PML-NBs; abrogation of the PML-NB transcriptional repressor proteins Daxx and 
SP100 appears to enhance viral transcription during infection with Epstein-Barr virus (EBV), 
Ad and human cytomegalovirus (HCMV) (Adler et al., 2011; Kim et al., 2011; Tsai et al., 
2011; Schreiner et al., 2012).  
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The nucleolus appears to play a key role in viral genome replication. The RNA virus West Nile 
virus (WNV) and the DNA viruses HSV-1, Ad and HCMV redistribute certain nucleolar 
proteins to viral genome replication centres, which appears to be necessary for replication 
(Lawrence et al., 2006; Calle et al., 2008a; Stow et al., 2009; Lymberopoulos and Pearson, 
2010; Strang et al., 2010; Strang et al., 2012; Xu et al., 2011). The nucleolus is also required for 
RNA trafficking during infection with certain RNA viruses. Human immunodeficiency virus 
(HIV-1) and herpes virus Saimiri (HVS) both hijack the nucleolus in order to traffic viral 
mRNA from the nucleus to the cytoplasm (Michienzi et al., 2000; Michienzi et al., 2002; Boyne 
and Whitehouse, 2006; Michienzi et al., 2006). The mRNA from these viruses is unsuitable for 
trafficking alongside normal cellular RNA; HIV-1 mRNA is incompletely spliced, making it 
prone to nonsense-mediated decay (Feinberg et al., 1986; Terwilliger et al., 1986) whilst HVS 
mRNAs are intronless thus cannot enter the usual mRNA export route that is intrinsically linked 
to splicing (Albrecht et al., 1992; Boyne and Whitehouse, 2006). 
In addition to the nucleolus, CBs also appear to play a role in viral RNA trafficking. During 
infection with the RNA plant virus Groundnut Rosette virus (GRV), CBs are fragmented from 
1-6 punctate domains per cell into smaller, more numerous microfoci. This was shown to 
promote the trafficking of the GRV movement protein ORF3 to the nucleolus, facilitating the 
assembly of viral RNA-protein complexes required for viral spread (Kim et al., 2007a; Kim et 
al., 2007b; Canetta et al., 2008). Interestingly, similar CB microfoci have also been observed 
during infection with the highly unrelated human DNA virus, Ad (Rebelo et al., 1996; 
Rodrigues et al., 1996). Although it has been suggested that CBs are required for the expression 
of Ad late proteins (James et al., 2010), the role of the CB during Ad infection is still unclear. 
A thorough understanding of viral life cycles is not only crucial for development of new anti-
viral agents, but also for the safe use of viruses as vectors for gene therapy, vaccine and 
oncolytic (cancer-killing) regimens. To date, Ads account for the highest proportion of viral 
vectors in clinical trials worldwide. As these Ad vectors are intended for use in the clinical 
setting, it is imperative that the Ad lifecycle is fully understood in order to ensure vector safety 
and efficacy. Unfortunately, although Ad early gene expression and DNA replication are well 
characterised, the later stages of Ad infection, in particular the mechanisms controlling Ad late 
gene expression, are less well defined. As CBs have been suggested to play a role in Ad late 
protein expression, characterising the interaction of Ads with CBs may expand our knowledge 
of the late phase of the Ad lifecycle. 
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1.2  Adenoviruses 
1.2.1 Adenovirus classification 
In 1953, an infectious agent was extracted from human adenoids and was later termed 
‘adenovirus’ (Ad) (Rowe et al., 1955; Enders et al., 1956). By the late 1960s, over 30 related 
isolates had been isolated and classified according to neutralisation properties (Stevens et al., 
1967). Members of the Adenoviridae family are non-enveloped icosahedral viruses with double-
stranded DNA genomes ranging from 26-45 kbp in size. Ads infect a broad range of vertebrate 
species and have been classified into five clades based on genome sequencing and bioinformatic 
analysis; the Mastadenoviruses (isolates originating from mammals), Aviadenoviruses (isolates 
from birds), Atadenoviruses (isolates from birds, mammals and reptiles that share high AT 
genome content) (Benko and Harrach, 1998; Both, 2002), Siadenoviruses (several bird isolates, 
one amphibian and one reptilian isolate) (Davison et al., 2003; Zsivanovits et al., 2006; Rivera 
et al., 2009) and the Ichtadenoviruses, consisting of a single isolate from a sturgeon (Kovacs et 
al., 2003).  
Human Ads originate from the Mastadenoviridae, and to date there are over 55 different 
serotypes of human Ads divided into seven species (A to G) (Table 1-1). Classification of Ads 
is based on multiple parameters including neutralisation by specific antisera, haemagglutination 
properties and genome sequence homology (reviewed in Berk, 2007). The species B Ads are 
further subdivided into groups B1 (serotypes 3, 7, 16, 21 and 50) and B2 (serotypes 11, 14, 34 
and 35) based on conservation of restriction endonuclease sites (Wadell et al., 1986; Segerman 
et al., 2003). This classification of the species B viruses also broadly correlates with tissue 
tropism; B1 viruses generally cause upper respiratory tract infection whilst the B2 viruses cause 
kidney and urinary tract infections (Wadell, 1984). The species B viruses have also been re-
classified according to receptor usage (Tuve et al., 2006). More recently, it has been proposed 
that Ads should be completely re-classified according to whole genome sequence similarity as 
opposed to serological approaches (Seto et al., 2011; Singh et al., 2012). 
1.2.2 Pathology and disease associated with human adenovirus infection  
Ads are known to cause acute respiratory, gastrointestinal and ocular infections in a serotype-
specific manner (Table 1-1). Species A, F and G are most commonly associated with 
gastroenteritis, species B:1, C and E with respiratory disease, B:2 can cause urinary tract disease 
and species D can cause keratoconjunctivitis (reviewed in Zhang and Bergelson, 2005; Berk, 
2007). Some Ads are responsible for a variety of clinical manifestations, such as the species B:2 
virus Ad3 which in addition to respiratory infection can also cause conjunctivitis (O'Donnell et 
al., 1986; Guo et al., 1988). A more severe and highly contagious form of conjunctivitis termed 
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epidemic keratoconjuctivitis is caused by the species D serotypes 8, 19 and 37 and by an Ad 
chimera composed of elements from Ads 8, 22 and 37 (Aoki et al., 2008; Ford et al., 1987). 
Ad4 can cause considerable morbidity as the causative agent of acute respiratory disease which 
has been reported in military recruits (Hilleman et al., 1956; Gray et al., 2000). Recently, a 
novel Ad termed titi monkey adenovirus was identified as capable of infecting both monkeys 
and humans, resulting in respiratory disease (Chen et al., 2011). 
However, in the majority of cases, Ad infections in immunocompetent individuals are mild and 
self-limiting. In contrast, Ad infections in immunocompromised individuals can cause more 
serious infection (Hale et al., 1999). Those at risk include young people due to lack of previous 
exposure, transplant patients on immunosuppressive drugs and AIDS patients. Indeed, certain 
Ad serotypes that are rarely isolated from the immunocompetent population, such as Ad35, are 
more frequently isolated from immunocompromised individuals (Flomenberg et al., 1987; 
Hierholzer, 1992). Although there is currently no definitive treatment for Ad infection, the 
nucleoside phosphonate analogue cidofovir is used in most transplant centres albeit with 
substantial adverse side effects (reviewed in De Clercq, 2003). However, a lipid conjugate of 
cidofovir known as CMX001 was recently shown to exhibit substantial efficacy against Ad 
infections in immunocompromised patients with negligible side effects, indicating a promising 
new treatment for Ad infection (Florescu et al., 2012). 
1.2.3 Adenoviruses as gene therapy and oncolytic vectors 
Gene therapy is the transfer of therapeutic genes into cells with the aim of correcting a defective 
gene. In order to achieve this, the DNA must be transported into the cell and delivered to the 
nucleus for gene expression. Transfer of the therapeutic gene into the target cell requires a 
vector, and these can be broadly classified as viral or non-viral vectors. Non-viral vectors 
include liposomes, polypeptides and nanoparticles (reviewed in Mintzer and Simanek, 2009). 
To date, Ad vectors have been utilised in 428 clinical trials and account for the largest 
proportion (23.2%) of all gene therapy clinical trials worldwide, inclusive of both viral and non-
viral vectors (Wiley.co.uk/genemedicine, as of June 2012). Ads possess many characteristics 
ideal for a virus vector: their genome can be easily manipulated, they are able to infect a wide 
range of dividing and non-dividing cells and they can be easily and inexpensively grown to high 
titres (reviewed in Shen and Post, 2007). Ads are believed to hold promise for oncolytic 
(cancer-killing) regimens, vaccination regimens and gene-addition for inherited diseases.  
The first-generation Ad vectors had the E1 region of the genome deleted, which both prevented 
virus replication and provided coding capacity for insertion of a therapeutic transgene (Yang et 
al., 1995). However these vectors were rapidly cleared by the host immune system (Yang et al., 
1995). The E1 deletions were combined with additional deletions in E2, E3 and E4 gene regions 
  
 Table 1-1. The adenovirus serotypes and the associated clinical manifestation following infection by each species.  
Adapted from Jones et al., 2007; Ishiko et al., 2008; Walsh et al., 2009; Hall et al., 2010; Walsh et al., 2010; Kaneko et al., 2011a; Kaneko et al., 2011b; Kaneko et al., 
2011c; Robinson et al., 2011 
Species Serotype(s) Associated disease GC content of genome 
(%) 
Oncogenic potential  
(in rodents) 
A 12, 18, 31 Gastroenteritis 48-49 High 
B1 3, 7, 16, 21, 50 Respiratory disease 50-52 Moderate 
B2 11, 14, 34, 35, 55 Urinary tract disease 50-52 Low 
C 1, 2, 5, 6 Respiratory disease 57-59 Low 
D 8, 9, 10, 13, 15, 17, 19, 20, 22-30, 32, 33, 36-39, 42-49, 51, 53, 
54, 56 
Keratoconjunctivitis 57-61 Low 
E 4 Respiratory disease, conjunctivitis 57-59 Low 
F 40, 41 Gastroenteritis Unknown Unknown 
G 52 Gastroenteritis Unknown Unknown 
6
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to reduce toxicity and further increase coding capacity (Engelhardt et al., 1994; Armentano et 
al., 1995). Unfortunately, there was still stimulation of the inflammatory response following 
administration of these vectors and rapid antibody neutralisation was elicited upon subsequent 
inoculation. This lead to the development of helper-dependent (“gutless”) vectors, which have 
all the coding genes deleted (Schiedner et al., 1998). Despite improved toxicity and 
immunogenic profiles due to lack of immunogenic peptide expression, immune responses were 
still generated to the virus capsid (reviewed in Brunetti-Pierri and Ng, 2008).  
Indeed, most Ad vectors to date have exhibited a sub-optimal capacity to produce beneficial 
therapeutic effect (efficacy) and often induce potent host immune responses. The high 
prevalence of species C Ads within the general population means that most humans have been 
exposed to these Ads, therefore upon administration there is rapid clearance of these vectors by 
pre-existing antibodies (reviewed in Bessis et al., 2004). Interestingly, although the E1 region is 
believed to be essential for Ad replication, E1-deleted Ad vectors still express residual late 
proteins, leading to inflammatory responses and reduced vector efficacy (Yang et al., 1994b; 
Yang et al., 1994c; Yang et al., 1995). The presence of Ad DNA or transgene DNA in host cells 
also stimulates innate inflammatory responses (Everett et al., 2003; Zhu et al., 2007). In 
addition, intravenous (IV)-administered vectors become sequestered by the liver, resulting in 
low levels of vector transduction at the target site and local toxicity in the liver (Engelhardt et 
al., 1994; Lieber et al., 1997; Everett et al., 2003). High doses of Ad vectors can lead to 
exaggerated responses, which have been shown to be lethal in mouse studies (reviewed in 
Varnavski et al., 2005) and also one case in a human clinical trial (Raper et al., 2003).  
Whilst immune stimulation has served as a major drawback in Ad gene therapy regimens, it can 
serve as an advantageous property for oncolytic (cancer killing) and vaccine vectors by 
enhancing immune responses to tumour cells or vaccine antigens, respectively. Oncolytic Ads 
are intended to specifically target, invade and replicate within tumour cells resulting in tumour 
cell lysis, releasing progeny virions able to infect and kill surrounding tumour cells. The most 
well-studied oncolytic Ad has been ONYX-015, which contains a mutation in the E1B-55K 
region of the Ad genome (Bischoff et al., 1996). This mutation abolished the ability of the E1B-
55K protein to bind and inhibit p53, thus restricting virus replication to cells in which the p53 
pathway is already inhibited, which occurs in a high proportion of human cancers. Although the 
efficacy of ONYX-015 was found to be inadequate in Phase I and II trials when used as a single 
agent (Mulvihlll et al., 2001; Nemunaitis et al., 2001), utilising ONYX-15 in combination with 
chemotherapy or radiotherapy resulted in complete tumour regression (Khuri et al., 2000; 
Geoerger et al., 2003). A similar E1B-deleted virus, termed H101, has been certified for use 
against head and neck cancer in China (Garber, 2006). An immunostimulatory Ad expressing 
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CD40L was recently found to substantially boost anti-tumour immune responses in clinical 
trials for bladder cancer (Malmstrom et al., 2010; Pesonen et al., 2012). 
Both replication-deficient and replication-competent Ads have also shown promise in vaccine 
regimens. These Ads are engineered to express antigens from microbial sources in order to 
trigger immune responses to the antigen, resulting in adaptive immunity against the pathogen. 
Expression of polyvalent HIV-1 antigens by a recombinant Ad26 vector resulted in induction of 
potent anti-HIV-1 immune responses in rhesus macaque monkeys (Barouch et al., 2010). 
Additionally, combining the Ad vaccine with protein adjuvants and other viral or DNA vaccines 
appeared to enhance immune responses to malaria and HIV-1 (Koup et al., 2010). This indicates 
that as with oncolytic regimens, combination therapies using Ad vectors may hold promise for 
boosting immune responses in vaccine regimens. 
1.2.4 Adenovirus structure 
The adenovirus capsid comprises a non-enveloped icosahedron of approximately 90 nm in 
diameter. The proteins comprising the capsid act to promote entry into the host cell, facilitate 
disassembly of the capsid and deliver the genome to the nucleus for replication. The virus 
particle has been visualised by cryo-electron microscopy at 10 Å resolution (Silvestry et al., 
2009) and the crystal structure has been solved at 3.5 Å resolution (Reddy et al., 2010). The Ad 
particle comprises 13 structural proteins. The capsid shell is formed of 252 capsomeres of which 
240 are trimeric hexon protein (polypeptide II) and the remaining 12 are penton protein 
(polypeptide III) (reviewed in Hall et al., 2010). Pentons are located at each of the 12 vertices of 
the capsid, and comprise a pentamer of penton base protein with a trimeric fibre protein 
(polypeptide IV) projection. The other minor capsid components are proteins IIIa, VI, VIII and 
IX (reviewed in Vellinga et al., 2005) (Figure 1-1). Black and Center, 1979; Chatterjee et al., 1985; Anderson et al., 1989 
Within the capsid core, the remaining structural polypeptides V, VII, Mu (polypeptide X) and 
terminal protein (TP) are associated with the double-stranded DNA genome. Located at either 
end of the DNA genome are inverted terminal repeats (ITRs) which range in size from 36-200 
bp. Each 5′ terminus of the DNA is covalently linked to a TP and is non-covalently associated 
with the basic Ad proteins pV, pVII and Mu to form the viral chromatin (Black and Center 
1979; Chatterjee et al., 1985; Anderson et al., 1989) (Figure 1-1).  
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Figure 1-1. The structure of the adenovirus capsid. 
A schematic diagram of the structural proteins associated with the adenovirus capsid. The major capsid 
components are hexon, penton base and fibre. The minor capsid components are IIIa, VI, VIII and IX. 
Proteins V, VII, Mu, TP, IVa2 and protease are associated with the DNA genome within the capsid core. 
Figure is taken from White and Blair, 2012, with permission.White and Blair, (2012 
Capsid proteins
Hexon (II)
Penton base (III)
Fibre (IV)
IIIa
VI
VIII
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1.2.1.1 Major capsid components 
1.2.1.1.1 Hexon (polypeptide II) 
Hexon is the major structural protein of the Ad capsid and forms the facets of the icosahedron 
(Van Oostrum and Burnett, 1985). As determined by crystallography studies of the Ad2 hexon, 
each hexon capsomere is composed of three identical subunits producing a pseudo-hexagonal 
structure (Roberts et al., 1986; Athappilly et al., 1994). Hexon capsomeres are found associated 
with proteins IX and VI (Furcinitti et al., 1989; Matthews and Russell, 1994; Fabry et al., 
2009). Hexons associated with pentons are termed ‘peripentonal hexons’ or H1, whereas the 
remainder on the faces of the icosahedron are termed ‘groups of nine’ (GON) (Van Oostrum et 
al., 1987). Depending on their orientation, the GON hexons are further subdivided into H2 and 
H3. Hexons that are not GONs or peripentonal hexons are classed as H4 (Van Oostrum et al., 
1987). The protein-protein interaction networks between the GONs and the other capsid 
proteins was recently characterised by cryo-electron microscopy at 3.6 Å resolution (Liu et al., 
2010). 
1.2.1.1.2 Penton base (polypeptide III) 
Penton base are found at each of the 12 vertices of the capsid and play an important role in the 
stability of the Ad capsid (Ensinger and Ginsberg, 1972). Penton monomers form pentamers 
which are known as penton base. Penton base is found associated with a trimer of fibre protein 
(polypeptide IV), and this complex is known as penton (Pettersson and Hoglund, 1969; Wadell 
and Norrby, 1969). Penton is important in facilitating uptake of the virus into host cells, with 
fibre promoting initial attachment and interactions of the penton base with cellular integrins 
promoting internalisation (Wickham et al., 1993; Wickham et al., 1994). During infection with 
certain Ad serotypes, it has been shown that some penton and penton base structures are also 
able to form large particles known as dodecahedra, which comprise 12 copies of penton or 
penton base (Fender et al., 1997; Fuschiotti et al., 2006). Although the exact function of 
dodecahedra during Ad infection is currently undefined, they have been shown to interact with 
cellular junctions and induce cell remodelling, therefore may play a role in dissemination of the 
virus (Fender et al., 2012). 
1.2.1.1.3 Fibre (polypeptide IV) 
Fibre is found projecting from each of the 12 vertices of the capsid and plays an important role 
in the initial attachment of the particle to host cells (Philipson et al., 1968). Whilst the majority 
of Ad serotypes express only one form of fibre protein, the species F serotypes express both 
long and short fibres (Kidd et al., 1993; Seiradake and Cusack, 2005). Fibre consists of an N-
terminal tail, a variable length shaft and a C-terminal knob domain, and it is the knob domain 
that facilitates interaction with host cell-surface molecules (Louis et al., 1994; Xia et al., 1994). 
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Although there are five potential fibre binding sites on the penton base, only three fibre 
molecules are able to bind due to steric hindrance, resulting in a trimeric fibre molecule (Van 
Oostrum and Burnett, 1985; Hong and Engler, 1996). 
1.2.1.2 Minor capsid components 
1.2.1.2.1 Polypeptide IIIa 
Protein IIIa is believed to play a role in capsid assembly and stabilisation of the capsid vertices 
(Bourdin et al., 1980; Lemay et al., 1980; Chroboczek et al., 1986; Silvestry et al., 2009; Ma 
and Hearing, 2011). There are 60 copies of IIIa per capsid, with five copies of IIIa arranged 
symmetrically on the underside of each penton base (Saban et al., 2006). It appears that IIIa 
may be located in-between penton base and peripentonal hexons (San Martin et al., 2008). In 
addition to its structural functions, IIIa is also believed to be involved in viral genome 
packaging (Ma and Hearing, 2011). IIIa is processed from a precursor form (pre-IIIa) to mature 
IIIa by the Ad protease (Boudin et al., 1980). 
1.2.1.2.2 Polypeptide VI 
Polypeptide VI (pVI) associates with hexon and there are approximately 1.5 pVI per hexon 
trimer (Saban et al., 2006). The protein also appears to associate with IIIa, penton base and viral 
DNA (Stewart et al., 1993; Saban et al., 2006). The precursor form of pVI, pre-VI, is cleaved 
by the Ad protease, adenain, to yield the mature pVI (Anderson et al., 1973; Weber, 1976; Sung 
et al., 1983b; Tremblay et al., 1983). The cleavage peptide of pre-VI is thought to function as a 
co-factor for adenain (Mangel et al., 1993). Roles attributed to pVI include disruption of the 
host cell endosome following capsid internalisation, nuclear import of hexon, capsid assembly 
and transcriptional activation of early viral genes (Matthews and Russell, 1995; Wodrich et 
al.,2003; Wiethoff et al.,2005; Wodrich et al., 2010; Schreiner et al., 2012). 
1.2.1.2.3 Polypeptide VIII 
There are 120 copies of pVIII per capsid, with groups of three located along the icosahedral 
threefold symmetry axis of the capsid, acting in cohesion with pIX for stabilisation of the 
GONs. In addition, single copies of pVIII are also found linking each peripentonal hexon to the 
GONs in co-operation with IIIa (Saban et al., 2006). Similar to pVI, pVIII is synthesised in a 
precursor form (pre-VIII) which is subsequently cleaved to the mature protein by the activity of 
adenain (Weber, 1976; Tremblay et al., 1983). Although the function of pVIII is currently 
undefined, mutations in pVIII appear to result in heat instability of the capsid, suggesting a role 
in capsid stability (Liu et al., 1985). 
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1.2.1.2.4 Polypeptide IX 
This protein is only found in Ads of the Mastadenovirus clade. There are 240 copies of pIX per 
capsid arranged as trimers on the outer face of each facet (Saban et al., 2006; Fabry et al., 2009; 
Boulanger et al., 1979). Ad mutants lacking pIX display increased heat sensitivity, indicating 
that pIX contributes to stability of the capsid (Colby and Shenk, 1981; Ghoshchoudhury et al., 
1987). Interestingly, IX-deleted Ad vectors display enhanced tropism for cell lines which do not 
express the Cocksackie B and Adenovirus Receptor (CAR), the primary attachment receptor for 
Ad species A, C, D, E and F (de Vrij et al., 2011). This suggests that pIX may play a role in the 
cell tropism of Ads. Polypeptide IX is expressed during the delayed early phase before any of 
the other structural proteins and may function in activation of late gene transcription (Lutz et al., 
1997; Rosa-Calatrava et al., 2001). Polypeptide IX has also been shown to play a role in nuclear 
reorganisation by sequestering the PML protein, the major structural component of PML-NBs, 
resulting in increased virus replication (Rosa-Calatrava et al., 2001; Rosa-Calatrava et al., 
2003). Matthews and Russell, 1995; Wodrich et al., 2003; Wiethoff et al., 2005; Maier and Wiethoff, 2010; Wodrich et al., 2010; Schreiner et al., 2012). 
1.2.1.3 Core proteins 
1.2.1.3.1 Polypeptide V 
Within the core of the Ad particle, pV is found associated with pVI, pVII and the viral DNA 
(Chatterjee et al., 1985, 1986) and functions to link the core of the virion to the outer capsid 
(Matthews and Russell, 1998b). Polypeptide V contains numerous nuclear localisation signals 
and appears to associate with the cellular protein p32 to promote the transport of Ad DNA into 
the host cell nucleus (Matthews and Russell, 1998a). It is also responsible for redistribution of 
the nucleolar proteins C23 (nucleolin) and B23 (nucleophosmin) during infection. The reason 
for the redistribution of these two proteins is currently unclear; redistribution of C23 was 
suggested to antagonise the transcriptional repressor function of C23 (Matthews, 2001). 
Although the redistribution of B23 was suggested to facilitate the assembly of viral chromatin 
(Matthews, 2001; Samad et al., 2007; Samad et al., 2012), some data indicates that B23 
redistribution promotes virion assembly (Ugai et al., 2012). 
1.2.1.3.2 Polypeptide VII 
Polypeptide VII is the most abundant core protein with around 800 copies found per capsid. 
Although the arrangement of the Ad genome with the core proteins is not well defined, it is 
thought that pVII is most tightly associated with the Ad genome (Sung et al., 1983a; Chatterjee 
et al., 1986). Polypeptide VII is synthesised as a precursor (pre-VII) and is cleaved by adenain 
into mature form (Anderson et al., 1973; Weber, 1976; Tremblay et al., 1983). Polypeptide VII 
contains multiple nuclear localisation signals and interacts with DNA to facilitate nuclear 
import of the Ad genome (Lee et al., 2003; Wodrich et al., 2006). The nuclear import of Ad 
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DNA appears to involve an interaction of pVII with transportin, a subunit of nucleoporins 
(Hindley et al., 2007). The binding of pVII to incoming Ad DNA may facilitate subversion of 
the host Mre11, Rad50 and Nbs1 (MRN)-dependent DNA damage response (Karen and 
Hearing, 2011). Polypeptide VII is thought to interact with Ad E1A following DNA replication, 
facilitating the release of pVII from DNA to allow transcription of late-phase genes (Chen et al., 
2007). Polypeptide VII also plays a role in condensing the viral DNA prior to packaging into 
newly-assembled capsids (Vayda et al., 1983; Vayda and Flint, 1987).  
1.2.1.3.3 Mu (polypeptide X) 
Mu is a very small (19 amino acid), highly basic polypeptide and is present in around 100 
copies per virion. Pre-Mu is cleaved by adenain to produce the mature polypeptide (Weber, 
1976; Tremblay et al., 1983). Mu contains a nucleolar localisation signal and has been shown to 
play a role in the condensation of Ad DNA (Anderson et al,. 1989). Pre-Mu appears to regulate 
E2 protein expression; pre-Mu was shown to inhibit the expression of pre-TP without altering 
the expression of DNA-Binding Protein (DBP) (Lee et al., 2004). (Anderson et al., 1989; Lee et al., 2004). 
1.2.1.3.4 Terminal protein (TP) 
TP is found attached to the 5′ ends of Ad DNA (Rekosh et al., 1977). Pre-TP was found to 
associate in a functional complex with Ad DNA polymerase (Ad-pol) and the cellular protein 
nuclear factor 1 (NF-I) to prime Ad DNA replication (Enomoto et al., 1981; Chen et al., 1990; 
Gounari et al., 1990; Mul et al., 1990). Pre-TP may also be anchored to the nuclear matrix via 
an interaction with the enzyme carbamyl phosphate I synthetase, aspartate transcarbamylase and 
dihydroototase (CAD) (Angeletti and Engler, 1998). During the late phase of infection, pre-TP 
is cleaved by adenain to produce mature TP (Weber, 1976; Tremblay et al., 1983). 
1.2.1.3.5 IVa2 
IVa2 is an ATP-binding protein and appears to bind specific viral DNA sequences near the left 
terminal end of the Ad genome, facilitating packaging of the genome into capsid precursors 
(Zhang and Imperiale, 2000; Zhang et al., 2001; Ostapchuk and Hearing, 2003; Ostapchuk et 
al., 2005; Ostapchuk and Hearing, 2008). IVa2 is present in six to eight copies per capsid and is 
required for genome packaging. IVa2 binds to specific sequences on Ad DNA known as the ‘A 
repeats’ which are located at the far left of the genome (Ostapchuk et al., 2005; Tyler et al., 
2007). To facilitate genome packaging, IVa2 forms a complex on the packaging sequence with 
Ad L4-22K (Ewing et al., 2007; Tyler et al., 2007; Ostapchuk et al., 2011; Yang and Maluf, 
2012). IVa2 is also thought to function as a transcriptional enhancer at the late region 4 
promoter (L4P) (Morris et al., 2010) and the major late promoter (MLP) (Tribouley et al., 1994; 
Lutz and Kedinger, 1996). IVa2 may also interact with pVII (Zhang and Arcos, 2005). 
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1.2.1.3.6 Protease (adenain) 
The Ad protease, adenain, is synthesised in an inactive form and becomes partially activated 
following interaction with Ad DNA (Mangel et al., 2003; Gupta et al., 2004). Partially active 
adenain is able to cleave pre-VI, producing mature VI and an 11 amino acid cleavage product 
(Wodrich et al., 2003). The 11 amino acid cleavage peptide binds to adenain resulting in full 
activation of the protease (McGrath et al., 2003). Activated adenain is then able to cleave the 
precursor forms of late proteins IIIa, VI, VII, VIII, TP and Mu to yield an infectious virus 
particle (Tremblay et al., 1983; Anderson, 1990; Webster et al., 1993). Adenain may also 
facilitate cell lysis and the subsequent release of virus progeny by cleaving the cellular protein 
cytokeratin (Brown et al., 2002; Brown and Mangel, 2004). 
1.2.5  Life cycle of human adenoviruses 
1.2.5.1 Cell entry 
The classical pathway of Ad infection has been investigated in species C Ads (i.e. Ad2 and 5) in 
great detail. However, there are differences in recognition of cell surface molecules by species B 
Ads which leads to alternate cellular trafficking compared to species C Ads. The classical 
infection pathway is utilised by Ad species A, C, D, E, and F. Initial attachment to host cells in 
vitro is mediated by fibre binding to the Coxsackie and Adenovirus Receptor (CAR) (Bergelson 
et al., 1997; Roelvink et al., 1998) (Figure 1-2). CAR is a cellular attachment molecule and 
generally located in close proximity to tight junctions in polarised epithelial cells (reviewed in 
Philipson and Pettersson, 2004). As CAR expression is generally restricted to tight junctions 
and the basolateral membrane in vivo, there has been some debate as to whether CAR functions 
as the cellular attachment protein for Ads in vivo when it is located in seemingly inaccessible 
sites at the cell surface. Indeed, an alternative hypothesis for the interaction of the fibre with 
CAR is to facilitate escape of the virus following replication. Excess fibre protein produced 
during infection may facilitate disruption of CAR tight junction interactions, allowing release of 
the virus into the airway lumen (Walters et al., 2002). However, a splice variant of CAR known 
as CAR Ex
8 
has been detected on the apical surface of polarised airway epithelial cells 
(Excoffon et al., 2010), therefore it is plausible that this variant of CAR may allow initial 
adhesion of the virus in vivo. In addition, it was recently found that Ad transduction of polarised 
epithelial cells is enhanced by a cytokine response from macrophages; production of chemokine 
8 enhanced the apical localisation of CAR and avβ3 integrin, facilitating Ad transduction of 
target cells (Lutschg et al., 2011). 
In contrast to other Ad species, the species B Ads do not utilise CAR as the primary cell surface 
attachment receptor (Roelvink et al., 1998). The species B Ads were classified into three groups 
by Tuve et al (2006) according to conserved restriction endonuclease cleavage sites, which also  
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Figure 1-2. The cellular entry pathways of species C and species B adenoviruses. 
The entry pathway of species C Ads appears to include the following stages. A1. Attachment of the virus 
fibre protein to the primary receptor, CAR, on the host cell surface. A2. Subsequent interaction of cellular 
αvβ3/5 integrins with the RGD motif of penton base. This results in clathrin-mediated endocytosis of the 
virus into early endosomes. A3. Within the acidic environment of the endosome, the virus capsid begins 
to dismantle leading to release of vertex proteins. A4. Protein VI promotes lysis of the endosomal 
membrane, allowing escape of the partially dissembled virus capsid into the cytoplasm. A5. The Ad 
capsid associates with microtubules in the cytoplasm and is trafficked via dynein to the microtubule 
organising centres (MTOCs) located adjacent to the nucleus. A6. At the nuclear pore, the viral genome is 
imported into the nucleus.  
In contrast to species C Ads, the entry pathway of species B Ads appears to involve the following stages. 
B1. The virus fibre protein attaches to the primary receptor, CD46 or DSG-2. B2. Subsequent interaction 
of the RGD motif in the penton base protein with cellular αvβ3/5 integrins. This interaction stimulates 
membrane ruffling (B2) and macropinocytic uptake of the virus into the cell (B3). The subsequent escape 
of the virus from the endosome (B4) and trafficking of the capsid to the nucleus (B5) is currently 
undefined. Taken from White and Blair, 2012, with permission. 
White and Blair, (2012 
Nucleus
Species C Ad Species B Ad
αv-
integrin
CAR
Early endosome
Endosomal lysis
Microtubules
Dynein
Nuclear pore 
complex
CD46 or 
DSG-2
A1
A2
A3 A4
A5
A6
B5
B1
B2
B3
B4
αv-
integrin
 16 
 
correlates with receptor usage; the Species B Group I Ads (Ad16, -21, -35, and -50) nearly 
exclusively use CD46, Group II (Ad3, -7p, and -14) appear to utilise desmoglein 2 (DSG-2) 
whilst Group III (Ad11p) can use both CD46 and DSG-2 (Segerman et al., 2003; Marttila et al., 
2005; Tuve et al., 2006; Wang et al., 2010).  
Following adhesion of Ads to the host cell surface, there is a secondary low-affinity interaction 
between the arginine-glycine-aspartate (RGD) motif (conserved among all human Ads except 
species F) within one of the exterior loops of the Ad penton base protein and αv integrins 
(primarily αvβ3 and αvβ5) on the host cell surface (Wickham et al., 1993; Mathias et al., 1994; 
Wickham et al., 1994; Nemerow and Stewart, 1999). As each penton base is a pentamer, the 
penton base is able to bind five integrin molecules, which promotes integrin clustering and 
triggers various cell signalling pathways. In species C Ads, the initial interaction of penton base 
with the integrin molecule is believed to induce a conformational change in the integrin which 
stimulates phosphoinositide 3-kinase (PI3K). The stimulation of PI3K leads to activation of Rac 
GTPase and cell division control protein 42 (CDC42), resulting in the polymerisation of actin 
monomers and cytoskeletal rearrangement within the cell (Li et al., 1998a; Li et al., 1998b). 
This facilitates the internalisation of species C Ads by endocytosis into clathrin-coated vesicles 
in a dynamin-dependent manner (Wickham et al., 1994; Wang et al., 1998) (Figure 1-2).  
In contrast to species C Ads, the species B2 Ad3 appears to utilise an alternate entry mechanism 
(Figure 1-2). Entry of Ad3 into various cell types was shown to be minimally affected by 
dynamin mutation, indicating Ad3 does not utilise dynamin-dependent endocytosis as the 
primary cell entry mechanism (Wang et al., 1998; Meier et al., 2002). Instead, Ad3 uptake 
appears to be mainly by macropinocytosis, as Ad3 interaction with CD46 and cell surface 
integrins has been observed to induce membrane ruffling and fluid phase uptake (Amstutz et al., 
2008) (Figure 1-2). The species B2 Ad35 has also been reported to utilise macropinocytosis for 
entry into epithelial cells, suggesting this may be a common entry pathway in species B Ads 
(Kaelin et al., 2010). Cellular factors required for macropinocytic uptake of Ad3 and Ad35 
include the sodium-proton (Na
+
/H
+
) exchanger, actin, p21-activated kinase 1 (PAK1), Rac, 
protein kinase C (PKC) and C-terminal binding protein 1 of E1A (CtBP1) (Amstutz et al., 2008; 
Kaelin et al., 2010).  
Additional factors appear to influence the cell transduction of Ads in vivo. Despite the evidence 
that interactions with CAR facilitate attachment of Ad5 in vitro, the biodistribution of Ads in 
mouse models does not correlate with in vivo CAR expression. Although liver hepatocytes 
generally have low CAR expression, intravenously (IV)-administered Ad5 vectors exhibit high 
liver transduction (Lieber et al., 1997; Fechner et al., 1999; Shayakhmetov et al., 2004). 
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Furthermore, mutation of fibre residues necessary for CAR binding was shown to have no effect 
on the biodistribution of Ads following systemic delivery, suggesting the liver transduction of 
Ads is independent of CAR (Alemany and Curiel, 2001; Martin et al., 2003). Later studies 
revealed the role of blood factors such as protein C, complement family member 4b binding 
protein (C4BP), Factor VII (FVII), Factor IX (FIX) and Factor X (FX) in Ad5 biodistribution in 
vivo, with FX demonstrating the greatest contribution to liver transduction (Shayakhmetov et 
al., 2004; Parker et al., 2006). These blood factors were shown to interact with Ad5 and 
facilitate binding of the Ad5 capsid protein hexon to heparan sulphate proteoglycans (HSPGs) 
and low density lipoprotein receptor (LDLR)-related proteins on the cell surface of liver 
hepatocytes (Kalyuzhniy et al., 2008; Waddington et al., 2008). A secondary interaction with αv 
integrins is then required for internalisation (Bradshaw et al., 2010). Recent in vivo studies have 
confirmed the role of FX in Ad5 liver transduction in a non-human primate model (Alba et al., 
2012). FX was also shown to facilitate hepatocyte transduction with Ad5 vectors with fibre 
proteins of species D Ads, indicating the role of FX in hepatocyte transduction may extend to 
serotypes other than Ad5 (Parker et al., 2007; Waddington et al., 2007). However, studies using 
species B fibre-pseudotyped or chimeric-fibre Ad5 vectors revealed greatly reduced liver 
tropism compared to wildtype Ad5 (Sakurai et al., 2008; Ganesh et al., 2009; Greig et al., 2009; 
Rogee et al., 2010). As these vectors all contain Ad5 hexon, this indicates that additional factors 
than hexon, FX and HSPGs contribute to liver tropism. A recent study into the role of other 
capsid proteins in Ad5 liver tropism revealed that whilst the binding of both wildtype Ad5 and 
Ad5 containing pseudotyped Ad35 fibre (Ad5F35) was enhanced by FX, the transduction of 
Ad5F35 was reduced compared to Ad5 (Corjon et al., 2011). It was found that Ad5F35 vectors 
accumulated in the late endosome resulting in fewer virus particles reaching the cell nucleus. 
Entry into this trafficking pathway appeared to be dictated by the fibre protein (Corjon et al., 
2011). In contrast to species B and C Ads, certain species A Ads were shown to have enhanced 
affinity for respiratory or intestinal epithelial cells and this appeared to be mediated by FIX 
binding to cell surface heparan sulphate-containing glycosaminoglycans (Lenman et al., 2011).  
Taken together, it appears that CAR may only play a small role in the cell surface attachment of 
Ads administered intravenously; it seems that blood factors such as FX and FIX may have a 
greater influence on biodistribution. Following cell entry, it appears that fibre protein may then 
dictate the intracellular fate of the virus. It should be noted that although Ad dissemination in 
the bloodstream is unlikely during infection, Ad vectors are frequently administered 
intravenously in gene therapy regimens.  
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1.2.5.2 Transit of adenovirus to the nucleus 
With regards to species C Ads, recent data indicates that capsid disassembly may commence at 
the cellular attachment stage (Burckhardt et al., 2011). The lumen of the early endosome 
following internalisation rapidly becomes more acidic due to the activity of the H+ ATPase, 
which may induce conformational changes in certain viral capsid components, facilitating 
capsid disassembly (Greber et al., 1993; Wiethoff et al., 2005). It is thought the fibre proteins 
dissociate first, followed by penton base, pIIIa, pV, pVI and finally pIX. It appears that species 
C Ads do not traffic through the late endosome or lysosome (Gastaldelli et al., 2008). Protein VI 
plays an important role in lysis of the endosome by disrupting the endosomal membrane, 
allowing the partially uncoated virus particle to be released into the cytoplasm (Wiethoff et al., 
2005; Maier et al., 2010; Moyer et al., 2011) (Figure 1-2).  
The pathway of Ad3 from macropinosomes into the cytoplasm is less well defined, however it 
appears to be a much slower process than the escape of species C Ad2 from endosomes (30-40 
minutes [Ad3] vs. 15 minutes [Ad2]) (Amstutz et al., 2008). Furthermore, Ad5 viruses carrying 
species B fibre proteins appear to remain within endosomes for longer than wildtype Ad5 
(Miyazawa et al., 2001; Shayakhmetov et al., 2003), indicating a lower pH may be required for 
species B capsid disassembly compared to species C.  
Once species C Ads escape from the endosome, the partially uncoated virus particle associates 
with microtubules in the cytoplasm (Dales and Chardonnet, 1973; Mabit et al., 2002; Kelkar et 
al., 2006) (Figure 1-2). Transport of the species C Ads along microtubules is dependent on 
integrin signalling upon infection; the activation of p38 mitogen-activated protein kinase 
(MAPK) (Suomalainen et al., 1999; Suomalainen et al., 2001) facilitates trafficking of the virus 
particle by hexon-dynein interaction to the microtubule organising centres (MTOCs) located 
adjacent to the nucleus (Leopold et al., 2000; Bremner et al., 2009). The dynein co-factor 
dynactin appears to enhance the speed and efficiency of Ad particle transport to the nucleus 
(Engelke et al., 2011). Ad pVI appears to play an integral role in movement of the virus particle 
to the nucleus; a PPXY motif exposed on pVI during capsid disassembly recruits Nedd4 E3 
ubiquitin ligases, leading to ubiquitination of pVI which facilitates trafficking of the particle 
along microtubules (Wodrich et al., 2010). Once the virus particle arrives at the MTOC, the 
nuclear export factor chromosome region maintenance 1 (CRM1) or an associated factor is 
thought to facilitate detachment of the virus from microtubules and promote association of the 
virus with the nuclear pore complex (NPC) (Strunze et al., 2005). 
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1.2.5.3 Import of species C adenoviruses into the nucleus 
As the Ad capsid is too large to diffuse through the nuclear pore, the particle undergoes further 
disassembly resulting in release of the Ad genome into the nucleus (Greber et al., 1997). 
Docking of the capsid with the NPC is mediated by interactions between hexon and a 
cytoplasmic filament component of the NPC known as Nup214 (Trotman et al., 2001) as well as 
kinesin-1 light chain (Strunze et al., 2011). Soluble histone H1 appears to interact with a 
conserved hexon sequence in species C Ads, which recruits binding of the H1 importin 
7/importin β import factor. However, this sequence is not conserved in species B Ads, 
indicating they may undergo a different import pathway (Trotman et al., 2001). The chaperone 
heat-shock cognate 70 stress protein (Hsc70) is also required for nuclear import of Ad DNA 
(Saphire et al., 2000). A nucleoporin associated with Nup214 known as Nup358 interacts with 
the kinesin-1 heavy chain, resulting in an indirect association between the capsid and the kinesin 
motor (Strunze et al., 2011). Action of kinesin-1 then disrupts the Nup214-docked capsid 
resulting in release of capsid proteins and associated nucleoporins into the cytoplasm. The 
action of kinesin-1 simultaneously increases the nuclear envelope permeability (Strunze et al., 
2011) allowing the interaction of pVII with multiple nuclear import pathways, leading to import 
of the DNA-protein VII complex into the nucleus (Trotman et al., 2001; Wodrich et al., 2006; 
Hindley et al., 2007). Once the complexes are inside the nucleus, pVII binds the transcription 
factors template activating factor (TAF)-1β and TAF-II (Kawase et al., 1996; Haruki et al., 
2006). This leads to remodelling of chromatin on the virus genome, resulting in transcription of 
Ad genes. 
1.2.6 The genome of species C adenoviruses 
The genome organisation of species C Ads is highly conserved and encodes the five early 
transcription units E1A, E1B, E2A, E2B, E3 and E4, intermediate genes IX and IVa2 and late 
genes L1-5 (Figure 1-3) (Galibert et al., 1979; Herisse et al., 1980; Akusjarvi et al., 1981; 
Herisse et al., 1981; Gingeras et al., 1982; Kruijer et al., 1982; Sung et al., 1983a; Akusjarvi et 
al., 1984; Alestrom et al., 1984; Roberts et al., 1984). The late transcription units are expressed 
from the MLP whilst the intermediate genes L4-33K and L4-22K are initially expressed from a 
novel promoter located in the L4 region, the L4P (Morris et al., 2010). Additional minor 
transcriptional units include the virus-associated (VA) RNAs I and II (Mathews, 1975). At 
either end of the genome are the ITRs, which are important for genome replication. The Ad 
genome is traditionally divided into 100 map units (mu) and the Ad E1A gene is conventionally 
placed at the far left of the genome. 
The expression of the Ad genes during infection is regulated on a temporal basis consisting of 
four stages; immediate early, delayed early, intermediate and late, depending upon the time 
  
 
 
Figure 1-3. The genome of species C adenovirus. 
The genome is represented as map units (mu) from the 5′ end of the rightward strand. The rightward strand encodes the E1A, E1B, IX, L1 – L5, VA RNA and E3 
transcription units. The leftward strand encodes the E2A, E2B, E4 and IVa2 transcriptional units. Early expressed units are represented by white arrows, intermediate units by 
grey arrows and late expressed units are represented by the black arrows. The expression of the intermediate genes L4-33K and L4-22K is under the control of the L4 
promoter (L4P). The expression of the L1-L5 units is under the control of the major late promoter (MLP). Pol – Polymerase. DBP – DNA Binding Protein. VA-RNA – Virus-
Associated RNA. Pr – Protease. ADP – Adenovirus Death Protein. ORF – Open Reading Frame. Taken from White et al (2012), with permission. 
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point at which the gene product can be detected (Akusjarvi, 2008; Morris et al., 2010). The 
immediate early gene E1A is expressed shortly after the viral genome enters the host cell 
nucleus. The expression of other early units E1B, E2A, E3 and E4 is driven by the activity of 
E1A alongside a variety of cellular factors (reviewed in Berk, 2007). The MLP is also active at 
this stage at low level, producing only the L1-52/55K proteins. Proteins encoded in the early 
gene regions act to promote cell cycle progression, genome replication and suppression of host 
cell anti-viral mechanisms. At the onset of DNA replication, the intermediate transcription units 
E2B, IVa2 and IX become activated (Berk, 2007). Gene transcription from the L4P is also 
activated at this time point (Morris and Leppard, 2009; Morris et al., 2010). The intermediate 
genes act to up-regulate expression from the MLP. Following genome replication, transcription 
from the MLP proceeds to the full length of the unit resulting in expression of the late genes. 
Late proteins function mainly to co-ordinate virus capsid assembly and the subsequent release 
of progeny virions from the host cell. 
1.2.6.1 Early gene expression in species C adenoviruses 
1.2.6.1.1 E1A 
E1A is the immediate early unit and is the first gene to be expressed upon entry of the virus to 
the host cell nucleus (Berk and Sharp, 1978; Chow et al., 1979; Nevins et al., 1979). The 
expression of E1A was recently shown to be facilitated by the Ad capsid protein pVI (Schreiner 
et al., 2012). The primary E1A transcript is processed by alternative splicing to yield five 
mRNAs which in Ad5 have sedimentation coefficients of 13S, 12S, 11S, 10S and 9S (Stephens 
and Harlow, 1987; Ulfendahl et al., 1987). Alternative splicing of the E1A transcript is 
regulated in a temporal manner, such that during the early stages of infection the two major E1A 
mRNA species are the 13S and 12S mRNAs (Perricaudet et al., 1979; Hearing and Shenk, 
1983; Boulanger and Blair, 1991). The 9S mRNA product is the most abundant protein at late 
times, whilst the 11S and 10S are minor mRNA species at late stages of infection (Stephens and 
Harlow, 1987; Ulfendahl et al., 1987). The 13S, 12S, 11S, 10S and 9S mRNAs encode the 289 
residue (R), 243R, 217R, 171R and 55R proteins respectively. The E1A proteins drive 
numerous cellular processes during infection including transcriptional activation, transcriptional 
repression, immune subversion, immortalisation of primary rodent cells and transformation in 
cooperation with Ad E1B-55K or activated cellular RAS (reviewed in Berk, 2005).  
The 9S E1A mRNA is expressed during the late stage of infection due to temporal changes in 
splice site usage (Ulfendahl et al., 1987). The encoded 55R E1A protein appears to stimulate 
transcriptional activation and promote viral replication (Miller et al., 2012). The 10S and 11S 
E1As are also expressed at late time points, however the roles of the 217R and 171R E1As 
during infection is less clear. Deletion mutants for the 217R and 171R proteins do not exhibit 
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defective growth and they appear dispensable for transformation activities (Ulfendahl et al., 
1987). Although the 217R E1A was shown to have transcriptional activation properties in 
transient transfection assays, this activity appeared negligible in the context of virus infection 
(Ulfendahl et al., 1987).  
Ad 289R and 243R E1As are expressed immediately following entry of the viral genome into 
the host cell nucleus. Ad 289R E1A is required for stimulating transcription from the four early 
Ad transcription units by associating with cellular transcription factors that bind to the early Ad 
promoters (Berk et al., 1979; Jones and Shenk, 1979; Webster and Ricciardi, 1991; Liu and 
Green, 1994). E1A was found to bind the transcriptional co-activators p300/CBP (Eckner et al., 
1994; Arany et al., 1995; Lundblad et al., 1995; Avantaggiati et al., 1996; Yang et al., 1996; 
Somasundaram and El-Deiry, 1997) as well as a subunit of the Mediator complex known as 
MED23 (Boyer et al., 1999b; Stevens et al., 2002) to activate transcription in vitro. E1A 
alongside IVa2, E4orf3 and viral DNA replication was also found to promote transcription of 
the intermediate genes L4-33K and L4-22K from the L4P (Morris et al., 2010). 
Both the 289 and 243R E1As are responsible for driving progression of the cell cycle from G1 
to S-phase in infected cells (Braithwaite et al., 1983; Spindler et al., 1985; Zerler et al., 1987). 
This function of E1A alongside the activity of E1B or activated RAS is sufficient to induce 
transformation of primary rodent cells (Spindler et al.,1984; Howe et al., 1990; Stein et al., 
1990, Yew and Berk, 1992). E1A binds to the cellular retinoblastoma protein (pRb) and the Rb-
related proteins p107 and p130 (Barbeau et al., 1992; Dyson et al., 1992). The Rb proteins are a 
family of tumour suppressors which directly bind and inhibit the activity of the E2F family of 
transcription factors. The Rb-E2F complex also recruits transcriptional repressors such as 
histone deacetylase complexes (HDACs) and Polycomb (PcG) histone methyltransferases to 
chromatin (Chellappan et al., 1991; Nevins, 1992; Kato et al., 1993; Brehm et al., 1998). Under 
normal circumstances, cell signalling leads to phosphorylation and inactivation of Rb by CDK-
cyclin complexes, relieving E2F repression and allowing progression of the cell cycle. Binding 
of E1A to Rb displaces Rb from E2F thus facilitates transcription from E2 promoters (Nevins et 
al., 1997; Dyson, 1998; Nevins, 2001; Trimarchi et al., 2001; Ghosh and Harter, 2003; Frolov 
and Dyson, 2004). The activation of E2Fs results in enhanced transcription of cell cycle 
regulatory proteins including CDK2 and cyclins E and A, resulting in progression to S-phase of 
the cell cycle. 
E1A has been implicated in innate immune subversion by abrogating interferon (IFN) signalling 
(Ackrill et al., 1991; Gutch and Reich, 1991). This was shown to be facilitated by direct 
interaction of E1A with Stat1 (Look et al., 1998) and IFN regulatory factor 9 (IRF9) (Leonard 
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and Sen, 1997), components of the IFN signalling pathway. E1A of Ad12, but not Ad5, was 
also shown to facilitate immune evasion by down-regulating the expression of MHC class I 
from the surface of rodent cells (Ackrill and Blair, 1988).  
E1A is also involved in attenuation of p53 function by two separate mechanisms; preventing 
acetylation and subsequent activation of p53 and preventing up-regulation of p21 by impairing 
binding of the transcription factor SP1 to the p21 promoter (Savelyeva and Dobbelstein, 2011). 
However, expression of E1A alone induces apoptosis in host cells (Rao et al., 1992; Debbas and 
White, 1993; Yageta et al., 1999). E1A interferes with proteasome function resulting in the 
stabilisation of p53 (Lowe and Ruley, 1993; Zhang et al., 2004). E1A can also trigger apoptosis 
in a p53-independent mechanism by inducing proteasomal degradation of the anti-apoptotic 
BCL-2 family member myeloid leukaemia sequence 1 (MCL-1), which results in the release of 
pro-apoptotic BAK and initiation of apoptosis (Cuconati et al., 2003). However, during 
infection a multitude of Ad proteins act to prevent p53-dependent and independent apoptosis, 
including products of the E1B transcriptional unit.  
1.2.6.1.2 E1B 
The major gene products of the E1B region are the E1B-55K and E1B-19K proteins. Both 
proteins act to suppress p53-dependent and independent cell cycle arrest and apoptosis triggered 
by the activity of E1A (Debbas and White, 1993). E1B-19K is a homologue of the cellular anti-
apoptotic protein BCL-2 (Rao et al., 1992), and acts to prevent initiation of the apoptotic 
cascade by binding BAK and also another pro-apoptotic cellular protein, BAX (Cuconati et al., 
2002; Cuconati and White, 2002). E1B-19K can also prevent p53-mediated apoptosis induced 
by TNF-α and Fas ligand by the same mechanism (Debbas and White, 1993). 
E1B-55K was observed to sequester p53 in peri-nuclear bodies, termed aggresomes (Sarnow et 
al., 1982; Zantema et al., 1985; Liu et al., 2005), a subcellular structure that forms at the MTOC 
in response to misfolded proteins (Kopito, 2000; Garcia-Mata et al., 2002). E1B-55K was also 
found to bind p53 in the nucleus preventing p53-mediated transcriptional activation (Yew and 
Berk, 1992; Querido et al., 1997; Teodoro and Branton, 1997; Martin and Berk, 1998, 1999). In 
addition, E1B-55K can function as an E3 small ubiquitin-like modifier 1 (SUMO1)-p53 ligase; 
the SUMOylation and subsequent sequestration of p53 in nuclear PML-NBs may facilitate 
export of p53 from the nucleus (Pennella et al., 2010). E1B-55K also suppresses p53 activity by 
preventing p53 acetylation by p300/CBP-associated factor (PCAF) (Liu et al., 2000). 
Acetylation of p53 promotes high-affinity DNA binding, promoting transcription at p53 
promoters. The interaction of E1B-55K with HDAC complexes may also suppress p53-
dependent transcription (Punga and Akusjarvi, 2000).  
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E1B-55K is able to form a ubiquitin ligase complex with the Ad E4 open reading frame 6 
(E4orf6) protein (Sarnow et al., 1984) alongside the cellular proteins elongins B and C, cullin 5 
and Rbx-1 (Yew et al., 1994). In this complex, E1B-55K acts as the substrate recognition 
domain whilst E4orf6 binds elongin C (Blanchette et al., 2004). This complex promotes the 
ubiquitination and proteasomal degradation of proteins involved in the DNA damage response, 
including p53 (Querido et al., 2001; Harada et al., 2002), the MRN complex (Stracker et al., 
2002) which is involved in DNA double-strand break repair (D'Amours and Jackson, 2002; 
Stracker et al., 2002; Carson et al., 2003; Petrini and Stracker, 2003; van den Bosch et al., 
2003) and DNA ligase IV (Baker et al., 2007). In cells infected with E4 deletion mutants, the 
MRN complex promotes concatemerisation of viral DNA by non-homologous end joining 
(Weiden and Ginsberg, 1994; Boyer et al., 1999a; Evans and Hearing, 2003). Following 
reorganisation of PML-NBs into nuclear tracks by Ad E4orf3, E4orf6 interacts with MRN 
within the modified PML-NBs (Carvalho et al., 1995; Doucas et al., 1996; Evans and Hearing, 
2005). A complex of E1B-55K, E4orf6, E4orf3 and MRN is then exported to cytoplasmic 
aggresomes, where accelerated degradation of ubiquitinated MRN complex proteins occurs (Liu 
et al., 2005).  
E1B-55K also plays a role in the export of late viral mRNAs from the nucleus into the 
cytoplasm whilst simultaneously inhibiting the export of cellular mRNAs (Beltz and Flint, 
1979). It is also believed that E1B-55K may stimulate translation of late viral mRNAs (Harada 
and Berk, 1999). Although the exact mechanism by which E1B-55K enhances late viral mRNA 
export and/or protein synthesis is currently unknown, it has been proposed that the E1B-
55K/E4orf6 complex may interact with a cellular factor involved in both mRNA export and 
mRNA translation (Berk, 2007). Ubiquitin ligase activity of the E1B-55K/E4orf6 complex 
appears to be required for mRNA export, indicating that ubiquitination of cellular target 
proteins may be required for Ad late mRNA export (Woo and Berk, 2007; Blanchette et al., 
2008). In addition, the accumulation of late mRNAs in the cytoplasm appears to require the 
Nxf1/TAP exporter (Yatherajam et al., 2011) and is dependent on the nuclear export signal of 
E4orf6 (Weigel and Dobbelstein, 2000). 
1.2.6.1.3 E2 
Proteins encoded by the E2 region of Ads are indispensible for viral replication (De Jong et al., 
2003b) (see Chapter 1.2.6.2). The three proteins encoded in this region are Ad-pol, DBP and 
pTP. Cellular proteins including octamer transcription factor 1 (Oct-1) and NF-I are also 
required for efficient replication (de Jong and van der Vliet, 1999). 
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1.2.6.1.4 E3 
The E3 region encodes a number of proteins with roles in host immune subversion. The E3-19K 
protein binds to MHC class 1 molecules, preventing their trafficking to the cell surface (Fessler 
et al., 2004). This abrogates the presentation of viral peptides by MHC class I to circulating 
cytotoxic T cells. E3-19K also reduces cell surface levels of the NK cell-activating ligand 
NKG2D, preventing NK cell recognition of infected cells (McSharry et al., 2008). The E3-
10.4K and 14.5K proteins also affect cell surface receptor expression by forming the Receptor 
Internalisation and Degradation (RID) complex (Gooding et al., 1991). The RID complex acts 
to down-regulate cell surface expression of the Fas and TRAIL ligands, preventing circulating 
NK and T cells from killing the infected cell (Shisler et al., 1997). E3 14.7K plays a role in 
preventing host cell death by blocking TNF-α and TRAIL-induced apoptosis (Gooding et al., 
1991; Tollefson et al., 2001; Schneider-Brachert et al., 2006). In addition, E3 14.7K interacts 
with four cellular proteins designated the 14.7K-interacting proteins (FIPs) (reviewed in 
Horwitz, 2004). The FIPs have diverse roles within the cell, including NF-κB signal 
transduction and mitochondrial-induced apoptosis. 
1.2.6.1.5 E4 
The E4 region encodes a multitude of proteins with a variety of functions. E4orf3 is a highly 
multifunctional protein with roles in immune evasion, suppression of p53 activity, mRNA 
transport and inhibition of the MRN complex. E4orf3 suppresses induction of the host IFN 
response by re-organising nuclear PML-NBs (Ullman et al., 2007, 2008) (see Chapter 1.4.2). 
E4orf3 targets the transcriptional co-repressor TIF-1 to the rearranged PML-NBs for 
proteasome-mediated degradation (Yondola and Hearing, 2007; Forrester et al., 2012). E4orf3 
was also implicated in reorganisation of several protein components of the cytoplasmic mRNA 
processing bodies (p-bodies), a structure involved in mRNA degradation (Greer et al., 2011). P-
body proteins appear to be targeted to cytoplasmic aggresomes, the site of protein 
inactivation/degradation. The targeting of proteins involved in mRNA degradation to sites of 
protein degradation may facilitate the accumulation of late Ad mRNAs (Greer et al., 2011). 
E4orf3 is also able to suppress p53 function by forming a nuclear complex capable of inducing 
formation of heterochromatin at p53 target promoters, preventing p53 binding to DNA (Soria et 
al., 2010).  
E4orf3 shares some activities with another E4 protein, E4orf6. Both E4orf3 and E4orf6 
influence alternative splicing of late Ad mRNAs, resulting in accumulation of late mRNA 
transcripts in the nucleus (Bridge et al., 1991; Nilsson et al., 2001). E4orf3 and E4orf6 are also 
able to inhibit MRN complex function independently of the E1B-55K/E4orf6 ubiquitin ligase 
activity (Boyer et al., 1999a; Shepard and Ornelles, 2004). In addition to shared functions with 
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E4orf3, E4orf6 forms a complex with E1B-55K; the ubiquitin ligase activity of the E1B-
55K/E4orf6 complex is required for the nuclear export of Ad late mRNAs (Bridge and Ketner, 
1990; Woo et al., 2007; Blanchette et al., 2008). E4orf6 is also responsible for SUMO-1 
modification of E1B-55K (Lethbridge et al., 2003).  
E4orf4, E4orf6 and E4orf6/7 play roles in transcription. E4orf4 functions as a transcriptional co-
repressor; it appears to regulate early gene transcription by associating with the key cellular 
phosphatase, protein phosphatase 2A (PP2A) (Bondesson et al., 1996; Mannervik et al., 1999). 
This complex negatively regulates the transcription of early viral genes by down-regulating 
transcription of JunB, a component of the transcription factor AP-1 (Kleinberger and Shenk, 
1993). E4orf6 was recently shown to associate with the cellular transcription factor homeobox 
B7 (HoxB7), facilitating transcription from Ad promoters (Muller et al., 2012). E4orf6/7 
appears to act as a transcriptional enhancer by promoting the dimerisation of a heteromeric E2F 
complex at the E2 promoter (Obert et al., 1994). In addition, E4orf6/7 induces transactivation of 
E2F by recruitment of the E2F complex to the E2F-1 promoter (Schaley et al., 2000).  
1.2.6.2 DNA replication in species C adenoviruses 
Species C Ads have been shown to undergo an infectious cycle of around 36 hours, with virus 
replication being initiated at approximately 8 hours post-infection (h.p.i) (Wigand and Kumel, 
1977; Bodnar and Pearson, 1980; Rowe et al., 1984; Glenn and Ricciardi, 1988). During the 
early phase of infection the early region genes are expressed, some of which (the E2 proteins 
DBP, Ad-pol and pTP) are required for the initiation of DNA replication (Lichy et al., 1981; 
Lichy et al., 1982). Ad-pol and pTP form a heterodimer (Lichy et al., 1982) and the cellular 
transcription factors NFI and NFIII promote the assembly of the pre-initiation complex at the 
binding site of the pTP-Ad-pol complex (Mul et al., 1990). Both Oct-1 and NFI was shown to 
bend the replication origin into a favourable structural conformation for pre-initiation complex 
assembly (Mysiak et al., 2004a; Mysiak et al., 2004c). In addition to E2 and cellular proteins, 
the ITRs located at either end of the genome contain the origin of replication as defined by cis-
acting sequences (Leegwater et al., 1985; Nowock et al., 1985).  
Following formation of the pre-initiation complex, pTP functions as a primer for replication and 
replication is carried out by Ad-pol (King et al., 1997; Webster et al., 1997). DBP is thought to 
act as a helicase, unwinding DNA to allow access of the polymerase to a single-stranded 
template (Dekker et al., 1997). DNA synthesis is initiated by Ad-pol catalysing a covalent 
reaction between pTP and a deoxycytidine triphosphate (dCTP), forming the dCTP-pTP 
complex (Nagata et al., 1982; de Jong et al., 2003a; Mysiak et al., 2004b). Two further 
nucleotides (AT) are then added to the complex to form the intermediary pTP-CAT complex (de 
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Jong et al., 2003a). This complex is then able to bind the GTA sequence at position 1 of the 
genome and initiate elongation. Elongation occurs by a strand-displacement mechanism which 
involves Ad-pol, pTP, DBP and cellular protein NF-II (Nagata et al., 1983; de Jong and van der 
Vliet, 1999; de Jong et al., 2003a). This process results in the production of a DNA duplex 
which contains one parental and one daughter strand. A complementary strand to the displaced 
parental strand is then synthesised. The mechanism of this is still unclear; the displaced strand 
may anneal to other displaced strands, or annealing of the ITRs may result in a pan handle 
structure from which DNA replication can be initiated (reviewed in Liu et al., 2003).  
1.2.6.3 Intermediate gene expression in species C adenoviruses 
Upon initiation of DNA replication, the intermediate genes IVa2 and IX are expressed 
(Natarajan et al., 1984; Matsui et al., 1986; Vales and Darnell, 1989; Winter and Dhalluin, 
1991). The expression of IVa2 is regulated by a currently undefined cellular repressor which is 
titrated out upon genome replication (Huang et al., 2003; Iftode and Flint, 2004). IX and IVa2 
alongside viral DNA replication play roles in up-regulating transcriptional activity of the MLP 
(Tribouley et al., 1994; Lutz and Kedinger, 1996; Lutz et al., 1997). Transcription from the L4P 
is stimulated by a combination of DNA replication, IVa2, E1A and E4orf3 and results in 
production of the MLP-positive regulators L4-22K and L4-33K (Morris et al., 2010).  
1.2.6.4 Late gene expression in species C adenoviruses 
Following the initiation of DNA replication, there is a large increase in late gene expression and 
mRNA synthesis due to activation of the MLP (Manley et al., 1980). The MLP directs 
transcription from the major late transcriptional unit (MLTU) regions L1 to L5. The primary 
transcript is differentially spliced and polyadenylated to produce an array of late proteins 
(reviewed in Akusjarvi, 2008). Each mRNA has an identical tripartite leader sequence of non-
coding RNA at the 5′ end formed from the removal of three introns during splicing (Akusjarvi 
and Pettersson, 1978; Chow and Broker, 1978; Dunn et al., 1978; Ziff and Evans, 1978; Berget 
and Sharp, 1979). Transcription from the MLP reaches a maximum at 18 h.p.i and stays 
constant for the remainder of infection, resulting in high yields of virus structural and non 
structural proteins required for formation of the Ad capsid or for packaging of the Ad genome 
into the capsid. 
The temporal regulation of MLP expression is both transcriptional and post-transcriptional and 
these effects require the activity of L4-22K and L4-33K. Early phase transcripts from the MLP 
are not alternately spliced or elongated beyond the L3 poly(A) sequence (Shaw and Ziff, 1980; 
Iwamoto et al., 1986), with the L1-poly(A) site being preferentially used, leading to an 
accumulation of large amounts of L1-52/55K protein (Nevins and Wilson, 1981). In the L1 
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region the 52/55K splice-acceptor site is exclusively utilised during the early phase. However 
the action of the splicing factor L4-33K changes the preference to the distal IIIa acceptor site 
during the late stage of infection (Larsson et al., 1992; Farley et al., 2004; Tormanen et al., 
2006; Akusjarvi, 2008).  
Both L4-22K and L4-33K, in the presence of L4-100K, are able to induce production of late 
phase proteins (Morris and Leppard, 2009). The L4-22K and L4-33K proteins act post-
transcriptionally to produce the full complement of major late transcriptional unit mRNAs 
(Farley et al., 2004; Tormanen et al., 2006; Morris and Leppard, 2009) and also up-regulate 
IVa2, which acts in conjunction with L4-22K and/or L4-33K to up-regulate MLP activity 
(Tribouley et al., 1994; Lutz and Kedinger, 1996; Ostapchuk et al., 2006; Ali et al., 2007; 
Morris and Leppard, 2009). It was recently shown that L4-33K activity is controlled in a 
phosphorylation-dependent manner by cellular kinases; DNA-protein kinase appears to act as an 
inhibitory factor whereas phosphorylation by PKA appears to enhance L4-33K function 
(Persson et al., 2012). 
 Alternative late pre-mRNA splicing is also controlled by the reversible phosphorylation of 
cellular splicing factors known as serine/arginine-rich splicing factors (SRSFs). During the early 
stages of infection, SRSFs bind to the intronic IIIa-repressor element within the L1 transcript 
which prevents recruitment of the U2 subunit of the spliceosome at the distal IIIa 3′ site 
(Kanopka et al., 1996). E4orf4 dephosphorylates SRSFs by activating PP2A, allowing splicing 
to commence at the distal site resulting in expression of late-phase transcripts (Kanopka et al., 
1998). 
Following transcription and processing, mature late viral mRNAs are selectively exported to the 
cytoplasm whilst cellular mRNA export is inhibited. Although not well defined, this process 
appears to require the ubiquitin ligase activity of the Ad E1B-55K/E4orf6 complex and is 
dependent upon the cellular mRNA export receptor known as Nxf1/TAP (Woo and Berk, 2007; 
Blanchette et al., 2008; Yatherajam et al., 2011). Once in the cytoplasm, late viral mRNAs are 
selectively translated whilst the translation of cellular mRNAs is inhibited. The L4-100K 
protein is responsible for the inhibition of cellular protein synthesis by binding the elongation 
initiation factor 4G (eIF4G), displacing the kinase Mnk1 (Cuesta et al., 2000; Xi et al., 2004). 
Displacement of Mnk1 from the cap initiation complex prevents Mnk1-mediated 
phosphorylation and activation of the cap binding protein eIF4E, resulting in inhibition of cap-
dependent translation (Cuesta et al., 2000; Xi et al., 2004). However, the presence of the 
common tripartite leader in the 5′ UTR of Ad late mRNAs allows selective translation of these 
mRNAs (Logan and Shenk, 1984; Dolph et al., 1988; Dolph et al., 1990; Huang and Flint, 
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1998). L4-100K binds Ad mRNAs with a preference for tripartite leader-containing mRNAs 
(Adam and Dreyfuss, 1987; Xi et al., 2004). This results in enhanced association of late mRNAs 
with eIF4G and poly(A) binding protein, facilitating translation of viral late mRNAs by an 
alternative mechanism known as ‘ribosome shunting’ (Yueh and Schneider, 1996, 2000). This 
translation mechanism involves initial assembly of the 40S ribosome subunits onto the 5′ end of 
the capped mRNA followed by minimal scanning. ‘Shunting elements’ in the tripartite leader 
then direct the translocation of the 40S ribosome to the initiation site of the mRNA.  
1.2.6.5 Capsid assembly in species C adenoviruses 
Following transcription of Ad genes and translation of Ad mRNA transcripts, the resulting Ad 
proteins are transported from the cytoplasm into the nucleus for particle assembly. With regards 
to hexon, the L4-100K protein acts as a protein scaffold to aid assembly of hexon monomers 
into trimers (Hong et al., 2005). The hexon trimers then associate with pVI to be targeted to the 
nucleus (Kauffman and Ginsberg, 1976). Penton base monomers appear to independently 
assemble into pentamers in the cytoplasm. Likewise, fibre proteins autonomously assemble into 
trimers in the cytoplasm. Both penton base and fibre contain nuclear localisation signals (NLS), 
allowing import of assembled multimers into the nucleus. Subsequent assembly of penton 
capsomers is thought to occur spontaneously in the nucleus (Karayan et al., 1994; Franqueville 
et al., 2008). 
Once all capsid components are located inside the nucleus, L4-33K functions as a scaffold for 
the assembly of virus particles (Fessler and Young, 1999). In Ad5-infected cells, distinct 
nuclear penton aggregates are visible at 48 h.p.i which may correspond to capsid assembly 
platforms (Franqueville et al., 2008). In contrast, Ad3-infected cells display smaller, more 
punctuate aggregates of pentons, which may indicate differences in capsid assembly between 
these two serotypes (Hall et al., 2010). 
Once the procapsid has been assembled, the Ad genome is packaged into the virus particle at a 
precise vertex. A packaging sequence containing several AT-rich regions is located at the far 
left of the genome and is believed to direct insertion of the genome into the capsid (Ostapchuk 
and Hearing, 2005). The subsequent uptake of DNA into the capsid is then thought to be 
provided by the ATPase activity of IVa2 (Ostapchuk and Hearing, 2008). Once the DNA is 
packaged, sealing of the pro-capsid is promoted by binding of L4-22K, L1-52/55K and IVa2 to 
the DNA packaging sequence (Perez-Romero et al., 2005; Ewing et al., 2007). IIIa also 
associates with L1-52/55K and with the viral DNA packaging domain (Ma and Hearing, 2011). 
The L3-23K cysteine protease (adenain) then promotes maturation of the particle to a mature 
capsid. Adenain is activated by Ad DNA and the cleavage peptide of pre-VI; the activated 
 30 
 
protease cleaves the protein precursors of VI, VII, VII, Mu and TP resulting in formation of the 
mature infectious virion. However, some studies have shown that the packaging of the Ad 
genome may be intrinsically linked to capsid assembly (Zhang and Imperiale, 2003), therefore it 
may be that the capsid is assembled around a DNA complex, rather than the Ad genome being 
imported into a pre-assembled capsid. 
1.2.6.6 Virus release from host cells 
During infection with species C Ads, the accumulation of Ad death protein (ADP) leads to lysis 
of host cells (Tollefson et al., 1996a; Tollefson et al., 1996b). ADP localises to intracellular 
membranes and may interact with the anaphase-promoting complex (APC) inhibitor MAD2B to 
promote cell lysis by an as yet undefined mechanism (Ying and Wold, 2003). However, species 
B Ads do not encode ADP so cannot release progeny virions by this route; it is yet to be seen if 
they possess an alternative lysis mechanism. Ads also promote cell lysis by the activity of the 
Ad protease cleaving the cytoskeletal component cytokeratin (Chen et al., 1993). Ads may also 
induce autophagy in infected cells to promote release of infectious virions (Jiang et al., 2008). 
The dynein co-factor dynactin appears to enhance trafficking of species C Ad particles to the 
cell periphery (Engelke et al., 2011). 
1.3 The eukaryotic nucleus 
1.3.1 Sub-compartmentalisation of the nucleus 
The nucleus is a highly heterogeneous structure containing multiple subdomains. Development 
of protein tagging and immunofluorescence techniques has allowed the identification of a 
number of nuclear domains which display dynamic behaviour both in regard to their location 
within the cell and their protein constituents. Unlike cytoplasmic organelles, nuclear domains do 
not have outer membranes and are divided into distinct sub-compartments defined by location 
of chromosomes (Lichter et al., 1988) or excess replication (Wei et al., 1998), transcription 
(Jackson et al., 1993) or splicing components (Spector et al., 1991).  
Functionally specialised nuclear bodies include the nucleolus, PML-NBs, Cajal Bodies (CBs), 
splicing speckles and paraspeckles (Figure 1-4). Less well-characterised nuclear bodies include 
cleavage bodies (Schul et al., 1996; Schul et al., 1999b; Gall, 2000; Bleoo et al., 2001; Li et al., 
2006b), PcG domains (reviewed in Margueron and Reinberg, 2011), nuclear stress bodies 
(nSBs) (reviewed in Biamonti, 2004; Gabriela Thomas et al., 2011), Oct1/PTF/Transcription 
(OPT) domains (Pombo et al., 1998; Harrigan et al., 2011) and polymorphic interphase 
karyosomal associations (PIKAs) (Saunders et al., 1991; Pombo et al., 1998). DNA replication, 
RNA transcription and DNA repair have also been observed to occur in defined nuclear foci of 
around 100 nm in diameter. Transcription and replication foci appear to contain all the 
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Figure 1-4. The sub-compartmentalisation of the mammalian cell nucleus.  
The nucleus is enclosed by the nuclear membrane and a meshwork of intermediate filaments known as 
the nuclear lamina. The membrane is penetrated by nuclear pores allowing the exchange of factors 
between the nucleus and the cytoplasm. Chromatin domains originating from the same chromosome form 
the chromosome territories (dark grey regions), which may overlap or create interchromatin spaces (white 
regions). Perichromatin domains (light grey regions) are regions of less dense, transcriptionally active 
chromatin. Proteinaceous sub-nuclear bodies including the Cajal body, PML body, nucleolus, splicing 
speckles, paraspeckles, Polycomb group (PcG) bodies, Oct-1/PTF/Transcription (OPT) domains, nuclear 
stress bodies, Polymorphic Interphase Karyosomal Associations (PIKAs) and cleavage bodies are located 
in the interchromatin space. The perinucleolar compartment is located at the periphery of the nucleolus. 
DNA replication, RNA transcription and DNA repair occur in small foci (‘factories’) of around 100nm. 
Adapted from Lanctot et al., 2007; Hemmerich et al., 2011. 
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necessary enzymatic activity for their reactions therefore have been termed ‘factories’. It has 
been proposed that RNA polymerase II (RNA pol II) is bound to a transcription factory that 
subsequently attracts chromatin templates to the site (Cook, 1999; Cook, 2010). DNA 
replication also appears to occur at sites where necessary factors are already concentrated 
(Leonhardt et al., 2000). In contrast to transcription and replication foci, repair of damaged 
DNA may to require orchestrated recruitment of necessary repair factors (Lukas et al., 2005). 
1.3.2 Nucleolus 
The nucleolus is a highly multifunctional unit with its best-characterised role being ribosome 
subunit biogenesis. At the end of mitosis, nucleoli form around the tandem repeat clusters of 
ribosomal DNA (rDNA) genes, resulting in a sub-nuclear domain concentrated in proteins 
required for rDNA transcription and processing (reviewed in Boisvert et al., 2007). The genes 
encoding the initial 45S ribosomal RNA (rRNA) are found on nucleolar organising regions 
(NORs) located on specific chromosomes and these NORs decondense following mitosis, 
facilitating the formation of the nucleolus containing transcription factories (Roussel et al., 
1996). Transcription of the 45S rRNA is carried out by RNA pol I and the transcript is cleaved 
to produce the mature 28S, 18S and 5.8S s rRNAs (reviewed in Boisvert et al., 2007). These 
RNAs are post-transcriptionally modified by nucleolar-RNA containing protein complexes 
known as the small nucleolar ribonucleoproteins (snoRNPs). The rRNAs are then assembled 
with the ribosomal subunits and exported to the cytoplasm (Boisvert et al., 2007).  
In order to carry out this complex set of reactions, the nucleolus is organised into regions which 
have different functions. Electron microscopic analysis of the nucleolus has identified that it 
consists of three main sub-compartments; the fibrillar centres (FC; regions containing rDNA), 
the surrounding dense fibrillar component (DFC; regions involved in rRNA transcription and 
initial processing) and the granular component (GC; regions involved in initial ribosome 
assembly) (Scheer and Hock, 1999). In addition to rRNA synthesis and ribosome assembly, the 
nucleolus is also implicated in sensing stress (Rubbi and Milner, 2003), inducing p53 activation 
(Itahana et al., 2003; Korgaonkar et al., 2005; Gjerset, 2006), cell cycle control (Cockell and 
Gasser, 1999; Diaz-Cuervo and Bueno, 2008; Hwang and Madhani, 2009), DNA repair (Lee et 
al., 2005; Kotoglou et al., 2009; Mastrocola and Heinen, 2010) and RNA processing (reviewed 
in Gerbi et al., 2003). 
Cell cycle regulation by the nucleolus is mediated by post-translational modification of cell 
cycle proteins. The SUMO-specific protease termed SUMO1/sentrin-specific peptide 5 
(SENP5) is found concentrated within nucleoli (Gong and Yeh, 2006) and depletion of SENP5 
caused defects in cell cycle regulation and nucleolar morphology (Di Bacco et al., 2006). 
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Protein phosphatase 1γ (PP1γ) is found concentrated in nucleoli during interphase and relocates 
to the cytoplasm and kinetochores during mitosis (Trinkle-Mulcahy et al., 2006). At the onset of 
anaphase, a PP1γ-specific binding protein termed cell division cycle-associated 2 (CDCA2) 
induces the redistributed of PP1γ from the cytoplasm to chromosomes (Vagnarelli et al., 2006). 
PP1γ appears to remain associated with chromosomes during interphase and accumulates in 
nucleoli (Trinkle-Mulcahy et al., 2006), indicating a role for the nucleolus in chromosome 
segregation. 
In addition to protein modifications, protein sequestration in the nucleolus also appears to 
facilitate cell cycle regulation. Telomerase reverse transcriptase (TRT) is sequestered into 
nucleoli by interaction with the nucleolar protein C23 (Khurts et al., 2004) and is released at the 
end of mitosis to facilitate telomere replication at the end of G2 phase (Wong et al., 2002). This 
indicates that the nucleolus may regulate the activity of telomerase during the cell cycle. This is 
supported by evidence that the nucleolar sequestration of TRT is lost in transformed or DNA-
damaged cells, indicating loss of this activity may contribute to tumorigenesis (Wong et al., 
2002). 
The nucleolus also appears to regulate stress responses. p14
ARF
 is a positive regulator of p53 
stabilisation and activation by sequestering the p53-ubiquitin ligase HDM2 in the nucleolus 
(Wsierska-Gadek and Horky, 2003). This results in an increase in levels of p53, facilitating 
transcription of p21 and cell cycle arrest. Ribosome subunit biogenesis in the nucleolus is also 
tightly regulated following cellular stress. Following stress, c-Jun N terminal kinase 2 (JNK2) 
phosphorylates the transcription factor TIF-1A, which can no longer interact with RNA pol I 
thus inhibiting transcription (Mayer et al., 2005). Ribosome subunit transcription is also thought 
to be negatively regulated by a mTor-PI3K-MAPK pathway following various stress stimuli 
(James and Zomerdijk, 2004). DNA damage has also been shown to reduce RNA pol I synthesis 
in an ATR-dependent manner by abrogating assembly of the transcription initiation complex 
(Kruhlak et al., 2007). Epigenetic modifications also appear to play a role in the regulation of 
rRNA synthesis following stress. Post-translational modification of histone proteins resulted in 
transcriptionally silent chromatin in the nucleolus (Tanaka et al., 2010; Xie et al., 2012). 
The nucleolus is also involved in RNA modification. The most prevalent post-transcriptional 
modifications of rRNA are 2′-0-ribose methylation and pseudouridylation, which are carried out 
on the pre-rRNA template by snoRNPs in the nucleolus (reviewed in Kiss, 2002; Matera et al., 
2007). The snoRNAs have complementary sequences to the target RNAs and thus act as a guide 
for modification. SnoRNAs responsible for 2′-0-methylation have a conserved motif known as a 
C/D box, which is thought to determine the site of modification which is then carried out by a 
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snoRNP (KissLaszlo et al., 1996; Omer et al., 2002). The C/D box snoRNAs interact with a 
specific set of proteins to form the C/D RNPs; fibrillarin, NOP56, NOP58 and 15.5K (Omer et 
al., 2002; Aittaleb et al., 2003; Bortolin et al., 2003; Rashid et al., 2003; Tran et al., 2003). The 
snoRNAs which catalyse pseudouridylation of target RNAs typically exhibit short consensus 
sequences known as H/ACA boxes and a characteristic hairpin loop structure (Ganot et al., 
1997b). Akin to C/D box snoRNAs, H/ACA box snoRNAs dictate the site of pseudouridylation 
(Ganot et al., 1997a). These RNAs interact with proteins dyskerin, NHP2, GAR1 and NOP10 to 
form the H/ACA snoRNP (Baker et al., 2005; Charpentier et al., 2005). 
Nucleoli have also been implicated in the production and modification of RNP classes other 
than rRNPs. Post-translational modification and assembly of spliceosomal small nuclear 
ribonucleoprotein (snRNPs), telomerase and microRNAs (miRNAs) were found to involve the 
nucleolus (reviewed in Gerbi et al., 2003). Numerous RNA pol III-transcribed RNAs appear to 
required modification or maturation in the nucleolus, including the 7S RNA of the signal 
recognition particle (SRP) (Jacobson and Pederson, 1998), a tRNA processing enzyme known 
as RNase P (Jacobson et al., 1997) and spliceosomal snRNP U6 (Ganot et al., 1999). This 
indicates that RNA pol III-transcribed RNAs may follow a specific nucleolar import pathway 
for modification. In addition to RNA modifications, the nucleolus has also been implicated in 
RNA editing. Photobleaching experiments revealed that the RNA editing enzymes RNA 
specific RNA deaminase 1 (ADAR1) and ADAR2 are in constant flux into and out of the 
nucleolus (Desterro et al., 2003), with ADAR2-mediated RNA editing occurring within the 
nucleolus (Vitali et al., 2005). 
Finally, the nucleolus also appears to be involved in the production of small interfering RNA 
(siRNA). An miRNA known as miR206 was shown to colocalise with the 28S rRNA in the GC 
of the nucleolus (Politz et al., 2006). This indicates that miRNAs may be able to associate both 
with nascent ribosomes in the nucleolus and with mature ribosomes in the cytoplasm. In plant 
cells, multiple siRNA processing enzymes were found to localise in the nucleolus alongside 
siRNAs, indicating that processing of siRNAs may occur in this compartment (Li et al., 2006a). 
It was also suggested that storage or sequestration of the RNA-induced silencing (RISC) 
complex may also occur in the nucleolus (Pontes et al., 2006). 
1.3.3 Promyelocytic leukaemia nuclear bodies (PML-NBs)  
PML-NBs are defined by the localisation of marker proteins to form ring-shaped structures 
within the nucleus, and generally do not contain nucleic acid (Boisvert et al., 2000). Despite 
being devoid of DNA, PML-NBs can associate via chromatin with transcriptionally active gene 
regions including the MHC class 1 gene locus and the p53 gene locus (Shiels et al., 2001; Sun 
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et al., 2003; Wang et al., 2004; Kumar et al., 2007). PML-NBs are often found in close 
proximity to other nuclear bodies, such as CBs, splicing speckles and nucleoli (Grande et al., 
1996). They are dynamic structures and can change in terms of size, number and position within 
the nucleus as the cell cycle progresses (Chang et al., 1995; Kurki et al., 2003). PML-NBs 
appear to be stress responsive; they have been noted to disperse in response to cellular shock 
induced by heat, heavy metal exposure (Maul et al., 1995), DNA damage (Carbone et al., 2002; 
Bernardi et al., 2004; Conlan et al., 2004; Salomoni et al., 2005) and viral infection (Doucas et 
al., 1996; Ahn and Hayward, 1997; Leppard and Everett, 1999; Adamson and Kenney, 2001; 
Burkham et al., 2001). Moreover, there is transcriptional up-regulation of PML-NB constituents 
following stress; PML is up-regulated at the transcriptional level by p53 (de Stanchina et al., 
2004) and both PML and SP100 are transcriptionally up-regulated by IFN-γ treatment 
(Grotzinger et al., 1996), resulting in an increase in the number and size of PML-NBs.  
PML is a tumour suppressor protein which becomes fused to the retinoic acid receptor α 
(RARα) in acute promyelocytic leukaemia, leading to inactivation of the PML protein (Dethe et 
al., 1991; Kakizuka et al., 1991). PML is essential for the formation of PML-NBs (Ishov et al., 
1999). Multiple proteins have been associated with PML-NBs either partially or temporally, 
including the transcriptional repressor Daxx and the transcriptional regulator SP100 (Ishov et 
al., 1999). Formation of PML-NBs appears to require protein modification by SUMOs, which 
are conjugated to target proteins by the activity of three proteins; the E1 SUMO-activating 
enzyme (SAE1/SAE2 heterodimer), the E2 SUMO-conjugating enzyme UBC9 and E3 SUMO 
protein ligases (Johnson and Blobel, 1997; Johnson et al., 1997; Schwarz et al., 1998). Multiple 
PML-NB proteins are covalently modified by conjugation to SUMOs (Sternsdorf et al., 1997; 
Zhong et al., 2000a; Van Damme et al., 2010). This modification is reversible and appears to be 
crucial for the recruitment of proteins to PML-NBs, as it enables non-covalent interactions 
between SUMOylated proteins with proteins containing SUMO-interacting motifs (Shen et al., 
2006). SUMO-1 modification of PML appears to induce formation of PML-NBs (Muller et al., 
1998) and is essential for the recruitment of Daxx (Ishov et al., 1999). The current model for the 
formation of PML-NBs suggests that disassembly (e.g. during mitosis) is due to 
deSUMOylation of PML, whilst SUMOylation of PML (e.g. during interphase) facilitates 
interaction of PML with other SUMOylated proteins, resulting in formation of PML-NBs (Shen 
et al., 2006).  
The function of PML-NBs appears to be a site for protein recruitment and modification 
including phosphorylation, acetylation, ubiquitination and SUMOylation. These modifications 
can have varied outcomes including protein activation, inactivation, sequestration or 
degradation. As a result, PML-NBs have been implicated in a diverse array of cellular functions 
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including senescence, apoptosis, immune signalling and transcriptional regulation (reviewed in 
Bernardi and Pandolfi, 2007; Bernardi et al., 2008; Tavalai and Stamminger, 2008). The 
implication of PML-NBs in such an array of cellular functions may also be a reflection of the 
heterogeneous nature of PML-NBs. Alternative PML isoforms can result in formation of 
different PML-NBs (Muratani et al., 2002). Indeed, subsets of PML-NBs within a cell appear to 
have diverse protein compositions and can also be associated with different chromosomal 
regions (Shiels et al., 2001). 
In addition to their formation being dependent on SUMOylation, PML-NBs have been proposed 
to act as a key cellular site for protein SUMOylation (Van Damme et al., 2010; Saitoh et al., 
2006). Indeed, protein SUMOylation appears to be induced by PML in yeast (Quimby et al., 
2006) and the SUMOylation of PML itself and target proteins appears to depend on PML (Shen 
et al., 2006). Although PML has been proposed to act as a U3 SUMO ligase, this is yet to be 
proven in a mammalian system. However, other U3 SUMO ligases have been shown to locate in 
PML-NBs (reviewed in Seeler and Dejean, 2003), indicating they are a key site for protein 
SUMOylation. SUMOylated proteins can also be recruited to PML-NBs for further 
modifications including acetylation and phosphorylation (Georges et al., 2011). SUMOylation 
of target proteins may also trigger their release from PML-NBs (Park et al., 2007). 
PML-NBs also appear to have roles in transcriptional regulation. Transcriptional activators, 
repressors and histone modifiers are all present in PML-NBs (Ishov et al., 1999; Zhong et al., 
2000a; Kiesslich et al., 2002; Seeler et al., 1998; Wu et al., 2001). PML-NBs are frequently 
found in close proximity to highly acetylated chromatin (Boisvert et al., 2000) and nascent 
RNA has been detected at the periphery of PML-NBs, particularly at the G1 phase of the cell 
cycle (Kiesslich et al., 2002). PML-NBs have been suggested to modulate transcription at the 
MHC class I gene locus by modifying chromatin architecture (Shiels et al., 2001; Wang et al., 
2004; Kumar et al., 2007). PML-NBs have also been implicated in heterochromatin remodelling 
at the G2 phase of the cell cycle (Luciani et al., 2006) and chromatin condensation by PML-
NBs is suggested to induce transcriptional suppression during cellular senescence (Zhang et al., 
2005; Ye et al., 2007; Vernier et al., 2011). Dellaire and Bazett-Jones, 2004; Dellaire and Bazett-Jones, 2007 
Another key role for PML-NBs is DNA damage control. PML-NBs colocalise with sites of 
DNA repair and single-stranded DNA (ssDNA) (Bischof et al., 2001; Boe et al., 2006) and also 
contain numerous proteins involved in DNA repair and cell cycle checkpoint control (reviewed 
in Dellaire and Bazett-Jones, 2004, 2007). Moreover, PML is phosphorylated and activated by 
several DNA damage-activated kinases including ATM, ATR, homeodomain-interacting 
protein kinase 2 (HIPK2) and checkpoint kinase 2 (CHK2) (Dellaire et al., 2006). Some studies 
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have also indicated a role for PML-NBs in DNA repair. However, the association of DNA 
repair proteins with PML-NBs generally occurs at late time points following DNA damage 
(Carbone et al., 2002; Dellaire et al., 2006) and the association of PML-NBs with ssDNA is 
more proficient in cells defective in certain DNA repair functions (Boe et al., 2006). 
Nevertheless, there is accumulating evidence of a role for PML-NBs in homologous 
recombination repair (HRR). PML-knockout cells exhibit a high level of sister chromatid 
exchange, which occurs when there is defective HRR pathway (Zhong et al., 1999). PML-NBs 
were also shown to interact with telomeres in certain cancer cells which maintain telomere 
length in a telomerase-independent manner by a mechanism known as alternative lengthening of 
telomeres (ALT) (Bernardi and Pandolfi, 2003). Although the process is not well understood, it 
is thought to involve HR of telomeric DNA (Muntoni and Reddel, 2005; Draskovic et al., 
2009). However, ALT can occur in telomerase-negative cell lines in the absence of PML-NBs, 
indicating that PML-NBs are not essential for HR (Jeyapalan et al., 2008). 
Although the role of PML-NBs in active DNA repair remains inconclusive, the role of PML in 
induction of cell cycle arrest and apoptosis following DNA damage is well clarified. PML 
knockout mouse cell lines exhibit marked defects in apoptosis induction following activation by 
a panel of pro-apoptotic stimuli (Bernardi and Pandolfi, 2003; Takahashi et al., 2004). 
Following DNA damage, ATR activation results in phosphorylation and activation of PML. By 
association with the nucleolar protein L11, PML sequesters the p53 ubiquitin ligase HDM2 in 
the nucleolus resulting in an increased stability of p53 (Bernardi et al., 2004). PML also 
promotes the phosphorylation of p53, which enhances the acetylation and activation of p53 by 
CBP (Hofmann et al., 2002b). Additional p53 regulators have also been shown to accumulate in 
PML-NBs, including protein inhibitor of activated STAT (PIAS), herpes virus-associated 
ubiquitin-specific protease (HAUSP) and the deacetylase sirtuin 1 (SIRT1) (Campagna et al., 
2011). This indicates that a fine balance between p53-suppressors (e.g. SIRT1) and p53 
activators (e.g. CBP) within the PML-NB may dictate the activation or suppression of p53.  
PML can also stimulate apoptosis by p53-independent pathways. Following DNA damage, 
PML induces the autophosphorylation and activation of CHK2, which is then released from 
PML-NBs to exert apoptotic effect (Yang et al., 2002; Yang et al., 2006). PML also interacts 
with a positive regulator of Fas-induced apoptosis known as FLICE-associated huge protein 
(FLASH) (Milovic-Holm et al., 2007). Under steady state conditions, FLASH is located at the 
PML-NB. Following Fas activation, FLASH is released from PML-NBs and targets to the 
mitochondria where it stimulates the cleavage and activation of caspase 8 (Milovic-Holm et al., 
2007). In contrast to PML which appears primarily pro-apoptotic, Daxx has been reported to 
 38 
 
both stimulate and suppress apoptosis (Torii et al., 1999; Zhong et al., 2000b; Chen and Chen, 
2003; Meinecke et al., 2007).  
PML, Daxx and SP100 have all been implicated in the anti-viral functions of PML-NBs. Daxx 
induces transcriptional silencing at viral promoters following viral infection by interaction with 
a histone deacetylase (Saffert and Kalejta, 2006; Huang et al., 2008). SP100 has also been 
implicated in suppression of early viral gene expression (Negorev et al., 2009). In addition, 
PML can stimulate IFN-γ-mediated apoptosis by interfering with ubiquitination. Under steady 
state conditions, an E3-ubiquitin ligase (E3-UbL) complex targets and ubiquitinates Death-
associated protein kinase 1 (DAPK1), a positive stimulator for IFN-γ-mediated cell death. Upon 
IFN-γ treatment, the E3-UbL complex is sequestered by PML into PML-NBs, preventing 
DAPK1 ubiquitination and degradation, thus stimulating apoptosis (Lee et al., 2010).  
Another key cellular function of PML-NB appears to be senescence. As mentioned previously, 
PML is able to induce p53 activation by a number of mechanisms, resulting in stimulation of 
senescence pathways (Hofmann et al., 2002b; Bernardi and Pandolfi, 2003; de Stanchina et al., 
2004). PML-NBs also appear important for formation of heterochromatin domains known as 
senescence-associated heterochromatin foci (SAHFs) which are believed to suppress activity of 
growth-inducing genes (Narita et al., 2003). The formation of these domains appears to depend 
on the histone chaperones HIRA and anti-silencing factor 1 (ASF1) which stimulates the 
incorporation of histone protein 1 (HP1) and the transcriptional silencing histone macro2A on to 
target chromatin (Zhang et al., 2005; Ye et al., 2007; Jiang et al., 2011b). Prior to its association 
at SAHFs, HIRA traffics via PML-NBs and this appears to be critical for SAHF formation and 
induction of senescence (Zhang et al., 2005). 
PML appears to control the activity of various cellular phosphatases and kinases in order to 
exert tumour suppressor functions. PML abrogates PP1A-mediated pRb phosphorylation by 
dephosphorylating pRb, facilitating suppression of proliferation and increased differentiation in 
neuronal progenitor cells (Regad et al., 2009). PML can also exert anti-neoangiogenic activities 
by abrogating the pro-angiogenic mTOR-PKB pathway at two different levels. PML firstly 
enhances PP2A phosphorylation of the proto-oncogene PKB by sequestering both proteins into 
PML-NBs, resulting in dephosphorylation and inactivation of PKB (Trotman et al., 2006). 
Secondly, PML can promote nuclear retention of the suppressor protein phosphatase and tensin 
homologue (PTEN) by abrogating its ubiquitination by HAUSP (Song et al., 2008). 
Ubiquitination of PTEN appears to correlate with nuclear retention and tumour suppressor 
activity (Song et al., 2008).  
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1.3.4 Splicing speckles 
Nuclear speckles (interchromatin granule clusters [ICGs]), are sub-nuclear domains containing 
high levels of factors required for pre-mRNA processing, transcriptional elongation and 
chromatin remodelling complexes (reviewed in Lamond and Spector, 2003). Nuclear speckles 
range in size from one to several micrometers in diameter and are composed of granules 
connected by thin fibrils (Thiry, 1995). Splicing speckles, like many nuclear bodies, are highly 
dynamic structures; fluorescence microscopy studies revealed dynamic change in the shape and 
fluorescence intensity of speckles over time (Misteli et al., 1997) whilst photobleaching 
experiments revealed that there is a rapid flux of speckle components between speckles and the 
surrounding nucleoplasm (Kruhlak et al., 2000; Phair and Misteli, 2000). Splicing speckles vary 
in number and size according to levels of splicing and transcription factors (Spector et al., 1991; 
Spector, 1993; Melcak et al., 2000; Huang and Spector, 1996; Misteli et al., 1997), cell cycle 
stage (Reuter et al., 1985; Spector and Smith, 1986; Ferreira et al., 1994; Thiry, 1995; Verheijen 
et al., 1986; Leser et al., 1989; Ferreira et al., 1994; Prasanth et al., 2003; Brown et al., 2008) 
and following virus infection (Jimenez-Garcia and Spector, 1993; Bridge et al., 1995).  
The exchange rate of factors between speckles and the nucleoplasm appears be dictated by 
phosphorylation. Phosphorylation of the serine/arginine-rich domain of SRSFs appears 
necessary for translocation of SRSFs from speckles to sites of transcription and pre-mRNA 
processing (Misteli et al., 1998) and is also required for their association with the spliceosome 
(Mermoud et al., 1994). Kinases involved in regulation of SRSFs and RNA pol II are also 
present in speckles (Colwill et al., 1996; Ko et al., 2001; Kojima et al., 2001; Sacco-Bubulya 
and Spector, 2002). Increased exit of proteins from speckles can be induced by introduction of 
genes (Jimenez-Garcia and Spector, 1993; Bridge et al., 1995) or over-expression of kinases 
(Colwill et al., 1996; Sacco-Bubulya and Spector, 2002).  
The structural proteins of nuclear speckles are not well defined. Recent studies revealed that 
depletion of the large SRSF protein Son abrogated the recruitment of RNA-processing factors to 
nuclear speckles, indicating a role for Son in speckle assembly (Sharma et al., 2010). Speckles 
also contain abundant long-lived polyadenylated pre-mRNAs which are thought to play a role in 
the structure of speckles (Huang and Spector, 1996; Hutchinson et al., 2007). Furthermore, it 
was recently shown that a tethered, spliced RNA pol II mRNA transcript recruited pre-mRNA 
splicing factors resulting in formation of speckles, indicating that ongoing transcription is 
necessary for speckle formation (Shevtsov and Dundr, 2011). 
Nuclear speckles contain a plethora of proteins involved in gene expression, including pre-
mRNA splicing and 3′ end-processing factors, transcription factors, RNA pol II, mRNA export 
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and translation factors (Larsson et al., 1995; Mortillaro et al., 1996; Zeng et al., 1997; Schul et 
al., 1998b; Saitoh et al., 2004; Dostie et al., 2000). Splicing speckles are believed to act as a 
local store of splicing factors whilst splicing itself occurs primarily in the surrounding 
perichromatin fibrils (reviewed in Spector and Lamond, 2011). Furthermore, numerous kinases 
and phosphatases responsible for regulation of splicing components are enriched in speckles, 
indicating a role for splicing speckles in the regulation and storage of splicing factors (Colwill et 
al., 1996; Trinkle-Mulcahy et al., 1999; Ko et al., 2001; Kojima et al., 2001; Trinkle-Mulcahy 
et al., 2001; Brede et al., 2002; Sacco-Bubulya and Spector, 2002). Splicing speckles contain 
high concentrations of spliceosome components such as snRNPs and SRSFs (Perraud et al., 
1979; Spector et al., 1983; Fu and Maniatis, 1990; Fu, 1995; Saitoh et al., 2004). SRSFs appear 
to be involved in both constitutive and alternative pre-mRNA splicing (Caceres et al., 1997; 
Xiao and Manley, 1997; Lai et al., 2001; Lin et al., 2005). SRSFs are required to commit the 
pre-mRNA to the splicing pathway (Fu, 1993) and have been shown to be co-transcriptionally 
recruited alongside other splicing factors to the RNA pol II complex to facilitate co-
transcriptional splicing (Gornemann et al., 2005; Lacadie and Rosbash, 2005; Listerman et al., 
2006). Splicing speckles have also been shown to contain a long, nuclear retained non-coding 
mRNA termed metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) (reviewed in 
Wilusz et al., 2009). MALAT1 appears to be involved in the recruitment of SRSFs from nuclear 
speckles to sites of active transcription (Bernard et al., 2010).  
Despite often being close to sites of active transcription, speckles are generally found in 
nucleoplasmic regions containing little to no DNA (Thiry, 1995). Their close association with 
sites of active transcription indicates a close association with gene expression. Indeed, 
chromosomal regions rich in gene-coding regions (R bands) appear to associate with speckles at 
much higher frequency than chromosomal regions encoding lower numbers of genes (G bands) 
(Shopland et al., 2003). Moreover, certain genes have been shown to preferentially locate in 
close proximity to splicing speckles, although this appears to be independent of transcription or 
pre-mRNA splicing at these loci (Huang and Schneider, 1991; Xing et al., 1993; Xing et al., 
1995; Smith et al., 1999; Johnson et al., 2000; Moen et al., 2004; Brown et al., 2008). Several 
components of the RNA pol II complex have been shown to be enriched in speckles (Bregman 
et al., 1995; Mortillaro et al., 1996; Mintz et al., 1999; Saitoh et al., 2004). A regulator of the 
RNA pol II complex, the CDK9/cyclin T1 complex, also partially colocalises with speckles 
(Herrmann and Mancini, 2001). This complex is responsible for phosphorylation of RNA pol II, 
stimulating transcriptional elongation (reviewed in Price, 2000). Furthermore, the cellular 
protein termed factor that binds to inducer of short transcripts protein 1(FBI-1) was found to 
colocalise in speckles with its cellular co-factor positive transcription elongation factor b (P-
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TEFb) and the HIV-1 transcriptional activator Tat (Pendergrast et al., 2002; Pessler et al., 
1997). A chromatin remodelling factor known as high mobility group (HMG)-17 has also been 
shown to localise in a similar nuclear distribution to FBI-1 (Hock et al., 1998). Therefore 
although transcription is not believed to occur within splicing speckles, a subset of 
transcription-associated proteins appears to be present in speckles. This indicates a strong link 
between splicing and transcription, which may facilitate formation of splicing complexes once 
transcription is initiated or regulation of transcription by modification of specific factors. 
In addition to acting as a store for splicing factors, recent data indicates splicing speckles may 
also have a direct role in splicing. Pre-mRNA splicing is an essential mechanism for gene 
expression in mammals where protein coding regions in genes are separated by non-coding 
regions (introns). Splicing is conducted by the spliceosome, a multimeric complex composed of 
the U1, U2, U4, U5 and U6 snRNPs alongside an assortment of protein factors (reviewed in 
Wahl et al., 2009). In addition, some transcripts are spliced by an alternative spliceosome (the 
U12 spliceosome) in which U1, U2, U4 and U6 snRNPs are replaced by the U11, U12, U4atac 
and U6atac snRNPs (Will and Luhrmann, 2005). RNA splicing can occur either co- or post-
transcriptionally. The distinction between co- and post-transcriptional splicing appears to be 
important for regulation of splicing; co-transcriptional splicing may allow regulation by 
transcription-dependent factors, whereas post-transcriptional splicing may allow regulation by 
more diverse mechanisms (reviewed in Han et al., 2011; Razin et al., 2011). The ratio of co-
transcriptional versus post-transcriptional splicing is currently unknown, as are the factors 
governing the selection. It seems that whilst constitutive introns are co-transcriptionally 
processed, alternative splicing can occur after transcription, when the mRNA is released into the 
nucleoplasm (Vargas et al., 2011). Co-transcriptional splicing appears to occur for the majority 
of constitutively expressed transcripts; in-situ hybridisation revealed the location of spliced 
mRNAs at their corresponding gene loci (Zhang et al., 1994) and spliced mRNA was shown to 
locate at sites of disrupted chromatin (Bauren and Wieslander, 1994; Pandya-Jones and Black, 
2009). In transcriptionally-synchronised cells, introns were removed from nascent RNA prior to 
completion of transcription (Singh and Padgett, 2009). Splicing factors also appear to be 
recruited to nascent transcripts in a co-transcriptional manner (Gornemann et al., 2005; Lacadie 
and Rosbash, 2005; Listerman et al., 2006; Pandit et al., 2008). It has been proposed that as 
most eukaryotic cells contain short exons and long introns, this allows sufficient time for the 
splicing machinery to recognise the 5′ and 3′ splice sites associated with the exon, facilitating 
co-transcriptional splicing of exons located at the 5′ end of genes. In contrast, pre-mRNA 
introns located at the 3′ end of multiple-intron transcripts more frequently undergo post-
transcriptional splicing, presumably because termination of transcription and cleavage of the 
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transcripts occurs before the splicing machinery is able to remove the introns (Bauren and 
Wieslander, 1994; Pandya-Jones and Black, 2009).  
Although the majority of nascent pre-mRNA appears to locate to adjacent perichromatin fibrils 
(Monneron and Bernhard, 1969; Fakan and Bernhard, 1971; Fakan and Nobis, 1978; Cmarko et 
al., 1999), nucleoplasmic pre-mRNAs were found to accumulate at nuclear speckles (Dias et al., 
2010; Vargas et al., 2011; Girard et al., 2012). This indicates that whilst co-transcriptional 
splicing occurs primarily in the surrounding perichromatin fibrils, post-transcriptional splicing 
may occur at the splicing speckles (Vargas et al., 2011; Girard et al., 2012). As multiple 
splicing factors contain signals for speckle retention, it is possible that spliceosomes along with 
their RNA substrate may have an enhanced affinity for speckles (Spector and Lamond, 2011; 
Girard et al., 2012). The subsequent release of spliced mRNA from speckles may then depend 
on interactions with the mRNA nuclear export pathway (Dias et al., 2010; Girard et al., 2012).  
Nuclear speckles have also been implicated in alternative splicing. Most eukaryotic genes are 
subject to alternative splicing, whereby different mRNA spliceoforms are produced from the 
same pre-mRNA transcript (reviewed in Luco and Misteli, 2011). Alternative splicing allows 
for increased regulation of gene expression and increased variety in the resulting proteome. The 
transcription elongation regulator 1 (TCERG1) functions as an integrator between transcription 
and splicing and appears to be enriched in nuclear speckles (Sanchez-Alvarez et al., 2006). This 
protein was found to dictate alternative splicing of pre-mRNA, implying that splicing speckles 
may play a role in alternative splicing (Montes et al., 2012). In addition, MALAT1 appears to 
play a role in alternative splicing by modulating the phosphorylation status of the essential 
splicing factor SRSF2 (Tripathi et al., 2010). 
1.3.5 Paraspeckles 
Paraspeckles are nuclear subdomains defined by location of several paraspeckle marker 
proteins; paraspeckle protein 1 (PSP1), PSP2, non-POU domain-containing, octamer binding 
protein (NONO) and splicing factor proline/glutamine-rich (SFPQ) (Dundr and Misteli, 2002; 
Fox et al., 2002). Paraspeckles appear in the nucleus as foci in close proximity to, but distinct 
from, splicing speckles. Recent bioinformatic data found that a long non-coding mRNA known 
as NEAT1 was specifically localised to paraspeckles, whilst NEAT2 localised exclusively to 
splicing speckles (Hutchinson et al., 2007; Chen and Carmichael, 2009; Clemson et al., 2009; 
Sasaki et al., 2009; Sunwoo et al., 2009). Depletion of NEAT1 was shown to disrupt 
paraspeckle morphology, indicating it is a necessary structural component (Chen and 
Carmichael, 2009; Clemson et al., 2009; Sasaki et al., 2009; Sunwoo et al., 2009). The NEAT1 
locus encodes two forms of NEAT1, a short transcript (NEAT1_1) and a long transcript 
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(NEAT1_2) (Guru et al., 1997). Depletion of NEAT1_2 was shown to disrupt paraspeckle 
morphology, indicating it that it is a necessary structural factor (Sasaki et al., 2009). Although 
NEAT1_1 cannot induce paraspeckle formation alone, its over-expression increased the number 
of paraspeckles in NEAT1_2-expressing cells (Clemson et al., 2009), indicating it may regulate 
paraspeckle formation under certain conditions. The formation of speckles is proposed to occur 
via a recruitment mechanism; NEAT1_2 interacts with SFPQ and NONO, leading to 
recruitment of additional factors PSP1 and NEAT1_1 to form paraspeckles (Sasaki et al., 2009; 
Souquere et al., 2010). 
The function of paraspeckles appears to be regulation of the expression of highly-edited 
transcripts by associating these transcripts with other nuclear bodies (Bond and Fox, 2009; Chen 
and Carmichael, 2010). An alternatively spliced form of the cationic amino acid transporter 
mRNA termed CTN-RNA was shown to localise to paraspeckles (Prasanth et al., 2005). The 3′ 
untranslated region (UTR) of this transcript contains inverted retrotransposon sequences which 
form intra-strand double-stranded RNAs (Prasanth et al., 2005). This structure is recognised by 
ADAR, which catalyses the conversion of adenosines to inosines (Bass and Weintraub, 1988; 
Wagner et al., 1989). ADAR-mediated modification of the 3′ UTR of CTN-RNA appears to 
lead to its accumulation in paraspeckles and retention in the nucleus, thereby inhibiting its 
expression (Prasanth et al., 2005). Inverted retrotransposon sequences are found in the 3′ UTR 
of a number of mammalian mRNAs, therefore the expression of these transcripts may also be 
regulated by paraspeckle retention (Faulkner et al., 2009).  
Paraspeckles have been found to be absent in human embryonic stem cells (Chen and 
Carmichael, 2009), indicating the regulation of certain mRNA expression by these structures 
may be developmentally regulated. In addition, NEAT1-knockout mice appear viable and fertile 
(Nakagawa et al., 2011), indicating paraspeckles are not an essential structure and therefore may 
be required for mRNA regulation under certain stress conditions. 
1.3.6 Cajal Bodies 
Cajal bodies are highly conserved, intranuclear subdomains that function in RNA metabolism 
(reviewed in Cioce and Lamond, 2005; Morris, 2008). There are normally between one and ten 
CBs per cell and typically appear in transmission electron micrographs (TEMs) as a tangled ball 
of fibrillar threads (Cajal, 1903; Hardin et al., 1969; Monneron and Bernhard, 1969; Lafarga et 
al., 1983). Their number and size can vary in response to cell cycle stage, transcriptional 
activity, snRNP level and cellular stresses such as virus infection (Andrade et al., 1993; Carmo-
Fonseca et al., 1993; Sleeman et al., 2001; Fernandez et al., 2002). The number of CBs in a cell 
may be dictated by the ability of the CB to fuse into larger structures or divide into smaller ones 
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(Boudonck et al., 1999; Platani et al., 2002). In addition, de novo formation of CBs may also 
occur; this appears to be closely correlated with the snRNP cycle (Navascues et al., 2004).  
CBs are able to move throughout the nucleoplasm mostly by diffusion, although active 
processes may be employed in some instances (Platani et al., 2000; Gorisch et al., 2004). It 
seems that not all CBs within a cell are dynamic at the same time and can be either mobile or 
tethered to specific regions of chromatin (Platani et al., 2000; Sleeman et al., 2003; Dundr et al., 
2004). The structural integrity of CBs appears to depend on the CB proteins coilin, WD Repeat-
containing Antisense to p53 (WRAP53) and FLASH (Barcaroli et al., 2006b; Mahmoudi et al., 
2010). Genes encoding U1 and U2 snRNAs as well as histone gene loci associate with CBs 
(Frey and Matera, 1995; Smith et al., 1995; Gao et al., 1997; Schul et al., 1998a; Jacobs et al., 
1999; Schul et al., 1999a; Frey and Matera, 2001; Shopland et al., 2001). In addition to their 
close association with specific gene loci, CBs can also associate with other nuclear bodies 
including PML-NBs, cleavage bodies and nucleoli (Carmo-Fonseca et al., 1993; Bohmann et 
al., 1995; Malatesta et al., 1994; Grande et al., 1996; Schul et al., 1999b; Li et al., 2006b), 
indicating a role for CBs in intranuclear trafficking.  
Although CBs can be surrounded by transcription sites (Jordan et al., 1997), they contain 
inactive RNA pol II (Xie and Pombo, 2006), indicating that they are not sites of active 
transcription. In addition, they do not contain poly(A) RNA or the essential splicing factors U2 
Auxiliary Factor (U2AF) and SRSF2 and are therefore unlikely to function in splicing (Raska, 
1995; Cmarko et al., 1999; Gall, 2000). However, poly(A) RNA was recently shown to be 
present in the CBs of European larch microsporocytes (Kolowerzo et al., 2009; Smolinski and 
Kolowerzo, 2012). Larch microsporocyte CBs did not contain nascent RNA or splicing factors, 
indicating the CB is not a site of transcription or splicing; instead it was suggested that CBs may 
act as a storage site for certain mRNAs prior to nuclear export. However, the presence of 
mRNA in CBs is yet to be observed in animal cells (Visa et al., 1993; Huang et al., 1994).  
The well-characterised functions of CBs are the assembly and recycling of the spliceosomal 
machinery (reviewed in Cioce and Lamond, 2005; Morris, 2008). CBs have been shown to be 
enriched in many snRNP and snoRNP components, including the U snRNPs that form part of 
the spliceosome for pre-mRNA splicing (Carmo-Fonseca et al., 1992; Matera and Ward, 1993). 
CBs also contain nonspliceosomal RNAs including the U7 snRNP necessary for histone 3′-end 
processing and the human telomerase RNA (hTR) component of telomerase (Bachand et al., 
2002; Jady et al., 2004; Zhu et al., 2004). In contrast to the U7 snRNP of amphibian (Wu and 
Gall, 1993) and HeLa cells (Frey and Matera, 1995), the U7 snRNP of Drosophila 
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melanogaster is found within separate sub-nuclear structures known as histone locus bodies 
(HLBs) rather than CBs (Liu et al., 2006).  
The snRNP assembly functions attributed to CBs are U2 snRNP assembly (Nesic et al., 2004), 
reformation of the ‘tri-snRNP’ post-splicing (Schaffert et al., 2004; Stanek and Neugebauer, 
2004) and U snRNA modification (Jady et al., 2003). The biogenesis of snRNPs involved a 
series of reactions in both the cytoplasm and the nucleus. Small nuclear RNA (snRNA) 
molecules U1, U2, U4 and U5 are synthesised in the nucleus by RNA pol II (Murphy et al., 
1982). Following transcription, there is addition of a 7-methylguanosine (m
7G) cap at the 5′ end 
of the RNA molecule and additional nucleotides are added at the 3′ end (Mattaj, 1986; Jacobson 
et al., 1993). The m
7
G cap is bound by the cap-binding complex (CBC) to promote transport of 
snRNAs into the cytoplasm, alongside the phosphorylated adaptor protein for RNA export 
(PHAX) (Ohno et al., 2000). Interestingly, recent data also suggests that trafficking of snRNAs 
via the CB may be required for snRNA export (Suzuki et al., 2010). Once in the cytoplasm, the 
RNA undergoes maturation of the 3′ end and this facilitates binding of Smith (Sm) proteins to 
form the snRNP, which is facilitated by the multimeric survival motor neuron (SMN) complex 
(reviewed in Kolb et al., 2007; Chari et al., 2009). The 5′ end of the RNA molecule is processed 
to form a 2,2,7-methylguanosine (m3G) cap (Mattaj, 1986) which is then recognised by 
snurportin 1 (Huber et al., 1998). The SMN protein complex functions to import snRNPs from 
the cytoplasm into the nucleus via importin β (Narayanan et al., 2004). Recently, the RNA 
chaperone protein WRAP53 was also identified as an essential factor for cytoplasmic snRNP 
assembly and subsequent trafficking into the nucleus (Mahmoudi et al., 2010).  
Once inside the nucleus, SMN interacts with coilin (Hebert et al., 2001) and phosphorylation of 
coilin appears to dictate the interaction of coilin with SMN and the Sm protein B′ (SmB′) 
(Toyota et al., 2010). At the CB, snRNAs undergo post-transcriptional modifications including 
2′-O-methylation and pseudouridylation, which are guided by the CB-specific guide RNAs 
(scaRNAs) (Darzacq et al., 2002; Jady et al., 2004). Akin to the nucleolar snoRNPs, the 
scaRNAs guide complementary base-pairing between RNAs and target sequences in order to 
synchronise RNA modification. U2 snRNP assembly is also believed to occur within the CB 
(Nesic et al., 2004) and the reformation of the tri-snRNP after each round of splicing (Schaffert 
et al., 2004; Stanek and Neugebauer, 2004). Following modification at the CB, mature snRNPs 
acquire additional accessory proteins from splicing speckles (Misteli and Spector, 1997) and 
undergo further maturation before the mature spliceosome complex is assembled at transcription 
sites on pre-mRNAs (reviewed in Nilsen, 2003; Patel and Bellini, 2008). U snRNPs can then be 
recycled back to CBs from other regions of the nucleus by the SMN complex (Stanek et al., 
2008).  
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In addition to snRNP biogenesis, CBs are involved in the recruitment of telomerase to 
telomeres. Telomeres are regions of repetitive DNA sequence located at the end of linear 
chromosomes, and function to protect the DNA from degradation. However, limitations in the 
cellular DNA replication machinery result in telomere shortening over time, leading to cellular 
senescence (Harley et al., 1990; Bodnar et al., 1998). Cancer cells act to prevent telomere 
shortening and cellular senescence by activating telomerase, a ribonucleoprotein complex which 
acts to extend telomere length (Counter et al., 1992; Kim et al., 1994; Shay and Bacchetti, 
1997). Active telomerase consists of three subunits known as hTERT, hTR and dyskerin; 
hTERT functions as the reverse transcriptase catalytic subunit, hTR is the RNA subunit which 
functions as a template for telomere extension whilst dyskerin is required for telomerase 
stability (Feng et al., 1995; Nakamura et al., 1997; Mitchell et al., 1999; Cohen et al., 2007). 
CBs were shown to accumulate telomerase and transiently associate with telomeres (Zhu et al., 
2004; Jady et al., 2006). The accumulation of telomerase within CBs was found to be due to the 
activity of WRAP53, which was shown to play a role in hTR trafficking (Tycowski et al., 2009; 
Jady et al., 2004; Venteicher et al., 2009). The association of telomerase or telomeres with CBs 
appears to occur during S phase of the cell cycle (Jady et al., 2006; Li et al., 2010). Studies of 
mouse, Xenopus and human TR indicates that CBs may be necessary for telomerase recruitment 
to telomeres under steady-state conditions, whilst WRAP53 activity appears to be essential for 
telomerase recruitment under both steady state conditions and when telomerase is over-
expressed (Li et al., 2010; Tomlinson et al., 2010; Stern et al., 2012). Indeed, disruption of 
WRAP53 function leads to ablation of telomerase trafficking in dyskeritosis congenita, a 
genetic disorder characterised by defective tissue maintenance and cancer predisposition (Zhong 
et al., 2011). 
CBs, or the related HLBs in Drosophila, are responsible for expression of replication-dependent 
histone mRNAs. Histone expression is activated during S-phase to ensure sufficient histone 
levels for packaging of newly replicated DNA before the onset of cell division. Histone 
expression commences at the G1/S transition and is controlled by the cyclin E/CDK2-mediated 
phosphorylation and activation of Nuclear Protein Ataxia Telangiectasia (NPAT) (Zhao et al., 
1998; Ma et al., 2000). Phosphorylated NPAT activates a histone H4 transcription factor known 
as HiNF-P, stimulating histone gene transcription (Miele et al., 2005). Metazoan replication-
dependent histone mRNAs are intronless so do not require splicing and are also the only 
mRNAs which do not undergo polyadenylation (reviewed in Marzluff et al., 2008). Instead, 
production of mature histone mRNA requires cleavage of a conserved 3′ stem-loop structure. 
The stem loop binds Stem Loop Binding Protein (SLBP) whilst a conserved downstream 
sequence known as the histone downstream element binds the U7 snRNP (Mowry and Steitz, 
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1987). Cleavage between these two elements is then conducted by recruitment of cleavage 
factor and currently undefined elements (Dominski et al., 2005, Kolev and Steitz, 2005, Wagner 
et al., 2007; Kolev et al., 2008; Sullivan et al., 2009). Another protein shown appears to be 
required for both histone gene transcription and histone mRNA 3′ end processing is FLASH 
(Barcaroli et al., 2006a; Yang et al., 2009), which appears to associate with the transcription 
factor p73 (a homologue of p53) to promote histone gene transcription (De Cola et al., 2012). 
MYC has also been implicated in histone gene transcription by HLBs (Daneshvar et al., 2011). 
The association of FLASH with Lsm10 and Lsm11 to form the U7 snRNP is required for 
histone 3′ end-processing (Burch et al., 2011). Depletion of HLB proteins involved in histone 
expression impacts progression of the cell cycle (Ma et al., 2000; Zhao et al., 2000; Miele et al., 
2005; Barcaroli et al., 2006a; Bongiorno-Borbone et al., 2010).  
As the coilin knockout mouse model is still viable, this indicates that neither coilin nor CBs are 
required for the essential steps of spliceosome assembly (Tucker et al., 2001). However, coilin 
knockout mice exhibit decreased fertility, fecundity and viability (Walker et al., 2009). The 
general consensus for CBs function is to enhance processes that would normally occur at slower 
rates in the nucleoplasm, possibly by bringing together essential factors (Stanek and 
Neugebauer, 2006). Indeed, a recent model proposed that tri-snRNP assembly occurs 
approximately 10 times faster in CBs than in the surrounding nucleoplasm (Novotny et al., 
2011). In contrast to coilin, SMN knockout is embryonic lethal, as it is an essential factor in 
snRNP biogenesis and delivery to the nucleus (Schrank et al., 1997). Mutations in SMN is the 
causative agent of the autosomal recessive disorder spinal muscular atrophy (SMA), which 
results in progressive atrophy of motor neurons and muscle wasting (Lefebvre et al., 1995). 
However, it is currently unclear how mutation in a ubiquitously-expressed protein can cause 
damage in only a subset of cell types. SMN-deficient mice were found to have altered 
stoichiometry of snRNAs, resulting in widespread and tissue-specific splicing defects 
(Gabanella et al., 2007; Zhang et al., 2008). The formation of the minor spliceosome was also 
found to be severely abrogated in SMN-depleted cells, resulting in inhibition of splicing at some 
U12-type introns (Boulisfane et al., 2011). This indicates that defects in splicing of a subset of 
U12-type introns may contribute to the pathogenesis of SMA. However, SMN depletion does 
not appear to impact post-transcriptional modification of snRNAs, indicating that affects on 
differential splicing in SMN-deficient cells are not due to deficient snRNP maturation 
(Deryusheva et al., 2012). In addition to SMN, NPAT, FLASH and HinF-P homozygous 
knockouts are also embryonic lethal, highlighting their essential roles in histone gene 
transcription and processing (Di Fruscio et al., 1997; Xie et al., 2009; De Cola et al., 2012).  
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1.3.7 Other nuclear bodies 
In recent years a number of additional nuclear bodies have been discovered, although their 
functions are not well characterised. Cleavage bodies have been shown to associate with CBs in 
a cell-cycle dependent manner (Schul et al., 1996; Schul et al., 1999b; Li et al., 2006b). PcG 
bodies are believed to be involved in transcriptional silencing; PcG proteins form transcriptional 
repressive complexes which silence target genes by inducing post-translational modification of 
histones (Margueron and Reinberg, 2011). The nSB (also known as the Sam68 nuclear body) 
forms in response to cellular stresses including heat shock, heavy metal exposure, protease 
inhibition or translation inhibition and is often found in close proximity to the nucleolus 
(Biamonti, 2004). During stress, general transcription is suppressed in cells and there is 
hyperactivation of transcription of repetitive non-coding satellite III (sat III) repeats on 
chromosome 9q11-12 (Valgardsdottir et al., 2005). The sat III transcripts remain associated 
with the chromosome locus and recruit various heat-shock specific transcription factors such as 
ASF/SF2, resulting in nSB formation (Shevtsov and Dundr, 2011). PIKAs were first observed 
as a nuclear substructure consisting of a group of small related auto-antigens. They appear to be 
variable in both size and number particularly during the cell cycle (Saunders et al., 1991). 
Although the PIKA proteins may associate with chromatin (Saunders et al., 1991), the function 
of PIKAs is still undefined. OPT domains are small nuclear foci that are present in the cell at the 
G1 phase but are absent by the S phase (Pombo et al., 1998). They often colocalise with large 
PIKA domains and contain high concentrations of the transcription factors PTF and Oct1 as 
well as TATA-binding protein (TBP), SP1 and RNA pol II (Pombo et al., 1998). These domains 
appear to act as sites of transcription and certain chromosomes preferentially associate with this 
domain, indicating OPT domains may facilitate expression of certain genes (Pombo et al., 
1998). OPT domains may play a role in DNA damage signalling; incomplete DNA synthesis 
during S phase was shown to stimulate the formation of OPT domains at sites of damaged DNA 
in the following G1 phase (Harrigan et al., 2011). 
1.3.8 Transcription and DNA replication foci 
In recent years it has become apparent that RNA transcription, DNA replication and DNA repair 
occur in small foci within the nucleus of around 100 nm. Pulse-labelling of mammalian cells 
during S-phase with nucleoside analogues such as bromodeoxyuridine (BrdU) resulted in the 
appearance of DNA replication at several discrete sites within the nucleus, termed ‘replication 
foci’ (Nakamura et al., 1986; Nakayasu and Berezney, 1989). Immunolabelling of replisome 
components including DNA pol A revealed that these components also exhibit punctate nuclear 
staining in S-phase nuclei of mammalian and yeast cells (Meister et al., 2005; Meister et al., 
2007; Natsume et al., 2008). These were termed ‘replication factories’ as they were shown to 
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colocalise with replication foci thus indicating ongoing DNA synthesis at this site (Hiraga et al., 
2005; Kitamura et al., 2006). Although the dynamics of DNA replication factories are not well 
understood, it is believed that factories form after the initiation of DNA replication (Cardoso et 
al., 1993; Jackson, 1995; Yan and Newport, 1995; Kitamura et al., 2006). Akin to numerous 
other nuclear bodies, replication factories show dynamic assembly and disassembly kinetics 
dependent on cell cycle stage (Leonhardt et al., 2000; Somanathan et al., 2001). Each 
replication focus is believed to contain multiple replicons that initiate replication in synchrony 
during S phase (Berezney et al., 2000). Interestingly, as S phase proceeds, an early firing 
replication factory becomes in close proximity to a later firing factory indicating that a change 
in local chromatin state may trigger replication from the adjacent factory in a temporal manner 
(Sporbert et al., 2002; Sadoni et al., 2004).  
In recent years, accumulating evidence indicates that transcription occurs in designated regions 
within the nucleus, termed ‘transcription factories’. There are three types of transcription 
factory; containing RNA pol I, II or III alongside a specific set of co-factors (Melnik et al., 
2011). Transcription by RNA pol I synthesises rRNAs (with the exception of the 5S rRNA), 
RNA pol II is responsible for mRNA synthesis whilst RNA pol III is required for transcription 
of 5S rRNA, tRNA and other small nuclear RNAs. The nucleolus is an example of a 
transcription factory as it is the site of rDNA transcription by RNA pol I (reviewed in Boisvert 
et al., 2007; Sirri et al., 2008). Ribosomal DNA was shown to slide over these centres and 
nascent RNAs were released into the surrounding DFC (Hozak et al., 1994). RNA pol II and III 
transcripts also arise in a limited number of nuclear foci which are enriched in phosphorylated, 
active RNA pol II or RNA pol III, respectively (Iborra et al., 1996; Jackson et al., 1998; Kimura 
et al., 1999; Pombo et al., 1999).  
Transcription factories can be highly variable in size depending on tissue-specific demands 
(reviewed in Sexton et al., 2007). A single transcription factory can co-ordinate transcription 
from several different loci, either on the same chromosome or from different chromosomes 
Osborne et al., 2004; Osborne et al., 2007; Papantonis et al., 2010; Schoenfelder et al., 2010). 
Genes sharing transcription factories are commonly genes which are under the control of the 
same regulatory factors (Schoenfelder et al., 2010), indicating that different transcription 
factories may be highly specialised for transcription of a specific subset of genes. Co-expressed 
genes are often found in-cis on the chromosome, which may facilitate co-ordinated expression 
from one transcription factory (Caron et al., 2001; Boutanaev et al., 2002; Spellman and Rubin, 
2002; Zhou et al., 2006). In contrast, the vast majority of tissue-specific genes are found 
scattered throughout the genome (Yager et al., 2004). Instead, these genes appear to be directed 
to specific transcription factories alongside distal functionally-related genes (Fraser and 
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Bickmore, 2007; Xu and Cook, 2008) and this may also be the case for stress-responsive genes 
(Papantonis et al., 2010; Larkin et al., 2012). Although not well defined, it is thought that 
movement of these genes to common transcription foci may be mediated by actin-myosin motor 
movement (Chuang et al., 2006). Transcription factories are also often located in close 
proximity to splicing speckles and perichromatin fibrils and to sites of mRNA export 
components (reviewed in Maniatis and Reed, 2002; Hagiwara and Nojima, 2007), facilitating 
efficient processing and export of an mRNA once transcribed.  
1.4 Impact of adenovirus infection on nuclear substructures 
In order to facilitate infection, multiple viruses have been shown to redistribute components of 
nuclear bodies. A comprehensive summary of known virus interactions with the nucleolus, 
PML bodies, splicing speckles and CBs is provided in Tables 1-2, 1-3, 1-4 and 1-5 respectively. 
The redistribution of nuclear substructures during Ad infection is discussed below. 
1.4.1 The nucleolus 
Nucleoli are disrupted during the late stages of Ad infection, with several nucleolar proteins 
being redistributed to novel new compartments within the nucleus (Walton et al., 1989; Puvion-
Dutilleul and Christensen, 1993; Rodrigues et al., 1996; Lam et al., 2010). B23 and Upstream 
Binding Factor (UBF) are sequestered into viral replication centres and appear to be crucial for 
Ad DNA replication (Okuwaki et al., 2001; Lawrence et al., 2006; Samad et al., 2007). When 
complexed with Ad core proteins, B23 may act as a stimulator for DNA replication (Okuwaki et 
al., 2001). However, recent data indicates a role for B23 in the assembly of viral chromatin 
rather than DNA replication (Samad et al., 2012). A role for B23 in capsid assembly has also 
been suggested (Ugai et al., 2012). The role of UBF during Ad replication is currently not well 
defined; although UBF is known to directly inhibit RNA pol I activity (Copenhaver et al., 1994; 
Voit and Grummt, 2001; Mais et al., 2005; Prieto and McStay, 2007), the sequestration of UBF 
during Ad5 infection does not appear to affect RNA pol I distribution or prevent rRNA 
synthesis (Lawrence et al., 2006). 
Akin to UBF and B23, the nucleolar proteins processing of precursor 1 (hPOP1) and Nopp140 
were also found to be depleted from the nucleolus during Ad5 infection (Lam et al., 2010). 
Following Ad infection, hPOP1 was shown to be redistributed into a nucleoplasmic speckle 
pattern separate from viral DNA replication centres, whilst Nopp140 displayed some 
colocalisation with DBP but was mainly enriched in centres adjacent to DBP (Lam et al., 2010; 
Lawrence et al., 2006). Although hPOP1 is normally involved in rRNA processing (Lygerou et 
al., 1996; Welting et al., 2006) and Nopp140 normally functions an snRNA chaperone  
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Table 1-2. Nucleolar targeting by viruses. 
Whilst numerous virus proteins are known to locate to the nucleolus, only virus proteins with a known 
effect on the nucleolus are listed. Ad – Adenovirus. HSV-1 – herpes simplex virus 1. HCMV – human 
cytomegalovirus. GRV – Groundnut rosette virus. PSLV – Poa semilatent virus. WNV – West Nile virus. 
CuMV – Cucumber mosaic virus. FCV – feline calcivirus. AAV2 – adeno-associated virus 2. HVS – 
herpesvirus saimiri. HIV-1 – human immunodeficiency virus 1. *suggested not proven. 
Virus  Protein Effect on domain Function Reference 
Ad pV Nuclear export and 
degradation of C23 
Subversion of C23-
mediated transcriptional 
repression* 
Matthews, 2001 
 
B23 and UBF 
redistributed to DNA 
replication centres 
Ad DNA replication*/ 
assembly of virus 
chromatin/ virion 
assembly* 
Okuwaki et al., 2001; Samad 
et al., 2007; Lam et al., 
2010; Ugai et al., 2012 
Not 
known 
UBF redistributed to 
DNA replication centres 
Unknown Lawrence et al., 2006 
HSV-1 ICP4 Redistribution of C23 to 
DNA replication centres 
Viral DNA replication* Calle et al., 2008b 
Not 
known 
Redistribution of 
fibrillarin 
Unknown Lymberopoulos and 
Pearson, 2007 
UL24 Dispersal of B23 by 
UL24 
Nuclear egress Lymberopoulos and 
Pearson, 2007; Bertrand and 
Pearson, 2008; 
Lymberopoulos et al., 2011 
UL12 US12 interacts with C23 Nucleocapsid egress Sagou et al., 2010 
US11 US11 interacts with C23 Trafficking of US11 to 
the cytoplasm 
Greco et al., 2012 
Not 
known 
Sequestration of UBF 
into DNA replication 
centres 
Viral DNA replication Stow et al., 2009 
HCMV UL44 C23 is redistributed to 
viral replication centres 
Maintenance of 
replication centre 
architecture 
Strang et al., 2010; Strang et 
al., 2012 
Pp65 Pp65 locates to the 
nucleolus 
Cell cycle progression to 
G1/S phase* 
Arcangeletti et al., 2011 
GRV ORF3 ORF3 interacts with 
fibrillarin  
Formation of viral 
snRNPs and viral spread 
Kim et al., 2007a; Canetta et 
al., 2008 
PSLV TGBp1 TGBp1 interacts with 
fibrillarin 
Viral spread* Semashko et al., 2012a 
WNV WNV 
capsid 
Dead box helicase 56 
(DX56) redistributed to 
the cytoplasm 
Particle assembly Xu et al., 2011 
CuMV 2b 2b interacts with the 
RNA silencing 
machinery 
Abrogates RNA 
silencing machinery 
Zhang et al., 2006; Goto et 
al., 2007 
FCV NS6, 
NS7 
C23 interacts with 
NS6/7and 3’UTR 
Viral DNA replication Cancio-Lonches et al., 2011 
AAV2 AAP AAP targets capsid 
proteins to the nucleolus 
Capsid assembly Sonntag et al., 2010 
HVS ORF57 ORF57 traffics via the 
nucleolus 
Viral mRNA export Boyne and Whitehouse, 
2006 
HIV-1 Rev Rev localises to the 
nucleolus 
Viral mRNA export Cochrane et al., 1990; 
Fankhauser et al., 1991; 
Michienzi et al., 2000 
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(Meier and Blobel, 1992; Isaac et al., 1998), their colocalisation with DBP and UBF implicates 
roles for these proteins in viral DNA replication.  
In contrast to the proteins described above, C23 is exported from the nucleolus to the cytoplasm 
following Ad2 infection (Matthews, 2001). This redistribution of C23 may be a mechanism by 
Ad2 to subvert the transcriptional repressive abilities of C23 (Yang et al., 1994a). Indeed, it was 
suggested that the Ad genome contains potential C23 binding sites (Matthews, 2001).  
Multiple Ad proteins localise to the nucleolus during infection; pV (Matthews and Russell, 
1998b; Matthews, 2001), Mu (Lee et al., 2004), pVII (Lee et al., 2003), IVa2 (Lutz et al., 1996) 
and E4orf4 (Miron et al., 2004). Ad2 pV was shown to redistribute C23 and B23 from the 
nucleolus into the cytoplasm in transfected cells (Matthews, 2001). Although the inhibition of 
rRNA synthesis using actinomycin D relocates multiple nucleolar proteins to the nucleoplasm, 
including B23 and C23 (Yung et al., 1985; Perlaky et al., 1997), it does not affect the 
localisation of transfected pV, indicating pV is not dependent on B23 or C23 for its nucleolar 
association (Matthews, 2001). However, findings in Ad5-infected cells appear to contrast with 
findings in pV-transfected cells described above. In Ad2-infected cells, C23 is degraded whilst 
B23 is redistributed from the nucleoli to a speckled pattern within the nucleus (Matthews, 
2001). This indicates that other viral proteins may impact on the activity of pV and the 
localisation of nucleolar proteins during infection. 
The role of other Ad proteins localising to the nucleolus is less well defined. Pre-Mu locates to 
the nucleolus and appears to modulates E2 expression (Lee et al., 2004). IVa2 colocalises with 
nucleoli in Ad-infected cells but was not found to impact either the location of specific 
nucleolar proteins or indeed rRNA synthesis (Lutz et al., 1996). Polypeptide VII contains both 
nuclear and nucleolar targeting sequences and appears to colocalise with human chromosomes 
(Lee et al., 2003). The nucleolar localisation of E4orf4 was shown to correlate with cell death 
(Miron et al., 2004). The toxicity of E4orf4 appears to be due to an interaction of E4orf4 with a 
subunit of PP2A, leading to inactivation of PP2A and the unscheduled activation of the APC. 
This results in mitotic defects and apoptosis of host cells (Mui et al., 2010). 
1.4.2 PML-NBs 
Ad infection was shown to induce the rearrangement of PML protein from punctate PML-NBs 
into nuclear tracks and this was found to be caused by the Ad E4orf3 protein (Carvalho et al., 
1995; Puvion-Dutilleul et al., 1995). E4orf3 targets and disrupts PML-NBs via its interaction 
with PML isoform II (Evans and Hearing, 2003; Hoppe et al., 2006; Leppard et al., 2009) and  
the rearrangement of PML-NBs was found to correspond to efficient viral replication (Doucas et al., 
1996). PML disruption by E4orf3 appears to be a mechanism to subvert antiviral responses 
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Table 1-3. Viruses targeting promyelocytic leukaemia bodies (PML-NBs). 
Ad – adenovirus. HCMV – human cytomegalovirus. HSV-1 – herpes simplex virus 1. EBV – Epstein 
Barr virus. VZV – varicella zoster virus. * suggested not proven. 
Virus  Protein(s)  Effect on domain Functional 
significance 
Reference 
Ad E4orf3 Redistribution of 
PML 
Immune subversion* 
 
Leppard and Everett, 1999; 
Hoppe et al., 2006; Ullman et al., 
2007; Ullman and Hearing, 2008; 
Leppard et al., 2009 
E1B-55K E1B-55K binds and 
degrades Daxx  
Inhibits Daxx- 
dependent p53 
transcription 
Zhao et al., 2003; Schreiner et al., 
2010; Schreiner et al., 2011 
E1B-55K binds PML Immune subversion* 
 
Wimmer et al., 2010 
 
Sequestration of p53 
in PML-NBs 
Inactivation and 
nuclear export of p53 
Pennella et al., 2010 
pIX Sequestration of PML 
by pIX 
Immune subversion* Rosa-Calatrava et al., 2001; Rosa-
Calatrava et al., 2003 
HCMV IE1/IE2 Disruption of PML  Alleviates PML-
mediated 
transcriptional 
repression 
Ahn and Hayward, 1997; 
Wilkinson et al., 1998; Ahn et al., 
1999; Ahn and Hayward, 2000; 
Xu et al., 2001 
Various  Disruption/decreased 
number of PML-NBs 
Unknown Salsman et al., 2008 
UL35 SP100 and Daxx 
recruited to novel 
UL35 bodies 
Manipulation of cell 
cycle and DNA 
damage responses 
Salsman et al., 2008; Salsman et 
al., 2011 
UL82 Daxx degradation  Relieves transcriptional 
repression by Daxx 
Hofmann et al., 2002a; Cantrell 
and Bresnahan, 2006 
HSV-1 ICP0 Redistributes PML Immune subversion Maul et al., 1993; Everett et al., 
2006; Everett et al., 2008 
Not known PML redistributed to 
replication 
compartments 
Genome replication* Burkham et al., 1998; Burkham et 
al., 2001; Sourvinos and Everett, 
2002; Everett and Murray, 2005; 
Everett et al., 2007  
Vmw110 Degradation of PML Immune subversion Everett and Maul, 1994; Everett 
et al., 1998; Chee et al., 2003; 
Cuchet et al., 2011 
ICP4 and 
ICP27 
Interact with Daxx Viral transcriptional 
activation  
Tang et al., 2003 
UL8.5, 
UL14, 
US10 
Disruption of PML-
NBs 
Suppression of PML-
NB-mediated 
apoptosis* 
Salsman et al., 2008 
EBV BZLF1 Redistribution of 
PML-NB proteins 
Activation of gene 
expression and the lytic 
cycle  
Bell et al., 2000; Sivachandran et 
al., 2010; Tsai et al., 
2011;Salsman et al., 2008 
VZV ORF61 PML-NB disruption Prevents capsid 
entrapment in PML-
NBs  
Reichelt et al., 2011; Wang et al., 
2011 
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mediated by Daxx and PML (Ullman et al., 2007; Ullman and Hearing, 2008). In addition to 
independent function, E4orf3 can associate in a complex with E1B-55K to disrupt PML 
distribution (Leppard and Everett, 1999). Following Ad infection, SP100 is also redistributed 
into tracks alongside PML. However, as infection progresses SP100 appears to segregate into 
DNA replication centres separate from the PML tracks (Doucas et al., 1996). 
E1B-55K can also act independently to affect PML-NB function. E1B-55K sequesters p53 in 
PML-NBs prior to facilitating the nuclear export of p53 (Pennella et al., 2010). Following 
SUMO-1 conjugation, E1B-55K interacts with and targets Daxx for degradation in a 
proteasome-dependent manner (Schreiner et al., 2010, 2011). This abrogates the transcriptional 
repressive and anti-viral activities of Daxx and also inhibits Daxx-dependent p53 transcription 
(Zhao et al., 2003). SUMO1 modification of E1B-55K also appears to facilitate its binding to 
PML isoforms IV and V (Wimmer et al., 2010).;  
In addition to E1B-55K and E4orf3, E1A and pIX have been shown to interact with PML-NBs. 
E1A was found to concentrate in PML tracks; this was dependent on the LXCXE motif of E1A 
responsible for pRb binding (Carvalho et al., 1995). It was also found that the interaction of 
E1A with the SUMO-conjugating enzyme UBC9 interferes with PML-NB SUMOylation 
(Yousef et al., 2010). Ad pIX sequesters PML within nuclear inclusions and this was shown to 
be necessary for efficient viral replication (Rosa-Calatrava et al., 2001; Rosa-Calatrava et al., 
2003). Schreiner et al., 2010; Schreiner et al., 2011 
1.4.3 Splicing speckles 
Whilst expression of early Ad proteins does not appear to alter mRNA biogenesis, the onset of 
late phase infection results in reorganisation of splicing factors within the nucleus. Ads hijack 
the transcriptional and splicing factors of the cell to facilitate viral replication (Pombo et al., 
1994; Bridge et al., 1995, 1996; Gama-Carvalho et al., 2003b). U2AF and the pre-mRNA and 
alternative splicing factor ASF/SF2 were shown to be redistributed to sites of active 
transcription and splicing during adenovirus infection (Gama-Carvalho et al., 1997, 2003b; 
Lindberg et al., 2004). There is a dynamic change in splicing factor distribution following the 
switch to late phase infection (Puvion-Dutilleul et al., 1994; Aspegren et al., 1998). During the 
intermediate phase, ASF/SF2 is redistributed into ring-like structures surrounding DNA 
replication centres and colocalises with snRNPs (Bridge et al., 1993a; Gama-Carvalho et al., 
2003b). At later stages, both ASF/SF2 and snRNPs are found at enlarged interchromatin 
granules at the nuclear periphery (Bridge et al., 1993b). Viral late RNA also accumulates in 
these late stage structures, and interestingly E4-deletion mutants have significantly reduced late 
mRNAs in these structures (Bridge et al., 1996; Bridge et al., 2003). The clusters of ICGs at late  
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Table 1-4. Viruses targeting splicing speckles. 
Ad – adenovirus. IBV – influenza B virus. HTLV-1 – human T-cell lymphotrophic virus 1. HCMV – 
human cytomegalovirus. HSV-1 – herpes simplex virus 1. HPV-5 – human papillomavirus 5. SRPK1 – 
SR Protein Kinase 1. CSF-64 – Cleavage Stimulatory Factor 64 kDa. PTB – Polypyrimidine-tract 
Binding protein. *suggested but not proven. 
Virus Protein Effect on domain Function Reference 
Ad E4 
region 
Late mRNAs accumulate 
in enlarged ICGs  
Late mRNA export* Bridge et al., 1993a 
Not 
known 
Movement of splicing 
factors to transcription 
sites 
Activation of late 
phase alternative 
splicing* 
Gama-Carvalho et al., 
2003b; Lindberg et al., 
2004 
IBV NS1 Redistribution of SRSF2 to 
novel sub-nuclear 
structures 
Gene expression/ 
inhibition of cellular 
splicing? 
Fortes et al., 1995; 
Schneider et al., 2009 
HTLV-1 Tax Tax localises with 
snRNPs, and SRSF2 in 
nuclear foci 
Activation of viral 
gene expression* 
Semmes and Jeang, 1996; 
Bex et al., 1997 
HCMV Not 
known 
SRPK1 redistributed to the 
cytoplasm, up-regulation 
of CSF-64, temporal 
regulation of PTB 
Temporal control of 
HCMV pre-mRNA 
processing* 
Gaddy et al., 2010 
HSV-1 ICP22 Remodelling of speckles 
into punctate foci 
Enhanced viral gene 
expression* 
Salsman et al., 2008 
Not 
known 
Replication compartments 
coalesce with splicing 
speckles 
Viral mRNA export Chang et al., 2011 
ICP27 Redistribution of snRNPs 
and SRSF2, inactivation of 
SRPK1, inhibition of 
spliceosome assembly 
Impairment of host 
cell and HSV-1 
splicing 
Sandrigoldin et al., 1995; 
SandriGoldin and Hibbard, 
1996; Bryant et al., 2001; 
Sciabica et al., 2003  
IE63 Redistribution of snRNPs, 
interacts with p32 to 
disrupt cellular splicing 
Host cell splicing 
shutoff and export of 
splicing independent 
transcripts 
Phelan et al., 1993; Wadd 
et al., 1999; Bryant et al., 
2000 
Not 
known 
Splicing factors recruited 
to transcription sites, 
nascent mRNA trafficked 
to SRSF2 domains 
Transcription and 
splicing of viral 
mRNAs 
Melcak et al., 2000 
HVS ORF57 ORF57 associates with Sm 
proteins in splicing 
speckles, redistributes 
SRSF2 
Enhance intronless 
viral RNA splicing 
Majerciak et al., 2008 
HIV-1 Vpr Binds SF3b subunit of the 
spliceosome 
Checkpoint mediated 
G2 cell cycle arrest 
Terada and Yasuda, 2006 
Tat Associates with FBI-1 in 
splicing speckles 
Stimulation of viral 
gene transcription 
Pendergrast et al., 2002 
HPV-5 E2 Interacts with ASF/SF2, 
SRSF2 and snRNPs U1 
and U5 in splicing 
speckles 
Facilitates splicing of 
viral transcripts 
Lai et al., 1999 
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stages are thought to reflect an intranuclear mRNA trafficking route for late Ad mRNAs from 
the nucleus to the cytoplasm (Besse and Puvion-Dutilleul, 1995). Gama-Carvalho et al., 1997; Gama-Carvalho et al., 2003b; Lindberg et al., 2004 
1.4.4 Cajal Bodies  
During Ad5 infection, the nucleolar proteins fibrillarin, UBF and RNA pol I associate in 
punctate nuclear microfoci alongside the CB marker protein, coilin (Rebelo et al., 1996; 
Rodrigues et al., 1996). These microfoci do not contain snRNPs or Ad mRNA, indicating they 
are not involved in Ad gene transcription (Rebelo et al., 1996; Rodrigues et al., 1996). Although 
it was initially suggested that the disassembly of CBs during Ad infection is secondary to the 
block of host protein synthesis during Ad infection (Rebelo et al., 1996), recent work indicates 
that coilin plays a role in Ad late protein expression (James et al., 2010). However, the exact 
function of CBs during the later stages of Ad infection is still undefined. Intriguingly, the 
redistribution of CBs into microfoci has also been shown to occur during infection with the RNA 
plant virus GRV. The rearrangement of CBs during GRV infection was shown to facilitate the transport 
of the GRV ORF3 protein to the nucleolus, whereby viral RNA was packaged into a viral snRNP with 
fibrillarin (Kim et al., 2007a; Kim et al., 2007b). 
In contrast to the redistribution of coilin, CB-associated actin was found to be relocated to the 
nuclear periphery following Ad5 infection (Gedge et al., 2005). It has been proposed that the 
actin content of CBs is related to the disassembly of CBs (Gedge et al., 2005; James et al., 
2010). Although a functional significance for this has not yet been elucidated, it is possible that 
actin is redistributed to late transcription sites, as the assembly of transcription complexes is 
dependent on actin (Hofmann et al., 2004). Alternatively, redistributed actin was also found to 
locate in close proximity to sites of Ad capsid assembly (Gedge et al., 2005), suggesting a 
possible role for nuclear actin in capsid assembly. 
 57 
 
Table 1-5. Viruses targeting Cajal bodies (CBs). 
Ad – adenovirus. GRV – Groundnut rosette virus. MVM – minute virus of mouse. EBV – Epstein Barr 
virus. HVS – herpesvirus saimiri. CuMV – cucumber mosaic virus. HIV-1 – human immunodeficiency 
virus, PV – poliovirus. FMDV – foot and mouth disease virus. HCV – hepatitis C virus. BPV – bovine 
papillomavirus. IRES - internal ribosome entry site. *suggested not proven 
Virus Viral 
protein(s) 
Effect on domain Function Reference 
Ad Not known Redistribution of coilin 
and fibrillarin into 
nuclear microfoci 
Facilitates late 
protein expression 
Rebelo et al., 1996; 
Rodrigues et al., 1996; 
James et al., 2010 
Not known CB-associated actin is 
redistributed to the 
nuclear periphery 
Unknown Gedge et al., 2005 
GRV ORF3 CB proteins coilin and 
fibrillarin redistributed to 
nuclear microfoci 
Trafficking of 
ORF3 to the 
nucleolus for viral 
RNP assembly 
Kim et al., 2007a; Kim et 
al., 2007b; Canetta et al., 
2008 
MVM NS1, NS2 Interacts with SMN in 
novel viral replication 
compartments 
Viral replication or 
capsid assembly* 
Young et al., 2002a, b; 
Young et al., 2005 
Herpesvirus UL3, UL30 Disruption of CBs Unknown Salsman et al., 2008 
Hordeivirus Movement 
protein 
Interacts with coilin Unknown Semashko et al., 2012b 
EBV EBNA2 Interacts with SMN Transactivation of 
the LMP1 promoter 
Barth et al., 2003 Voss et 
al., 2001 
EBNA3, 
EBNA6 
Colocalise with SMN Unknown Krauer et al., 2004 
EBNA3C Stabilises Gemin3 Blockage of p53-
mediated apoptosis 
Cai et al., 2011 
Influenza Not known Redistribution of CBs 
into microfoci 
Unknown Fortes et al., 1995 
NS1 Redistribution of 
snRNPs 
Inhibition of host 
cell splicing 
HVS HSURs Use SMN complex to 
assemble viral snRNPs 
Replication Golembe et al., 2005 
CuMV 2b Localises to CBs, binds 
siRNAs and miRNAs 
Abrogates gene 
silencing machinery 
Duan et al., 2012; 
Hamera et al., 2012 
HIV-1 Integrase Binds Gemin 2 Viral cDNA 
synthesis 
Hamamoto et al., 2006 
PV 2A Cleavage of Gemin 3 Reduced snRNP 
assembly 
Almstead and Sarnow, 
2007 
FMDV Not known Gemin5 binds IRES Enhanced viral 
protein translation 
Pacheco et al., 2009 
HCV Not known Gemin5 binds IRES Enhanced viral 
protein translation 
BPV E2 Binds SMN Transcriptional 
activation at E2 
promoters 
Strasswimmer et al., 
1999 
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1.5 Project Aims 
Although the early phase and DNA replication stages of Ad infection are well characterised, the 
mechanism controlling Ad late gene expression are not well understood. Understanding late 
gene expression is crucial for Ad vector development, since E1-deleted Ad vectors retaining late 
coding regions still express residual late proteins, resulting in induction of immune responses to 
the vector (Yang et al., 1994b; Yang et al., 1994c; Yang et al., 1995). Interestingly, it was 
shown that during the late phase of Ad infection, CBs are redistributed from 1-6 punctate 
domains per cell into numerous microfoci (Rebelo et al., 1996; Rodrigues et al., 1996). 
Moreover, the CB marker protein coilin appears to be required for Ad late protein expression 
(James et al., 2010). However, the mechanism by which CBs contribute to Ad late protein 
expression is unknown. Therefore characterising the role of the CB during Ad5 infection may 
facilitate the understanding of the control of Ad late phase protein expression. 
The main aims of this investigation were as follows; 
 Characterise the subcellular redistribution of key CB proteins during Ad5 infection 
 Determine the time point at which CB proteins are redistributed from CBs 
 Determine the function of key CB proteins during Ad5 infection. 
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Chapter 2 – Materials and Methods  
2. Chapter 2 - Materials and Methods 
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2.1 Materials 
2.1.1 Chemicals and reagents 
Unless otherwise stated, all chemicals were obtained from Sigma Aldrich (Dorset, UK). The 
standard cell culture medium Dulbecco’s modified Eagles medium (DMEM), L-glutamine and 
trypsin were all purchased from Sigma-Aldrich (Dorset, UK). Keratinocyte 2 Medium was 
purchased from PromoCell (Heidelberg, Germany). Foetal calf serum (FCS) was purchased 
from Biosera (Sussex, UK). Optimem-1 and Lipofectamine-2000 were obtained from Invitrogen 
(Paisley, UK). The Biorad DC Assay Kit and thick filter paper were purchased from Bio-Rad 
Inc (Hertfordshire, UK). Polyvinylidine fluoride (PVDF) membrane was purchased from 
Millipore (Watford, UK). The enhanced chemiluminescence (ECL) detection kit was purchased 
from GE Healthcare (Little Chalfont, UK). Normal goat serum (NGS) and Vectashield 
mounting medium were obtained from Vector Laboratories (Peterborough, UK). EDTA-free 
protease inhibitor cocktail and Slide-a-Lyser mini dialysis units were purchased from Pierce 
(Cramlington, UK). Caesium chloride was purchased from Invitrogen (Paisley, UK). Phosphate 
buffered saline (PBS) tablets were purchased from Oxoid (Hampshire, UK). 
2.1.2 Custom primers 
Table 2-1 describes all PCR primers used in this study. All primers were purchased from 
Invitrogen. Salt-adjusted melting temperatures (Tm) were calculated using Oligocalc 
(www.basic.northwestern.edu/biotools/oligocalc.html). The design strategy for all primers is 
described in Appendix Figures 1-6. 
2.1.3 siRNA 
Table 2-2 describes all siRNAs used in this study. 
2.1.4 Antibodies 
All primary antibodies raised against Ad proteins are described in Table 2-3. All primary 
antibodies directed against cellular proteins are described in Table 2-4. Secondary antibodies 
were used in Western blotting, indirect immunofluorescence and flow cytometry and are 
described in Table 2-5. 
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Table 2-1. PCR primers.  
Tm – melting temperature. GC – guanine/cytosine content. F – forward primer. R- reverse primer. 
Target mRNA  Primer name Sequence (5′ to 3′) Tm 
(
o
C) 
% 
GC 
Ad5 IIIa IIIa (F) ACAGTCGCAAGATGATGCAAGA 60.1 45 
IIIa (R) GCCAGCGCGTTTACGATCG 61.6 63 
Ad5 Hexon Hexon (F) ACAGTCGCAAGATGGCTACC 60.5 55 
Hexon (R) GCAGTACGCAGTATCCTCAC 60.5 55 
Ad5 Fibre Fibre (F) CAGTCGCAAGATGAAGCGC 59.5 58 
Fibre (R) ACAGTGGTTACATTTTGGGAGG 60.1 45 
Ad5 L4-100K L4-100K (F) AGATGGAGTCAGTCGAGAAGA 59.5 48 
L4-100K (R) ACTTGTTCCTCGTTTGCCTCT 59.5 48 
Ad5 DBP (RT1) Early DBP (F) ACC AGC GCG TCT TGT GAT GA 60.5 55 
DBP (R) CAG CTG CGG GAG AAG GAA A 59.5 58 
Ad5 DBP (RT2) Late DBP (F) ACC AGC GCG TCT TGT GAT GA 60.5 55 
DBP (R) GGC GAT ATC AGG AGA AGG AAA 59.5 48 
Ad5 13S E1A E1A 13S/11S (F) CCT TTC CCG GCA GCC CGA 62.9 72 
E1A 13S (R) CAG ACA CAG GAG TAG ACA AAC 59.5 48 
Ad5 12S E1A E1A 12S (F) GAT CGA AGA GGT ACT GGC TGA  61.2 52 
E1A 12S/10S (R) ACA GGA CCT CTT CAT CCT CG 60.5 55 
Ad5 11S E1A E1A 11S/10S (F) TGA TCG AAG AGC CGA GCA G 59.5 58 
E1A 13S/11S (R) CAG ACA CAG GAG TAG ACA AAC 59.5 48 
Ad5 10S E1A E1A 11S/10S (F) TGA TCG AAG AGC CGA GCA G 59.5 58 
E1A 10S (R) ACA GGA CCT CTT CAT CCT CG 60.5 55 
Ad5 9S E1A E1A 9S (F) CTG ATC GAA GAG TCC TGT GTC 61.2 52 
E1A 9S (R) TCT CAC GGC AAC TGG TTT AAT G 60.1 45 
Ad5 IVa2 IVa2 (F) GAA ACC AGA GGG CGA AGA C 59.5 58 
IVa2 (R) CAT CTC GAT CCA GCA TAT CTC 59.5 48 
Ad5 IX IX (F) CTC GTT TGA TGG AAG CAT TGT GA 60.9 43 
IX (R) GTC AAC TTG TCA TCG CGG G 59.5 58 
Human GAPDH GAPDH (F) CTCAACTACATGGTTTACATGTTC 60.3 38 
GAPDH (R) GCAAATGAGCCCCAGCCTT 59.5 58 
Ad5 pre-IVa2 pre-IVa2 (F) GGA AAC CAG AGG TAA GAA ACG 59.5 48 
pre-IVa2 (R) GAC TTT TGA GGG CGT AGA GC 60.5 55 
Ad5 pre-DBP pre-DBP (F) CTG TCC TTC TTC TCG ACT GAC 61.2 52 
DBP (R) ACC AGC GCG TCT TGT GAT GA 60.5 55 
Ad5 pre-E1A pre-E1A (F) TTA AAA GGT CCT GTG TCT GAA CC 60.9 43 
E1A 9S (R) TCT CAC GGC AAC TGG TTT AAT G 60.1 45 
Ad5 pre-tripartite 
leader (TPL) 
pre-TPL (F) ATC GCT GTC TGC GAG GGC 60.8 67 
pre-TPL (R) CTG TCC AAC GCC CTC TAC G 61.6 63 
pre-GAPDH pre-GAPDH (F) TAT CGT GGA AGG ACT CAT GGT AT 60.9 43 
pre-GAPDH (R) GCA TGG ACT GTG GTC TGC AA 60.5 55 
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Table 2-2. siRNAs. 
GC – Guanine/cytosine content. 
 Target  Name  Sequence (5’ to 3’) GC  
(%) 
Source 
Human 
coilin 
Coilin siRNA 2a GAG AGG AGU UGC UGA GAA UTT 47 Eurogentec 
 Coilin siRNA 2b AUU CUC AGC AAC UCC UCU CTT 42 
Human 
SMN 
Human SMN 
siRNA (sc-36510) 
Sequence not provided. Supplied as a 
pool of three target-specific 19-25 
nucleotide siRNAs 
- Santa Cruz 
None AllStars negative 
control siRNA 
(SI03650318) 
Sequence not provided - Qiagen 
 
Table 2-3. Primary antibodies specific for adenovirus proteins. 
IgG – immunoglobulin. GST- Glutathione S-transferase. 
Antibody Specificity Species and isotype Source 
2Hx2 Ad hexon Mouse monoclonal IgG In house as described previously (Cepko 
et al., 1981). Hybridoma cells HB-117 
were obtained from the American Type 
Culture Collection (ATCC) 
Ad5PB Ad5 penton base Rabbit polyclonal sera In house (unpublished results) 
B6-8 Ad E2A-72K Mouse monoclonal IgG K Leppard, Warwick University, UK 
(Reich et al., 1983) 
DBP Ad E2A-72K Rabbit polyclonal sera K Leppard, Warwick University, UK 
(Made in house; raised to bacterially 
expressed GST-DBP) 
Ad5F Ad5 fibre Rabbit polyclonal sera In house (Caygill et al., 2012) 
TB5 Ad5 fibre  Mouse monoclonal IgG In house as previously described 
(Franqueville et al., 2008) 
Ad3F Ad3 fibre Rabbit polyclonal sera P. Fender, le Centre National de la 
Recherche Scientifique (CNRS), France 
sc-430 Ad 2/5 E1A Rabbit polyclonal IgG Santa Cruz 
IIIa Ad2/5 IIIa Rabbit polyclonal IgG G. Akusjarvi, Uppsala University, 
Sweden (Everitt et al., 1992) 
IX Ad IX Rabbit polyclonal sera In house as described previously 
(Boulanger et al., 1979) 
Pn Ad IVa2 Rabbit polyclonal IgG M. Imperiale, University of Michigan, 
USA (Tribouley et al., 1994) 
L4-33K Ad2 L4-33K Rabbit polyclonal sera W. Deppert, Hamburg University, 
Germany (Gambke and Deppert, 1981) 
L4-100K Ad2 L4-100K Rabbit polyclonal IgG W. Deppert, Hamburg University, 
Germany (Gambke and Deppert, 1981) 
ab36851 Capsid proteins 
from Ad 
serotypes 2, 3, 4, 
5 and 6 
Goat polyclonal IgG Abcam 
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Table 2-4. Primary antibodies specific for cellular proteins. 
IgG – immunoglobulin. 
Antibody Specificity Species and isotype Source 
ab5821-100 Human fibrillarin Rabbit polyclonal IgG Abcam 
PG-M3 Human PML Mouse monoclonal IgG1 Santa Cruz 
11G5 Human Aly Mouse monoclonal IgG1 Abcam 
D6 Human C23 Mouse monoclonal IgG1 Santa Cruz 
0412 Human B23 Mouse monoclonal IgG1 Santa Cruz 
H-300 Human coilin Rabbit polyclonal IgG Santa Cruz 
F-7 Human coilin Mouse monoclonal IgG1 Santa Cruz 
8 Human SMN Mouse monoclonal IgG1 BD Biosciences 
H-195 Human SMN Rabbit polyclonal IgG Santa Cruz 
A301-442A Human WRAP53 Rabbit polyclonal IgG Bethyl Laboratories 
C65 Human GAPDH Mouse monoclonal IgG1 Calbiochem 
Y12 Human Smith (Sm) antigen Mouse monoclonal IgG3 Abcam 
M5409 None Mouse monoclonal IgG2a Sigma Aldrich 
UNLB None Rabbit polyclonal IgG BioLegend 
 
Table 2-5. Secondary antibodies.  
IgG – immunoglobulin. HRP - horseradish peroxidise. 
Antibody Specificity Species Label Source 
A-21447 Goat IgG Donkey Alexa Fluor-647 Invitrogen 
A-11029 Mouse IgG Goat Alexa Fluor-488 Invitrogen 
A-21202 Mouse IgG Donkey Alexa Fluor-488 Invitrogen 
A-11070 Rabbit IgG Goat Alexa Fluor-488 Invitrogen 
A-21206 Rabbit IgG Donkey Alexa Fluor-488 Invitrogen 
A-11020 Mouse IgG Goat Alexa Fluor-594 Invitrogen 
A-21203 Mouse IgG Donkey Alexa Fluor-594 Invitrogen 
A-11037 Rabbit IgG Goat Alexa Fluor-594 Invitrogen 
A-21207 Rabbit IgG Donkey Alexa Fluor-594 Invitrogen 
A-6782 Mouse IgG Sheep HRP Sigma Aldrich 
A-6154 Rabbit IgG Goat HRP Sigma Aldrich 
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2.1.5  Cells and cell lines 
Primary human keratinocytes were kindly provided by Miriam Whittmann (University of Leeds, 
UK). All cell lines were purchased from the European Collection of Animal Cell Cultures 
(Salisbury, UK).  
A549 Human lung adenocarcinoma cell line (Giard et al., 1973). 
HeLa Human cervical carcinoma cell line isolated from the 
cervical tumour of Henrietta Lacks (Gey et al., 1952). 
2.1.6  Viruses 
Ad5  Wild type Ad5 virus was kindly provided by W.C Russell 
(University of St. Andrews, UK). 
Ad3  Wild type Ad3 virus was kindly provided by W.C Russell 
(University of St. Andrews, UK). 
Ad12  Wild type Ad12 virus was kindly provided by Bela Tarodi 
(University of Szeged, Hungary). 
2.1.7  Buffers and solutions 
2.1.7.1  Agarose gel electrophoresis 
10x Tris-Borate (TBE) Buffer (1 l) 
108 g Tris, 55 g Boric acid, 40 ml 0.5 M EDTA (pH 8.0) 
10x Orange Gel Loading Buffer (20 ml) 
 5 g Ficoll 400, 2 ml 1 M Tris-HCl (pH 7.4), 4 ml 1 M EDTA (pH 8.0), 0.04 g Orange G 
2.1.7.2  SDS-PAGE 
5x Resolving Gel Buffer (RGB) pH 8.5 
1.875 M Tris-HCl (227.06 g/l), 0.5% (w/v) SDS 
 10x Stacking Gel Buffer (SGB) pH 6.5 
1.25 M Tris-HCl (151.37 g/l), 1% (w/v) SDS 
12% Resolving Acrylamide Gel (20 ml) 
30% Acrylamide (8 ml), dH2O (8 ml), 5x RGB (4 ml), 10% (w/v) APS (200 μl), 1% TEMED 
(20 μl) 
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5% Stacking Gel (12 ml) 
30% Acrylamide (2 ml), dH2O (8.8 ml), 10x SGB (1.2 ml), 10% (w/v) APS (100 μl), TEMED 
(20 μl) 
5x SDS-PAGE loading buffer (50 ml) 
5 g (10% w/v) SDS, 12.5 ml 1 M Tris-HCl (pH 6.8), 50 mg Bromophenol Blue, 25 ml glycerol, 
1.75 ml mercaptoethanol 
SDS-PAGE 10x running buffer (1 l) pH 8.3 
30.3 g Tris, 144.2 g glycine, 10 g SDS 
2.1.7.3  Western blotting  
Western blotting (Towbin) transfer buffer pH 8.3 
25 mM Tris, 92 mM Glycine, 20% methanol 
Western blotting blocking buffer 
10% (w/v) Marvel, 0.1% Tween-20 in PBS 
2.1.7.4  Lysis buffers 
RIPA Buffer 
50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1% NP40 substitute, 0.5% DOC, 0.1% SDS  
Membrane Lysis Buffer (MLB) 
50 mM HEPES-KOH (pH 7.5), 150 mM NaCl, 2 mM mgCl2, 2 mM CaCl2, 1% Triton X-100, 
10% glycerol 
2.1.7.5 Spectophotometry 
TE Buffer 
10 mM Tris-HCl (pH 8.0), 1 mM EDTA 
2.1.7.6  Virus purification 
DNase solution 
20 mM Tris-HCl (pH 7.4), 50 mM NaCl, 1 mM DTT, 0.1 mg/ml BSA, 10 mg/ml bovine 
pancreatic DNase 1, 50% glycerol 
CsCl solutions 
1.5d – 90.8 g CsCl, 109.2 g 10 mM Tris-HCl pH 8.0 
1.35d – 70.4 g CsCl, 129.6 g 10 mM Tris-HCl pH 8.0 
1.25d – 54.0 g CsCl, 146.0 g 10 mM Tris-HCl pH 8.0 
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2.2 General Methods 
2.2.1 Cell culture 
Unless otherwise stated, cell lines were grown in DMEM supplemented with 10% (v/v) heat-
inactivated FCS and 20 mM L-glutamine (referred to hereon in as ‘complete DMEM’). Primary 
human keratinocytes were grown in Keratinocyte Media 2. Cells were grown in CellBIND® 
culture flasks (Corning) and maintained at 37 °C in a humidified atmosphere containing 5% 
CO2.  
2.2.2 SDS-PAGE and Western Blotting 
2.2.2.1 Preparation of whole cell lysates 
Ice-cold RIPA buffer was supplemented with 1% protease inhibitor cocktail (100 mM 
AEBSF.HCl, 80 µm aprotinin, 5 mM bestatin, 1.5 mM E-64, 2 mM leupeptin, 1 mM  
pepstatin A) and 200 μl was added to each well of a 6-well plate. Cells were incubated on ice at 
4 °C for 15 minutes. Cells were scraped in the buffer using a cell scraper and were transferred to 
a microcentrifuge tube. Cells were centrifuged at 15,000 g for 10 minutes at 4 °C. Supernatant 
(whole cell lysate) was transferred to a fresh microcentrifuge tube and stored at -80 °C. 
2.2.2.2 Preparation of nuclear and cytoplasmic fractions 
Cells were detached from 6-well plates by trypsin treatment (0.5 ml). Once cells had detached, 
they were neutralised with 0.5 ml complete DMEM. Following a PBS wash, cells were 
resuspended in 1 ml of ice-cold MLB supplemented with 1% protease inhibitor cocktail and 
incubated on ice for 30 minutes. Nuclei were pelleted at 10,000 g for 20 minutes at 4 °C. The 
supernatant (cytoplasmic fraction) was transferred to a new tube on ice. Nuclei were lysed in 
200 μl RIPA buffer on ice for 15 minutes. Samples were centrifuged at 15,000 g for 10 minutes 
at 4 °C to remove cellular debris. The supernatant (nuclear fraction) was removed and 
transferred to a fresh tube. Samples were either stored at -80 °C or analysed by SDS-PAGE. 
2.2.2.3 Protein quantification 
The concentration of protein in whole cell lysates was determined using the BioRad DC assay 
system which is based on the Lowry assay (Bio-Rad Inc.). In brief, Reagent A′ was prepared by 
adding 20 µl of Reagent S to 1 ml of Reagent A. 125 µl Reagent A′ was then added to 25 µl 
standards of bovine serum albumin (BSA) (concentrations 0-5 mg/ml) in sterile quotient (SQ) 
water or to 25 μl whole cell lysate. Each tube was vortexed. Reagent B (1 ml) was added to each 
tube and the tube was immediately vortexed. After 15 minutes the absorbance was measured at 
750 nm using a spectrophotometer (Genova), calibrating between each reading using the 0 
mg/ml BSA standard. The BSA standards were used to plot a calibration curve and the protein 
concentration of the samples was subsequently determined. 
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2.2.2.4 SDS-PAGE 
Protein extracts analysed by SDS-PAGE were separated on a 10, 12% or 15% resolving gel and 
a 5% stacking gel. SDS loading buffer (5x) was added to each sample to give a final 
concentration of 1x buffer. The sample was loaded directly onto the gel and electrophoresis was 
conducted in SDS-PAGE running buffer at 100 V for approximately 15 minutes or until the 
bromophenol blue had passed into the stacking gel. Electrophoresis was then conducted at 150 
V for 1.5 hours or until the bromophenol blue band had reached the bottom of the gel. 
2.2.2.5 Western Blotting 
Two sheets of BioRad blotting paper were soaked in Towbin transfer buffer. PVDF membrane 
was soaked in methanol followed by transfer buffer. One sheet of blotting paper was placed on 
the conductance plate of a transfer chamber (Biometra) and the PVDF membrane was placed on 
top. The SDS-PAGE gel was rinsed in transfer buffer before being placed directly onto the 
PVDF membrane. The second sheet of blotting paper was placed on top before the lid of the 
transfer chamber was closed. Electrophoretic transfer was conducted for 1 hour at 15 V. Bound 
antibody was detected using the ECL detection system (GE Healthcare) and images were 
captured on a Las 3000 Imager (Fujifilm). Densitometric analysis was carried out using 
Advanced Image Data Analyser (AIDA) software.  
2.2.3 Nucleic acid extraction and purification 
2.2.3.1 Total RNA extraction (Trizol-chloroform extraction) 
Cell monolayers at approximately 90% confluency in 6-well dishes were washed in PBS before 
addition of 500 μl Trizol (Invitrogen) per well. Cells were incubated for 5 minutes at room 
temperature before being transferred to a microcentrifuge tube. Chloroform (200 μl) was added 
to the sample, vigorously mixed then centrifuged at 13,000 g for 15 minutes at 4 °C. The upper 
aqueous layer of the supernatant was transferred to a new microcentrifuge tube, 200 μl 
chloroform was added and the sample was centrifuged at 13,000 g for 10 minutes at 4 °C. The 
upper layer of the supernatant was transferred to a new microcentrifuge tube and 200 μl 
isopropanol was added. Following vigorous mixing the tube was incubated at room temperature 
for 10 minutes. The sample was centrifuged at 13,000 g for 10 minutes at 4 °C to pellet the 
RNA. Ethanol (70%) in diethyl pyrocarbonate-treated H2O (DEPC-H2O) (Invitrogen) was added 
without resuspending the pellet. The solution was centrifuged at 7,500 g for 10 minutes at 4 °C 
and the supernatant was removed. The sample was pulse-centrifuged to remove the remaining 
ethanol then the pellet was left to air dry for 20 minutes. The pellet was resuspended in 25 μl 
DEPC-H2O. In order to remove contaminant DNA, five units of RNAse-free DNAse (Promega) 
were added to the sample along with 5x DNAse buffer in a total reaction volume of 50 μl. The 
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sample was incubated with the DNAse at 37 °C for 30 minutes before inactivation of the 
enzyme by incubation at 65 °C for 10 minutes. The RNA sample was stored at -80 °C. 
2.2.3.2 Extraction of nuclear and cytoplasmic RNA 
Cells were detached from 6-well plates by trypsin treatment (0.5 ml). Once cells had detached, 
they were neutralised with 0.5 ml complete DMEM. Following a PBS wash, cells were 
resuspended in 1 ml of ice-cold MLB supplemented with 1% protease inhibitor cocktail and 
incubated on ice for 30 minutes. Nuclei were pelleted at 10,000 g for 20 minutes at 4 °C. The 
supernatant (cytoplasmic fraction) was transferred to a new tube on ice and 800 μl Trizol was 
added. The nuclear pellet was resuspended in 500 μl Trizol. Samples were incubated at room 
temperature for 5 minutes. Samples were subject to Trizol-chloroform RNA extraction as 
detailed in Chapter 2.2.3.1. 
2.2.4 Nucleic acid analysis 
2.2.4.1 Quantification by spectrophotometry 
Purified RNA was analysed using a Nanodrop 1000 spectrophotometer, with OD260: OD280 
ratios higher than 1.7 indicative of good quality RNA and lower values indicating protein 
contamination. OD260: OD230 ratios were also taken, with 2.0 signifying pure RNA and lower 
values indicating contamination by phenol or other organic compounds. 
2.2.4.2 Reverse-transcription (RT) 
Reverse-transcription (RT) of RNA was conducted as detailed in the Roche Transcriptor First 
Strand cDNA Synthesis Kit manual (version April 2007) using random hexamer primers 
(Roche). In brief, random hexamer primers were added to 1 μg total RNA in a total reaction mix 
of 13 µl. The template primer mixture was subject to initial denaturation at 65 °C for 10 minutes 
in a thermal block cycler with a heated lid. The samples were cooled on ice before addition of 
the following components to a total reaction volume of 20 µl; 4 μl 5x Transcriptor Reverse 
Transcriptase Reaction Buffer, 0.5 μl Protector RNAse Inhibitor, 2 μl Deoxynucleoside 
Triphosphate (dNTPs) Mix (10 µm) and 0.5 μl Transcriptor Reverse Transcriptase (Roche). The 
tubes were placed in a thermal block cycler and incubated for 10 minutes at 25 °C followed by 1 
hour at 50 °C to synthesise cDNA from mRNA. 
2.2.4.3 Semi-quantitative PCR 
Semi-quantitative PCR amplification of cDNA was performed using 1 μl cDNA in a reaction 
mix containing 2.5 μl of 1 μM custom-made primers (see Table 1), 0.5 μl dNTPs (10 µm), 0.125 
μl Phusion DNA polymerase and 5x Standard High Fidelity (HF) buffer (Invitrogen) in a total 
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reaction volume of 25 µl. PCR reaction conditions were chosen according to the manufacturer’s 
recommendations for Phusion polymerase with an annealing temperature of 60 °C. 
2.2.4.4 Quantitative PCR (qPCR) 
Quantitative PCR of cDNA was carried out using 1 μl cDNA in a reaction mix containing 2.5 μl 
of 1 μM custom primers, 7.5 μl SYBR Green PCR Master Mix (Qiagen) and 4 μl DEPC-H20. 
An initial 5 minute incubation at 95 °C was carried out to activate the HotStarTaq Plus DNA 
polymerase. Two-step cycling procedure was then performed on a Rotorgene 6000 cycler 
(Corbett) according to instructions in the Rotor-Gene SYBR Green Handbook (version July 
2011) with an annealing temperature of 60 °C. Data was analysed using Rotorgene 6000 
software (Corbett). Standard curves were produced for each set of primers. The average Ct 
value was determined from duplicate reactions and was normalised against the average Ct value 
obtained for the ‘housekeeping’ control transcript, GAPDH. The identities of the products 
obtained were confirmed by melting curve analysis. 
2.2.4.5 Agarose gel electrophoresis 
Agarose was dissolved in 1x TBE buffer to a final concentration of 0.8-2% (w/v) depending on 
the size of the DNA to be identified. Samples were loaded in Orange G loading buffer and 
1/10,000 dilution of stock SYBR Green I (concentration not provided) (Sigma Aldrich), with a 
1Kb
+
 DNA ladder (Invitrogen) to determine approximate size. Electrophoresis was conducted at 
100 V for approximately 1 hour in 1x TBE buffer. 
2.2.5 Transfection using siRNA 
2.2.5.1 Standard siRNA transfection 
Cells were seeded in 6 well plates and grown to ~50% confluence in complete DMEM. Tubes A 
and B were made up; tube A containing the optimised amount of stock siRNA in 250 μl 
Optimem-1 and tube B containing 3 μl Lipofectamine-2000 in 250 μl Optimem-1. The tubes 
were left to stand at room temperature for 10 minutes before addition of tube B to tube A, 
producing tube AB. Tube AB was incubated at room temperature for 30 minutes before addition 
to the wells. After 4 hours the media was replaced with complete DMEM. Cells were incubated 
at 37 °C for 24 hours. 
2.2.5.2 Reverse siRNA transfection 
Stock siRNA was diluted to 1 μM in Optimem-1 and 5 μl was added to each well of a 96-well 
tissue culture plate. An eppendorf tube containing 0.2 μl Lipofectamine 2000 and 15 μl 
Optimem-1 was prepared and incubated at room temperature for 5 minutes. The contents of the 
tube were then added to the well and the plate was incubated for 30 minutes at room 
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temperature with occasional agitation. Cells (80 μl of 2.5 x 104 cells/ml) were then added to 
each well. Cells were incubated for 6 hours to allow adherence to the well. The medium was 
then exchanged for complete DMEM and cells were incubated for a further 18 hours. 
2.2.6 Virus infection 
2.2.6.1 Standard infection 
Cells were seeded in 6-well plates and grown to approximately 80% confluence in complete 
DMEM. Adenovirus was diluted in 1 ml DMEM and, unless otherwise stated, was adsorbed to 
the cells at a multiplicity of infection (MOI) of 5 FFU/cell. After 1 hour, 1 ml of complete 
DMEM was added to each well. The cells were incubated at 37 °C in a humidified atmosphere 
containing 5% CO2.  
For treatment with cytosine arabinoside (AraC), 20 μg/ml was added at the same time as virus 
infection. Cells were then incubated for 24 hours before harvesting. For treatment with 
cycloheximide (CHX), 30 μg/ml was added at 12 h.p.i with Ad5 and cells were incubated with 
the CHX-containing medium for 6 hours. Cells were harvested at 24 h.p.i. 
2.2.6.2 Second-round infection (virus yield assay) 
Ad5-infected cells were treated with trypsin and once detached were neutralised in complete 
DMEM. Cells were pelleted at 350 g for 5 minutes at 4 °C. The supernatant was removed and 
cell pellets were frozen in liquid nitrogen, thawed in warm water and sonicated in a bath-type 
sonicator. The freeze-thaw-sonicate process was repeated twice. The cell suspension was made 
up to 250 μl with DMEM. A ten-fold dilution series was constructed to a final dilution of 10-5. 
A set of positive controls comprising ten-fold dilutions of Ad5 virus stock was also prepared. A 
100 μl aliquot of each dilution was then added to 1 ml DMEM before addition to the cells.  
2.2.7 Indirect immunofluorescence 
Cells were grown to sub-confluence on coverslips in 6 well plates prior to infection or 
transfection and then incubated at 37 °C for 24 or 48 hours. Cells were washed three times in 
PBS prior to fixation for 10 minutes in 10% formalin. Cells were washed three times in PBS 
before permeabilisation with 0.1% (v/v) Triton X-100 in PBS for 10 minutes at room 
temperature. Cells were washed three times in PBS before blocking in 10% (v/v) NGS in PBS 
for 20 minutes. Cells were washed three times in PBS before being incubated with 200 μl of 
primary antibody (diluted in 0.1% Triton X-100, 1% NGS in PBS) for 1 hour at room 
temperature. Cells were washed three times in PBS before being incubated with the appropriate 
secondary Alexa-Fluor conjugate antibody for 30 minutes in the dark. Cells were washed three 
times in PBS. Cell nuclei were stained by incubating with 4’, 6-diamidino-2-phenylindole 
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(DAPI) (Sigma Aldrich) in PBS for 2 minutes before washing three times with PBS. Coverslips 
were mounted on slides using Vectashield mounting medium. Confocal microscopy was 
performed using an inverted LSM510 confocal microscope (Zeiss) coupled to LSM Image 
Browser (Zeiss). All images are single confocal sections of 0.8 µm. The same exposures were 
used throughout any one experiment. Different exposures were used between different 
experiments.  
2.2.8 Flow cytometry 
Cells were detached from 6-well plates by trypsin treatment (0.5 ml). Once detached, cells were 
neutralised with 0.5 ml complete DMEM. The samples were transferred to an eppendorf tube 
and cells were pelleted by centrifugation (all centrifugation steps were conducted at 350 g for 4 
minutes at 4 °C. Supernatant was removed and the cells were resuspended in 200 μl of 10% 
formalin. The samples were incubated at room temperature for 10 minutes then cells were 
pelleted by centrifugation. The supernatant was removed and the cells resuspended in 200 μl 1% 
Triton X-100 in PBS and incubated at room temperature for 5 minutes. Cells were pelleted by 
centrifugation before resuspension in 10% NGS in PBS. The sample was subsequently divided 
into two eppendorf tubes, each containing 100 μl and labelled tube 1 and tube 2. Samples were 
incubated at room temperature for 10 minutes. Samples were pelleted and the supernatant 
removed. Tube 1 cells were resuspended in 50 μl of primary antibody diluted in 1% NGS, 0.1% 
Triton X-100 in PBS while tube 2 cells were resuspended in 50 μl of isotype-matched control 
antibody in 1% NGS, 0.1% Triton X-100 in PBS. Cells were incubated for one hour at room 
temperature. Cells were then pelleted by centrifugation and the supernatant was removed. Cells 
were resuspended in 50 μl of the appropriate Alexa Fluor-488-labelled secondary fluorescent 
conjugate antibody in 1% NGS, 0.1% Triton-X-100 in PBS and incubated for 30 minutes at 
room temperature in the dark. Cells were pelleted by centrifugation and the supernatant was 
removed. The cells were resuspended in 200 μl PBS and kept on ice in the dark until running on 
a Fortessa flow cytometer (BD Biosciences). A total of 10,000 cells were analysed in each 
sample and the geometric mean fluorescence of the whole cell population was calculated using 
FlowJo software (TreeStar Inc.).  
2.2.9 MTT assay 
Stock (5 mg/ml in PBS) 3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) 
(Sigma Aldrich) was diluted to 2.5 mg/ml in complete DMEM and 40 μl was added to each well 
of a 96-well plate. Cells were incubated for 4 hours at 37 °C. The medium was removed and 
cells were washed in PBS. In living cells, the yellow tetrazole MTT was reduced to insoluble 
purple formazan dye which was subsequently solubilised using 200 μl stock DMSO (Sigma 
Aldrich) (Carmichael et al., 1987). Cells were incubated at room temperature in the dark with 
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agitation for 10 minutes. The coloured solution was quantified using a spectrophotometer 
reading at 570 nm. A reading was also taken at 620 nm to account for background.  
2.2.10 Plaque assay 
Virus dilutions were prepared from infected cell lysate as described in Chapter 2.2.6.2. At 4 
h.p.i, carboxylmethylcellulose (CMC) (1.6% in PBS) was diluted 1:2 in complete DMEM and 2 
ml was added to each well of a 6-well plate. Cells were then incubated for 6 days at 37 °C and 
5% CO2. Wells were washed in PBS before fixation in 1% gluteraldehyde in PBS for 10 
minutes. Cells were washed in PBS before addition of crystal violet (0.05% (w/v) crystal violet, 
20% ethanol, 80% SQ water) and incubated at room temperature for 10 minutes. The crystal 
violet was then washed off and the plaques were counted. 
2.2.11 Production of wild type viruses 
2.2.11.1  Propagation of wild type viruses 
Wild type Ad12 virus was propagated in the A549 cell line. Wild type Ad5 virus was 
propagated in the HeLa cell line. Wildtype Ad3 virus was a kind gift from Kathryn Hall (Leeds 
Institute of Molecular Medicine, Leeds).  
To propagate adenovirus, a T175 cell culture flask containing monolayer cells at approximately 
90% confluency was infected with Ad5 or Ad12 virus at an MOI of 1 as described in Chapter 
2.2.6.1. Infected cells were incubated at 37 °C and 5% CO2 for three days or until cytopathic 
effect was evident. Cells were pelleted at 1,500 g for 5 minutes at room temperature and the 
supernatant was discarded. Pellets were frozen in liquid nitrogen, thawed in warm water then 
sonicated for 45 seconds in a bath type sonicator and this process was repeated twice. The cell 
pellet was split between five T175 cell culture flasks each containing cell monolayers of 
approximately 90% confluency. This process was repeated until pellets from 30 T175 flasks 
were obtained. Pellets were stored at -80 °C. 
2.2.11.2  Virus purification 
Viruses were purified using the caesium chloride (CsCl) density centrifugation method as 
previously described (Tollefson et al., 1999). Infected cell pellets from 30 T175 flasks were 
frozen in liquid nitrogen, thawed in warm water and sonicated for 45 seconds in a bath type 
sonicator; this process was repeated twice. Pellets were combined and resuspended in 10 ml of 
sterile 0.1 M Tris-HCl (pH 8.0). To this, 1 ml of 5% (w/v) sodium deoxycholate (DOC) was 
added, mixed and incubated at room temperature for 30 minutes or until viscous. Aliquots of 
100 μl of 2 M mgCl2 and 50 μl of DNase 1 (10 mg/ml) solutions were added and the solution 
was incubated at 37 °C for 30 minutes with mixing every 10 minutes until the viscosity 
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decreased. The virus lysate was centrifuged at 3,000 rpm for 15 minutes at 4 °C. The 
supernatant was transferred to a clean tube and stored on ice. CsCl gradients for each 5 ml of 
clarified virus lysate were set up in SW40 ultraclear Beckman tubes using a kwill (NHS 
Supplies) to layer the lower density CsCl above the higher density CsCl as follows: 1 ml of 1.5 
d CsCl (bottom), 2.5 ml 1.35 d CsCl, 2.5 ml 1.25 d CsCl (top). Virus lysate (5 ml) was layered 
on top of the gradients and 0.1 M Tris-HCl (pH 8.0) was used to balance. The gradients were 
centrifuged in a SW40 rotor in a Beckman (L5-50B) centrifuge at 35,000 rpm for 1 hour at 10 
°C at the slowest acceleration and deceleration settings. The virus band located at the 1.35/1.25 
d interface was collected by aspiration from the two tubes. The virus band was layered on top of 
2 ml 1.35 d CsCl in a SW55 centrifuge tube, diluting with 0.1 M Tris-HCl (pH 8.0) to achieve 
layering if required. Samples were centrifuged in a Beckman (L5-50B) centrifuge in a SW40 
rotor at 35,000 rpm for 15 hours at 4 °C at minimum acceleration without braking. Infectious 
whole virus particles were present as the lower of two visible bands; both bands were collected. 
The CsCl was then removed from the purified virus by extensive dialysis against 3 changes of 
10 mM HEPES-KOH buffer (pH 8.0) using a Slide-a-Lyser dialysis cassette 3500MWCO over 
the course of a day at 4 °C. Sterile glycerol was added to the virus preparation at a 10% (v/v) 
ratio. The virus preparation was divided into 10 μl aliquots and stored at -80 °C.  
2.2.11.3 Virus quantification 
2.2.11.3.1 Virus particles per ml (vp/ml) 
Virus stocks were diluted 1:10 in TE buffer containing 0.1% (v/v) SDS. The solution was 
incubated for 5 minutes at 50 °C before determination of the OD260. Virus particles per ml 
(vp/ml) were calculated according to the following equation (Maizel et al., 1968): 
1 unit A260 = 1.1 x 10
12
 vp/ml x dilution factor 
2.2.11.3.2 Focus-forming units per ml (FFU/ml) 
A549 cells were grown to confluency in 6 well plates. Virus preparations were serially diluted 
10
-2
 to 10
-6
 in 1 ml DMEM. The dilutions were then added to the wells and incubated for 1 hour 
at 37 °C. Complete DMEM (1 ml) was then added to each well and the samples were incubated 
for 24 hours. Samples were then subject to flow cytometry (see Chapter 2.2.8) using mouse 
anti-hexon or mouse isotype control antibodies. The dilution that gave around 50% FITC-
positive cells is then used to calculate the FFU/ml using the following equation: 
FFU/ml =% positive (as a fraction) x dilution factor x number of cells in sample (6 x 10
5
). 
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Chapter 3 – Defining the redistribution of Cajal body proteins during 
Ad5 infection 
3. Chapter 3 - Defining the redistribution of Cajal body proteins 
during Ad5 infection 
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3.1 Introduction 
Cajal bodies (CBs) are highly multifunctional nuclear subdomains which contain numerous 
proteins including coilin, fibrillarin, snRNPs, SMN and WRAP53 (Raska et al., 1990; Carvalho 
et al., 1999; Mahmoudi et al., 2010). During Ad5 infection, coilin and fibrillarin are 
redistributed into numerous microfoci termed ‘rosettes’ (Rebelo et al., 1996; Rodrigues et al., 
1996; James et al., 2010). In contrast, snRNPs are redistributed into ring-shaped structures in 
the nucleoplasm (demarking regions of active splicing and transcription), before accumulating 
in enlarged interchromatin granules at late stages of infection (Rebelo et al., 1996; Rodrigues et 
al., 1996; Bridge et al., 2003). As snRNPs no longer locate to CBs following Ad5 infection, this 
indicates that snRNP trafficking and/or assembly in CBs may be abrogated during Ad5 
infection. It has been previously shown that the location of snRNPs in CBs is dependent on the 
snRNP trafficking proteins, WRAP53 and SMN (Girard et al., 2006; Mahmoudi et al., 2010). 
However, the subcellular location of WRAP53 and SMN following Ad5 infection is currently 
unknown. To further define the impact of Ad5 infection on CB proteins, this chapter will 
address the subcellular distribution of SMN and WRAP53 following Ad5 infection. To address 
the potential function of CB proteins during infection, their redistribution will be defined by 
immunofluorescence microscopy relative to markers of other nuclear substructures including 
PML-NBs, nucleoli, splicing factors, viral DNA replication centres and sites of virus assembly.  
Defining the time point at which a cellular protein is redistributed can aid with identification of 
potential viral proteins responsible for redistribution of the cellular protein. In addition, defining 
the time point at which a cellular protein is redistributed may also aid in characterising the role 
of the protein during infection. The time point at which CB proteins are redistributed from CBs 
will also be addressed by confocal microscopy utilising inhibitors of DNA replication and 
protein translation as well as virus marker proteins for certain stages of infection. 
The redistribution of CBs during Ad5 infection has previously been characterised only in the 
HPV-18 transformed cervical cancer cell line, HeLa (James et al., 2010; Rebelo et al., 1996; 
Rodrigues et al., 1996). Considering the natural infection by Species C Ads is respiratory tract 
epithelium (Schmitz et al., 1983), this chapter will investigate the redistribution of CBs in the 
respiratory epithelial cell line, A549, before extending the study to primary cells. Finally, the 
disassembly of CBs has to date only been characterised in terms of species C Ad5 infection 
(James et al., 2010; Rebelo et al., 1996; Rodrigues et al., 1996). To establish whether the 
redistribution of CBs is specific to species C Ad infection or conserved across Ad species, CB 
redistribution will also be investigated following infection with species B virus Ad3 and species 
A virus Ad12. 
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3.2 Impact of Ad5 infection on the cellular levels of CB proteins 
In order to study the redistribution of CBs during Ad5 infection, the time between initial 
infection and host cell lysis in the cell line of choice must firstly be established. Marker proteins 
of early and late phase infection can also allow identification of the time points at which early 
and late phase infection commence. A549 cells were chosen as the cell line in which to study 
Ad5 infection as they are derived from respiratory epithelial cells, which are the cellular target 
for natural species C Ad infection in vivo (Schmitz et al., 1983). From extensive review of the 
literature, the general consensus for virus titre when studying Ad infection of cell lines appears 
to be an MOI of 1-10 FFU/cell. Therefore an intermediate MOI of 5 was chosen for this study.  
For western blotting analysis of Ad protein levels across a time course of infection, A549 cells 
were mock or Ad5 infected (Chapter 2.2.6.1) and cells were harvested at 0, 4, 8, 12, 16, 24 and 
48 h.p.i. The final time point to be harvested was 48 h.p.i, as by this time there was evidence of 
cytopathic effect (CPE) in a substantial proportion of the Ad5-infected cells indicating that the 
cells were beginning to lyse (Hilleman and Werner, 1954; Rowe et al., 1955). Protein from 
whole cell lysates were analysed by SDS-PAGE and Western blotting (Chapter 2.2.2), using an 
anti-E1A and an anti-penton base antibody as markers for early and late phase infection, 
respectively. Membranes were also incubated with an antibody raised against the cellular 
‘housekeeping’ protein GAPDH as an internal loading control.  
As shown in Figure 3-1, the level of GAPDH remained constant across the time course, 
indicating that Ad5 infection does not alter the levels of housekeeping proteins during infection. 
E1A 293R and 249R proteins were first detectable at 8 h.p.i, consistent with their known 
immediate early expression (Berk and Sharp, 1978; Nevins et al., 1979). At 24 h.p.i, penton 
base was first detected, with increased expression at 48 h.p.i. This indicates that in A549 cells at 
an MOI of 5, the immediate early protein E1A and late protein penton base are first detectable at 
4-8 h.p.i and 16-24 h.p.i, respectively. 
The levels of CB proteins coilin, SMN, WRAP53, Sm (a component of all spliceosomal 
snRNPs) and fibrillarin were investigated over the time course. As shown in Figure 3-1, the 
protein levels of SMN, Sm and fibrillarin remained constant across the time course. Although 
the cellular levels of coilin and WRAP53 appeared to stay stable up until 24 h.p.i, there was an 
apparent decrease in coilin and WRAP53 levels by 48 h.p.i (Figure 3-1). Quantification of 
changes in CB protein levels was carried out by densitometric analyses of the protein band 
signal intensities (Figure 3-2). No significant alterations in protein levels were observed across 
the time course for SMN, Sm or fibrillarin, indicating that the levels of these proteins are not 
altered during the course of Ad5 infection. In contrast, the protein levels of both coilin and 
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Figure 3-1. Ad5 and CB protein levels over a time course of Ad5 infection in A549 cells. 
A549 cells were mock or Ad5 infected and incubated for 4, 8, 12, 16, 24 or 48 hours. Cell lysates were 
prepared and equal masses of protein from each sample (20 µg) were separated by SDS-PAGE and 
analysed by Western blotting. Bound antibody was detected using the ECL system and images were 
captured using a LAS 3000 imager. GAPDH was used as a loading control. During the time course of 
Ad5 infection, Ad5 E1A proteins 289R and 243R were first detected at 8 h.p.i and penton base was first 
detected at 24 h.p.i. Levels of SMN, Sm and fibrillarin stayed constant during the time course whilst 
levels of coilin and WRAP53 were decreased at 48 h.p.i. The lanes corresponding to the mock-infected 
samples for WRAP53 and coilin were moved from the same exposure on the same gel in order to align 
with the other panels (as indicated by the dashed lines). The anti-WRAP53 antibody exhibited cross-
reactivity with an unidentified protein of approximately 100 kDa. The anti-coilin antibody cross-reacted 
with an unidentified protein of approximately 65 kDa, which was cropped from the image in this instance. 
h.p.i – hours post-infection. R – residue. kDa – kilodaltons. 
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Figure 3-2. Densitometric analysis of CB protein levels over a time course of Ad5 infection. 
 Signal intensities from Western blots were calculated by densitometric analysis and were normalised to 
the signal intensity of the loading control, GAPDH. (i) coilin (ii) SMN (iii) fibrillarin (iv) Sm (v) 
WRAP53. Results are shown as the mean fold change in protein level (± standard error of the mean 
[SEM]) from three independent experiments. Results are relative to 24 hours post-mock infection, which 
was set to a value of 1. All statistics were calculated using the paired 1-sample t-test. Protein levels of 
SMN, fibrillarin and Sm remained constant during the Ad5 infection time course, whereas WRAP53 and 
coilin were reduced at 48 h.p.i. * p < 0.05. 
  
C
E
A
D
Coilin SMNB
Fibrillarin
WRAP53
Sm
 79 
 
WRAP53 were significantly reduced by 48 h.p.i (p < 0.05) (Figure 3-2, A and E). This indicated 
that coilin and WRAP53 may be degraded at a late stage of Ad5 infection.  
As shown in Figure 3-1, there was a strong cross reaction of the WRAP53 antibody with an 
unidentified protein of around 100 kDa. As this cross-reacting protein appeared to be absent 
from cell lysates until 24 h.p.i, this indicated that it is likely to be a late-expressed Ad protein. 
Therefore an Ad protein in its denatured form may share some structural homology with 
denatured WRAP53. Alternatively, the non-specific band may correspond to a cellular protein 
that is normally not expressed in A549 cells but whose expression is greatly induced upon Ad 
infection.  
3.3 Analysis of CB redistribution in Ad5-infected A549 cells by 
immunofluorescence microscopy  
3.3.1 A time course of coilin redistribution in Ad5-infected A549 cells 
Having established the kinetics of Ad5 infection in A549 cells, the most appropriate time point 
to study the redistribution of CBs during Ad5 infection was investigated by indirect 
immunofluorescence microscopy. Previous work showed that the redistribution of coilin from 
CBs occurred after Ad DNA replication (James et al., 2010). Ad DNA replication has been 
estimated to commence at around 8 h.p.i, with late phase protein expression reaching a peak at 
18 h.p.i (Akusjarvi, 2008). Therefore in order to span the intermediate and late phases of 
infection, the following time points were chosen for immunofluorescence analysis of CB 
redistribution; 0, 12, 18, 24 and 48 h.p.i. A549 cells were mock or Ad5 infected (Chapter 
2.2.6.1) before fixation at the appropriate time post-infection. Cells were subject to indirect 
immunofluorescence (Chapter 2.2.7), using an anti-coilin antibody as a marker of CBs and an 
anti-E1A antibody as a marker of Ad5-infected cells.  
As shown in Figure 3-3, there were three distinct distributions of coilin during the infection time 
course. At 12 h.p.i, the prominent CB distribution evident in Ad5-infected cells (as depicted by 
positive E1A staining [green]) was indistinguishable from the CB distribution found in mock-
infected cells; 1-6 punctate domains per cell (image g, arrow). By 24 h.p.i with Ad5, 
approximately 90% of cells exhibited positive E1A staining. In addition, at this time point the 
majority of Ad5-infected cells exhibited CBs which had been disassembled into rosettes (image 
k, arrow) as previously described (James et al., 2010). By 48 h.p.i, the majority of Ad5-infected 
cells exhibited microfoci that were distributed evenly throughout the nucleoplasm rather than 
the discrete ring structures characteristic of rosettes; this distribution was termed ‘speckled’ 
(image o, arrow). Importantly, all cells exhibiting CB redistribution, either rosette or speckled, 
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Figure 3-3. The redistribution of coilin during Ad5 infection of A549 cells.  
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell and incubated for 0, 12, 18, 24 or 48 
hours. Cells were fixed and subjected to indirect immunofluorescence using a mouse anti-coilin and a 
rabbit anti-E1A antibody followed by incubation with the appropriate fluorescent-labelled secondary 
antibodies. Nuclei were stained using DAPI. Confocal microscopy was performed using an inverted 
LSM510 confocal microscope coupled to LSM Image Browser. In mock-infected cells, coilin remained 
within large punctate Cajal bodies (CBs) for the duration of the time course (image c, arrow). By 12 h.p.i 
with Ad5, the majority of cells were positive for the Ad5 early marker protein E1A (image f) indicating 
that they were infected. At this time the cells exhibited a punctate distribution of coilin (image g, white 
arrow) that was indistinguishable from that seen in mock-infected cells (image c, arrow). By 24 h.p.i, the 
majority of Ad5-infected cells exhibited a redistribution of coilin into microfoci arranged into clusters 
(image k, arrow). By 48 h.p.i, the majority of Ad5-infected cells exhibited coilin microfoci that were 
distributed evenly throughout the nucleoplasm (image o, arrow). These data indicated that CBs undergo a 
stepwise dismantling during Ad5 infection. Bars = 10 µm.  
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Figure 3-4. The temporal appearance of Cajal body (CB), rosette and speckle distributions of coilin 
during Ad5 infection of A549 cells. 
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell and incubated for 0, 12, 18, 24 or 48 
hours. Cells were fixed and subjected to indirect immunofluorescence using a mouse anti-coilin and a 
rabbit anti-E1A antibody followed by incubation with the appropriate fluorescent-labelled secondary 
antibodies. Nuclei were stained using DAPI. Confocal microscopy was performed using an inverted 
LSM510 confocal microscope coupled to LSM Image Browser. At early stages of infection, large 
punctate CBs were evident in Ad5-infected cells (image a, arrow) that were indistinguishable from CBs in 
uninfected cells. As infection progressed from 18-24 h.p.i, coilin was redistributed into microfoci 
arranged into clusters (image b, white arrow), termed ‘rosettes’. At late stages of infection (24-48 h.p.i) 
the coilin microfoci were distributed evenly throughout the nucleoplasm (image c, arrow), termed 
‘speckles’. Over the time course of Ad5 infection, three fields of 100 cells from each coverslip were 
analysed for their coilin distribution and categorised as CB, ‘rosette’ or ‘speckles’. Results are shown as 
the mean percentage of cells (± SEM) from three independent experiments. These data indicated that 
during Ad5 infection, CBs are disassembled into rosettes at a late stage of infection (18-24 h.p.i) prior to 
further disassembly into speckles at very late time points (24-48 h.p.i). Bars = 10 µm. 
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were positive for E1A. This indicated that CB redistribution occurred only in the Ad5-infected 
cells and was not simply a reaction by the cell to the presence of virus in the vicinity. 
To quantify the redistribution of CBs during the infection time course, three fields of 100 cells 
from each coverslip were analysed for their coilin distribution (Figure 3-4). Cells were 
categorised as either CB (image a), ‘rosettes’ (image b) or ‘speckles’ (image c) and this 
experiment was repeated twice. Throughout the time course, the mock-infected cells retained 
100% CB distribution. At 12 h.p.i, 100% of the Ad5-infected cells still exhibited intact CBs. 
However, at 18 h.p.i a small proportion (4.5%) of Ad5-infected cells exhibited CBs which had 
been reorganised into rosettes. As infection progressed to 24 h.p.i, the proportion of Ad5-
infected cells positive for rosettes increased to 49.1%. By 48 h.p.i, the percentage of Ad5-
infected cells exhibiting rosettes had decreased to 5.5% whilst 93.7% of cells were positive for 
coilin speckles. The peak in percentage of Ad5-infected cells positive for rosettes occurs at 24 
h.p.i, whereas the peak for cells positive for speckles occurs much later in infection, at 48 h.p.i. 
This indicated that rosette structures are formed transiently during Ad infection and are 
disassembled into speckles late in infection. There was evidence of rosettes that had already 
disassembled into speckles at earlier times than 48 h.p.i, an observation consistent with the 
asynchrony of virus infection (Gama-Carvalho et al., 2003a). As the peak in percentage of cells 
positive for CBs redistribution into rosettes was at 24 h.p.i, this was the time point chosen to 
study the redistribution of additional CB components.  
3.3.2 Analysis of CB trafficking proteins SMN and WRAP53 during Ad5 infection by 
immunofluorescence microscopy 
As snRNPs no longer locate to residual CB structures containing coilin in Ad5-infected cells 
(Bridge et al., 1993a), this indicates that snRNP trafficking to CBs is impaired during Ad5- 
infection. The transport of snRNPs to CBs was recently shown to depend on the trafficking 
proteins WRAP53 and SMN (Mahmoudi et al., 2010). However, the subcellular location of the 
snRNP trafficking proteins WRAP53 and SMN following Ad5 infection is unknown. To 
establish the impact of Ad5 infection on the subcellular distribution of WRAP53 and SMN, 
A549 cells were mock or Ad5 infected (Chapter 2.2.6.1). At 24 h.p.i, cells were fixed and 
subject to indirect immunofluorescence (Chapter 2.2.7).  
As show in Figure 3-5, in mock-infected cells, coilin was located in punctate CBs (image b, 
arrow). WRAP53 was also concentrated in CBs (image c, arrow), as described previously 
(Mahmoudi et al., 2010). WRAP53 and coilin colocalised in CBs as shown by the yellow 
regions in the overlay (image i, arrow). In Ad5-infected cells, WRAP53 was redistributed into 
microfoci (image g, arrow) and colocalised with coilin in rosettes as shown by the yellow 
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Figure 3-5. The redistribution of WRAP53 relative to coilin following Ad5 infection of A549 cells.  
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell and incubated for 24 hours. Cells were 
fixed and subjected to indirect immunofluorescence. Cells were incubated with a mouse anti-coilin, a 
rabbit anti-WRAP53 and a goat anti-Ad capsid antibody followed by incubation with the appropriate 
fluorescent-labelled secondary antibodies. Nuclei were stained using DAPI. Confocal microscopy was 
performed using an inverted LSM510 confocal microscope coupled to LSM Image Browser. In mock-
infected cells, coilin (image b, arrow) and WRAP53 (image c, arrow) were found in punctate CBs and 
colocalised in these structures as shown by the yellow regions in the overlay (image i, arrow). In Ad5-
infected cells, coilin (image f, arrow) and WRAP53 (image g, arrow) were both redistributed into 
microfoci arranged into clusters, The microfoci of coilin and WRAP53 partially colocalised, as shown by 
the yellow regions in the overlay (image j, arrow). Bars = 10 µm.  
 84 
 
 
Figure 3-6. The redistribution of SMN relative to coilin following Ad5 infection of A549 cells.  
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell and incubated for 24 hours. Cells were 
fixed and subjected to indirect immunofluorescence. Cells were incubated with a mouse anti-SMN, a 
rabbit anti-coilin and a goat anti-Ad capsid antibody followed by incubation with the appropriate 
fluorescent-labelled secondary antibodies. Nuclei were stained using DAPI. Confocal microscopy was 
performed using an inverted LSM510 confocal microscope coupled to LSM Image Browser. In mock-
infected cells, coilin (image b, arrow) and SMN (image c, arrow) were found in punctate CBs and 
colocalised in these structures as shown by the yellow regions in the overlay (image i, arrow). In Ad5-
infected cells, coilin was redistributed into microfoci (image f, arrow) whilst SMN was redistributed into 
rod-shaped structures within the nucleus (image g, arrow). As shown in the overlay (image j), the rod-
shaped structures of SMN (white arrow) did not colocalise with the coilin microfoci (blue arrow). Bars = 
20 µm.  
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regions in the overlay (image j, arrow). This suggested that WRAP53 is a component of rosettes 
in Ad5-infected cells. It should be noted that the WRAP53 antibody exhibited a high degree of 
cross-reactivity in Western blotting analysis (Figure 3-1), therefore it is possible that some of 
the staining seen in immunofluorescence analysis may be due to recognition of the unidentified 
100 kDa cross-reactive species by this antibody. 
The subcellular distribution of SMN following Ad5 infection was also assessed. As shown in 
Figure 3-6, in mock-infected cells coilin was concentrated in CBs (image b, arrow) where it 
colocalised with SMN (image i, arrow), as previously documented (Hebert et al., 2001; 
Mahmoudi et al., 2010). In Ad5-infected cells, coilin was redistributed into microfoci (image f, 
arrow). Strikingly, in Ad5-infected cells, SMN was localised diffusely in the nucleoplasm and, 
in some cells, was concentrated in nucleoplasmic rod-shaped structures (image g, white arrow). 
There was no colocalisation between redistributed SMN (image j, white arrow) and coilin 
rosettes (image j, blue arrow). This indicated that SMN was redistributed to a domain separate 
from coilin, fibrillarin and WRAP53 during Ad5 infection.  
3.3.3 The redistribution of SMN during Ad5 infection 
To assess the disassembly of SMN from CBs over a time course of Ad5 infection, cells were 
mock or Ad5 infected (Chapter 2.2.6.1). At 0, 12, 18, 24 and 48 h.p.i, cells were fixed and 
subjected to indirect immunofluorescence (Chapter 2.2.7) using a mouse anti-SMN antibody 
along with a rabbit anti-E1A antibody as a marker of Ad5-infected cells.  
As shown in Figure 3-7, Ad5-infected cells (as defined by positive E1A staining; image f) at 12 
h.p.i exhibited a CB distribution of SMN (image g, arrow) were indistinguishable from CBs in 
uninfected cells (compare image c and image g). As infection progressed to 24 h.p.i, SMN was 
present diffusely in the nucleoplasm and in some stronger-staining nuclear structures in the 
majority of cells (image k, white arrow). This distribution of SMN was termed ‘nucleoplasmic’. 
At 48 h.p.i, SMN staining appeared fainter than at earlier time points and SMN appeared to be 
distributed diffusely throughout the cell (image o, arrow); this distribution was termed 
‘diffuse/undetectable’. As Western blotting analysis indicated that the total cellular level of 
SMN was unchanged by 48 h.p.i (Chapter 3.2), this suggested that the reduced SMN staining at 
48 h.p.i by immunofluorescence was not due to reduced levels of SMN protein. The reduced 
SMN staining at 48 h.p.i may be due to decreased accessibility of the antibody to its epitope; it 
is possible that there is an increased association of SMN with another protein during the late 
phase of Ad5 infection, causing masking of the antigenic site. Further investigation would be 
required to investigate these possibilities. 
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Figure 3-7. The redistribution of SMN during a time course of Ad5 infection in A549 cells.  
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell and incubated for 12, 24 or 48 hours. 
Cells were fixed and subjected to indirect immunofluorescence using a mouse anti-SMN and a rabbit anti-
E1A antibody followed by incubation with the appropriate fluorescent-labelled secondary antibodies. 
Nuclei were stained using DAPI. Confocal microscopy was performed using an inverted LSM510 
confocal microscope coupled to LSM Image Browser. In mock-infected cells, SMN remained within 
large punctate Cajal bodies (CBs) for the duration of the time course (image c, arrow). By 12 h.p.i with 
Ad5, the majority of cells were positive for the Ad5 early marker protein E1A (image f) indicating that 
they were infected. At this time the cells exhibited a punctate distribution of SMN (image g, white arrow) 
that was indistinguishable from that seen in mock-infected cells (image c, arrow). By 24 h.p.i, the 
majority of Ad5-infected cells exhibited a redistribution of SMN into the nucleoplasm and into stronger-
staining structures within the nucleus (image k, arrow). By 48 h.p.i, the majority of Ad5-infected cells 
exhibited low-level SMN staining (image o, arrow). Bars = 10 µm.  
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Figure 3-8. The temporal reduction in size of SMN foci during Ad5 infection of A549 cells. 
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell and incubated for 24 hours. Cells were 
fixed and subjected to indirect immunofluorescence using a mouse anti-SMN and a rabbit anti-E1A 
antibody followed by incubation with the appropriate fluorescent-labelled secondary antibodies. Nuclei 
were stained using DAPI. Confocal microscopy was performed using an inverted LSM510 confocal 
microscope coupled to LSM Image Browser. At 24 h.p.i, the majority of cells were positive for the Ad5 
early marker protein E1A (image b) indicating that they were infected. In some Ad5-infected cells, CBs 
containing SMN were noticeably smaller (image e, blue arrow) than conventional CBs (image e, white 
arrow). Bars = 10 µm.  
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Interestingly, it was noted that CBs in some Ad5-infected cells were noticeably smaller than 
conventional CBs (Figure 3-8, image e; compare regular CB [white arrow] with small CB [blue 
arrow]). These ‘small CBs’ were only observed in the Ad5-infected cells and were not found in 
the mock infected cells, indicating that the reduction in CB size was a result of Ad5 infection. 
Furthermore, the occurrence of small CBs in Ad5-infected cells appeared to increase as the 
infection time course progressed. It is possible that as Ad5 infection progressed, SMN was 
released from CBs into the nucleoplasm, resulting in a gradual reduction in CB size. Further 
studies measuring CB diameters following Ad5 infection would be required to address this.  
In order to quantify the disassembly of SMN from CBs over the time course of Ad5 infection, 
three fields of 100 cells from each time point were analysed for their SMN distribution (Figure 
3-9). The distribution of SMN in cells was categorised as either ‘CB’ (image a, arrow), 
‘nucleoplasmic’ (image b, arrow) or ‘diffuse/undetectable’ (image c, arrow). At 18 h.p.i, 19% of 
Ad5-infected cells exhibited nucleoplasmic SMN and this increased to a peak of 39% of cells by 
24 h.p.i. At 48 h.p.i, only 5% of cells exhibited a nucleoplasmic distribution of SMN, indicating 
this was a transient SMN distribution during Ad5 infection. The diffuse/undetectable 
distribution of SMN appeared to be a late phase occurrence; the first appearance of this 
distribution was at 24 h.p.i (18% of cells) with increased prevalence at 48 h.p.i (95% of cells). 
This indicated that following Ad5 infection, SMN was released from CBs into the nucleoplasm 
prior to locating diffusely throughout the cell at very late stages of infection. 
3.4 The rearrangement of CB proteins relative to other nuclear bodies and 
host factors 
From the previous section it was shown that, following Ad5 infection, the CB proteins coilin 
and WRAP53 are redistributed to rosettes whilst SMN is redistributed to separate structures 
within the nucleoplasm. However, it is not known whether these CB proteins are redistributed to 
known sub-nuclear structures or to novel domains. Indeed, both coilin and SMN have 
previously been shown to interact with protein components of other nuclear bodies. SMN can 
form an RNAse-sensitive complex with the nucleolar proteins B23 and C23, and can directly 
interact with fibrillarin (Pellizzoni et al., 2001a; Lefebvre et al., 2002). Coilin is known to 
interact with the nucleolar protein Nopp140 (Isaac et al., 1998) and PML-NB protein PIASγ 
(Sun et al., 2005). Therefore it is possible that during Ad5 infection these proteins may become 
associated with other nuclear substructures. If so, identifying these associated nuclear bodies 
may give clues to the function of CB proteins during Ad5 infection. To this end, the 
redistribution of coilin and SMN was assessed relative to splicing factors, nucleoli, PML-NBs, 
Ad DNA replication centres and Ad virus assembly platforms. 
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Figure 3-9. The temporal appearance of Cajal body (CB), nucleoplasmic and diffuse/undetectable 
distributions of SMN during Ad5 infection of A549 cells. 
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell and incubated for 0, 12, 18, 24 or 48 
hours. Cells were fixed and subjected to indirect immunofluorescence. Images show the three major SMN 
distributions identified during the Ad5 infection time course. Three fields of 100 cells from each sample 
were counted and the SMN distribution was categorised as either ‘CB’, ‘nucleoplasmic’ or 
‘diffuse/undetectable’. Results are displayed in the graph as the mean percentage of cells (± SEM) from 
three independent experiments. These data indicated that during Ad5 infection, SMN is redistributed from 
CBs into novel nuclear structures at a late stage of infection (18-24 h.p.i) prior to further disassembly into 
diffuse/undetectable staining at very late time points (24-48 h.p.i). Bars = 10 µM. 
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3.4.1 Cellular splicing factors 
During Ad infection, spliceosomal snRNPs are found surrounding ssDNA sites in a diffuse 
nucleoplasmic distribution (Bridge et al., 1993a). Cells at this stage are known as ‘ring cells’ 
and this snRNP pattern is indicative of active transcription and splicing (Aspegren et al., 1998; 
Gama-Carvalho et al., 2003a). At later stages of infection, snRNPs accumulate in enlarged ICGs 
at the nuclear periphery (Bridge et al., 1993a). In order to stain areas of active splicing, mock- 
and Ad5-infected cells were subjected to indirect immunofluorescence microscopy using a 
mouse anti-Sm antibody along with a rabbit anti-coilin or a rabbit anti-SMN antibody. An anti-
Ad capsid antibody was used to identify Ad5-infected cells.  
As shown in Figure 3-10 and previously (Bridge et al., 1993a; Rebelo et al., 1996), in mock-
infected cells, Sm was located diffusely in the nucleoplasm and also concentrated in CBs (image 
b, arrow) and coilin was also found in CBs (image c, arrow). Sm and coilin colocalised in CBs, 
as shown by the yellow regions in the overlay (image i, arrow). In Ad5-infected cells, Sm was 
located diffusely in the nucleoplasm and was concentrated in enlarged nuclear ICGs (image f, 
arrow). As shown in the overlay (image j), Sm in enlarged ICGs (white arrow) did not 
colocalise with coilin in rosettes (image j, blue arrow). This indicated that rosettes are closely 
associated, but do not colocalise with, regions of active splicing.  
The redistribution of SMN relative to snRNPs was also investigated (Figure 3-11). In mock-
infected cells, Sm was located diffusely in the nucleoplasm and was concentrated in CBs (image 
b, arrow). SMN was also located in CBs (image d, arrow) and colocalised with Sm in these 
structures (image i, arrow). A rabbit anti-SMN antibody was used in this experiment, which 
appeared to give greater cytoplasmic SMN staining than that observed when using the mouse 
anti-SMN antibody (see Figure 3-6). In Ad5-infected cells, Sm was redistributed into diffusely 
in the nucleoplasm and within enlarged nuclear ICGs (image f, arrow). SMN was also 
redistributed into the nucleoplasm (image g, arrow). The rabbit anti-SMN antibody appeared to 
give a more diffuse staining of SMN in the nucleus of Ad5-infected cells than the mouse anti-
SMN antibody, which was found to stain rod-shaped structures of SMN in the nucleus of Ad5-
infected cells (Figure 3-6). Due to the diffuse nucleoplasmic distributions of SMN and Sm 
following Ad5 infection, a specific association of redistributed SMN with Sm was difficult to 
establish. Both proteins localised in the nucleoplasm and were excluded from nucleoli. 
However, SMN did not specifically accumulate in enlarged ICGs (image j, white arrow). This 
indicated that following Ad5 infection, snRNPs partially colocalised with SMN in the 
nucleoplasm, but SMN did not localise to enlarged snRNP-containing ICGs. 
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Figure 3-10. The redistribution of coilin relative to spliceosomal snRNPs in Ad5-infected A549 cells. 
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell and incubated for 24 hours. Cells were 
fixed and subjected to indirect immunofluorescence using a mouse anti-Sm, a rabbit anti-coilin and a goat 
anti-Ad capsid antibody followed by incubation with the appropriate fluorescent-labelled secondary 
antibodies. Nuclei were stained using DAPI. Confocal microscopy was performed using an inverted 
LSM510 confocal microscope coupled to LSM Image Browser. In mock-infected cells, Sm was located 
diffusely within the nucleoplasm, with increased concentration in punctate CBs (image b, arrow). Coilin 
was found primarily within punctate CBs (image c, arrow). As shown by the yellow regions in the 
overlay, coilin and Sm colocalised in CBs (image i, arrow). In Ad5-infected cells, Sm was redistributed 
from CBs into numerous foci within the nucleus (image f, arrow). Coilin was redistributed from CBs into 
microfoci (image g, arrow). As shown in the overlay (image j), there was no colocalisation between the 
foci of Sm (white arrow) and the foci of coilin (blue arrow) in Ad5-infected cells. Bars = 10 µm. 
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Figure 3-11. The redistribution of SMN relative to spliceosomal snRNPs in Ad5-infected A549 cells. 
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell and incubated for 24 hours. Cells were 
fixed and subjected to indirect immunofluorescence using a mouse anti-Sm, a rabbit anti-SMN and a goat 
anti-Ad capsid antibody followed by incubation with the appropriate fluorescent-labelled secondary 
antibodies. Nuclei were stained using DAPI. Confocal microscopy was performed using an inverted 
LSM510 confocal microscope coupled to LSM Image Browser. In mock-infected cells, Sm was located 
diffusely within the nucleoplasm, with increased concentration in punctate CBs (image b, arrow). SMN 
was found primarily within punctate CBs (image c, arrow). As shown by the yellow regions in the 
overlay, SMN and Sm colocalised in CBs (image i, arrow). In Ad5-infected cells, Sm was redistributed 
from CBs into numerous foci within the nucleus (image f, arrow). SMN was redistributed from CBs into 
the nucleoplasm (image g, arrow). As shown in the overlay (image j), there was no colocalisation between 
the foci of Sm (white arrow) and nucleoplasmic SMN (blue arrow) in Ad5-infected cells. Bars = 10 µm. 
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3.4.2 Nucleoli 
Similar to CBs, nucleolar proteins have been shown to be redistributed during Ad5 infection; 
B23 is redistributed to viral DNA replication centres (Hindley et al., 2007), C23 (nucleolin) is 
exported to the cytoplasm (Matthews, 2001) and fibrillarin is redistributed into rosettes along 
with coilin (Rebelo et al., 1996; Rodrigues et al., 1996). CBs have long been known to have a 
close association with the nucleolus, with both coilin and SMN previously shown to interact 
with nucleolar proteins (Isaac et al., 1998; Pellizzoni et al., 2001a; Lefebvre et al., 2002; Sun et 
al., 2005). Therefore it is possible that during Ad5 infection, CB proteins and nucleolar proteins 
may become associated in novel domains. To this end, the distribution of coilin and SMN 
relative to the nucleolar marker proteins B23, C23 and fibrillarin was investigated in mock and 
Ad5-infected A549 cells (Chapter 2.2.6.1) at 24 h.p.i by indirect immunofluorescence 
microscopy (Chapter 2.2.7).  
As shown in Figure 3-12, mock-infected cells exhibited a primarily nucleolar distribution of 
fibrillarin (image b, blue arrow) and were also found within CBs (image b, white arrow). Coilin 
was located in punctate CBs (image c, arrow). Fibrillarin in CBs colocolised with coilin, as 
shown by the yellow regions in the overlay (image i, white arrow) whilst fibrillarin in nucleoli 
did not colocolise with coilin (image i, blue arrow). In Ad5-infected cells, there was partial 
colocalisation of these two proteins in rosettes (image j, white arrow), as shown previously 
(Rebelo et al., 1996; Rodrigues et al., 1996). Fibrillarin within nucleoli of Ad5-infected cells 
did not colocalise with coilin (image j, blue arrow). This indicated that a proportion of fibrillarin 
was associated with rosettes whilst the bulk remained associated with the nucleolus. 
As shown in Figure 3-13, in mock-infected A549 cells, B23 was concentrated in the nucleolus 
(image b, arrow) whilst coilin was localised in CBs (image c, arrow). CBs were closely 
associated, but did not colocalise with, nucleoli (image i; CBs [white arrow] are separate to 
nucleoli [blue arrow]). Following Ad5 infection, coilin was redistributed into rosettes (image g, 
arrow). Interestingly, B23 was not redistributed from the nucleolus in Ad5-infected cells (image 
f, arrow), contrasting with previously published data (Hindley et al., 2007). There was no 
colocalisation between coilin rosettes (image j, white arrow) and B23 in nucleoli (image j, blue 
arrow). This indicated that there was no association of coilin with B23 during Ad5 infection. 
Finally, the redistribution of coilin relative to C23 was assessed (Figure 3-14). In mock-infected 
cells, coilin was localised in CBs (image c, arrow) whereas C23 was concentrated in the 
nucleolus (image b, white arrow) and was also found diffusely in the nucleoplasm (image c, 
blue arrow). In Ad5-infected cells at 24 h.p.i, coilin was redistributed into rosettes (image g, 
arrow) whilst C23 staining was reduced in the nucleolus (image f, white arrow) with some  
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Figure 3-12. The redistribution of coilin relative to fibrillarin in Ad5-infected of A549 cells.  
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell and incubated for 24 hours. Cells were 
fixed and subjected to indirect immunofluorescence using a mouse anti-coilin, a rabbit anti-fibrillarin and 
a goat anti-Ad capsid antibody followed by incubation with the appropriate fluorescent-labelled 
secondary antibodies. DAPI was used to stain nuclei. Confocal microscopy was performed using an 
inverted LSM510 confocal microscope coupled to LSM Image Browser. In mock-infected cells, 
fibrillarin (image b) was found in the nucleolus (blue arrow) and in CBs (white arrow). Coilin was also 
located in CBs (image c, arrow) and colocalised with fibrillarin in these structures, as shown by the 
yellow regions in the overlay (image i, arrow). In Ad5-infected cells, a proportion of fibrillarin remained 
associated with the nucleolus (image f, blue arrow) whilst CB-associated fibrillarin was redistributed into 
microfoci (image f, white arrow). Coilin was also reorganised into microfoci (image g, arrow); coilin and 
fibrillarin partially colocalised in these microfoci, as shown by the yellow regions in the overlay (image j, 
white arrow). Nucleolar fibrillarin did not colocalise with coilin (image j, blue arrow). Bars = 10 µm. 
 95 
 
 
Figure 3-13. The redistribution of coilin relative to B23 in Ad5-infected of A549 cells.  
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell and incubated for 24 hours. Cells were 
fixed and subjected to indirect immunofluorescence using a mouse anti-B23, a rabbit anti-coilin and a 
goat anti-Ad capsid antibody followed by incubation with the appropriate fluorescent-labelled secondary 
antibodies. DAPI was used to stain nuclei. Confocal microscopy was performed using an inverted 
LSM510 confocal microscope coupled to LSM Image Browser. In mock-infected cells, B23 (image b) 
was found in the nucleolus (image b, arrow) whilst coilin was located in CBs (image c, arrow). As shown 
in the overlay (image i), there was no colocalisation of B23 (blue arrow) with coilin (white arrow). In 
Ad5-infected cells, B23 remained associated with the nucleolus (image f, arrow), whereas coilin was 
reorganised into microfoci (image g, arrow). As shown in the overlay (image j), there was no 
colocalisation of B23 (blue arrow) with coilin (white arrow) in Ad5-infected cells. Bars = 10 µm. 
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Figure 3-14. The redistribution of coilin relative to the C23 in Ad5-infected of A549 cells.  
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell and incubated for 24 hours. Cells were 
fixed and subjected to indirect immunofluorescence using a mouse anti-C23, a rabbit anti-coilin and a 
goat anti-Ad capsid antibody followed by incubation with the appropriate fluorescent-labelled secondary 
antibodies. DAPI was used to stain nuclei. Confocal microscopy was performed using an inverted 
LSM510 confocal microscope coupled to LSM Image Browser. In mock-infected cells, C23 (image b) 
was found in the nucleolus (white arrow) and the nucleoplasm (blue arrow), whilst coilin was located in 
CBs (image c, arrow). As shown in the overlay (image i), there was no colocalisation of nucleolar C23 
(blue arrow) with coilin in CBs (white arrow). In Ad5-infected cells, C23 staining was reduced in the 
nucleolus (image f, white arrow) with increased staining in the cytoplasm (image f, blue arrow). Coilin 
was redistributed into microfoci (image g, arrow). As shown in the overlay (image j), there was no 
colocalisation of nucleolar C23 (blue arrow) with coilin microfoci (white arrow) in Ad5-infected cells. 
Bars = 10 µm. 
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cytoplasm staining (image f, blue arrow) consistent with previous observations (Matthews, 
2001) (Figure 3-14). There was no colocalisation between coilin rosettes (image j, white arrow) 
with C23 in nucleoli (blue arrow). This indicated that during Ad5 infection, C23 is not 
associated with rosettes. 
The redistribution of SMN relative to nucleolar markers was also assessed. As shown in Figure 
3-15, in mock-infected cells, fibrillarin was concentrated in nucleoli (image b, blue arrow) and 
was also found in CBs (image b, white arrow). SMN was concentrated in CBs (image c, arrow). 
Fibrillarin and SMN colocalised in CBs, as shown by the yellow regions in the overlay (image i, 
blue arrow). SMN did not colocalise with fibrillarin in nucleoli (image i, white arrow). In Ad5-
infected cells, fibrillarin remained in nucleoli (image f, blue arrow) with partial redistribution 
into rosettes (image f, white arrow). In contrast, SMN was redistributed into the nucleoplasm 
(image g, arrow). As shown in the overlay (image j), there was no colocalisation of SMN (white 
arrow) with fibrillarin in nucleoli (blue arrow) or with fibrillarin microfoci (yellow arrow).  
The localisation of SMN relative to B23 was also investigated (Figure 3-16). In mock-infected 
cells, B23 was located in the nucleolus (image b, arrow) whilst SMN was concentrated in CBs 
(image c, arrow). As shown in the overlay (image i), there was no colocalisation between B23 in 
nucleoli (blue arrow) and SMN in CBs (white arrow). In Ad5-infected cells, SMN was 
redistributed into the nucleoplasm (image g, arrow) whilst B23 remained within nucleoli (image 
f, arrow). There was no colocalisation between redistributed SMN (image j, white arrow) and 
nucleoli containing B23 (image j, blue arrow).  
The redistribution of SMN relative to C23 was determined (Figure 3-17). In mock-infected 
cells, C23 was concentrated in the nucleolus (image b, white arrow) with diffuse staining in the 
nucleoplasm (image b, blue arrow). SMN was concentrated in CBs (image c, white arrow) and, 
as previously mentioned (Section 3.4.1), the rabbit anti-SMN antibody also exhibited strong 
cytoplasmic staining (image c, blue arrow), in contrast to findings with the mouse anti-SMN 
antibody (Figure 3-3). In Ad5-infected cells, SMN became increasingly nucleoplasmic as 
infection proceeded (image g, white arrow) and there was increased cytoplasmic staining of 
SMN in some cells (image g, blue arrow). In Ad5-infected cells, C23 staining was reduced in 
the nucleus (image f, white arrow) and in the nucleoplasm (image f, blue arrow), and increased 
in the cytoplasm (image f, yellow arrow), consistent with previous observations (Matthews, 
2001). As shown in the overlay (image j), C23 and SMN colocalised in the cytoplasm in some 
Ad5-infected cells (blue arrow) whilst SMN in the nucleoplasm did not colocalise with 
nucleoplasmic C23 (white arrow). These data indicated that during Ad5 infection there was 
colocalisation of SMN and C23 in the cytoplasm. 
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Figure 3-15. The redistribution of SMN relative to fibrillarin in Ad5-infected A549 cells.  
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell and incubated for 24 hours. Cells were 
fixed and subjected to indirect immunofluorescence using a mouse anti-SMN, a rabbit anti-fibrillarin and 
a goat anti-Ad capsid antibody followed by incubation with the appropriate fluorescent-labelled 
secondary antibodies. DAPI was used to stain nuclei. Confocal microscopy was performed using an 
inverted LSM510 confocal microscope coupled to LSM Image Browser. In mock-infected cells, 
fibrillarin (image b) was found in the nucleolus (blue arrow) and in CBs (white arrow). SMN was also 
located in CBs (image c, arrow) and colocalised with fibrillarin in these structures, as shown by the 
yellow regions in the overlay (image i, arrow). In Ad5-infected cells, a proportion of fibrillarin remained 
associated with the nucleolus (image f, blue arrow) whilst CB-associated fibrillarin was redistributed into 
microfoci (image f, white arrow). SMN was reorganised into separate structures within the nucleoplasm 
(image g, arrow). As shown in the overlay (image j), redistributed SMN (white arrow) did not colocalise 
with nucleolar fibrillarin (blue arrow) or fibrillarin microfoci (yellow arrow). Bars = 10 µm. 
 99 
 
 
Figure 3-16. The redistribution of SMN relative to B23 in Ad5-infected of A549 cells.  
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell and incubated for 24 hours. Cells were 
fixed and subjected to indirect immunofluorescence using a mouse anti-B23, a rabbit anti-SMN and a 
goat anti-Ad capsid antibody followed by incubation with the appropriate fluorescent-labelled secondary 
antibodies. DAPI was used to stain nuclei. Confocal microscopy was performed using an inverted 
LSM510 confocal microscope coupled to LSM Image Browser. In mock-infected cells, B23 (image b) 
was found in the nucleolus (image b, arrow) whilst SMN was located in CBs (image c, arrow). As shown 
in the overlay (image i), there was no colocalisation of B23 (blue arrow) with SMN (white arrow). In 
Ad5-infected cells, B23 remained associated with the nucleolus (image f, arrow), whereas SMN was 
reorganised from CBS into the nucleoplasm (image g, arrow). As shown in the overlay (image j), there 
was no colocalisation of B23 (blue arrow) with nucleoplasmic SMN (white arrow) in Ad5-infected cells. 
Bars = 10 µm. 
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Figure 3-17. The redistribution of SMN relative to the C23 in Ad5-infected of A549 cells.  
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell and incubated for 24 hours. Cells were 
fixed and subjected to indirect immunofluorescence using a mouse anti-C23, a rabbit anti-SMN and a 
goat anti-Ad capsid antibody followed by incubation with the appropriate fluorescent-labelled secondary 
antibodies. DAPI was used to stain nuclei. Confocal microscopy was performed using an inverted 
LSM510 confocal microscope coupled to LSM Image Browser. In mock-infected cells, C23 (image b) 
was found in the nucleolus (white arrow) and the nucleoplasm (blue arrow), and SMN was located in CBs 
(image c, arrow). Cytoplasmic SMN was also observed when using the rabbit anti-SMN antibody (image 
c, blue arrow). As shown in the overlay (image i), there was no colocalisation of nucleolar C23 (blue 
arrow) with SMN in CBs (white arrow). In Ad5-infected cells, C23 (image f) staining was reduced in the 
nucleolus (white arrow) and in the nucleoplasm (blue arrow), with increased staining in the cytoplasm 
(yellow arrow). SMN (image g) was redistributed into the nucleoplasm (white arrow), and, in some cells, 
also exhibited increased cytoplasmic staining (blue arrow). As shown by the yellow regions in the overlay 
(image j, blue arrow), C23 colocalised with SMN in the cytoplasm of Ad5-infected cells. No such 
colocalisation was observed for C23 and SMN in the nucleoplasm (image j, white arrow). Bars = 10 µm. 
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Figure 3-18. The redistribution of coilin relative to PML-NBs in Ad5-infected A549 cells.  
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell and incubated for 24 hours. Cells were 
fixed and subjected to indirect immunofluorescence. Cells were incubated with a mouse anti-PML, a 
rabbit anti-coilin and a goat anti-Ad capsid antibody followed by incubation with the appropriate 
fluorescent-labelled secondary antibodies. Nuclei were stained using DAPI. Confocal microscopy was 
performed using an inverted LSM510 confocal microscope coupled to LSM Image Browser. In mock-
infected cells, PML was found in discrete foci within the nucleus (image b, arrow). Coilin was also found 
within punctate nuclear foci (image c, arrow). As shown in the overlay (image i), the majority of PML 
foci (blue arrow) and coilin foci (white arrow) did not colocalise. However, a subset of PML and coilin 
foci did partially overlap (image i, yellow arrow). In Ad5-infected cells, PML was redistributed within the 
nucleus and exhibited a decrease in staining intensity (image f, arrow). Coilin was redistributed from CBs 
into microfoci (image g, arrow). As shown in the overlay (image j), redistributed PML (blue arrow) did 
not colocolise with coilin microfoci (white arrow). Bars = 20 µm. 
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3.4.3 PML-NBs 
During Ad5 infection, PML-NB components are redistributed and/or degraded in order to 
subvert immune responses and transcriptional repression (Puvion-Dutilleul et al., 1995; Doucas 
et al., 1996; Leppard and Everett, 1999; Zhao et al., 2003; Hoppe et al., 2006; Ullman et al., 
2007; Ullman and Hearing, 2008; Schreiner et al., 2010). As PML-NB components are 
redistributed and/or degraded at an early stage of Ad infection (Doucas et al., 1996), it appears 
unlikely that CB proteins, which are not redistributed until a much later stage, would be 
associated with the novel PML tracks (James et al., 2010). However, the observed redistribution 
of coilin into novel nuclear microfoci warranted investigation of colocalisation with 
redistributed PML-NBs during Ad infection. As SMN was redistributed diffusely within the 
nucleoplasm and into larger nucleoplasmic accumulations rather than discrete foci, potential 
colocalisation of SMN with PML-NBs was not investigated. As shown in Figure 3-18, and 
previously (Grande et al., 1996), in mock-infected cells, both PML (image b, arrow) and coilin 
(image c, arrow) were located in punctate nuclear foci. As shown in the overlay (image i), PML 
foci (blue arrow) and coilin foci (white arrow) were generally not associated in mock-infected 
cells. However, some coilin and PML foci partially overlapped, as shown by the yellow regions 
in the overlay (image i, yellow arrow). In Ad5-infected cells, PML staining was greatly reduced 
(image f, arrow) and coilin was redistributed into rosettes (image g, arrow). There was no 
colocalisation between coilin rosettes (image j, white arrow) and residual PML foci (image j, 
blue arrow). This indicated that rosettes are not associated with PML-NBs during Ad5 infection. 
3.4.4 Viral DNA replication centres 
Large, globular DNA replication centres containing DBP can be used as a marker of the onset of 
viral DNA replication (Pombo et al., 1994, Puvion-Dutilleul 1990a,b). Dual staining of DBP 
with SMN or coilin was performed to determine whether CB proteins are associated with DNA 
replication centres.  
As shown in Figure 3-19A, in mock-infected cells there was no detectable DBP staining (image 
b) and coilin was found in CBs (image c, arrow). In Ad5-infected cells, DBP was present in 
large globular structures within the nucleus (image f, arrow) and coilin was redistributed into 
rosettes (image g, arrow). Coilin rosettes located at the periphery of, but did not colocalise with, 
DBP-containing DNA replication centres (image h, white arrow). This indicated that rosettes 
were located in close proximity to regions of Ad DNA replication.  
Dual staining of SMN and DBP was also performed (Figure 3-19B). Mock-infected cells were 
negative for DBP (image b) and SMN was located in CBs (image c, arrow). In Ad5-infected 
cells, DBP formed large globular structures within the nucleus (image f, arrow) whilst SMN  
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Figure 3-19. The redistribution of coilin and SMN relative to viral DNA replication centres in Ad5-
infected A549 cells.  
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell and incubated for 24 hours. Cells were 
fixed and subjected to indirect immunofluorescence. Cells were incubated with a rabbit anti-DBP 
antibody along with a mouse anti-coilin or a mouse anti-SMN antibody followed by incubation with the 
appropriate fluorescent-labelled secondary antibodies. Nuclei were stained using DAPI. Confocal 
microscopy was performed using an inverted LSM510 confocal microscope coupled to LSM Image 
Browser. As shown in A, mock-infected cells were negative for Ad5 DBP (image b) and coilin was found 
in CBs (image c, arrow). In Ad5-infected cells, DBP was present in large nuclear globular foci (image f, 
arrow) and coilin was redistributed into microfoci (image g, arrow). As shown in the overlay, coilin 
microfoci surrounded, but did not colocalise with, DBP-positive foci (image h, arrow). As shown in B, 
mock-infected cells were negative for Ad5 DBP (image b) and SMN was found in CBs (image c). In 
Ad5-infected cells, DBP was located in large nuclear foci (image f, arrow) and SMN was redistributed 
into rod-shaped structures within the nucleus (image g, arrow). As shown in the overlay (image h), DBP 
(blue arrow) did not colocolise with redistributed SMN (white arrow) in Ad5-infected cells.  
Bars = 10 µm. 
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Figure 3-20. Redistribution of SMN relative to virus assembly platforms in Ad5-infected A549 cells.  
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell and were incubated for 24 hours. Cells 
were fixed and subjected to indirect immunofluorescence using a rabbit anti-SMN and a mouse anti-fibre 
antibody or a mouse anti-SMN and a rabbit anti-penton base antibody followed by incubation with the 
appropriate fluorescent-labelled secondary antibodies. Nuclei were stained using DAPI. Confocal 
microscopy was performed using an inverted LSM510 confocal microscope coupled to LSM Image 
Browser. A. Redistribution of SMN relative to fibre during Ad5 infection. Mock-infected cells were 
negative for Ad5 fibre (image b) and SMN was found in CBs (image c, arrow). In Ad5-infected cells, 
fibre formed large nuclear aggregates (image f, arrow). SMN was redistributed from CBs into rod-shaped 
nuclear structures (image g, arrow). As shown by the yellow regions in the overlay, fibre protein 
colocalised with SMN in the nuclei of Ad5-infected cells (image h, arrow). B. Redistribution of SMN 
relative to penton base during Ad5 infection. Mock-infected cells were negative for Ad5 penton base 
(image b) and SMN was present in CBs (image c, arrow). In Ad5-infected cells, penton base formed large 
nuclear aggregates, with intense staining at the nuclear periphery (image f, arrow). SMN was redistributed 
into rod-shaped nuclear structures (image g, arrow). As shown by the yellow regions in the overlay 
(image h), penton base and SMN partially colocalised in the nuclei of Ad5-infected cells (white arrow). 
Penton base located at the nuclear periphery did not colocalise with SMN (blue arrow). Bars = 20 µm. 
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was located diffusely in the nucleoplasm and in nuclear rod-shaped structures (image g, arrow). 
SMN rod-shaped structures (image h, white arrow) were excluded from DBP-positive 
replication centres (image h, blue arrow). This suggested that SMN was not associated with 
DNA replication domains during Ad5 infection. 
3.4.5 Virus assembly platforms 
During the latter stages of Ad5 infection, large crystalline structures form within the nucleus 
and around the nuclear periphery, composed of large aggregations of late viral proteins 
(Franqueville et al., 2008). These structures are thought to correspond to regions of virus capsid 
assembly. As SMN was found to locate in nuclear rod-shaped structures in Ad5-infected cells, 
the colocalisation of SMN with regions of virus assembly was investigated. As shown in Figure 
3-20A, Mock-infected cells were negative for Ad5 fibre (image b, arrow) and SMN was located 
in punctate CBs in these cells (image c, arrow). In Ad5-infected cells, Ad5 fibre was located in 
nuclear aggregates (image f, arrow) and SMN was redistributed from CBs into nuclear rod-
shaped structures (image g, arrow). Redistributed SMN partially colocalised with regions of 
fibre staining, as shown by the yellow regions in the overlay (image h, arrow). To confirm the 
colocalisation of SMN with viral assembly platforms, the experiment was repeated using a 
different SMN antibody and an antibody raised against a different Ad late protein, the penton 
base. As shown in Figure 3-20B, in Ad5-infected cells penton base was found in nuclear 
aggregates (image b, arrow) and SMN was redistributed into nuclear rod-shaped structures 
(image g, arrow). Redistributed SMN colocalised with penton base within the nucleus, as shown 
by the yellow regions in the overlay (image h, white arrow). However, accumulations of penton 
base at the nuclear periphery did not co-localise with SMN (image h, blue arrow). This 
indicated that during Ad5-infection, SMN partially associated with regions of virus assembly. 
3.5  Defining the stage of infection during which CBs are rearranged 
Considering the relatively large coding capacity of Ads and the expression of over 30 virus 
proteins, identifying potential Ad proteins responsible for the redistribution and/or degradation 
of a cellular protein is somewhat daunting. It would be logical to assume that expression of the 
causative viral protein would shortly be followed by the cellular effect in question. Therefore 
the time point during infection at which a cellular protein is redistributed may correlate with the 
initial expression of the causative viral protein. It is not currently known which, if any, Ad 
protein is responsible for CB redistribution during Ad5 infection, and the stage of infection at 
which CB redistribution occurs has not been precisely defined. Although CB rearrangement in 
Ad5-infected cells is known to be inhibited upon treatment with the DNA replication inhibitor 
cytosine arabinoside (AraC) (Rebelo et al., 1996; Rodrigues et al., 1996; James et al., 2010), it 
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is not known whether the rearrangement is dependent on DNA replication itself or the 
expression of late proteins. The time point at which SMN is redistributed from CBs is also 
unknown. It cannot be assumed that SMN is redistributed at the same time as coilin, since SMN 
is non-essential for maintenance of CB architecture (Lemm et al., 2006), and depletion of coilin 
results in accumulation of SMN in Gems, which appear as punctate nuclear structures similar to 
CBs (Tucker et al., 2001). Therefore SMN could be redistributed from CBs at a different time 
point in infection to coilin, without any obvious impact on CB architecture. In this section, the 
stage of infection during which CB proteins are redistributed from CBs was investigated. 
3.5.1 Treatment of Ad5-infected cells with cytosine arabinoside (AraC) to determine the 
time point of CB rearrangement relative to Ad DNA replication 
Cytosine arabinoside (AraC) has long been used as a DNA replication inhibitor during virus 
infection (Gaynor et al., 1982). As the Ad late phase occurs after the onset of DNA replication 
(Green et al., 1970; Sharp et al., 1974; Tibbetts et al., 1974), the inhibition of DNA replication 
prevents progression to the later stages of infection. Therefore inhibiting DNA replication is a 
useful tool for determining whether a cellular process occurs during the early or late stages of 
Ad infection.  
3.5.1.1 Inhibition of Ad5 DNA replication using AraC 
In order to confirm that late protein expression was inhibited following AraC treatment, AraC at 
the optimised concentration (25 µg/ml) was added to mock- or Ad5-infected A549 cells at the 
same time as the Ad5 innoculum (Chapter 2.2.6.1) and incubated for 24 hours. Protein from 
whole cell lysates was separated by SDS-PAGE and analysed by Western blotting (Chapter 
2.2.2). Membranes were incubated with an anti-DBP and an anti-penton base antibody as 
markers of early phase and late phase protein expression, respectively. An anti-GAPDH 
antibody was used as an internal loading control.  
As shown in Figure 3-21, in the absence of AraC, there is expression of both DBP and penton 
base at 24 h.p.i. In the presence of AraC, penton base protein was not detected in Ad5-infected 
cells, whereas expression of DBP was unaffected. AraC treatment did not alter the levels of 
cellular proteins, as shown by the loading control GAPDH. This indicated that at the 
concentration used (25 μg/ml), AraC prevented the progression of the Ad5 lifecycle to the late 
phase without affecting the expression of early phase proteins or host cell proteins. 
3.5.1.2 Immunofluorescence microscopy of Ad5-infected cells treated with AraC 
To assess the impact of inhibition of DNA replication on the redistribution of CB components 
during Ad5 infection, A549 cells were treated with AraC at the same time as mock or Ad5  
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Figure 3-21. Inhibition of late phase protein expression in Ad5-infected A549 cells following 
treatment with the DNA replication inhibitor, cytosine arabinoside (AraC).  
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell in DMEM (‘- AraC’) or DMEM 
supplemented with 25 µg/ml AraC (‘+ AraC’). At 24 h.p.i, whole cell lysates were prepared and equal 
masses of protein from each sample (20 µg) were separated by SDS-PAGE and analysed by Western 
blotting using a mouse anti-DBP, a rabbit anti-penton base or a mouse anti-GAPDH antibody followed by 
the appropriate secondary HRP-conjugate antibody. Bound antibody was detected using the ECL system 
and images were captured using a LAS 3000 imaging system. Mock-infected cells (in the presence or 
absence of AraC) were negative for Ad5 DBP and penton base expression. Ad5-infected cells in the 
absence of AraC were positive for both DBP and penton base expression at 24 h.p.i. Ad5-infected cells 
treated with AraC were positive for DBP expression, but were negative for penton base expression. These 
data showed that AraC treatment inhibited late but not early phase protein expression in Ad5-infected 
cells. AraC did not alter the protein levels of the internal loading control, GAPDH, in mock- or Ad5-
infected cells. 
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Figure 3-22. Prevention of coilin redistribution from CBs following treatment of Ad5-infected A549 
cells with the DNA replication inhibitor, cytosine arabinoside (AraC). 
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell in DMEM (‘- AraC’) or DMEM 
supplemented with 25 µg/ml AraC (‘+ AraC’) and incubated for 24 hours. Cells were fixed and subjected 
to indirect immunofluorescence. Cells were incubated with a rabbit anti-DBP and a mouse anti-coilin 
antibody followed by incubation with the appropriate fluorescent-labelled secondary antibodies. Nuclei 
were stained using DAPI. Confocal microscopy was performed using an inverted LSM510 confocal 
microscope coupled to LSM Image Browser. In the absence of AraC, mock-infected cells were negative 
for DBP expression (image b) and coilin was located in punctate CBs (image c, arrow). In Ad5-infected 
cells in the absence of AraC, DBP was present in nuclear foci (image f, arrow) and coilin was 
redistributed into microfoci (image g arrow). In the presence of AraC, mock-infected cells were negative 
for DBP expression (image j) and coilin was found in punctate CBs (image k, arrow) which appeared 
indistinguishable from CBs seen in untreated, mock-infected cells (image c, arrow). Ad5-infected cells 
treated with AraC exhibited a diffuse nuclear localisation of DBP (image n, arrow) and coilin were 
retained in punctate CBs (image o, arrow). These data indicated that AraC treatment prevented the 
redistribution of coilin from CBs into microfoci in Ad5-infected cells. Bars = 20 µm. 
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Figure 3-23. Prevention of SMN redistribution from CBs following treatment of Ad5-infected A549 
cells with the DNA replication inhibitor, cytosine arabinoside (AraC).  
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell in DMEM (‘- AraC’) or DMEM 
supplemented with 25 µg/ml AraC (‘+ AraC’) and incubated for 24 hours. Cells were fixed and subjected 
to indirect immunofluorescence. Cells were incubated with a rabbit anti-DBP and a mouse anti-SMN 
antibody followed by incubation with the appropriate fluorescent-labelled secondary antibodies. Nuclei 
were stained using DAPI. Confocal microscopy was performed using an inverted LSM510 confocal 
microscope coupled to LSM Image Browser. In the absence of AraC, mock-infected cells were negative 
for DBP expression (image b) and SMN was located in punctate CBs (image c, arrow). In Ad5-infected 
cells in the absence of AraC, DBP was present in nuclear foci (image f, arrow) and SMN was 
redistributed into rod-shaped structures in the nucleus (image g, arrow). In the presence of AraC, mock-
infected cells were negative for DBP expression (image j) and SMN was found in punctate CBs (image k, 
arrow) which appeared indistinguishable from CBs seen in untreated, mock-infected cells (image c, 
arrow). Ad5-infected cells treated with AraC exhibited a diffuse nuclear localisation of DBP (image n, 
arrow) and SMN was found in punctate CBs (image o, arrow). These data indicated that AraC treatment 
prevented the redistribution of SMN from CBs into rod-shaped nucleoplasmic structures in Ad5-infected 
cells. Bars = 20 µm. 
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infection (Chapter 2.2.6.1). At 24 h.p.i, cells were subjected to indirect immunofluorescence 
(Chapter 2.2.7) using an antibody raised against the CB protein in question (coilin or SMN) 
along with an anti-DBP antibody as a marker of Ad5-infected cells. DBP was chosen as the 
marker of Ad5-infected cells as this protein has a very different sub-nuclear distribution 
depending on the stage of infection. Prior to DNA replication, DBP appears diffusely in the 
nucleoplasm (Puvion-Dutilleul 1990a, 1990b). Upon DNA replication and transition into the 
intermediate/late phase, DBP was present in distinct, globular structures within the nucleus 
containing ssDNA intermediates (Puvion-Dutilleul 1990a, 1990b). As a result, DBP can be used 
to distinguish between Ad5-infected cells in the early phase of infection (diffuse DBP) from 
cells which are undergoing viral DNA replication (punctate, globular DBP). 
As shown in Figure 3-22 and previously (James et al., 2010), In mock-infected cells in the 
absence of AraC, there was no detectable DBP (image b) and coilin was located in CBs (image 
c, arrow). In Ad5-infected cells in the absence of AraC, DBP formed characteristic globular foci 
(image f, arrow) known to demark virus DNA replication centres (Puvion-Dutilleul 1990a, 
1990b) and coilin was redistributed into rosettes (image g, arrow). In the presence of AraC, the 
mock-infected cells exhibited punctate CBs (image k, arrow) similar to those seen in untreated 
cells (image c, arrow). This suggested that AraC treatment did not have any effect on normal 
CB morphology in terms of alteration to the CB diameter. In Ad5-infected cells, the 
redistribution of coilin into rosettes was prevented in the presence of AraC; coilin remained in 
CBs (image o, arrow). This suggested that coilin redistribution from CBs is dependent on Ad 
DNA replication, as previously reported (Rebelo et al., 1996; Rodrigues et al., 1996; James et 
al., 2010). As DNA replication was inhibited in these cells, the redistribution of DBP into the 
characteristic globular domains associated with viral DNA replication was also prevented; DBP 
was located diffusely in the nucleoplasm (image n, arrow), characteristic of its distribution in 
the early phase (Puvion-Dutilleul 1990a, 1990b).  
The redistribution of SMN during Ad5 infection was also assessed in AraC-treated A549 cells 
(Figure 3-23). In untreated, mock-infected cells, there was no detectable DBP (image b) and 
SMN was located in punctate CBs (image c, arrow). In untreated, Ad5-infected cells, DBP 
formed large globular foci (image f, arrow) and SMN was redistributed into rod-shaped 
structures in the nucleus (image g, arrow). CBs in mock-infected cells treated with AraC 
displayed CBs analogous to those seen in untreated cells (compare image k [arrow] with image 
c [arrow]). In AraC-treated, Ad5-infected cells, the redistribution of SMN into nuclear rod-
shaped structures was prevented; SMN remained within intact CBs (image o, arrow). This 
indicated that, as with coilin, the redistribution of SMN occurs after Ad DNA replication.  
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3.5.2 Treatment of Ad5-infected cells with cycloheximide (CHX) to determine 
dependence of CB rearrangement on late phase protein expression 
Cycloheximide (CHX) is an inhibitor of protein biosynthesis and was previously used to inhibit 
the expression of late proteins during Ad infection when cells are treated during the intermediate 
phase (Horwitz et al., 1973; Sohn and Hearing, 2011). Therefore, CHX treatment during the 
intermediate/late phase of infection can be used to distinguish whether a process is reliant upon 
Ad DNA replication or the expression of Ad late proteins. 
3.5.2.1 Inhibition of Ad5 late phase protein expression using CHX  
To verify the inhibition of late protein synthesis using CHX, A549 cells were mock or Ad5 
infected and incubated for 12 hours (Chapter 2.2.6.1). At 12 h.p.i, the medium was exchanged 
for DMEM or DMEM supplemented with the optimised concentration of CHX (30 µg/ml) and 
cells were incubated for 6 hours (Sohn and Hearing, 2011). It was decided to remove the CHX 
media after 6 hours, as a similar level of protein inhibition was observed as for incubation with 
CHX for 12 hours, without the concomitant deleterious effects on cell morphology. The 
medium was exchanged for complete DMEM and incubated for a further 6 hours. Whole cell 
lysates were prepared and protein was separated by SDS-PAGE and analysed by Western 
blotting (Chapter 2.2.2). A mouse anti-DBP and a rabbit anti-penton base antibody were used as 
markers of early and late phase protein expression, respectively.  
As shown in Figure 3-24, treatment of Ad5-infected cells with CHX prevented expression of the 
late phase penton base protein. There was also a substantial decrease in the level of early DBP 
protein; this was probably due to the fact that continued DBP expression would be prevented 
during the intermediate/late phase by treatment with CHX and, as the half life of DBP is around 
5-7 hours (Neale and Kitchingman, 1989), this would result in a reduction in DBP levels by 24 
h.p.i. As DBP is a necessary factor for Ad DNA replication (Lindenbaum et al., 1986; Cleat and 
Hay, 1989), this reduction in DBP levels following CHX treatment may negatively impact DNA 
replication. This should be taken into account when analysing the impact of CHX treatment on 
the redistribution of CB proteins during Ad5 infection. 
3.5.2.2 Immunofluorescence microscopy of Ad5-infected cells following CHX treatment 
The impact of CHX treatment on the redistribution of CB proteins during Ad5 infection was 
assessed. A549 cells were mock or Ad5 infected (Chapter 2.2.6.1) and incubated for 12 hours. 
Cells were incubated with either complete DMEM or complete DMEM supplemented with 
CHX for 6 hours. The medium was replaced with complete DMEM and incubated for a further 
6 hours before harvesting. Cells were subjected to indirect immunofluorescence (Chapter 2.2.2)  
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Figure 3-24. Inhibition of Ad5 late protein expression following treatment with the protein 
translation inhibitor, cycloheximide (CHX) from 12-18 h.p.i.  
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell and incubated for 12 hours. Cells were 
incubated with complete DMEM (‘- CHX’) or complete DMEM supplemented with 30 µg/ml CHX (‘+ 
CHX’) from 12 to 18 h.p.i. At 24 h.p.i, whole cell lysates were prepared and equal masses of protein (20 
µg) were separated by SDS-PAGE and analysed by Western blotting. Bound antibody was detected using 
the ECL system and images were captured using a LAS 3000 imaging system. Mock-infected cells in the 
absence or presence of CHX did not express DBP or penton base. Ad5-infected cells that were not treated 
with CHX were positive for DBP and penton base expression at 24 h.p.i. Ad5-infected cells treated with 
CHX had reduced DBP expression at 24 h.p.i and were negative for penton base expression at this time 
point. CHX treatment did not alter the protein levels of the internal loading control, GAPDH, in mock- or 
Ad5-infected cells. These data indicated that CHX treatment of Ad5-infected cells reduced the level of 
early phase proteins and prevented expression of late phase proteins.  
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Figure 3-25. Prevention of coilin redistribution from CBs following treatment of Ad5-infected A549 
cells with the protein translation inhibitor, cycloheximide (CHX) from 12-18 h.p.i 
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell. At 12 h.p.i, complete DMEM (‘- CHX’) 
or complete DMEM supplemented with 30 µg/ml CHX (‘+ CHX’) was added to the cells. Following a 6 
hour incubation period, medium was replaced with fresh complete DMEM. Cells were fixed at 24 h.p.i 
and subjected to indirect immunofluorescence using a rabbit anti-DBP and a mouse anti-coilin antibody 
followed by incubation with the appropriate fluorescent-labelled secondary antibodies. Nuclei were 
stained using DAPI. Confocal microscopy was performed using an inverted LSM510 confocal 
microscope coupled to LSM Image Browser. In the absence of CHX, mock-infected cells were negative 
for DBP expression (image b) and coilin was located in CBs (image c, arrow). In Ad5-infected cells in the 
absence of CHX, DBP was present in the nucleus (image f), either in a limited number of large, bright 
foci (blue arrow; a distribution of DBP seen at earlier time points post-infection) or in numerous, smaller 
foci (white arrow; a distribution of DBP usually seen at later time points post-infection). In Ad5-infected 
cells, coilin was redistributed into microfoci (image g, arrow). As shown in the overlay, coilin microfoci 
typically surrounded DBP foci but did not colocalise with these structures (image q, white arrow); 
however, in some cells there was partial colocalisation of coilin foci around the periphery of DBP centres 
(image q, blue arrow). In the presence of CHX, mock-infected cells were negative for DBP expression 
(image j) and coilin was found in CBs (image k, arrow) which appeared indistinguishable from CBs seen 
in untreated, mock-infected cells (image c, arrow). In Ad5-infected cells treated with CHX, only the 
large, bright foci of DBP were seen (image n, arrow); there was no evidence of the numerous, smaller 
DBP foci usually seen at late time points post-infection. In Ad5-infected cells treated with CHX, coilin 
was retained in CBs (image o, white arrow) and was also present at low-level in adjacent, larger foci 
(image o, blue arrow). As shown in the overlay, coilin in these larger foci colocalised with DBP foci 
(image r, arrow). These data indicated that CHX treatment during the intermediate phase of Ad5-infection 
prevented redistribution of coilin from CBs into microfoci, and resulted in a partial accumulation of coilin 
in DBP-positive foci. Bars = 20 µm. 
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Figure 3-26. Prevention of SMN redistribution from CBs following treatment of Ad5-infected A549 
cells with the protein translation inhibitor, cycloheximide (CHX) from 12-18 h.p.i. 
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell. At 12 h.p.i, complete DMEM (‘- CHX’) 
or complete DMEM supplemented with 30 µg/ml CHX (‘+ CHX’) was added to the cells; cells were 
incubated for 6 hours. Medium was replaced with fresh complete DMEM. Cells were fixed at 24 h.p.i and 
subjected to indirect immunofluorescence using a rabbit anti-DBP and a mouse anti-SMN antibody 
followed by incubation with the appropriate fluorescent-labelled secondary antibodies. Nuclei were 
stained using DAPI. Confocal microscopy was performed using an inverted LSM510 confocal 
microscope coupled to LSM Image Browser. In the absence of CHX, mock-infected cells were negative 
for DBP (image b) and SMN was located in CBs (image c, arrow). In Ad5-infected, untreated cells, DBP 
was present in the nucleus (image f), either in a limited number of large, bright foci (blue arrow; a 
distribution of DBP seen at early time points post-infection) or in numerous, smaller foci (white arrow; a 
distribution of DBP usually seen at late time points post-infection). In Ad5-infected, untreated cells, SMN 
was redistributed into nuclear rod-shaped structures (image g, arrow). Mock-infected, CHX-treated cells 
were negative for DBP (image j) and SMN was found in CBs (image k, arrow) which appeared 
indistinguishable from CBs seen in mock-infected, untreated cells (image c, arrow). In Ad5-infected, 
CHX-treated cells CHX, only the large, bright foci of DBP were seen (image n, arrow). SMN was 
retained in CBs in these cells (image o, arrow). These data indicated that CHX treatment during the 
intermediate phase of Ad5 infection prevented the redistribution of SMN from CBs. Bars = 20 µm. 
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using an anti-DBP antibody to identify Ad5-infected cells along with an antibody raised against 
the CB protein in question (coilin or SMN).  
As shown in Figure 3-25, in mock-infected, untreated cells there was no detectable DBP (image 
b) and coilin was found in CBs (image c, arrow) and. In Ad5-infected, untreated cells, DBP 
formed large globular foci in the nuclei (image f, arrow) and coilin was redistributed into 
rosettes (image g, arrow). Treatment of mock-infected cells with CHX did not appear to affect 
the integrity of CBs in terms of CB diameter (compare image k [arrow] with image c [arrow]). 
Treatment of Ad5-infected cells with CHX prevented the formation of coilin rosettes (image o, 
arrow). This indicated that the redistribution of coilin from CBs to rosettes required protein 
synthesis in the late phase. Interestingly, coilin in the Ad5-infected, CHX-treated cells, coilin 
partially localised in Ad DNA replication centres with DBP (image r, arrow). This was in 
contrast to Ad5-infection of CHX-untreated cells, where coilin rosettes generally surrounded 
DBP-positive DNA replication centres (image q, white arrow) with some colocalisation of 
rosettes with DBP at the periphery of these domains (image q, blue arrow). This indicated that 
upon inhibition of intermediate/late phase protein expression in Ad5-infected cells, coilin is not 
redistributed into rosettes; instead, coilin remains within CBs and a subset of coilin becomes 
partially associated with Ad DNA replication domains. 
The impact of CHX treatment on SMN redistribution during the late phase of Ad5 infection was 
also assessed (Figure 3-26). Mock-infected, untreated cells were negative for DBP (image b) 
and SMN was present in punctate CBs (image c, arrow). In Ad5-infected, untreated cells, DBP 
formed globular nuclear foci (image f, arrow) and SMN was redistributed into the nucleoplasm 
and into nuclear rod-shaped structures (image g, arrow). In mock-infected cells, CHX treatment 
did not alter the morphology of CBs in terms of CB diameter (image k, arrow). In Ad5-infected, 
CHX-treated cells, SMN remained within intact CBs (image o, arrow). This indicated that, as 
with coilin, protein synthesis in the late phase is required for the redistribution of SMN during 
Ad5 infection. 
The formation of nuclear spot and ring structures by DBP is indicative of the onset of viral 
DNA replication and this was evident in untreated Ad5-infected cells (Figure 3-25 and Figure 3-
26, image f) and CHX-treated, Ad5-infected cells (Figure 3-25 and Figure 3-26, image n). This 
indicated that viral DNA replication was still occurring in Ad5-infected cells treated with CHX. 
In the Ad5-infected, untreated cells, the globular accumulations of DBP exhibited two distinct 
structures. Early in the infectious cycle, DBP located in a small number of large, bright foci 
(Figure 3-25 and Figure 3-26, image f, blue arrow), whilst at a later stage DBP is predominantly 
found in more numerous, weaker staining accumulations (Figure 3-25 and Figure 3-26, image f, 
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white arrow). In the Ad5-infected, CHX-treated cells, only the large, bright, less numerous foci 
of DBP were present (Figure 3-25 and Figure 3-26, image n, white arrow) i.e. the morphology 
present at an early stage of infection. This suggested that the temporal shift in DBP morphology 
was slowed in CHX-treated cells. The altered morphology of DNA replication centres could 
also be due to the reduced protein levels of DBP following CHX treatment (Figure 3-24). In 
addition, CHX has been previously shown to inhibit Ad DNA replication (Sohn and Hearing, 
2011), which could account for disrupted distribution of DBP, a protein required for Ad DNA 
replication. Further work is required to address these suggestions. 
3.5.3 Rearrangement of CBs in relation to L4-33K expression 
Ad5 L4-33K is expressed immediately following the initiation of Ad DNA replication 
(Akusjarvi, 2008; Morris et al., 2010) and therefore represents the onset of intermediate gene 
expression. By co-staining Ad5-infected cells with an anti-L4-33K antibody alongside an 
antibody raised against a CB protein (coilin or SMN) CB re-arrangement relative to the 
expression of L4-33K can be determined. The presence or absence of L4-33K expression in 
Ad5-infected cells along with the sub-nuclear distribution of the CB protein can establish 
whether CB disassembly occurs prior to, or following, expression of L4-33K. 
As shown in Figure 3-27A, mock-infected cells were negative for L4-33K (image b) and coilin 
was located in punctate CBs (image c, arrow) in these cells. At 24 h.p.i, the majority of Ad5-
infected cells expressed L4-33K (image b, arrow) and exhibited a rosette distribution of coilin 
(image c, white arrow). Ad5-infected cells expressing L4-33K either exhibited intact CBs 
(image h, white arrow) or rosettes (image h, blue arrow). Interestingly, no cells were found to 
exhibit rosettes in the absence of L4-33K expression, indicating that coilin is redistributed after 
L4-33K expression. To quantify the redistribution of coilin relative to L4-33K expression, the 
following parameters were used: the presence or absence of L4-33K and the distribution of 
coilin (‘CB’ or ‘rosette/speckled’). Three fields of 100 cells were counted from each sample and 
the experiment was repeated twice. As shown in Figure 3-27B, 53% of Ad5-infected cells were 
negative for L4-33K expression and exhibited CBs, indicating they are either uninfected cells or 
cells at an early stage of infection prior to L4-33K expression. The proportion of cells positive 
for L4-33K and rosettes was 39%. No cells were found to exhibit rosettes in the absence of L4-
33K expression, whilst 7% of L4-33K-positive cells exhibited intact CBs. This suggested that 
during Ad5 infection, the expression of L4-33K preceded the redistribution of coilin into 
rosettes. Interestingly, coilin and L4-33K exhibited partial co-localisation in rosettes in the Ad5-
infected cells (Figure 3-27A, image h, blue arrow), suggesting that L4-33K may be a component 
of rosettes in Ad5-infected cells. 
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Figure 3-27. The redistribution of coilin during Ad5 infection relative to expression of Ad5 L4-33K.  
Cells were mock or Ad5 infected at an MOI of 5 FFU/cell. At 24 h.p.i, cells were fixed and subjected to 
indirect immunofluorescence using a rabbit anti-L4-33K and a mouse anti-coilin antibody followed by 
incubation with the appropriate fluorescent-labelled secondary antibodies. Nuclei were stained using 
DAPI. Confocal microscopy was performed using an inverted LSM510 confocal microscope coupled to 
LSM Image Browser. A. Representative confocal microscopy images of coilin and L4-33K at 24 h.p.i. 
Mock-infected cells were negative for L4-33K (image b) and coilin was located in CBs (image c, arrow). 
In Ad5-infected cells, L4-33K (image f, arrow) and coilin (image g, arrow) were found in nuclear 
microfoci. As shown in the overlay (image h), cells expressing L4-33K exhibited coilin in CBs (white 
arrow) or in microfoci (blue arrow). No Ad5-infected cells contained coilin microfoci in the absence of 
L4-33K expression. Bars = 10 µm. B. Quantification of coilin and L4-33K distributions in Ad5-infected 
cells at 24 h.p.i. Cells were quantified using the following parameters: presence (+) or absence 
(-) of L4-33K and coilin distribution (CB or rosette). Three fields of 100 cells were counted from each 
coverslip. Results are the mean percentage of cells (± SEM) from three independent experiments.  
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Figure 3-28. The redistribution of SMN during Ad5 infection relative to expression of Ad5 L4-33K.  
Cells were mock or Ad5 infected at an MOI of 5 FFU/cell and incubated for 24 hours. Cells were fixed 
and subjected to indirect immunofluorescence. Cells were incubated with a rabbit anti-L4-33K and a 
mouse anti-SMN antibody followed by incubation with the appropriate fluorescent-labelled secondary 
antibodies. Nuclei were stained using DAPI. Confocal microscopy was performed using an inverted 
LSM510 confocal microscope coupled to LSM Image Browser. A. Representative confocal microscopy 
images of SMN and L4-33K at 24 h.p.i. Mock-infected cells were negative for L4-33K (image b) and 
SMN was located in CBs (image c, arrow). In Ad5-infected cells, L4-33K (image f, arrow) was found in 
nuclear microfoci and SMN was redistributed in the nucleoplasm (image g, arrow). As shown in the 
overlay (image h), cells expressing L4-33K exhibited SMN in CBs (white arrow) or nucleoplasmic SMN 
(blue arrow). No Ad5-infected cells contained redistributed SMN in the absence of L4-33K expression. 
Bars = 20 µm. B. Quantification of SMN and L4-33K distributions in Ad5-infected cells at 24 h.p.i. Cells 
were quantified using the following parameters: presence (+) or absence (-) of L4-33K and SMN 
distribution (CB or nucleoplasmic). Three fields of 100 cells were counted from each coverslip. Results 
are the mean percentage of cells (± SEM) from three independent experiments. 
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The redistribution of SMN in relation to L4-33K expression was also investigated. As shown in 
Figure 3-28A, Mock-infected cells did not express L4-33K (image b) and SMN was found in 
punctate CBs (image c, arrow). In Ad5-infected cells, there was a punctate distribution of L4-
33K (image f, arrow) and SMN was redistributed within the nucleoplasm and into rod-shaped 
structures in the nucleus (image g, arrow). Ad5-infected cells expressing L4-33K either contain 
intact CBs (image h, white arrow) or redistributed SMN (image h, blue arrow). No cells 
exhibited redistributed SMN in the absence of L4-33K expression. The cells were quantified 
using the following parameters; the presence or absence of L4-33K and the distribution of SMN 
(CB or nucleoplasmic/diffuse SMN). Three fields of 100 cells were counted from each coverslip 
and this experiment was repeated three times. As shown in Figure 3-28B, 47% of Ad5-infected 
cells were negative for L4-33K expression and exhibited intact CBs, indicating they are either 
uninfected or at an earlier stage of the infectious cycle. The proportion of cells exhibiting L4-
33K and redistributed SMN was 45%. Interestingly, no cells exhibited redistributed SMN in the 
absence of L4-33K expression, whilst 8% of cells exhibited intact CBs in L4-33K-positive cells. 
This suggested that, similar to the results obtained with coilin, the expression of L4-33K 
precedes the redistribution of SMN during Ad5 infection. 
3.5.4 Ad5-induced CB redistribution in primary human keratinocytes 
To date, the redistribution of CBs following species C Ad infection has only been reported in 
the cervical cancer cell line HeLa (Rebelo et al., 1996; Rodrigues et al., 1996; James et al., 
2010). Although cell lines are often good models for virus infection, the interaction of Ads with 
primary cells may be different to that of transformed cell lines. To address this question, CB 
distribution in Ad5-infected primary human keratinocytes was investigated. 
To establish an infection time course of Ad5 in primary human keratinocytes, cells were mock 
or Ad5 infected (Chapter 2.2.6.1), whole cell lysates were prepared at 0, 4, 8, 12, 16, 24 and 48 
h.p.i and protein was subjected to analysis by SDS-PAGE and Western blotting (Chapter 2.2.2). 
As found with A549 cells (Chapter 3.2), the first signs of CPE in the primary human 
keratinocytes were at 48 h.p.i, therefore this was the final time point at which cells were 
harvested. A mouse anti-DBP and a rabbit anti-penton base antibody were used to detect early 
and late phase protein expression, respectively. A mouse anti-GAPDH antibody was used as an 
internal loading control.  
As shown in Figure 3-29, DBP was first detected at 12 h.p.i. Penton base was first detected at 
24 h.p.i, with increased expression by 48 h.p.i. These results are similar to penton base 
expression in Ad5-infected A549 cells (Figure 3-1). These data indicated that the time course of  
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Figure 3-29. Ad5 infection of primary human keratinocytes.  
A. A time course of Ad5 infection in primary human keratinocytes. Cells were mock or Ad5 infected at 
an MOI of 5 FFU/cell and incubated for 0, 4, 8, 12, 16, 24 or 48 hours. Whole cell lysates were prepared 
and equal masses of protein (20 µg) were separated by SDS-PAGE and analysed by Western blotting. 
Bound antibody was detected using the ECL system and images were visualised using a Las 3000 
imaging system. DBP was first detected in the Ad5-infected cells at 12 h.p.i, with increased expression at 
48 h.p.i. Penton base was first detected at 24 h.p.i, with increased expression at 48 h.p.i. Mock-infected 
cells at 24 h.p.i were negative for both DBP and penton base expression. Levels of the internal loading 
control, GAPDH, remained constant during the time course of Ad5 infection. 
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Figure 3-30. B. The redistribution of coilin and SMN following Ad5 infection of primary human 
keratinocytes.  
Cells were mock or Ad5 infected at an MOI of 5 FFU/cell and incubated for 24 hours. Cells were fixed 
and subjected to indirect immunofluorescence using a rabbit anti-E1A antibody along with a mouse anti-
coilin or a mouse anti-SMN antibody followed by incubation with the appropriate fluorescent-labelled 
secondary antibodies. Nuclei were stained using DAPI. Confocal microscopy was performed using an 
inverted LSM510 confocal microscope coupled to LSM Image Browser. A. The redistribution of coilin 
following Ad5-infection of primary human keratinocytes. Mock-infected cells were negative for E1A 
(image b) and coilin was found in CBs (image c, arrow). Ad5-infected cells were positive for E1A (image 
f, red cells) and coilin was redistributed from CBs into microfoci in these cells (image g, arrow). B. The 
redistribution of SMN following Ad5-infection of primary human keratinocytes. Mock-infected cells 
were negative for E1A (image b) and SMN was located in CBs (image c, arrow). Ad5-infected cells were 
positive for E1A (image f, red cells); SMN was redistributed into nuclear rod-shaped structures (image g, 
white arrow) and also exhibited increased cytoplasmic staining (image g, blue arrow). Bars = 20 µm. 
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Ad5 infection time course in primary human keratinocytes was similar to that observed in A549 
cells. As the abundance of cells exhibiting rosette distribution of coilin in Ad5-infected A549 
cells reached a peak at 24 h.p.i (Figure 3-1), it was reasoned that this would be an appropriate 
time point to study the redistribution of CBs in the primary human keratinocytes. 
Primary human keratinocytes were mock or Ad5 infected (Chapter 2.2.6.1) and subjected to 
indirect immunofluorescence at 24 h.p.i (Chapter 2.2.7). Cells were stained using either a mouse 
anti-coilin or a mouse anti-SMN antibody along with a rabbit anti-E1A antibody to identify 
Ad5-infected cells. As shown in Figure 3-30A, mock-infected primary human keratinocytes 
were negative for E1A expression (image b) and coilin was located in large, punctate CBs in 
these cells (image c, arrow). Ad5-infected cells were positive for E1A expression (image f, red 
cells) and coilin was redistributed from CBs into rosettes in these cells (image g, arrow). These 
data are similar to results obtained with A549 cells (Figure 3-3) and previous data in HeLa cells 
(Rebelo et al., 1996; Rodrigues et al., 1996; James et al., 2010). Therefore, in addition to the 
transformed cell lines HeLa and A549, the redistribution of coilin from CBs into rosettes also 
occurs during Ad5 infection of primary human keratinocytes. 
The redistribution of SMN following Ad5 infection of primary human keratinocytes was also 
investigated (Figure 3-30B). Mock-infected primary human keratinocytes were negative for 
E1A expression (image b) and exhibited a punctate CB distribution of SMN (image c, arrow), 
with some nucleoplasmic and cytoplasmic staining. Ad5-infected primary human keratinocytes 
were positive for E1A staining (image f) and SMN was located in the nucleoplasm and in 
stronger-staining nucleoplasmic structures (image g, arrow), similar to that observed in Ad5-
infected A549 cells when using the mouse anti-SMN antibody (Figure 3-6). However, there also 
appeared to be increased cytoplasmic staining of SMN in Ad5-infected primary human 
keratinocytes (image g, blue arrow); this was not observed in studies in Ad5-infected A549 cells 
using the mouse anti-SMN antibody (Figure 3-6). This indicated that whilst the Ad5-induced 
redistribution of SMN from CBs into stronger-staining structures in the nucleoplasm occurred in 
both primary human keratinocytes and A549 cells, the location of SMN in the cytoplasm may 
differ between these two cell lines. Further studies in these two cell lines with additional SMN 
antibodies would be required to confirm this. Taken together, these data obtained with primary 
human keratinocytes validate the CB redistribution data found in A549 cells. Furthermore, these 
data also validate A549 cells as an appropriate host-cell model for the study of Ad5 infection. 
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Figure 3-31. The redistribution of coilin and SMN following Ad12 infection of A549 cells.  
A549 cells were mock or Ad12 infected at an MOI of 5 FFU/cell and incubated for 24 hours. Cells were 
fixed and subjected to indirect immunofluorescence. Cells were incubated with a mouse anti-hexon 
antibody along with a rabbit anti-coilin or a rabbit anti-SMN antibody followed by incubation with the 
appropriate fluorescent-labelled secondary antibodies. Nuclei were stained using DAPI. Confocal 
microscopy was performed using an inverted LSM510 confocal microscope coupled to LSM Image 
Browser. A. Redistribution of coilin following Ad12-infection of A549 cells. Mock-infected cells were 
negative for hexon expression (image b) and coilin was found in CBs (image c, arrow). Ad12-infected 
cells were positive for hexon (image f, green cells); these cells exhibited smaller, more numerous coilin 
foci in the nucleus (image g, white arrow) compared with CBs seen in uninfected cells (image g, blue 
arrow). B. Redistribution of SMN following Ad12-infection of A549 cells. Mock-infected cells were 
negative for hexon expression (image b) and SMN was found in CBs (image c, arrow). Ad12-infected 
cells were positive for hexon (image f, green cells); these cells exhibited nucleoplasmic SMN (image g, 
white arrow) and cytoplasmic SMN levels were increased (image g, blue arrow). Bars = 10 µm.  
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Figure 3-32. The redistribution of coilin and SMN following Ad3 infection of A549 cells.  
A549 cells were mock or Ad3 infected at an MOI of 0.5 FFU/cell and incubated for 24 hours. Cells were 
fixed and subjected to indirect immunofluorescence. Cells were incubated with a rabbit anti-Ad3 fibre 
antibody along with a mouse anti-coilin or a mouse anti-SMN antibody followed by incubation with the 
appropriate fluorescent-labelled secondary antibodies. Nuclei were stained using DAPI. Confocal 
microscopy was performed using an inverted LSM510 confocal microscope coupled to LSM Image 
Browser. A. Redistribution of coilin following Ad3-infection of A549 cells. Mock-infected cells were 
negative for fibre expression (image b) and coilin was found in CBs (image c, arrow). Ad3-infected cells 
were positive for fibre (image f, green cells) and coilin was redistributed into nuclear microfoci (image g, 
arrow). B. Redistribution of SMN following Ad3-infection of A549 cells. Mock-infected cells were 
negative for fibre expression (image b) and SMN was found in CBs (image c, arrow). Ad3-infected cells 
were positive for fibre (image f, green cells); these cells exhibited a diffuse nucleoplasmic distribution of 
SMN (image g, white arrow) whereas in uninfected cells, SMN was located in CBs (image g, blue arrow). 
Bars = 10 µm (A) or 20 µm (B). 
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3.6 Analysis of CB redistribution during infection with Species A Ad12 and 
Species B Ad3 by immunofluorescence microscopy 
To date, the redistribution of CBs has been characterised only in relation to infection with 
species C Ads (Rebelo et al., 1996; Rodrigues et al., 1996; James et al., 2010). To investigate 
whether the redistribution of CB proteins was a conserved feature of infection by adenoviruses 
of other species, A549 cells were infected with Ad12 (Species A) or Ad3 (Species B) at an MOI 
of 5 or 0.5, respectively (Chapter 2.2.6.1). At 24 h.p.i, cells were subjected to indirect 
immunofluorescence (Chapter 2.2.7) using an anti-coilin or an anti-SMN antibody and an anti-
Ad3 fibre or an anti-hexon antibody as markers of Ad3- and Ad12-infection, respectively.  
As shown in Figure 3-31A, mock-infected cells were negative for hexon (image b) and coilin 
was found in CBs (image c, arrow) in these cells. Ad12-infected cells were positive for hexon 
(image f; green cells) and exhibited coilin microfoci in the nucleus (image g, white arrow) 
which appeared smaller in size than CBs found in uninfected cells (image g, blue arrow). These 
coilin microfoci did not form the regular, circular clusters seen in Ad5-infected cells (Figure 3-
3), indicating that CB disassembly following Ad12 infection may differ to Ad5-infection.  
Ad12-infected cells were also investigated for SMN redistribution (Figure 3-31B). Mock-
infected cells were negative for hexon expression (image b) and SMN was located in CBs 
(image c, arrow) in these cells. Ad12-infected cells (image f, green cells) exhibited a diffuse 
distribution of SMN in the nucleus (image g, white arrow) and also strong SMN staining in the 
cytoplasm (image g, blue arrow). This contrasts with data in Ad5-infected cells, where SMN 
was redistributed into nuclear rod-shaped structures (Figure 3-6). However, these data with 
Ad12 were obtained using the rabbit anti-SMN antibody, which did not appear to stain the Ad5-
induced rod-shaped structures as strongly as the mouse anti-SMN antibody (Figure 3-7). 
The impact of Ad3 infection on the cellular localisation of coilin was investigated (Figure 3-
32A). Mock-infected cells were negative for Ad3 fibre expression (image b) and coilin was 
located in punctate CBs in these cells (image c, arrow). Ad3 infection resulted in the expression 
of Ad3 fibre (image f, green cells) and the redistribution of coilin into rosettes (image g, arrow) 
which were very similar to those seen during Ad5 infection (Figure 3-3).  
SMN distribution following Ad3 infection was also assessed (Figure 3-32B). Mock-infected 
cells were negative for Ad3 fibre (image b) and SMN was found within CBs in these cells 
(image c, arrow). Ad3-infected cells were positive for Ad3 fibre expression (image f, green 
cells) and exhibited a diffuse nucleoplasmic distribution of SMN (image g, white arrow). In 
contrast, the Ad3 fibre-negative cells (image f, blue arrow) exhibited CB distribution of SMN 
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(image g, blue arrow). These data showed that SMN was redistributed from CBs into the 
nucleoplasm during Ad3 infection. However, there was no evidence of increased cytoplasmic 
staining as seen with Ad12, nor were there concentrated regions of SMN in rod-shaped 
structures within the nucleus, as seen with Ad5. 
Taken together, these data indicated that CB disassembly may be a conserved mechanism 
amongst adenoviruses, since infection with Ads from species A (Ad12), species B (Ad3) and 
species C (Ad5) all induced CB disassembly. However, the coilin microfoci formed during 
Ad12 infection appeared to differ from those formed during infection with Ad5 or Ad3, 
indicating that the interaction of Species A viruses with coilin may differ to that of Ads 3 and 5. 
Moreover, the redistribution of SMN from CBs appeared to differ in all three viruses: Ad5 
induced rearrangement of SMN into nuclear rod-shaped structures, Ad3 infection resulted in 
diffuse nuclear SMN whilst Ad12 infection redistributed SMN diffusely within the nucleus and 
into the cytoplasm. This indicated that these viruses all interact with SMN in different ways. 
3.7 Chapter 3 Discussion 
The Cajal body (CB) is a multifunctional sub-nuclear body involved in the maturation and 
biogenesis of spliceosome components (reviewed in Morris, 2008). During Ad5 infection, the 
marker protein of CBs, p80 coilin, is redistributed into numerous microfoci (Rebelo et al., 1996; 
Rodrigues et al., 1996; James et al., 2010). In order to begin an analysis of the function of coilin 
microfoci (termed ‘rosettes’), the redistribution of coilin was investigated relative to known 
nuclear substructures by indirect immunofluorescence. Rosettes were not associated with PML-
NBs or nucleoli, suggesting that rosettes are not involved in functions related to these nuclear 
bodies. Rosettes appeared to enclose viral DNA replication centres and were surrounded by sites 
of splicing, as reported previously (James et al., 2010). It would be logical to consider that due 
to their close proximity to regions of splicing, rosettes may simply act as a local snRNP 
processing factory during Ad5 infection. However, unlike conventional CBs, rosettes do not 
contain snRNPs, indicating that rosettes do not function as sites for spliceosome subunit 
maturation (Bridge et al., 1993a; Rebelo et al., 1996). Taken together, these data indicated that 
rosettes may be providing a currently undefined function during Ad5 infection that is potentially 
distinct from normal CB function. 
Interestingly, it has recently been shown that CB proteins are involved in diverse cellular 
processes aside from snRNP maturation. Coilin was suggested to play a role in DNA damage 
responses (Morency et al., 2007; Gilder et al., 2011). Ads have been shown to disrupt 
components of the DNA damage response pathway during infection; the E1B-55K/E4orf6 
complex ubiquitinates and targets the MRN complex for degradation in order to prevent 
 128 
 
concatemerisation of the Ad genome and the subsequent inhibition of DNA replication 
(Stracker et al., 2002; Araujo et al., 2005; Liu et al., 2005). Therefore it is possible that CB 
disruption during Ad5 infection may be a mechanism to subvert coilin-mediated DNA damage 
responses. Indeed, analysis of coilin protein levels during Ad5 infection revealed that coilin 
levels are reduced by 48 h.p.i (Figures 3-1 and 3-2), indicating that coilin may be targeted for 
degradation during Ad5 infection. However, if coilin was a restrictive factor during Ad5 
infection, coilin depletion might be expected to enhance Ad5 infection; previous data suggested 
that coilin depletion resulted in decreased production of Ad5 late proteins and reduced the virus 
titre (James et al., 2010). This indicates that rather than being a restrictive factor, coilin may be 
required for a productive infection. Further work will be required to define the precise role of 
coilin during Ad5 infection and to clarify whether coilin is a target of the E1B-55K/E4orf6 
ubiquitin ligase complex. 
In contrast to coilin, spliceosomal snRNPs are redistributed into nucleoplasmic ring structures 
following Ad5 infection (Bridge et al., 1993a; Rebelo et al., 1996). This indicated that the 
trafficking of snRNPs to CBs was abrogated during Ad5 infection. However, the impact of Ad5 
infection on the snRNP chaperone proteins SMN and WRAP53 was unknown. 
Immunofluorescence microscopy of Ad5-infected cells revealed that WRAP53 was 
redistributed into rosettes along with coilin (Figure 3-5). In striking contrast, SMN was 
redistributed from CBs into the nucleoplasm and nuclear rod-shaped structures (Figure 3-6). 
This indicated that SMN plays a different role to the CB proteins found in rosettes (coilin, 
fibrillarin and WRAP53) during Ad5 infection. Indeed, previous work has shown that protein 
components of other nuclear substructures (such as PML-NBs and nucleoli) are also 
redistributed to different nuclear domains during Ad infection in order to facilitate diverse 
functions (Puvion-Dutilleul and Christensen, 1993; Muller and Dejean, 1999; Matthews, 2001; 
Zhao et al., 2003). For example, the nucleolar protein C23 (nucleolin) is redistributed into the 
cytoplasm, possibly to subvert the transcriptional-repressive properties of C23 (Matthews, 
2001). In contrast, another nucleolar protein, B23, is sequestered into viral replication centres 
and appears to promote viral replication, possibly by aiding the assembly of viral chromatin or 
progeny virions (Okuwaki et al., 2001; Lawrence et al., 2006; Samad et al., 2007; Samad et al., 
2012; Ugai et al., 2012). Therefore different CB proteins may be redistributed to different 
subnuclear regions in order to promote distinct functions during a productive Ad5 infection.  
In order to facilitate identification of the function of these novel SMN-containing domains, the 
redistribution of SMN was assessed relative to known nuclear domains. Immunofluorescence 
analysis of SMN redistribution in Ad5-infected cells revealed there was some overlap between 
redistributed SMN and sites of splicing (Figure 3-11). However, due to the nucleoplasmic 
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distribution of SMN and transcription/splicing factors during the later stages of Ad5 infection, it 
is possible that their partial colocalisation may simply be a result of their mutual nucleoplasmic 
distribution rather than a specific association. Interestingly, SMN has previously been reported 
to be involved in splicing regulation by both indirect and direct mechanisms (Pellizzoni et al., 
1998; Mourelatos et al., 2001; Pellizzoni et al., 2002; Zhang et al., 2008; Makarov et al., 2012). 
Further investigation is required to define a potential role of SMN in Ad splicing. It should be 
noted that snRNPs are not a definitive marker of active splicing since in uninfected cells under 
steady state conditions they are located diffusely within the cell and concentrate within CBs, 
which are not sites of active splicing (Bridge et al., 1993a). Therefore, in order to more 
accurately identify an association between SMN and regions of active splicing during Ad5 
infection, further immunofluorescence microscopic analyses using an antibody against an 
essential splicing factor such as SRSF2 is warranted.  
In addition to partial colocalisation with regions of splicing, SMN also colocalised with regions 
of virus assembly (Figure 3-20). This indicated that SMN is involved in assembly of Ad virions. 
Intriguingly, the SMN complex has previously been implicated in virion assembly during 
infection with minute virus of mice (MVM) (Young et al., 2002a, b; 2005). It is possible that 
the SMN complex is hijacked during Ad infection to facilitate assembly of progeny virions. 
Further work will be required to determine whether SMN plays a role in Ad virion assembly. 
Identifying the stage of Ad infection at which a protein is redistributed may also aid with 
identification of its function. In this chapter, the redistribution of both coilin and SMN was 
prevented when DNA replication was inhibited (Figure 3-22 and Figure 3-23), suggesting that 
progression to the intermediate and late phase of infection is required for redistribution of coilin 
and SMN. CB redistribution was also prevented when Ad5-infected cells were treated with 
CHX during the late phase of infection (Figure 3-25 and Figure 3-26), indicating that protein 
synthesis in the late phase may be required for CB redistribution. Finally, the redistribution of 
both coilin and SMN appeared to occur after the expression of L4-33K (Figure 3-27 and Figure 
3-28), indicating that CB disassembly occurs during the intermediate/late phase of Ad5 
infection. These data indicated that both coilin and SMN may be targeted for redistribution by 
intermediate and/or late phase Ad protein(s), possibly to facilitate a currently undefined function 
during the later stages of the Ad lifecycle. 
Although collectively these data give a strong argument for CB disassembly occurring during 
the intermediate/late phase, there were some limitations to these studies. CHX treatment 
resulted in a decreased accumulation of Ad DBP (Figure 3-24), an essential factor for Ad DNA 
replication. Furthermore, DNA replication centres appeared to have an altered morphology 
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following CHX treatment (Figure 3-25 and Figure 3-26). Indeed, CHX has been previously 
reported to directly inhibit Ad DNA replication (Sohn and Hearing, 2011). Therefore it should 
be noted that the observed inhibition of CB redistribution following CHX treatment may be due 
to DNA replication inhibition by CHX rather than inhibition of protein synthesis in the late 
phase. In addition, it was previously reported that treatment of HeLa cells with CHX induced 
the redistribution of CBs into microfoci (Rebelo et al., 1996). The lack of CB fragmentation 
observed in the current experiment may be due to the removal of CHX-containing media at 18 
h.p.i, allowing recovery of CB architecture by the time the cells were fixed (Rebelo et al., 
1996). Alternatively, the concentration of CHX used in this study (30 µg/ml) was lower than 
that used by Rebelo et al (100 µg/ml), therefore it is possible that CB reorganisation did not 
occur at this lower CHX concentration. Further work is required to address these suggestions. 
CHX treatment was found to result in the partial co-localisation of coilin with Ad5 DBP in Ad 
DNA replication centres (Figure 3-25). This indicated that in the absence of late protein 
expression, coilin became associated with regions of Ad DNA replication. It is possible that the 
location of coilin in DNA replication domains is prevented during late phase infection by the 
interaction of coilin with a late Ad protein, resulting in redistribution of CB into rosettes rather 
than in replication centres. Further work will be required to determine whether coilin interacts 
with any Ad late phase proteins and/or early Ad proteins involved in DNA replication.  
It was found in this study that disassembly of CBs occurred after the expression of L4-33K. 
This is in contrast to previous published data, which suggested that CB disassembly occurred 
prior to the L4-33K expression (James et al., 2010). The discrepancy between these data and the 
published data may be due to differences in the virus titres used (an MOI of 1000 FFU/cell 
[James et al.,] versus MOI of 5 FFU/cell [in this study]) or the different cell lines used (HeLa 
[James et al.,] versus A549 [in this study]). In addition, the exposures used on the confocal 
microscope may have impacted on the results. Setting a too low exposure for L4-33K may 
result in cells expressing low levels of L4-33K to appear negative for L4-33K. This could result 
in some cells appearing to exhibit rosettes in the absence of L4-33K expression. The reciprocal 
may also occur; too low an exposure for coilin may not detect the rosette structures, which are 
generally much smaller than normal CBs. This could result in some cells appearing to be 
positive for L4-33K but negative for rosettes. However, the latter is less likely as these cells 
would appear to express no coilin at all, which would register as unusual. For the acquisition of 
these data, the exposures for both coilin and L4-33K were carefully adjusted by firstly 
optimising the exposures for L4-33K and coilin in the Ad5-infected cells, to ensure detection of 
coilin rosettes and cells expressing low-level L4-33K. The mock-infected cells were then used 
to check for over-exposure of coilin or non-specific background staining of L4-33K. The results 
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of this careful optimisation gave a strong argument for the rearrangement of coilin following 
expression of L4-33K. However, it should be noted that the anti-L4-33K antibody used may 
also detect L4-22K (Ostapchuk et al., 2006), therefore the redistribution of CBs was likely 
shown relative to expression of L4-33K and/or L4-22K, rather than L4-33K alone. 
To date, the redistribution of CB proteins has only been assessed in the cancer cell line HeLa 
(Rebelo et al., 1996; Rodrigues et al., 1996; James et al., 2010). HeLa cells contain integrated 
HPV-18 DNA (Gey et al., 1952); this is not ideal for the study of viral infection as expression 
of HPV-18 oncogenes in these cells may interfere with cellular processes. In this study, the 
impact of Ad5 infection on the subcellular distribution of CB proteins was assessed in the non-
virally transformed cell line, A549. Coilin was redistributed following Ad5 infection of A549 
cells in a manner very similar to results previously obtained in HeLa cells (Figure 3-3). 
Redistribution of coilin and SMN also occurred following Ad5-infection of primary human 
keratinocytes (Figure 3-30). This indicated that the observed effects on CB proteins following 
Ad5 infection of cancer cell lines are also applicable to Ad5 infection of primary cells. 
Finally, the redistribution of CB proteins has previously only been assessed in cells infected 
with the species C Ads 2 and 5 (Rebelo et al., 1996; Rodrigues et al., 1996; James et al., 2010). 
In this study, the redistribution of the CB proteins coilin and SMN was assessed following 
infection with the Species A virus Ad12 and the Species B virus Ad3. Coilin was redistributed 
into microfoci following infection with both Ad3 and Ad12. Although SMN was redistributed 
into the nucleoplasm following infection with Ad3 and Ad12, the nuclear rod-shaped 
accumulations of SMN observed during Ad5 infection were not evident during infection with 
Ad3 or Ad12. Furthermore, Ad12 infection resulted in increased cytoplasmic SMN staining. 
However, only one time point post-infection was observed (24 h.p.i) and it is possible that the 
kinetics of infection with these viruses may differ to that of Ad5. Therefore it is possible that the 
appearance of the nuclear-peripheral SMN structures may occur at a different time post-
infection and so may have been missed in this study. Further work will be required to confirm 
this. Either way, these data indicated that the redistribution of CBs is a conserved event during 
Ad infection, suggesting that CB disassembly is an important process during the Ad lifecycle.  
Interestingly, other viruses have also been shown to redistribute coilin from CBs into microfoci, 
including GRV, Influenza B virus (IBV) and HCMV (Kim et al., 2007, Canetta et al., 2008, 
Salsman et al., 2008). However, the impact of infection with these viruses upon SMN 
distribution has not been established. It would be interesting to establish whether SMN is also 
redistributed into the nucleoplasm following infection with these viruses. It would also be 
tempting to identify the impact of virus infection on less well-characterised nuclear 
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substructures such as nSBs and cleavage bodies. As cleavage bodies have been shown to have a 
close association with CBs (Schul et al., 1996; Schul et al., 1999b; Li et al., 2006b), 
establishing the impact of Ad infection on the cleavage body is particularly appealing. 
In conclusion, the novel data from this investigation showed that during Ad5 infection, 
WRAP53 was redistributed from CBs into microfoci alongside coilin whilst SMN was 
redistributed to a novel nuclear domain. The redistribution of both coilin and SMN occurred 
during the intermediate/late phase of infection. Coilin microfoci did not co-localise with other 
well-characterised nuclear substructures or marker proteins. SMN partially colocalised with 
regions of splicing and virus assembly. The redistribution of CBs was conserved across Ad 
species A, B and C. Further work is now required to characterise the functions of SMN and the 
CB proteins redistributed to rosettes (coilin, WRAP53 and fibrillarin) during Ad infection.   
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4.1 Introduction 
In Chapter 3, the Ad5-induced rearrangement of the CB factors coilin, fibrillarin, WRAP53, 
snRNPs and SMN was characterised. It was found that coilin, fibrillarin and WRAP53 were 
redistributed into nuclear microfoci (‘rosettes’) during the intermediate/late phase of Ad5 
infection. This indicated that these CB proteins may play important roles during the late phase 
of Ad infection. Moreover, previous data suggested a potential role for coilin in Ad late phase 
protein expression (James et al., 2010). However, the mechanism by which coilin regulates Ad 
late protein expression is currently unknown. This chapter will focus on defining the role of 
coilin during Ad5 infection.  
An effective, frequently used method of studying the role of a protein in a particular cellular 
process is to deplete the protein from the cell by treatment with small inhibitory RNA (siRNA). 
These RNAs are complementary in sequence to the target mRNA and have a distinct structure 
of double-stranded 21-23bp RNA with two nucleotide protrusions at the 3′ end (Elbashir et al., 
2001). When transfected into the cell, they associate in an ATP-dependent mechanism with a 
large multimeric complex known as the RNA-induced silencing complex (RISC) which 
functions to guide the siRNA to its complementary RNA target sequence (Nykanen et al., 
2001). The double-stranded molecule unwinds, the reverse complementary strand remains 
associated with the RISC and degradation of the target mRNA is stimulated by exo- and 
endonucleases (Martinez et al., 2002). In this Chapter, depletion of cellular coilin was achieved 
by siRNA treatment and the impact on Ad virus titre, Ad protein levels and Ad mRNA levels 
was determined. 
4.2  Analysis of coilin depletion using siRNA 
The most appropriate time point after siRNA transfection at which to infect the cells with Ad5 
was established. Transfection with coilin siRNA (siCoilin) or scrambled control siRNA 
(siControl) (Table 2-2) was performed in A549 cells (Chapter 2.2.5.1) and cells were incubated 
for 24 hours or 48 hours. By 48 h.p.i, the cells had reached 90-100% confluency; a further time 
point of 72 hours was not taken as the cells would have been over-confluent by this time and the 
viability of the cells may have been compromised as a result. Protein in whole cell lysates was 
separated by SDS-PAGE and analysed by Western blotting (Chapter 2.2.2).  
As shown in Figure 4-1A, at 24 hours post-siRNA transfection the level of coilin protein in 
siCoilin-treated cells had decreased to around 60% of the level in siControl-treated cells. By 48 
hours post-transfection, coilin levels in siCoilin-treated cells had further decreased to around 
40% of the level in siControl-treated cells. From these data, it was decided that Ad5 infection 
would be carried out at 24 hours post-transfection, whereby a sufficient proportion of coilin 
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Figure 4-1. The depletion of coilin in A549 cells following siRNA treatment.  
A. Coilin levels at 24 and 48 hours post-siRNA transfection. Cells were treated with siControl or siCoilin 
and incubated for 24 or 48 hours. Whole cell lysates were prepared and equal masses of protein (20 µg) 
from each sample were separated by SDS-PAGE and analysed by Western blotting. Bound antibody was 
detected using the ECL system and images were captured using a LAS 3000 Imager. Signal intensities 
from Western blots were calculated by densitometric analysis and were normalised to the signal intensity 
of the loading control, GAPDH. Results are displayed relative to the siControl-treated, mock-infected 
sample, which was set to a value of 1. i. Western blots of coilin levels. Compared with siControl-treated 
cells, coilin levels in siCoilin-treated cells were reduced at 24 hours post-transfection, with further 
reduction at 48 hours. ii. Densitometric analysis of coilin levels. Compared with siControl-treated cells, 
coilin levels in siCoilin-treated cells were decreased at 24 and 48 hours post-transfection by 
approximately 40% and 60%, respectively. B. Coilin levels at 48 hours post-siRNA transfection 
following Ad5 infection at 24 hours post-siRNA transfection. Cells were treated with siControl or 
siCoilin and incubated for 24 hours. Cells were mock or Ad5 infected at an MOI of 5 FFU/cell and 
incubated for 24 hours. Whole cell lysates were prepared and protein was analysed as described above. i. 
Western blots of coilin levels. Compared with siControl-treated cells, coilin levels were reduced in cells 
treated with siCoilin. Coilin levels were reduced to a similar extent in siCoilin-treated, mock-infected 
cells and in siCoilin-treated, Ad5-infected cells. ii. Densitometric analysis of coilin levels. Compared with 
siControl-treated, mock-infected cells, coilin levels were reduced in siCoilin-treated, mock-infected cells 
and siCoilin-treated, Ad5-infected cells by 53% and 55%, respectively. 
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would be depleted from cells (around a 40% decrease) and cells would be harvested at 48 hours 
post-transfection (24 h.p.i), when coilin levels had decreased by around 60% compared to 
siControl-treated cells.  
The impact of Ad5 infection on the efficiency of coilin depletion was also assessed. Ad VA-
RNAs have previously been shown to inhibit RNA silencing during the late phase of Ad 
infection by abrogating the functions of the RISC complex and Dicer, a endoribonuclease 
enzyme responsible for cleavage of double-stranded RNA (dsRNA) and pre-miRNA into 
siRNA (Andersson et al., 2005). Therefore it was possible that Ad infection might affect the 
efficiency of coilin depletion by siRNA treatment. To investigate this possibility, siRNA 
transfection was performed in A549 cells using siControl or siCoilin (Chapter 2.2.5.1) and 
incubated for 24 hours. Cells were mock or Ad5 infected (Chapter 2.2.6.1) and incubated for a 
further 24 hours. Whole cell lysates were prepared, protein was separated by SDS-PAGE and 
analysed by Western blotting (Chapter 2.2.2).  
As shown by the representative Western blots in Figure 4-1B, siCoilin treatment appeared to 
reduce protein levels of coilin by a similar factor in both mock- and Ad5-infected cells. This 
observation was confirmed by densitometric analysis of the protein band intensities; in 
comparison to siControl-treated, mock infection, siCoilin treatment reduced coilin levels in 
mock- and Ad5-infected cells to 47% and 45%, respectively (Figure 4-1B). There was no 
significant difference in the level of coilin depletion achieved in Ad5-infected cells compared to 
mock-infected cells. This indicates that Ad5 infection at 24 hours post-transfection does not 
alter the level of coilin depletion by 48 hours post-transfection.  
4.3 Impact of coilin depletion on cell growth/viability using the MTT assay 
Previously published data reported a significant reduction in proliferation in coilin-depleted 
HeLa cells, although cells still appeared to be viable (Lemm et al., 2006). To assess the impact 
of coilin depletion on the viability and proliferation of A549 cells, the MTT assay was used as 
described in Chapter 2.2.9. The sensitivity of the MTT assay was assessed; serial dilution of 
A549 cells results in a linear, dilution-dependent decrease in the concentration of formazan 
detected (Appendix Figure 7). This indicated that the degree of change in formazan 
concentration directly correlates with the degree of change in the number/viability of the cells. 
As analysis on a plate reader requires the experiment to be carried out in 96-well plates, where 
the wells are very small, it was more practical to perform the siRNA transfection in parallel with 
cell plating (‘reverse siRNA transfection’) rather than growing cells to the desired confluency 
on a small surface area (conventional siRNA transfection). In order to determine whether coilin 
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Figure 4-2. The impact of coilin depletion on the cell growth and/or viability of A549 cells. 
A. ‘Reverse’ siRNA transfection and Ad5 infection of A549 cells. Cells were subjected to ‘reverse’ 
siRNA transfection using siControl or siCoilin and incubated for 24 hours. Cells were mock or Ad5 
infected at an MOI of 5 FFU/cell and incubated for 24 hours. Whole cell lysates were prepared and equal 
masses of protein from each sample (20 µg) were separated by SDS-PAGE and analysed by Western 
blotting. Bound antibody was detected using the ECL system and images were captured using a Las 3000 
Imager. Signal intensities from Western blotting were quantified by densitometric analysis and were 
normalised to the signal intensity of the loading control, GAPDH. Results are displayed as the mean fold 
change in protein level (± SEM) from three independent experiments. Results are displayed relative to the 
siControl-treated, mock-infected sample, which was set to a value of 1. Compared with siControl-treated 
cells, coilin levels were decreased to a similar extent in siCoilin-treated, mock-infected cells and siCoilin-
treated, Ad5-infected cells. Quantification of coilin levels by densitometric analysis showed that 
compared with siControl-treated, mock-infected cells, coilin levels in siCoilin-treated, mock-infected 
cells and siCoilin-treated, Ad5 infected cells were reduced by 57% and 58%, respectively. n/s – non-
specific cross-reacting protein species. B. MTT assay of A549 cells following coilin depletion and Ad5 
infection. Results are displayed as the mean fold change in absorbance at 570 nm (± SEM) from three 
independent experiments. Data is displayed relative to the siControl-treated, mock-infected sample, which 
was set to a value of 1. Statistics were calculated using the paired 1-sample t-test. There was no 
significant change in absorbance at 570 nm in siCoilin-treated cells compared with siControl treated cells, 
indicating that siCoilin treatment does not affect the cell viability.  
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had been depleted to a similar level following ‘reverse siRNA transfection’ as compared to 
conventional siRNA transfection, ‘reverse siRNA transfection’ was carried out on A549 cells in 
6-well plates (Chapter 2.2.5.2). Following a 24 hour incubation, cells were mock or Ad5 
infected (Chapter 2.2.6.1). At 24 h.p.i, whole cell lysates were prepared, protein was separated 
by SDS-PAGE and analysed by Western blotting (Chapter 2.2.2). As shown in Figure 4-2Ai, 
‘reverse’ siCoilin-treatment resulted in a decrease in coilin protein levels compared to siControl-
treated cells. This decrease was calculated from densitometric analysis (Figure 4-2Bii) as 57% 
and 58% for mock- and Ad5-infected cells, respectively. This is very similar to the depletion of 
coilin achieved following the conventional siRNA transfection procedure (reductions of 53 and 
55% respectively; Figure 4-1B). This indicates that the efficiency of depletion achieved is 
similar between these two methods. 
Once the ‘reverse siRNA transfection’ procedure had been validated, ‘reverse siRNA 
transfection’ was performed on A549 cells in 96-well plates (Chapter 2.2.5.2). Following a 24 
hour incubation, cells were mock or Ad5 infected (Chapter 2.2.6.1). At 24 h.p.i, cells were 
harvested and analysed by the MTT assay (Chapter 2.2.9). As shown in Figure 4-2Bii, the 
absorbance at 570 nm was not significantly altered compared to siControl treated, mock infected 
cells. This suggested that depletion of coilin to around 40% of siControl-treated cells did not 
affect either cell proliferation or viability. 
4.4 The impact of coilin depletion on the cellular levels of other CB proteins  
Coilin has been shown to interact with multiple protein partners including SMN, WRAP53 and 
SmB′, a component of the SMN complex (Hebert et al., 2001; Mahmoudi et al., 2010). It is 
possible that depletion of coilin may alter the levels of coilin-interacting proteins or proteins 
associated with the CB. If this is the case, any impact of coilin depletion on Ad5 infection could 
be indirectly due to alteration to the levels of a coilin-associated protein, rather than being a 
direct result of reduced coilin levels. To assess this possibility, the level of coilin-interacting or 
associated CB proteins (coilin, SMN, WRAP53, Sm and fibrillarin) following siRNA treatment 
(Chapter 2.2.5.1) and mock or Ad5 infection (Chapter 2.2.6.1) was assayed by SDS-PAGE and 
Western blotting (Chapter 2.2.2).  
As shown by the Western blots in Figure 4-3A, depletion of coilin did not appear to 
significantly alter the levels of SMN, WRAP53, Sm or fibrillarin. This was confirmed by 
densitometric analysis of protein levels (Figure 4-3B). This indicated that coilin depletion did 
not significantly alter the cellular protein levels of SMN, WRAP53, fibrillarin or Sm. 
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Figure 4-3. Western blot analysis of CB protein levels following coilin depletion and Ad5 infection.  
A549 cells were treated with siControl or siCoilin and incubated for 24 hours. Cells were mock or Ad5 
infected at an MOI of 5 FFU/cell and incubated for 24 hours. Whole cell lysates were prepared and equal 
masses of protein from each sample (20 µg) were separated by SDS-PAGE and analysed by Western 
blotting. Bound antibody was detected using the ECL system and images were captured using a LAS 
3000 imaging system. Signal intensities were calculated by densitometric analysis and were normalised to 
the signal intensity of the internal loading control, GAPDH. A. Representative western blots of CB 
proteins. Compared with siControl-treated cells, levels of coilin were reduced in siCoilin-treated cells 
whilst levels of SMN, WRAP53, fibrillarin and Sm were not affected. N/S – non-specific cross-reacting 
protein species. B. Densitometric analyses of signal intensities from Western blotting. Results are the 
mean fold change in protein level (± SEM) from three independent experiments, displayed relative to the 
siControl-treated, mock-infected sample, which was set to a value of 1. Compared with siControl-treated 
cells, coilin levels were significantly reduced in siCoilin-treated cells whilst levels of SMN, WRAP53, 
fibrillarin and Sm were not affected. Black bars = siControl-treatment. Grey bars = siCoilin-treatment. 
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Figure 4-4. Flow cytometric analysis of CB proteins following coilin depletion and Ad5 infection. 
A549 cells were transfected with siControl or siCoilin and incubated for 24 hours. Cells were mock or 
Ad5 infected and incubated for a further 24 hours. Cells were harvested and subjected to flow cytometric 
analysis. Results show the mean fold change in protein level (± SEM) from at least three independent 
experiments performed in duplicate. Data is shown as relative to the siControl-treated, mock-infected 
sample, which was set to a value of 1. Statistics were calculated using a paired 1-sample t-test. Compared 
with siControl-treated cells, levels of coilin were significantly decreased in siCoilin-treated, mock-
infected cells and siCoilin-treated, Ad5-infected cells. Levels of SMN, Sm and fibrillarin were not 
significantly affected by siCoilin treatment. Black bars = siControl-treated cells. Grey bars = siCoilin-
treated cells. *p<0.05. 
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To support the Western blotting data, it was also decided to analyse the levels of CB proteins 
following coilin depletion by flow cytometry (Chapter 2.2.8). WRAP53 levels were not assayed 
by this method due to the strong non-specific cross reaction of the WRAP53 antibody with an 
unidentified 100 kDa protein (Figure 3-1); flow cytometric analysis of WRAP53 levels using 
this antibody could be compromised by variations in the level of this non-specific protein. 
Cellular levels of coilin, SMN, fibrillarin and Sm were assayed by flow cytometry (Chapter 
2.2.8). As shown in Figure 4-4, flow cytometric analysis revealed there was no significant 
difference in expression levels of any of the CB proteins following siCoilin-treatment as 
compared to siControl-treated cells. This confirmed the Western blotting data that coilin 
depletion did not alter the levels of coilin-interacting proteins or associated CB proteins. Coilin 
depletion in the siCoilin-treated cells, although significant, appeared negligible by this method. 
However, from Western blotting analysis it was apparent that this antibody cross-reacted with a 
non-specific protein of around 65 kDa (Figure 4-3A), therefore the overall reduction in coilin 
levels will appear minimal by flow cytometric analysis due to non-specific binding of the 
antibody to the unidentified 65 kDa protein. 
4.5 Impact of coilin depletion on the subcellular distribution of CB proteins 
Coilin is required for CB integrity and recruitment of proteins to the CB (Tucker et al., 2001; 
Mahmoudi et al., 2010). Therefore it is possible that coilin depletion may alter the subcellular 
distribution of CB proteins. This could have a potential impact on Ad infection in an indirect 
manner by causing the redistribution of other CB proteins within the cell. To identify whether 
coilin depletion disrupted the subcellular distribution of WRAP53 or SMN, siRNA transfection 
was performed using siControl or siCoilin (Chapter 2.2.5.1) followed by mock or Ad5 infection 
(Chapter 2.2.6.1). Cells were then subjected to indirect immunofluorescence procedure (Chapter 
2.2.7) using an anti-SMN or an anti-WRAP53 antibody alongside anti-coilin antibodies. A goat 
anti-Ad capsid antibody was used to identify Ad5-infected cells.  
As shown in Figure 4-5, siControl-treated, mock-infected cells exhibited a punctate distribution 
of coilin in CBs (image b, arrow) and SMN was also located in CBs (image c, arrow); these 
proteins colocalised in CBs as shown by the yellow regions in the overlay (image q, arrow). 
Ad5 infection of siControl-treated cells resulted in the redistribution of coilin into rosettes 
(image f, arrow) and SMN into the nucleoplasm (image g, arrow), as previously described 
(Chapter 3.3). As shown in the overlay (image r), coilin microfoci (white arrow) did not co-
localise with areas of SMN staining (blue arrow). These data indicated that siControl treatment 
did not disrupt CB structure or affect the redistribution of coilin or SMN following Ad5 
infection.  
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Figure 4-5. Redistribution of SMN following Ad5 infection of coilin-depleted A549 cells. 
A549 cells were treated with siControl or siCoilin and incubated for 24 hours. Cells were mock or Ad5 
infected at an MOI of 5 FFU/cell and incubated for 24 hours. Cells were fixed and subjected to indirect 
immunofluorescence. Cells were incubated with a mouse anti-SMN, a rabbit anti-coilin and a goat anti-
Ad capsid followed by incubation with the appropriate fluorescent-labelled secondary antibodies. DAPI 
was used to stain nuclei. Confocal microscopy was performed using an inverted LSM510 confocal 
microscope coupled to LSM Image Browser. In siControl-treated, mock-infected cells, coilin was found 
in punctate CBs (image b, arrow) and SMN was also found in CBs (image c, arrow). Coilin and SMN co-
localised in CBs, as shown by the yellow regions in the overlay (image q, arrow). In siControl treated, 
Ad5-infected cells, coilin was redistributed from CBs into microfoci (image f, arrow). SMN was 
redistributed from CBs into the nucleoplasm and within stronger staining, rod-shaped structures (image g, 
arrow). Ad shown in the overlay (image r), there was no colocalisation between redistributed SMN (blue 
arrow) and coilin microfoci (white arrow). In siCoilin-treated, mock-infected cells, coilin staining was 
reduced in the majority of cells (image j, white arrow); in these cells, SMN was found within punctate 
nuclear structures (image k, white arrow). Some cells were not depleted of coilin, and retained punctate 
CBs (image j, blue arrow). The punctate structures of SMN in coilin-depleted cells (image k, white arrow) 
appeared smaller in size than CBs seen in cells that were not depleted of coilin (image k, blue arrow). As 
shown by the yellow regions in the overlay (image s), cells that were not depleted of coilin exhibited 
strong colocalisation of SMN and coilin in CBs (blue arrow) whilst in cells depleted of coilin, SMN was 
retained in punctate nuclear structures in the absence of coilin (white arrow). In siCoilin-treated, Ad5-
infected cells, coilin staining was reduced in the majority of cells, (image n, white arrow); SMN was 
redistributed into the nucleoplasm in these cells (image o, white arrow). Some cells were not depleted of 
coilin, and retained punctate CBs (image n, blue arrow). The redistribution of SMN into the nucleoplasm 
following Ad5-infection of coilin-depleted cells (image o, white arrow) appeared similar to SMN 
redistribution in cells that retained coilin expression (image o, blue arrow). As shown in the overlay 
(image t), in cells retaining coilin expression there was no colocalisation of coilin microfoci (blue arrow) 
with redistributed SMN (yellow arrow). In coilin-depleted cells, SMN was redistributed into the 
nucleoplasm in the absence of coilin (white arrow). Bars = 20 μm. 
  
 144 
 
In siCoilin-treated, mock-infected cells, coilin staining was reduced in the majority of cells 
(image j, blue arrow), whilst some cells retained coilin expression (image j, white arrow). In 
cells depleted of coilin, SMN was located within residual punctate structures (image k, blue 
arrow), which appeared to be slightly smaller in size than conventional CBs seen in cells that 
were not depleted of coilin (image k, white arrow). This indicated that SMN was maintained 
within punctate nuclear domains following coilin depletion. As shown in the overlay (image s), 
in cells retaining coilin expression, coilin and SMN colocalised in CBs (blue arrow), whilst in 
coilin-depleted cells, SMN was found within punctate nuclear domains in the absence of coilin 
(white arrow). In siCoilin-treated, Ad5-infected cells, the majority of cells exhibited reduced 
coilin staining (image n, white arrow) whilst some cells retained coilin expression (image n, 
blue arrow). In cells depleted of coilin, SMN was redistributed into the nucleoplasm (image o, 
blue arrow), in a similar manner to that seen following Ad5 infection of cells that were not 
depleted of coilin (image o, white arrow). This indicated that coilin depletion did not alter the 
redistribution of SMN following Ad5 infection. As shown in the overlay (image t), in cells 
retaining coilin expression, coilin microfoci (blue arrow) did not colocalise with redistributed 
SMN (yellow arrow). In coilin-depleted cells, SMN was redistributed into the nucleoplasm in 
the absence of coilin (image t, white arrow).  
The redistribution of WRAP53 by Ad5 in coilin-depleted cells was also assessed (Figure 4-6). 
In siControl-treated, mock-infected cells, WRAP53 was located in CBs (image b, arrow); coilin 
was also found in CBs (image c, arrow) and these two proteins colocalised in CBs as shown by 
the yellow regions in the overlay (image q, arrow). Ad5 infection of siControl-treated cells 
resulted in redistribution of coilin (image f, arrow) and WRAP53 (image g, arrow) into rosettes. 
These two proteins colocalised in rosettes, as shown by the yellow regions in the overlay (image 
r, arrow). In siCoilin-treated, mock-infected cells, the majority of cells exhibited a loss of coilin 
staining (image j, blue arrow), whilst a subset of cells retained coilin expression (image j, white 
arrow). In the coilin-depleted cells,, WRAP53 was located diffusely throughout the nucleoplasm 
and cytoplasm (image k, white arrow); this is in contrast to cells expressing coilin, in which 
WRAP53 is found concentrated within CBs along with coilin (image k, blue arrow). These data 
are consistent with previous studies indicating that coilin is required for maintenance of CB 
structure and for recruitment of WRAP53 to the CB (Mahmoudi et al., 2010). This showed that 
there was substantial alteration to the subcellular distribution of WRAP53 when coilin was 
depleted from the cells.  
In siCoilin-treated, Ad5-infected cells, the majority of cells exhibited a loss of coilin staining 
(image n, arrow). In these cells, WRAP53 was redistributed into nuclear microfoci (image o, 
arrow), indicating that Ad5 was able to redistribute WRAP53 in the absence of coilin. However,  
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Figure 4-6. Redistribution of WRAP53 following Ad5 infection of coilin-depleted A549 cells. 
A549 cells were treated with siControl or siCoilin and incubated for 24 hours. Cells were mock or Ad5 
infected at an MOI of 5 FFU/cell and incubated for 24 hours. Cells were incubated with a rabbit anti-
WRAP53, a mouse anti-coilin and a goat anti-Ad capsid antibody followed by incubation with the 
appropriate fluorescent-labelled secondary antibodies. DAPI was used to stain nuclei. Confocal 
microscopy was performed using an inverted LSM510 confocal microscope coupled to LSM Image 
Browser. . In siControl-treated, mock-infected cells, coilin was found in punctate CBs (image b, arrow) 
and WRAP53 was also found in CBs (image c, arrow). WRAP53 and coilin co-localised in CBs, as 
shown by the yellow regions in the overlay (image q, arrow). In siControl treated, Ad5-infected cells, 
coilin (image f, arrow) and WRAP53 (image g arrow) were redistributed into nuclear microfoci. As 
shown by the yellow regions in the overlay, there was partial colocalisation of WRAP53 and coilin in 
nuclear microfoci (image r, arrow). In siCoilin-treated, mock-infected cells, coilin was depleted in the 
majority of cells (image j, white arrow), whilst some cells were not depleted of coilin, and exhibited 
punctate CBs (image j, blue arrow). In cells depleted of coilin, WRAP53 was found diffusely in the 
nucleoplasm (image k, white arrow) whereas in cells expressing coilin, WRAP53 was found in CBs 
(image k, blue arrow). As shown by the yellow regions in the overlay (image s), cells that were not 
depleted of coilin exhibited strong colocalisation of WRAP53 and coilin in CBs (white arrow) whilst in 
cells depleted of coilin, WRAP53 was found diffusely in the cytoplasm (blue arrow). In siCoilin-treated, 
Ad5-infected cells, coilin expression was reduced in the majority of cells (image n, arrow) and WRAP53 
was redistributed into nuclear microfoci (image o, arrow). These microfoci of WRAP53 did not form the 
regular clusters seen in siControl-treated, Ad5-infected cells (compare image g [arrow] with image n 
[arrow]). As shown in the overlay, coilin-depleted cells exhibited WRAP53 microfoci that did not contain 
coilin (image t, arrow). Bars = 20 μm. 
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the WRAP53 microfoci seen in siCoilin-treated, Ad5-infected cells did not appear to form the 
regular ring-shaped clusters characteristic of rosettes seen in siControl-treated, Ad5-infected 
cells (compare image o [arrow] with image g [arrow]). This indicated that in coilin-depleted 
cells, Ad5 was able to rearrange WRAP53 into microfoci. However, coilin was required for 
formation of rosette structures. Therefore, it should be noted that any observations on Ad5 
infection following coilin depletion could be indirectly due to effects on the subcellular 
distribution of WRAP53, and the reduced capacity of Ad5 to rearrange WRAP53 into rosettes. 
4.6 Impact of coilin depletion on Ad5 virus yield 
To assess whether coilin depletion affected the production of infectious progeny viruses 
following infection, siRNA depletion using siControl or siCoilin was performed in A549 cells 
(Chapter 2.2.5.1). Following a 24 hour incubation, cells were mock or Ad5 infected (Chapter 
2.2.6.1). At 24 h.p.i, cells were harvested and the cell lysate was used to infect fresh A549 cells 
(Chapter 2.2.6.2). Two methods were employed in order to assess the impact of Ad5 infection 
on virus yield: the plaque assay (Chapter 2.2.10) and the flow cytometry assay (Chapter 2.2.8) 
staining for the Ad late protein hexon. Two methods were employed to study virus yield as each 
method has advantages and disadvantages. An advantage of the plaque assay is that it is a direct 
measurement of virus infectivity; however there is a large margin for error since the plaques are 
counted manually. An advantage of the flow cytometry assay is that it is quantitative. However, 
it is not a direct measure of infectivity; it is a measurement of late protein expression (although 
this will be closely correlated with virion production). Therefore both techniques were 
employed to assess the impact of coilin depletion on Ad5 virus yield. 
As shown in Figure 4-7A, plaque assay assessment of virus yield revealed that Ad5 infection of 
coilin-depleted A549 cells resulted in an 82% decrease in yield compared to Ad5 infection of 
siControl-treated cells. Similar results were obtained by flow cytometric analysis, where Ad5 
infection of siCoilin-treated A549 cells significantly reduced levels of hexon expression by 65% 
compared to Ad5 infection of siControl-treated cells (Figure 4-7B). Taken together, these 
results strongly suggested that depletion of coilin significantly reduces the yield of Ad5. 
4.7 The impact of coilin depletion on Ad5 protein expression 
Previously published data from Ad5 infection of siCoilin-treated HeLa cells suggested a role for 
coilin in the expression of late but not early Ad proteins (James et al., 2010). However, in the 
study by James et al only one early protein was assayed and the impact of coilin depletion on 
intermediate protein expression was not assessed. In order to gain a greater insight into the 
impact of coilin depletion on the expression of Ad5 proteins, the additional early protein E1A,  
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Figure 4-7. The impact of coilin depletion on Ad5 virus yield. 
A549 cells were treated with siControl or siCoilin and incubated for 24 hours. Cells were mock or Ad5 
infected at an MOI of 5 FFU/cell and incubated for 24 hours. Cells were harvested and ten-fold serial 
dilutions of cell lysate were used to infect fresh A549 cells. For analysis by plaque assay, cells were 
incubated for six days before plaques were counted. For the flow cytometric assay, cells were harvested at 
48 h.p.i and subjected to flow cytometric analysis staining for the Ad5 late protein, hexon. Data are the 
mean fold change (± SEM) from at least three independent experiments performed in triplicate. Results 
are expressed as relative to the siControl-treated, Ad5-infected sample, which was set to a value of 1. 
Statistics were calculated using the paired 1-tailed t-test. A. Plaque assay analysis of Ad5 virus yield. The 
virus yield was reduced by 82% following Ad5 infection of siCoilin-treated cells compared with Ad5 
infection of siControl-treated cells. The average virus titre following infection of A549 cells with cell 
lysate from siControl-treated, Ad5-infected cells was 1.5 x 10
8
 plaque-forming units (PFU)/ml. B. Flow 
cytometric analysis of hexon expression. Levels of hexon were reduced by 65% following Ad5 infection 
of siCoilin-treated cells compared with Ad5 infection of siControl-treated cells. *p<0.05, ***p<0.001. 
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intermediate proteins IVa2 and pIX and the late protein L4-100K were included along with the 
previously characterised DBP, IIIa, hexon and fibre protein. 
4.7.1 Western blotting analysis of Ad5 protein levels following Ad5 infection of coilin-
depleted A549 cells 
The impact of coilin depletion on Ad5 protein expression was initially analysed by Western 
blotting. Following siRNA treatment (Chapter 2.2.5.1) and mock or Ad5 infection (Chapter 
2.2.6.1), whole cell lysates were prepared and subjected to analysis by SDS-PAGE and Western 
blotting (Chapter 2.2.2). Membranes were incubated with antibodies raised against the Ad E1A, 
DBP, IVa2, L4-100K, IIIa and fibre proteins. Hexon and pIX were not included in this analysis 
since the hexon antibody 2Hx2 is not suitable for Western blotting, whilst there was an 
insufficient amount available of the anti-pIX antibody to complete Western blotting analysis.  
As shown by the Western blots in Figure 4.8A, Ad5 infection of coilin-depleted A549 cells 
resulted in a decrease in the levels of all Ad5 proteins as compared to siControl-treated cells. 
The decreases in Ad5 protein levels following coilin depletion were confirmed by densitometric 
analysis (Figure 4-8B). This indicated that depletion of coilin significantly reduces the 
expression levels of early, intermediate and late Ad proteins. 
4.7.2 Flow cytometric analysis of Ad5 protein levels following Ad5 infection of coilin-
depleted A549 cells 
Following the Western blotting analysis described in the previous section, quantitative analysis 
of Ad5 protein levels following infection of coilin-depleted cells was determined by flow 
cytometry (Chapter 2.2.8). The early Ad proteins E1A and DBP were assayed along with 
intermediate proteins IVa2 and pIX and the late proteins L4-100K, IIIa, fibre and hexon.  
Representative overlays from flow cytometric analysis of hexon expression are shown in Figure 
4-9A. The FITC area (FITC-A) value for the negative control samples (mock-infected samples 
stained with mouse anti-hexon antibody and mock- and Ad5-infected samples treated with a 
mouse isotype antibody) are located in the range of 0-10
1
, i.e. negative for hexon staining. An 
increase in the expression level of the protein in question results in a shift of the population to 
more positive FITC-A values. Both Ad5-infected samples (siControl and siCoilin treated) 
exhibited a shift of a proportion of the cells to 10
4
-10
5
, reflecting the high hexon expression in 
these cells. Compared with siControl-treated, Ad5-infected cells, there was a slight shift of the 
cell population to the left in the siCoilin-treated, Ad5-infected cells, indicating reduced 
fluorescence levels in these cells. There also appeared to be fewer cells expressing hexon in the 
siCoilin-treated, Ad5-infected cell population compared with the siControl-treated, Ad5- 
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Figure 4-8. The expression of Ad5 proteins following infection of coilin-depleted A549 cells. 
A549 cells were treated with siControl or siCoilin and incubated for 24 hours. Cells were mock or Ad5 
infected at an MOI of 5 FFU/cell and incubated for 24 hours. Equal masses of protein (20 µg) from whole 
cell lysates were subjected to separation by SDS-PAGE and analysed by Western blotting. Bound 
antibody was detected using the ECL system on a Las 3000 Imager. Signal intensities were calculated by 
densitometric analysis, normalising to the signal intensity of the loading control, GAPDH.  
A. Representative Western blots of Ad5 protein levels following infection of coilin-depleted cells. 
Compared with siControl-treated, Ad5-infected cells, levels of all Ad proteins studied (E1A 12S, E1A 
13S, DBP, IVa2, L4-100K, IIIa and fibre) were reduced in siCoilin-treated, Ad5-infected cells.   
B. Densitometric analysis of Western blots. Results are displayed as the mean fold change in protein level 
(± SEM) from at least three independent experiments. Results are displayed relative to the siControl-
treated mock-infected sample, which was set to a value of 1. All statistics were calculated using the paired 
1 sample t-test. Compared with Ad5 infection of siControl-treated cells, levels of all Ad proteins studied 
were significantly reduced following infection of siCoilin-treated cells. Black bars = siControl-treated 
cells. Grey bars = siCoilin-treated cells. *p<0.05, **p<0.01, ***p<0.001. 
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Figure 4-9. Flow cytometric analysis of Ad5 proteins following Ad5 infection of coilin-depleted cells. 
A549 cells were treated with siControl or siCoilin and incubated for 24 hours. Cells were mock- or Ad5-
infected at an MOI of 5 FFU/cell and incubated for 24 hours. Cells were harvested and subject to flow 
cytometric analysis. A. Example overlay from flow cytometric analysis of Ad5 hexon. Compared with 
infection of siControl-treated cells, Ad5 infection of siCoilin-treated cells resulted in decreased overall 
hexon expression (as shown by a shift of the FITC curve to the left) and also resulted in a decrease in the 
number of hexon-positive cells. B. Flow cytometric analysis of Ad5 proteins following infection of 
coilin-depleted cells. Results are the mean fold change in protein level (± SEM) from at least three 
independent experiments. Data are shown relative to the siControl-treated, Ad5-infected sample, which 
was set to a value of 1. Statistics were calculated using the paired 1 sample t-test. Compared with Ad5 
infection of siControl-treated cells, infection of siCoilin-treated cells resulted in decreased expression of 
all Ad proteins studied (E1A, DBP, pIX, IVa2, L4-100K, IIIa, hexon and fibre). Black bars = siControl-
treated cells. Grey bars = siCoilin-treated cells. *p<0.05, **p<0.01, ***p<0.001. 
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infected cells. These data indicated that coilin depletion reduced the level of hexon expression 
in cells, and also reduced the number of cells expressing hexon.  
The results of the complete flow cytometric analysis for all Ad proteins are displayed in Figure 
4-9B. It was found that depletion of coilin resulted in a significant decrease in the levels of all 
the Ad5 proteins studied. This indicated that coilin is required for Ad early, intermediate and 
late phase protein expression. 
4.7.3 The effect of varying the multiplicity of Ad infection in HeLa cells 
Previous flow cytometric analysis of siRNA-mediated coilin depletion in Ad5-infected HeLa 
cells reported a significant decrease in levels of the late proteins hexon, IIIa and fibre whilst 
levels of the early protein DBP were unaffected (James et al., 2010). This contrasts with the 
data in the previous sections (Chapter 4.7.1-4.7.2) where coilin depletion decreased the levels of 
Ad5 early, intermediate and late proteins. The discrepancy between these data and the published 
data by James et al may be due to differences in virus titre (an MOI of 1000 [James et al] vs. An 
MOI of 5 [in this study]) or the cell lines used (HeLa [James et al] vs. A549 [in this study]).  
To address the potential role of the cell line used, siRNA treatment was performed in HeLa cells 
(Chapter 2.2.5.1) followed by mock or Ad5 infection at an MOI of 5 FFU/cell (Chapter 2.2.6.1). 
At 24 h.p.i, cells were subjected to flow cytometric analysis (Chapter 2.2.8). As the coilin 
depletion data presented by James et al included analysis of Ad5 DBP, IIIa, fibre and hexon, 
these were the proteins investigated in this comparative assay. As shown in Figure 4-10A, there 
was a significant reduction in the protein levels of Ad DBP, IIIa, hexon and fibre in siCoilin-
treated, Ad5-infected cells as compared to siControl-treated, Ad5-infected cells. This is 
consistent with data obtained with A549 cells at this MOI (Chapter 4.7.2), indicating that the 
choice of cell line may not be the reason for the discrepancy between the results described here 
and those published by James et al. 
The potential role of MOI was also addressed. HeLa cells were treated with siRNA (Chapter 
2.2.5.1) prior to Ad5 infection at an MOI of 1000 (Chapter 2.2.6.1). Cells were harvested at 24 
h.p.i and subjected to flow cytometric analysis (Chapter 2.2.8). As shown in Figure 4-10B, 
although there was a significant decrease in the level of fibre protein in the siCoilin-treated 
Ad5-infected cells compared to siControl-treated Ad5-infected cells, the levels of DBP, IIIa and 
hexon were not significantly affected. This indicates that at a higher MOI, Ad infection is less 
susceptible to the inhibitory effect of coilin depletion. 
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Figure 4-10. Flow cytometric analysis of Ad5 protein levels following infection of coilin-depleted 
HeLa cells. 
HeLa cells were treated with siControl or siCoilin and incubated for 24 hours. Cells were mock or Ad5 
infected at an MOI of 5 or 1000 FFU/cell and incubated for 24 hours. Cells were harvested and subjected 
to flow cytometric analysis. Results are the mean fold change in protein level (± SEM) from three 
independent experiments. Results are displayed relative to the siControl-treated, Ad5-infected sample, 
which was set to a value of 1. All statistics were calculated using the paired 1 tailed t-test. A. Ad5 protein 
levels in coilin-depleted HeLa cells following infection at an MOI of 5 FFU/cell. Compared with Ad5 
infection of siControl-treated cells, levels of DBP, IIIa, hexon and fibre were significantly reduced 
following infection of siCoilin-treated cells. B. Ad5 protein levels in coilin-depleted HeLa cells following 
infection at an MOI of 1000 FFU/cell. Compared with Ad5 infection of siControl-treated cells, levels of 
DBP were significantly reduced following infection of siCoilin-treated cells, whilst levels of IIIa, hexon 
and fibre were not significantly affected. Black bars = siControl-treated cells. Grey bars = siCoilin-treated 
cells. *p<0.05, **p<0.01. 
A
B
 154 
 
4.8 Impact of coilin depletion on Ad5 mRNA levels 
The data from the previous section (Chapter 4.7) revealed that there was a significant reduction 
in Ad5 protein levels following infection of coilin-depleted cells compared to infection of 
siControl-treated cells. To establish whether the alterations in Ad5 protein levels were due to 
changes at the mRNA or the protein level, the levels of Ad5 mRNAs following coilin depletion 
was analysed. Exon-spanning primers were designed to amplify mature, spliced Ad5 mRNAs; 
E1A isoforms 13S, 12S, 11S, 10S, and 9S, DBP spliceoforms RT1 and RT2, L4-100K, IVa2, 
IIIa, hexon and fibre. Ad IX does not undergo splicing (Alestrom et al., 1980), therefore primers 
for this mRNA were designed within the single exon of IX. All primers are listed in Table 2-1 
and the design strategies for all primers are described in Appendix Figure 1-6. The specificity of 
the primers for their target mRNA was validated by semi-quantitative PCR (Chapter 2.2.4.3) 
and agarose gel electrophoresis (Chapter 2.2.4.5) as shown in Appendix Figure 8. Primer 
specificity was also verified by melting curve analysis. 
4.8.1 Ad5 mRNA expression following Ad5 infection of coilin-depleted A549 cells 
Since mRNA synthesis occurs prior to protein expression, if the alterations to Ad5 protein levels 
described in the previous section (Chapter 4.7) were due to changes at the mRNA level, these 
changes should occur earlier in the infectious cycle than the time point at which the effect on 
protein levels was observed. The decrease in Ad5 protein levels was observed at 24 h.p.i, 
therefore to ensure that any impact of coilin depletion on Ad5 mRNA levels would be observed, 
a time course of Ad5 hexon mRNA expression was carried out. Following siRNA treatment 
(Chapter 2.2.5.1), A549 cells were mock or Ad5 infected (Chapter 2.2.6.1). Cells were 
harvested at 18, 20, 22 and 24 h.p.i and total RNA was isolated by Trizol-chloroform extraction 
(Chapter 2.2.3.1). Total RNA was subjected to reverse transcription (Chapter 2.2.4.2) to 
produce cDNA from mRNA. Quantitative RT-PCR was performed (Chapter 2.2.4.4) using exon 
spanning primers specific for the mRNA target (Table 2-1).  
As shown in Figure 4-11A, the time course of hexon mRNA expression following Ad5 infection 
of siCoilin-treated cells revealed no difference in the levels of hexon mRNA from 16 to 24 h.p.i 
as compared to Ad5 infection of siControl-treated cells. This indicated that coilin depletion did 
not impact the total cellular levels of Ad5 hexon mRNA. 
4.8.2 Impact of coilin depletion on Ad5 mRNA expression at 20 hours post-infection 
Following the qPCR analysis of hexon mRNA levels from 16-24 h.p.i, the qPCR analysis at 20 
h.p.i was extended to include the spliced mRNA transcripts of E1A (9S, 10S, 11S, 12S, 13S), 
DBP (RT1 and RT2), L4-100K, IVa2, IIIa, hexon and fibre and the non-spliced mRNA  
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Figure 4-11. Ad5 mRNA levels following Ad5 infection of coilin-depleted A549 cells. 
A549 cells were treated with siControl or siCoilin and incubated for 24 hours. Cells were mock or Ad5 
infected at an MOI of 5 FFU/cell and incubated for 24 hours. Cells were harvested, total RNA was 
extracted by Trizol-chloroform extraction and cDNA was produced from RNA by reverse transcription. 
Quantitative PCR (qPCR) of cDNA was carried out using SYBR Green Taq PCR on a Rotorgene 6000 
cycler. Delta Ct values were calculated using Rotorgene 6000 software and were normalised to the 
‘housekeeping’ transcript, GAPDH. Results are shown as the mean fold change in mRNA level (±SEM) 
relative to the siControl-treated, Ad5-infected sample, which was set to a value of 1. Statistics were 
calculated using the paired one sample t-test. A. A time course of Ad5 hexon mRNA expression 
following coilin depletion. Hexon mRNA levels in siControl-treated, Ad5-infected cells were similar to 
those seen in Ad5-infected, siCoilin-treated cells from 18 to 24 h.p.i. B. Ad5 mRNA levels in siCoilin-
treated, Ad5-infected A549 cells at 20 h.p.i. Compared with Ad5 infection of siControl-treated cells, 
levels of 13S E1A, 12S E1A and IX mRNAs were significantly reduced following Ad5-infection of 
siCoilin-treated cells. Levels of E1A 11S, E1A 10S, E1A 9S, DBP RT1, DBP RT2, IVa2, L4-100K, IIIa, 
hexon and fibre mRNAs were not significantly affected. Black bars = siControl-treated cells. Grey bars = 
siCoilin-treated cells. *p<0.05, **p<0.01, ***p<0.001. 
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transcript of IX. To ensure there was no non-specific amplification of Ad DNA, a control 
sample of total cellular RNA which had not been subject to reverse transcription was used in all 
experiments for each primer pair. 
As shown in Figure 4-11B, the cellular levels of most Ad5 mRNA transcripts did not appear to 
be significantly altered following Ad5 infection of siCoilin-depleted cells compared to Ad5 
infection of siControl-treated cells. This indicates that coilin depletion did not alter the cellular 
levels of the majority of Ad5 mRNA transcripts. However, a significant decrease was observed 
in the levels of E1A 12S, E1A 13S and IX mRNAs following coilin depletion. This indicates 
that coilin may be required for the expression, processing or stability of these transcripts. 
4.8.3 Analysis of Ad5 pre-mRNA following depletion of coilin 
Although the cellular levels of the majority of Ad5 transcripts did not appear to be affected by 
coilin depletion, the levels of the Ad immediate early transcripts 13S and 12S E1A and the 
intermediate transcript IX were significantly reduced. Considering the levels of E1A 9S, 10S 
and 11S spliceoforms were unaffected by coilin depletion, it seemed unlikely that coilin 
depletion would be affecting transcription of E1A, since the levels of all mature transcripts 
would be expected to decrease. Nevertheless, to clarify whether the reduction in 12S and 13S 
E1As following coilin depletion was due to effects on transcription or mRNA splicing/stability, 
qRT-PCR analysis of E1A pre-mRNA was performed (Chapter 2.2.4.4) using intron-exon 
spanning E1A primers (Table 2-1). If the levels of Ad E1A pre-mRNAs were also reduced, this 
might indicate that the reduction in the mature E1A transcripts was due to decreased production 
of pre-mRNA transcripts, i.e. at the level of primary transcription. If the levels of E1A pre-
mRNAs were unaffected, this would suggest that the decrease seen in 13S and 12S transcripts is 
due to an effect at the level of mRNA splicing or stability. As IX mRNA is not subject to 
splicing, analysis of IX pre-mRNA was not possible by this method. To add strength to the 
investigation, the pre-mRNAs of IVa2, DBP and Ad late tripartite-leader (TPL)-containing 
mRNAs were also included in the analysis; the mature mRNAs of these transcripts were not 
altered following coilin depletion, therefore it would be expected that their corresponding pre-
mRNAs would also be unaffected. 
As shown in Figure 4-12, no significant difference was observed in the levels of E1A, DBP, 
IVa2 or TPL-containing pre-mRNA in siCoilin-treated cells compared to siControl-treated cells. 
This indicated that coilin depletion has no significant effect on Ad5 transcription. Therefore the 
observed decreases in levels of mature, spliced 13S and 12S E1As following coilin depletion 
may be due to altered stability or post-transcriptional processing of these transcripts following 
coilin depletion. 
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Figure 4-12. Expression levels of Ad5 pre-mRNAs following infection of coilin-depleted A549 cells. 
A549 cells were treated with siControl or siCoilin and incubated for 24 hours. Cells were mock or Ad5 
infected at an MOI of 5 FFU/cell and incubated for a further 24 hours. Cells were harvested and total 
RNA was extracted. Reverse transcription of total RNA was carried out to produce cDNA from RNA. 
QPCR analysis of cDNA was performed using exon-intron spanning primers specific for each pre-mRNA 
template. Delta Ct values were calculated using Rotorgene 6000 software and were normalised to the 
levels of the ‘housekeeping’ transcript, GAPDH. Results are displayed as the mean fold change in pre-
mRNA level (±SEM) from at least three independent experiments performed in duplicate. Results are 
displayed relative to the siControl-treated, Ad5-infected sample, which was set to a value of 1. Compared 
with Ad5-infection of siControl-treated cells, levels of Ad pre-mRNAs were not significantly altered 
following Ad5-infection of siCoilin-treated cells. Black bars = siControl-treated cells. Grey bars = 
siCoilin-treated cells. TPL – tripartite leader-containing pre-mRNA. 
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4.8.4 Analysis of cytoplasmic and nuclear mRNA levels following depletion of coilin 
From the results detailed in the previous section (Chapter 4.8.2 - 0), it was found that for the 
majority of Ad transcripts studied, there was no significant effect on production of mature Ad 
mRNAs following coilin depletion. However, coilin depletion resulted in a reduction in the 
levels of all Ad proteins (Chapter 4.7). This indicates that coilin may play a role at the post-
transcriptional, post-splicing level, either in mRNA transport or mRNA translation. Considering 
that coilin is primarily a nuclear protein, it was decided to investigate a potential role for coilin 
in the export of Ad mRNAs from the nucleus into the cytoplasm.  
To analyse the nuclear export of mRNA, cytoplasmic and nuclear RNA fractions can be isolated 
and, following standardisation of the mRNA levels to a ‘housekeeping’ transcript such as to 
GAPDH, the ratio of cytoplasmic to nuclear mRNA can be calculated. An increase in the 
cytoplasmic to nuclear mRNA ratio would indicate an increase in cytoplasmic levels compared 
to nuclear levels whereas a decrease would indicate reduced levels of cytoplasmic mRNA 
compared to nuclear mRNA levels. Therefore, a decrease in the cytoplasmic to nuclear mRNA 
ratio would suggest that less mRNA was reaching the cytoplasm, indicating a potential defect in 
mRNA transport.  
The purity of the nuclear and cytoplasmic fractions following the subcellular fractionation 
procedure was assessed. As there are no mRNA markers for cytoplasmic or nuclear fractions, 
the purity of the fractions was assessed at the protein level. A549 cells were mock or Ad5 
infected (Chapter 2.2.6.1) and either whole cell or cytoplasmic and nuclear fractions were 
isolated (Chapter 2.2.2.1-2.2.2.2). Protein from each fraction was separated by SDS-PAGE and 
analysed by Western blotting (Chapter 2.2.2). Histone H3 was used as a marker of the nuclear 
fraction and GAPDH as a marker of the cytoplasmic fraction. Ad5 penton base is found in both 
the nucleus and the cytoplasm of Ad-infected cells (Velicer and Ginsberg, 1968) and was used 
as a marker of Ad5 infection. 
As shown in Figure 4-13A, the whole cell lysates contained both GAPDH and Histone H3 and 
the Ad5-infected samples were positive for penton base protein. The cytoplasmic fraction was 
positive for the cytoplasmic marker GAPDH, but contained very low levels of the nuclear 
marker Histone H3. This indicated that there was minimal nuclear contamination of the 
cytoplasmic fraction. Similarly, the nuclear fraction contained Histone H3 but was negative for 
GAPDH, indicating that there was minimal cytoplasmic contamination in the nuclear fraction. 
Taken together, this indicated that a good separation of the cytoplasmic and nuclear fractions 
had been achieved. 
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Figure 4-13. Cytoplasmic: nuclear Ad5 mRNAs following infection of coilin-depleted A549 cells. 
A549 cells were treated with siControl or siCoilin and incubated for 24 hours. Cells were mock or Ad5 
infected at an MOI of 5 FFU/cell and incubated for 24 hours. A. Subcellular fractionation of mock- and 
Ad5-infected cells. Whole cell, nuclear and cytoplasmic fractions were isolated. Equal masses of protein 
(20 µg) from each sample were separated by SDS-PAGE and analysed by Western blotting. Histone H3 
was used as a nuclear marker, GAPDH as a cytoplasmic marker and Ad penton base as a marker of Ad5 
infection. Whole cell fractions contained both histone H3 and GAPDH. Nuclear fractions contained 
histone H3 but were negative for GAPDH. Cytoplasmic fractions contained GAPDH but were negative 
for histone H3. Penton base was detected in whole cell, nuclear and cytoplasmic fractions of Ad5-infected 
cells. B. Nuclear: cytoplasmic ratio of Ad5 mRNAs following infection of coilin-depleted cells. Total 
RNA was extracted from nuclear and cytoplasmic cell fractions and was subjected to reverse 
transcription. Quantitative PCR analysis of target cDNA was performed using exon-spanning primers 
specific for the mRNA target. Rotorgene 6000 software was used to calculate delta Ct values. The 
‘housekeeping’ transcript GAPDH was used to standardise transcript levels. Data are displayed as the 
mean fold change in cytoplasmic: nuclear mRNA (± SEM) relative to an siControl-treated Ad5-infected 
sample, which was set to a value of 1. Results are from at least three independent experiments performed 
in duplicate. Statistics were calculated using the paired 1 sample t-test. Compared with Ad5 infection of 
siControl-treated cells, the cytoplasmic: nuclear ratio of all Ad5 mRNAs studied was significantly 
reduced following infection of siCoilin-treated cells. Black bars = siControl-treated cells. Grey bars = 
siCoilin-treated cells. *p<0.05, **p<0.01, ***p<0.001. 
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The Ad mRNA levels in the nucleus and cytoplasm following coilin depletion and Ad5 
infection was investigated. Coilin depletion was carried out by siRNA transfection (Chapter 
2.2.5.1) and cells were incubated for 24 hours. Cells were mock or Ad5 infected (Chapter 
2.2.6.1). At 20 h.p.i, total cytoplasmic and nuclear RNAs were extracted from cells (Chapter 
2.2.3.2) and subject to reverse transcription (Chapter 2.2.4.2) to produce cDNA from mRNA. 
Target cDNAs were amplified by qPCR (Chapter 2.2.4.4) using exon-spanning primers specific 
for the cDNA target (Table 2-1). The levels of Ad cDNAs in the nuclear and cytoplasmic 
fractions were normalised to cDNA levels of the ‘housekeeping’ transcript GAPDH and the 
ratio of cytoplasmic to nuclear cDNA was subsequently calculated. 
As shown in Figure 4-13B, the cytoplasmic to nuclear cDNA ratios in siCoilin-treated, Ad5-
infected cells was significantly reduced compared to siControl-treated, Ad5-infected cells. This 
indicated that in coilin-depleted cells, Ad5 mRNA levels were decreased in the cytoplasm 
relative to the nucleus. As total mRNA levels for the majority of Ad mRNAs were unaffected 
following coilin depletion (Chapter 4.8.2), these data suggest that coilin depletion causes 
defective export of Ad mRNAs to the cytoplasm, resulting in accumulation of mature Ad 
mRNAs in the nucleus. Fischer et al., 2002; Strasser et al., 2002; Abruzzi et al., 2004; Masuda et al., 2005; Cheng et al., 2006 
4.9 Location of coilin relative to mRNA export factors in Ad5-infected cells 
In the previous section it was found that depletion of coilin reduced the transport of Ad mRNAs 
from the nucleus into the cytoplasm. A major pathway of mRNA transport into the cytoplasm 
involves the TREX complex, which is recruited to nascent mRNA in a transcription- and 
splicing-dependent manner (Fischer et al., 2002; Strasser et al., 2002; Abruzzi et al., 2004; 
Masuda et al., 2005; Cheng et al., 2006). Therefore the potential association of coilin with the 
TREX complex in Ad5-infected cells was assessed by immunofluorescence microscopy using a 
rabbit anti-coilin antibody along with a mouse antibody raised against a sub-component of the 
TREX complex, Aly (Strasser et al., 2002). A goat anti-Ad capsid antibody was used to identify 
Ad5-infected cells.  
As shown in Figure 4-14, coilin was located in punctate CBs in mock-infected cells. Aly was 
located in separate nucleoplasmic speckles, with exclusion from large rounded structures within 
the nucleus which are likely to be nucleoli. In Ad5-infected cells, coilin was redistributed into 
rosettes and Aly was also redistributed into punctate nucleoplasmic foci. However, there did not 
appear to be any colocalisation between rosettes and the microfoci containing Aly. This 
indicated that rosettes are not associated with the TREX complex during Ad5 infection. 
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Figure 4-14. The redistribution of coilin following Ad5 infection relative to the cellular TREX-
complex component, Aly.  
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell and incubated for 24 hours. Cells were 
fixed and subjected to indirect immunofluorescence. Cells were stained using a mouse anti-Aly and a 
rabbit anti-coilin antibody followed by incubation with the appropriate fluorescent-labelled secondary 
antibodies. Nuclei were stained using DAPI. Confocal microscopy was performed using an inverted 
LSM510 confocal microscope coupled to LSM Image Browser. In mock-infected cells, Aly was found 
diffusely within the nucleoplasm (image b, arrow) and coilin was located in punctate CBs (image c, 
arrow). As shown in the overlay (image i), there was no colocalisation between Aly (blue arrow) and 
coilin (white arrow). In Ad5-infected cells, Aly was rearranged into punctate foci that accumulated at the 
nuclear periphery (image f, arrow) and coilin was redistributed into rosettes (image g, arrow). As shown 
in the overlay (image j), there was no colocalisation between foci of Aly (blue arrow) and coilin foci 
(white arrow) in these cells. Bars = 20 μM. 
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Figure 4-15. The redistribution of coilin following Ad5 infection relative to the Ad splicing factor, 
L4-33K. 
A549 cells were mock or Ad5 infected at an MOI of 5 FFU/cell and incubated for 24 hours. Cells were 
fixed and subjected to indirect immunofluorescence. Cells were stained using a rabbit anti-L4-33K and a 
mouse anti-coilin antibody followed by incubation with the appropriate fluorescent-labelled secondary 
antibodies. Nuclei were stained using DAPI. Confocal microscopy was performed using an inverted 
LSM510 confocal microscope coupled to LSM Image Browser. Mock-infected cells were negative for 
L4-33K expression (image b) and coilin was located in punctate CBs (image c, arrow). In Ad5-infected 
cells, L4-33K was found in numerous nuclear foci arranged into clusters (image f, arrow). Coilin was 
redistributed into microfoci in Ad5-infected cells (image g, arrow). The coilin microfoci were less 
numerous than the L4-33K microfoci (compare image f, arrow with image g, arrow). As shown by the 
yellow regions in the overlay (image h, white arrows), there was partial colocalisation between coilin 
microfoci and L4-33K microfoci. However, some L4-33K microfoci did not colocalise with coilin (image 
h, blue arrow). Bars = 10 μM. 
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A key regulator of the switch from early to late splice site usage at the MLP is the Ad splicing 
factor, L4-33K. This protein is involved in the enhancement of IIIa splice site selection over that 
for 52/55K (Tormanen et al., 2006). As completion of splicing is closely related to mRNA 
export, the location of coilin and L4-33K during Ad5 infection was investigated (Figure 4-15). 
Mock-infected cells did not express L4-33K (image b) and coilin was found in punctate CBs in 
these cells (image c, arrow). In Ad5-infected cells, L4-33K was located in numerous microfoci 
within the nucleus, which appeared to form circular clusters (image f, arrow). Coilin was also 
redistributed into microfoci in Ad5-infected cells (image g, arrow); however, the microfoci of 
coilin were larger and less numerous than the microfoci of L4-33K. As shown by the yellow 
regions in the overlay (image h, white arrow), coilin microfoci partially co-localised with 
microfoci of L4-33K. However, there were foci of L4-33K that did not contain coilin (image h, 
blue arrow). This indicated that some regions of L4-33K-dependent splicing may be associated 
with coilin foci during the later stages of Ad infection. However, as mentioned previously 
(Chapter 3.8), the antibody used to detect L4-33K may also detect L4-22K (Ostapchuk et al., 
2006). Therefore it is possible that the partial co-localisation of coilin with L4-33K could be 
colocalisation with L4-33K and/or L4-22K rather than L4-33K alone. Further studies are 
required to determine whether coilin partially co-localises with one or both of these proteins. 
4.10 Chapter 4 Discussion 
It was previously shown that during the late phase of Ad infection, CBs were disassembled from 
1-6 punctate domains per cell into numerous microfoci (Rebelo et al., 1996; Rodrigues et al., 
1996; James et al., 2010). Furthermore, the marker protein of CB, p80 coilin, was suggested to 
play a role in the expression of Ad late phase proteins without altering the expression of an early 
protein (James et al., 2010). However, the exact role of coilin in Ad late protein expression was 
unknown. In this Chapter, the role of coilin during Ad5 infection was investigated by depleting 
coilin in A549 cells by siRNA treatment. The impact of coilin depletion on Ad virus titre, Ad 
protein levels and Ad mRNA levels was then assessed. It was found that coilin depletion 
reduced the expression of early, intermediate and late phase Ad proteins. Although the majority 
of Ad mRNAs were not found to be significantly affected following coilin depletion, the export 
of Ad mRNAs from the nucleus to the cytoplasm was found to be greatly reduced. This 
indicated that the reduced expression of Ad proteins may be due to reduced export of Ad 
mRNAs into the cytoplasm. The yield of infectious virus was also found to be reduced 
following coilin depletion, indicating that reduced production of Ad late proteins results in 
reduced virus progeny. These are all novel findings which have not previously been shown. 
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Interestingly, the redistribution of coilin from CBs into microfoci has also been observed during 
infection with GRV, a highly unrelated plant virus. This was found to facilitate the trafficking of 
the GRV ORF3 protein to the nucleolus, allowing assembly of viral RNPs necessary for virus 
spread (Kim et al., 2007, Canetta et al., 2008). This indicates that CBs may be hijacked by 
different viruses to support diverse functions during infection. Other viruses shown to 
redistribute CBs include IBV and various herpesviruses (Fortes et al., 1995; Salsman et al., 
2008). It would be interesting to establish the role of coilin and CBs during infection with these 
viruses to establish whether CB disassembly promotes functions similar to those reported during 
GRV and Ad infection or facilitates a novel role. As herpes viruses are DNA viruses requiring 
mRNA export from the nucleus, it would be of particular interest to determine whether, like 
Ad5, these viruses require coilin for mRNA export.  
Late Ad mRNA export has been shown to require the ubiquitin ligase activity of the E1B-
55K/E4orf6 complex, indicating that ubiquitination of a protein involved in mRNA export may 
be required for late Ad mRNA export (Woo and Berk, 2007; Blanchette et al., 2008). In 
addition to marking proteins for degradation, ubiquitination is also a reversible posttranslational 
modification of protein activity (reviewed in Hunter, 2007). Therefore it is possible that 
ubiquitination of a currently undefined target protein involved in mRNA export by the E1B-
55K/E4orf6 may either target that protein for degradation, or change the activity of the protein. 
To date, ubiquitination has not been shown to regulate coilin activity. Furthermore, the 
depletion of coilin appeared to reduce late Ad mRNA export, indicating that targeted 
ubiquitination and degradation of coilin by E1B-55K/E4orf6 would be unlikely to enhance 
mRNA export. However, as shown in Chapter 3.2, coilin appeared to be degraded at very late 
stages of Ad infection. It would therefore be interesting to investigate whether coilin is a target 
of E1B-55K/E4orf6 complex-dependent ubiquitination during the course of Ad5 infection. 
The export of Ad early and intermediate mRNAs was recently shown to occur via the CRM1 
export system (Schmid et al., 2012) whilst Ad late mRNAs are exported via the Nxf1/TAP 
export complex (Yatherajam et al., 2011). The Nxf1/TAP system is responsible for export of the 
majority of cellular mRNAs (Gruter et al., 1998; Katahira et al., 1999), whilst the CRM1 export 
system is primarily involved in the export of snRNAs and rRNAs (Fornerod et al., 1997; Moy 
and Silver, 1999) and a subset of mRNAs corresponding to fast-acting response genes such as 
cytokine mRNAs (Kimura et al., 2004). Whilst neither coilin nor the CB have been implicated 
in mRNA export in mammalian cells, CBs in larch microsporocytes were shown to accumulate 
poly(A) mRNA, suggesting a role for CBs in storage of mRNA prior to export (Kolowerzo et 
al., 2009; Smolinski and Kolowerzo, 2012). Interestingly, it was recently suggested that 
trafficking via the CB was required for final maturation and export of snRNAs, which are 
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exported via the CRM1 pathway (Suzuki et al., 2010). CBs are also known to be required for 
processing of histone mRNAs, which are exported via the Nxf1/TAP export system (Erkmann 
et al., 2005). Therefore it appears that CBs may have links to both the CRM1 and Nxf1/TAP 
RNA export pathways. The apparent dependence of both early and late Ad mRNA export on 
coilin indicates a common role for coilin in both the CRM1 and Nxf1/TAP-mediated export 
pathways. Further work will be required to define the exact role of coilin in Ad mRNA export, 
and indeed a potential role in the export of cellular mRNAs. If coilin does have a role in cellular 
mRNA export, it is possible that levels of the cellular ‘housekeeping’ transcript GAPDH would 
be altered following coilin depletion. Normalisation of the levels of other transcripts to GAPDH 
transcript levels could then result in no apparent effect of coilin depletion on the cellular mRNA 
in question. Therefore, absolute quantification of cellular mRNA levels would be required to 
establish a potential role of coilin in cellular mRNA export (Bustin, 2000). 
In addition to reducing Ad mRNA export, inhibition of CRM1 also appeared to compromise the 
stability of Ad early and intermediate mRNAs (Schmid et al., 2012). In this Chapter, it was 
found for the majority of Ad mRNAs that coilin depletion did not cause a significant alteration 
to total mRNA levels (Figure 4-11). This indicated that for the majority of Ad mRNAs, coilin 
depletion does not alter their stability. This indicated that whereas CRM1 activity is required for 
both stability and export of Ad mRNAs, coilin is required only for export. 
Whilst levels of the majority of Ad mRNAs were not found to be altered during Ad5 infection 
of siCoilin-treated cells as compared to siControl treated cells, E1A 13S and 12S and IX 
mRNAs were found to be significantly decreased (Figure 4-11). As Ad E1A mRNAs are 
spliced, it was possible to analyse pre-mRNAs and thus distinguish between a role for coilin in 
transcription or mRNA splicing/stability. It was found that coilin depletion did not affect pre-
mRNA production, indicating that the transcription of E1A was not affected by coilin depletion 
(Figure 4-12). This suggested that the effect of coilin depletion alters either splicing or stability 
of 12S and 13S E1A mRNAs. As IX mRNA is not spliced, it was not possible to analyse IX 
pre-mRNA by this method. However, considering that coilin depletion did not appear to alter 
production of E1A, DBP, IVa2 or TPL-containing pre-mRNAs, this indicates that coilin is not 
involved in Ad transcription, and as a result, the decrease observed in IX mRNA levels 
following coilin depletion may be due to decreased stability. The mechanism by which coilin 
depletion alters the stability of some, but not all, Ad mRNAs requires further investigation. 
The immediate early E1As 13S and 12S are required for the subsequent transcriptional 
activation of the other Ad transcriptional units (Berk et al., 1979; Jones and Shenk, 1979; 
Nevins and Wilson, 1981; Morris et al., 2010). Therefore it is surprising that a decrease in early 
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E1A transcripts, and subsequent decrease in E1A protein, did not impact on the production of 
the remaining early or major late transcripts. As E1A is produced in a greater excess than is 
required for saturation of cellular interaction partners (Barbeau et al., 1992), it is possible that a 
threshold decrease in E1A protein levels is required before a negative effect is observed on the 
expression of the remaining Ad transcripts. Further work is required to clarify these suggestions.  
The reduced early, intermediate and late phase protein expression following Ad5 infection of 
coilin-depleted cells reported in this Chapter contrasts with previously published data. James et 
al. (2010) reported that coilin depletion did not alter levels of DBP, whereas IIIa, hexon and 
fibre levels were significantly reduced. It was found that the discrepancies between the two sets 
of results were not due to the different cell lines used. However, Ad5 infection of coilin-
depleted cells at an MOI of 1000 (the MOI used by James et al.) significantly reduced levels of 
fibre, whilst levels of DBP, IIIa and hexon were unaffected (Figure 4-10). Therefore these data 
at an MOI of 1000 partially explained the results obtained by James et al, as DBP was not 
affected following the depletion; however, levels of IIIa and hexon were not affected. It is 
possible that the depletion of coilin was greater in the study by James et al, resulting in an 
inhibitory effect on Ad5 protein production that was not observed in the current study. 
Nevertheless, the two separate studies do contribute to the idea that a greater virus input 
somehow overrides the inhibitory effect of coilin depletion on early protein expression, such 
that effects are only seen later in infection. 
There are several points to consider when analysing the results from this Chapter. Coilin 
depletion was found to cause aberrant localisation of WRAP53 within the nucleus (Figure 4-6). 
Upon Ad5 infection of siCoilin-treated cells, WRAP53 was not redistributed within the nucleus 
in the same manner as in siControl-treated cells. Therefore the observed effects on the Ad 
lifecycle following coilin depletion could be due to mis-localisation of WRAP53 or other CB 
proteins that were not addressed in this study, rather than a direct effect due to reduced coilin 
levels. Further work will be required to investigate the roles of WRAP53 during Ad5 infection. 
In this study, the siRNA depletion system used was not optimal as in siCoilin-treated cells 
infected with Ad5, early Ad proteins would have been expressed when the coilin level was 
around 60% the level of siControl-treated cells, whereas by the time of late protein expression, 
the coilin level will be further decreased to around 40% of siControl-treated cells (Figure 4-1A). 
Therefore any observed effects on the late phase of Ad infection may be more pronounced than 
effects on early phase. Furthermore, although the export of Ad mRNAs was significantly 
reduced following coilin depletion, export was not completely inhibited. As the depletion of 
coilin achieved in this investigation was around 60% (Figure 4-1), it is possible that low level 
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coilin expression was sufficient to support residual export of Ad mRNAs. Further studies are 
needed to establish whether coilin is absolutely required for Ad mRNA export by establishing 
the cytoplasmic: nuclear Ad mRNA ratio in coilin-knockout cell lines as compared to the 
parental cell line, or by the use of an inducible small hairpin RNA in A549 cells. It would also 
be of great interest to analyse the impact of coilin over-expression on Ad mRNA export to 
determine if this has the opposite effect to coilin depletion i.e. enhances Ad mRNA export. This 
could be achieved by using either stably-transformed coilin over-expressing cell lines or by 
transient transfection of cells with a coilin expression plasmid under the control of a constitutive 
promoter. However, considering that Ads do not appear to up-regulate coilin levels during 
infection (Figure 3-1), it is possible that existing steady-state cellular levels of coilin may be 
sufficient to support Ad mRNA export. 
In summary, the novel results from this investigation uncovered a previously unknown role for 
coilin in the export of Ad5 mRNAs from the nucleus to the cytoplasm and a potential role for 
coilin in the post-transcriptional processing or stability of Ad5 13S, 12S and IX mRNAs. 
Depletion of coilin reduced the export of Ad5 mRNA, leading to reduced expression of Ad5 
proteins and reduced virus titre. Further work is now required to determine the exact function of 
coilin in Ad5 mRNA export. Furthermore, investigation of a role for coilin in mRNA export 
with other viruses is also warranted.  
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Chapter 5 – Characterising the role of SMN during Ad5 infection 
5. Chapter 5 – Characterising the role of SMN during Ad5 infection  
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5.1 Introduction 
In Chapter 3, it was shown that following Ad5 infection, the CB protein SMN is redistributed to 
a separate, as yet unidentified sub-nuclear domain to the CB proteins coilin, fibrillarin and 
WRAP53. Therefore SMN may play a different role to coilin, fibrillarin and WRAP53 during 
Ad5 infection. To date, there has been no reported involvement of SMN in Ad infection. In 
order to investigate the potential role of SMN during Ad5 infection, depletion of SMN was 
performed by siRNA treatment and the subsequent impact on Ad5 virus yield, protein levels and 
mRNA levels were assessed. 
5.2 Western blot analysis of SMN depletion following siRNA transfection 
In order to identify the most appropriate time point post-transfection to infect SMN-depleted 
cells with Ad5, siRNA treatment using scrambled control siRNA (siControl) or SMN siRNA 
(siSMN) (Table 2-2) was performed in A549 cells (Chapter 2.2.5.1) and incubated for 24 or 48 
hours. At 48 hours post-transfection, cells were 90-100% confluent; therefore a further time 
point was not taken as it was reasoned that cell viability may be compromised in over-confluent 
cells. Whole cell lysates were prepared and protein was separated by SDS-PAGE and analysed 
by Western blotting (Chapter 2.2.2). 
As shown in Figure 5-1A, at 24 hours post-transfection the level of SMN protein in siSMN-
treated cells was decreased by around 40% compared to siControl-treated cells. By 48 hours 
post-transfection, the level of SMN in siSMN-treated cells was decreased by around 70% 
compared to siControl-treated cells. It was therefore decided to infect cells with Ad5 at 24 hours 
post-transfection when a substantial proportion of SMN protein was depleted. It was decided to 
harvest cells at 24 h.p.i (i.e. at 48 hours post-transfection) when SMN protein levels would be 
approaching 30% of the level of siControl-treated cells. 
As mentioned in Chapter 4, the Ad VA-RNAs are known to interfere with the RNA silencing 
machinery (Andersson et al., 2005). To test whether Ad5 infection altered the efficiency of 
SMN depletion, siRNA depletion was performed using siControl or siSMN (Chapter 2.2.5.1) 
and incubated for 24 hours. Cells were mock or Ad5 infected (Chapter 2.2.6.1). At 24 h.p.i, 
whole cell lysates were prepared and protein was separated by SDS-PAGE and analysed by 
Western blotting (Chapter 2.2.2). As shown in Figure 5-1B, compared to siControl mock-
infected cells, the level of SMN in siSMN-treated, mock infected cells and siSMN-treated, Ad5- 
infected cells was 38% and 36%, respectively. This indicates that Ad5 infection of siSMN- 
treated cells did not affect the efficiency of SMN depletion. In addition, there was no difference 
in SMN protein levels between siControl-treated, mock-infected cells and siCoilin-treated, Ad5-
infected cells (Figure 5.1B), showing that Ad5 infection does not alter SMN levels.  
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Figure 5-1. Depletion of SMN from A549 cells by siRNA transfection. 
A549 cells were treated with siControl or siSMN and incubated for 24 hours. Cells were mock or Ad5 
infected and incubated for 24 hours. Cells were harvested and equal amounts of protein from whole cell 
lysates (20 µg) was subjected to separation by SDS-PAGE and analysis by Western blotting. Bound 
antibody was detected using the ECL system and images were captured using a Las 3000 Imager. Signal 
intensities were calculated by densitometric analysis, normalising to the signal intensity of the loading 
control, GAPDH. Results are displayed relative to the siControl-treated, mock-infected sample, which 
was set to a value of 1. A. i. Analysis of SMN levels at 24 and 48 hours post-transfection by Western blot. 
Compared with siControl-treated cells, siSMN-treated cells exhibited decreased SMN levels at 24 hours 
post-transfection and at 48 hours post-transfection. ii. Densitometric analysis of SMN levels at 24 and 48 
hours post-transfection. Compared with siControl-treated cells, SMN levels in siSMN-treated cells were 
reduced at 24 and 48 hours post-transfection by approximately 40% and 70%, respectively.  
B. i. Western blot analysis of SMN levels at 48 hours post-transfection, with mock or Ad5 infection 
performed at 24 hours post-transfection. Compared with siControl-treated cells, SMN levels were 
decreased in siSMN-treated, mock-infected cells and in siSMN-treated, Ad5-infected cells. ii. 
Densitometric analysis of SMN levels at 48 hours post-transfection, with mock or Ad5 infection 
performed at 24 hours post-transfection. Results are the mean fold change in protein level (± SEM) from 
at least three independent experiments. Results are displayed relative to the siControl-treated, mock-
infected sample, which was set to a value of 1. Compared with siControl-treated, mock-infected cells, 
SMN levels were reduced in siSMN-treated, mock-infected cells and siSMN-treated, Ad5-infected cells 
by 62% and 64%, respectively. 
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5.3 The effect of SMN depletion on cell proliferation and/or viability using 
the MTT assay 
SMN has previously been shown to be necessary for embryonic viability (Schrank et al., 1997; 
Miguel-Aliaga et al., 1999). Furthermore, SMN depletion in cultured cells appears to decrease 
cell proliferation and viability (Parker et al., 2008; Grice and Liu, 2011). The MTT assay was 
therefore used to determine whether SMN depletion by approximately 70% resulted in 
decreased cell proliferation and/or viability of A549 cells. As with coilin depletion (Chapter 4), 
the MTT assay required the experiment to be performed in 96-well plates by ‘reverse siRNA 
transfection’. In order to determine whether SMN is depleted to a similar level by the ‘reverse 
transfection’ procedure compared to conventional siRNA transfection, ‘reverse transfection’ 
using siControl or siSMN was carried out in 6 well plates (Chapter 2.2.5.2) and incubated for 24 
hours. Cells were mock or Ad5 infected (Chapter 2.2.6.1) and incubated for a further 24 hours. 
Cell lysates were prepared and protein was separated by SDS-PAGE and analysed by Western 
blotting (Chapter 2.2.2). As shown in Figure 5-2A, when compared to mock-infected, siControl-
treated cells, the level of SMN was substantially decreased in siSMN-treated mock-infected 
cells and siSMN-treated Ad5 infected cells, calculated from densitometric analysis as decreases 
of 61% and 63%, respectively (Figure 5-2B). This is comparable to the depletion achieved by 
conventional depletion (Figure 5-1B). 
To assess whether cell proliferation and/or viability of A549 cells were altered following SMN 
depletion, ‘reverse siRNA transfection’ was carried out using siControl or siSMN in 96-well 
plates (Chapter 2.2.5.2) and incubated for 24 hours. Cells were mock or Ad5 infected (Chapter 
2.2.6.1). At 24 h.p.i, cells were analysed by the MTT assay (Chapter 2.2.9). As shown in Figure 
5-2C, siSMN-treated, mock-infected cells did not exhibit significantly altered absorbance at 570 
nm compared to siControl-treated, mock-infected cells. This indicates that SMN depletion by 
60-70% does not alter the cell viability or proliferation of A549 cells. As expected and as 
reported in Chapter 4, Ad5 infection of siControl-treated cells resulted in decreased viability 
compared to siControl-treated mock-infected cells, although this decrease was not significant. 
Cells treated with siSMN prior to Ad5 infection did not exhibit any significant change in the 
absorbance at 570 nm compared to siControl-treated, Ad5-infected cells or compared to 
siControl-treated, mock-infected cells. This indicates that depletion of SMN by 70% of 
siControl-treated cells did not alter the proliferation or viability of A549 cells infected with 
Ad5. 
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Figure 5-2. The impact of SMN depletion on the cell viability and proliferation of A549 cells. 
A549 cells were treated with siControl or siSMN and incubated for 24 hours. Cells were mock or Ad5 
infected and incubated for 24 hours before harvesting. A. Representative Western blots of A549 cells 
subjected to ‘reverse siRNA transfection’ followed by mock or Ad5 infection. Equal masses of protein 
from each sample (20 µg) were separated by SDS-PAGE and analysed by Western blotting. Bound 
antibody was visualised using the ECL system on a Las 3000 Imager. SMN levels were similar in 
siControl-treated, mock-infected cells and siControl-treated, Ad5-infected cells. Compared with 
siControl-treated cells, SMN levels were reduced in siSMN-treated, mock-infected cells and siSMN-
treated, Ad5-infected cells by a similar degree. B. Densitometric analysis of Western blots from cells 
subjected to ‘reverse’ siRNA transfection followed by mock or Ad5 infection. Signal intensities were 
calculated by densitometric analysis, normalising to the signal intensity of the loading control, GAPDH. 
Results are the mean fold change in protein level (± SEM) from three independent experiments. SMN 
levels were similar in siControl-treated, mock-infected cells and siControl-treated, Ad5-infected cells. 
Compared with siControl-treated, mock-infected cells, SMN levels in siSMN-treated, mock-infected cells 
and siSMN-treated, Ad5-infected cells were reduced by 61% and 63%, respectively. C. Impact of SMN 
depletion on the viability of mock- and Ad5-infected A549 cells. Results are the mean fold change in 
absorbance at 570 nm (± SEM) from at least three independent experiments performed in triplicate. The 
absorbance at 570 nm was similar in siControl-treated, mock-infected cells and siControl-treated, Ad5-
infected cells. Compared with siControl-treated, mock-infected cells, there was no significant difference 
in absorbance at 570 nm in siSMN-treated, mock-infected cells or in siSMN-treated, Ad5-infected cells.  
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5.4 The impact of SMN depletion on cellular levels of other CB proteins  
SMN is known to interact with multiple cellular protein partners including the CB proteins 
coilin, WRAP53, Sm and the nucleolar protein fibrillarin (Liu et al., 1997; Hebert et al., 2001; 
Pellizzoni et al., 2001a; Mahmoudi et al., 2010). Therefore it is possible that SMN depletion 
may alter the levels of SMN-associated proteins. To address this, siRNA-mediated depletion of 
SMN was performed in A549 cells (Chapter 2.2.5.1) and incubated for 24 hours. Cells were 
mock or Ad5 infected (Chapter 2.2.6.1) and incubated for 24 hours. Whole cell lysates were 
prepared and protein was separated by SDS-PAGE and analysed by Western blotting (Chapter 
2.2.2). As shown in the Western blots in Figure 5-3A, depletion of cellular SMN did not appear 
to alter the levels of coilin, Sm, WRAP53 or fibrillarin. This was confirmed by densitometric 
analysis (Figure 5-3B). This indicates that SMN depletion does not alter the cellular levels of 
SMN-interacting proteins or associated CB proteins. 
To confirm the Western blotting data by a more quantitative method, levels of CB proteins 
following SMN depletion and Ad5 infection was also assayed by flow cytometry. As described 
in Chapter 4, WRAP53 were not assessed by this method as from Western blot analysis this 
antibody was found to exhibit non-specific binding to an unidentified protein of 65 kDa. SMN, 
fibrillarin, coilin and Sm were assayed by flow cytometry. As shown in Figure 5-4, siSMN-
treated cells did not appear to alter the levels of coilin, Sm or fibrillarin compared to siControl-
treated cells. Taken together, these data indicate that depletion of SMN does not significantly 
alter the cellular level of other CB proteins.  
Interestingly, a significant increase was found in SMN levels following Ad5 infection of 
siControl-treated cells compared to mock-infection of siControl-treated cells (Figure 5-4). This 
suggested that SMN levels are increased by 24 h.p.i with Ad5. This contrasts with the flow 
cytometric data in Chapter 4.4, where no such increase in SMN levels was found following Ad5 
infection. This inconsistency is likely due to fact that different SMN antibodies were used 
between these two sets of experiments; a mouse anti-SMN antibody was used in the flow 
cytometry experiments in Chapter 4.4, whereas a rabbit anti-SMN antibody was used in the 
experiments in this section. 
 
5.5 The impact of SMN depletion on the subcellular distribution of other CB 
proteins 
RNA interference of SMN has previously been shown to induce defects in CB formation, 
resulting in coilin become redistributed to multiple nuclear foci and also localising to the 
nucleolus (Girard et al., 2006). However, contrasting results indicated that SMN is not required  
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Figure 5-3. Western blot analysis of CB proteins following Ad5 infection of SMN-depleted cells. 
A549 cells were treated with siControl or siSMN and incubated for 24 hours. Cells were mock or Ad5 
infected and incubated for 24 hours. Cells were harvested, whole cell lysates were prepared and equal 
masses of protein (20 µg) was separated by SDS-PAGE and analysed by Western blotting. Bound 
antibody was detected using the ECL system and images were captured using a Las 3000 Imager. Signal 
intensities from Western blots were calculated by densitometric analysis and were normalised to the 
loading control, GAPDH. A. Representative Western blots of CB proteins following Ad5 infection of 
SMN-depleted cells. Levels SMN, coilin, WRAP53, fibrillarin and Sm were similar in siControl-treated, 
mock-infected cells and siControl-treated, Ad5-infected cells. SMN levels were decreased in siSMN-
treated, mock-infected cells and in siSMN-treated, Ad5-infected cells by a similar degree, whilst levels of 
coilin, WRAP53, fibrillarin and Sm were not altered. B. Densitometric analysis of CB protein levels 
following Ad5 infection of SMN-depleted cells. Results are the mean fold change in protein level (± 
SEM) from at least three independent repeats. Results are relative to the siControl-treated, mock-infected 
sample, which was set to a value of 1. Statistics were calculated using the paired one-tailed t-test. Levels 
of coilin, WRAP53, fibrillarin and Sm were similar in siControl-treated, mock-infected cells and 
siControl-treated, Ad5 infected cells. Compared with siControl-treated, mock-infected cells, levels of 
SMN in siSMN-treated, mock-infected cells and siSMN-treated, Ad5-infected cells were reduced by 61% 
and 64%, respectively. Black bars = siControl-treated cells. Grey bars = siSMN-treated cells. *p<0.05. 
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Figure 5-4. Flow cytometric analysis of CB proteins following Ad5 infection of SMN-depleted cells. 
A549 cells were treated with siControl or siSMN and incubated for 24 hours. Cells were mock or A5 
infected at an MOI of 5 FFU/cell and incubated for 24 hours. Cells were harvested and subjected to flow 
cytometric analysis. Results are the mean fold change in protein level (± SEM) from at least three 
independent experiments performed in duplicate. Results are displayed relative to the siControl-treated, 
mock-infected sample, which was set to a value of 1. Levels of coilin, Sm and fibrillarin were similar in 
siControl-treated, mock-infected cells and siControl-treated, Ad5-infected cells. A rabbit anti-SMN 
antibody was used in these experiments, and an increase in SMN levels was observed in siControl-treated, 
Ad5-infected cells compared with siControl-treated, mock-infected cells. Compared with siControl-
treated, mock-infected cells, levels of SMN were reduced in siSMN-treated, mock-infected cells but were 
not significantly reduced in siSMN-treated, Ad5-infected cells. Compared with siControl-treated, Ad5-
infected cells, SMN levels were reduced in siSMN-treated, Ad5-infected cells. Levels of coilin, Sm and 
fibrillarin were not significantly altered in siSMN-treated cells compared with siControl-treated cells. The 
Black bars = siControl-treated cells. Grey bars = siSMN-treated cells. * p<0.05, **p<0.01, ***p<0.001. 
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for the maintenance of CB structure (Lemm et al., 2006). Therefore it is possible that depletion 
of cellular SMN may disrupt the subcellular distribution of other CB proteins. If this is the case, 
any effect of SMN depletion on Ad5 infection could be due to a secondary effect of SMN 
depletion on the subcellular distribution of an SMN-interacting protein. It was decided to 
identify whether SMN depletion disrupted the subcellular distribution of the CB proteins 
WRAP53 or coilin by immunofluorescence microscopy. A549 cells were subject to siRNA 
depletion using siControl or siSMN (Chapter 2.2.5.1) and were incubated for 24 hours. Cells 
were mock or Ad5 infected (Chapter 2.2.6.1). At 24 h.p.i, cells were harvested and subjected to 
indirect immunofluorescence (Chapter 2.2.7).  
As shown in Figure 5-5, siControl-treated, mock-infected cells exhibited a punctate CB 
distribution of SMN (image b, arrow) and coilin (image c, arrow), with these two proteins 
colocalising in CBs, as shown by the yellow regions in the overlay (image q, arrow). Ad5 
infection of siControl-treated cells resulted in redistribution of SMN into rod-shaped structures 
in the nucleus (image f, arrow) whilst coilin was redistributed into microfoci (image g, arrow). 
As shown in the overlay, there was no colocalisation between redistributed SMN (image r, blue 
arrow) and coilin microfoci (image r, white arrow). In siSMN-treated, mock-infected cells, 
SMN staining was reduced in the majority of cells (image j, white arrow) whilst some cells 
retained SMN expression (image j, blue arrow). In cells depleted of SMN, coilin was 
maintained in punctate CBs (image k, blue arrow), consistent with previous studies indicating 
that SMN is not required for CB integrity (Lemm et al., 2006). These coilin foci in SMN-
depleted cells (image k, blue arrow) appeared to be very similar in morphology to CBs in cells 
expressing SMN (image k, white arrow). As shown in the overlay (image s), in cells expressing 
SMN, coilin and SMN colocalised in CBs (blue arrow), whilst in cells depleted of SMN, coilin 
was found in CBs in the absence of SMN (white arrow). In siSMN-treated, Ad5-infected cells, 
SMN staining was reduced in the majority of cells (image n, white arrow) whilst some cells 
retained SMN expression (image n, blue arrow). In cells depleted of SMN, coilin appeared to be 
redistributed into rosettes (image o, white arrow) in a similar manner to coilin redistribution 
following Ad5 infection of SMN-expressing cells (image o, blue arrow). As shown in the 
overlay (image t), in cells retaining SMN expression, there was no colocalisation of coilin 
microfoci (yellow arrow) with SMN structures (blue arrow) and in cells lacking detectable 
SMN, coilin microfoci were present (white arrow). These date indicated that, in the absence of 
SMN, coilin distribution was minimally affected and coilin was still redistributed into rosettes 
following Ad5 infection. 
The impact of SMN depletion on the subcellular distribution of WRAP53 was also assessed 
(Figure 5-6). In siControl-treated, mock-infected cells, SMN was found in CBs (image b,  
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Figure 5-5. The subcellular localisation of coilin following Ad5 infection of SMN-depleted cells. 
A549 cells were treated with siControl or siSMN and incubated for 24 hours. Cells were mock or Ad5 
infected at an MOI of 5 FFU/cell and incubated for a further 24 hours. Cells were harvested and subjected 
to indirect immunofluorescence. Cells were incubated with a mouse anti-SMN, a rabbit anti-coilin and a 
goat anti-Ad capsid antibody followed by incubation with the appropriate fluorescent-labelled secondary 
antibodies. Nuclei were stained using DAPI. Confocal microscopy was performed using an inverted 
LSM510 confocal microscope coupled to LSM Image Browser. In siControl-treated, mock-infected cells, 
coilin was found in punctate CBs (image b, arrow); SMN was also found in punctate CBs (image c, 
arrow). As shown by the yellow regions in the overlay, coilin and SMN colocalised in CBs (image q, 
arrow). In siControl-treated, Ad5-infected cells, SMN was redistributed from CBs into the nucleoplasm, 
concentrated in rod-shaped structures (image f, arrow) whilst coilin was redistributed into microfoci 
(image g, arrow). As shown in the overlay (image r), redistributed SMN (blue arrow) did not colocalise 
with redistributed coilin (white arrow). In siSMN-treated, mock-infected cells, SMN staining was reduced 
in the nucleus in the majority of cells (image j, white arrow) whilst some cells retained SMN expression 
(image j, blue arrow). Cells depleted of SMN retained coilin staining in punctate CBs (image j, blue 
arrow) which appeared identical to CBs found in cells expressing SMN (image j, white arrow). As shown 
by the yellow regions in the overlay (image s), cells retaining SMN expression exhibited colocalisation of 
coilin and SMN in CBs (blue arrow) whilst CBs in cells depleted of SMN contained only coilin (white 
arrow). In siSMN-treated, Ad5-infected cells, SMN staining was reduced in the majority of cells (image 
n, blue arrow) whilst some cells retained SMN expression (image n, white arrow). Coilin was 
redistributed into microfoci in cells depleted of SMN (image o, blue arrow); these microfoci were similar 
to those seen following infection of cells expressing SMN (image o, white arrow). As shown in the 
overlay (image t), cells expressing SMN showed no colocalisation of SMN (blue arrow) with coilin 
microfoci (yellow arrow), whilst cells depleted of SMN exhibited only coilin microfoci (white arrow). 
Bars = 20 μm. 
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Figure 5-6. The subcellular localisation of WRAP53 following Ad5 infection of SMN-depleted cells. 
A549 cells were treated with siControl or siSMN and incubated for 24 hours. Cells were mock or Ad5 
infected at an MOI of 5 FFU/cell and incubated for a further 24 hours. Cells were harvested and subjected 
to indirect immunofluorescence. Cells were incubated with a mouse anti-SMN, a rabbit anti-WRAP53 
and a goat anti-Ad capsid antibody followed by incubation with the appropriate fluorescent-labelled 
secondary antibodies. Nuclei were stained using DAPI. Confocal microscopy was performed using an 
inverted LSM510 confocal microscope coupled to LSM Image Browser. In siControl-treated, mock-
infected cells, SMN was found in punctate CBs (image b, arrow) and WRAP53 was also found in CBs 
(image c, arrow). As shown by the yellow regions in the overlay, SMN and WRAP53 colocalised in CBs 
(image q, arrow). In siControl-treated, Ad5-infected cells, SMN was redistributed from CBs into rod-
shaped structures in the nucleoplasm (image f, arrow). WRAP53 was redistributed into nuclear microfoci 
(image g, arrow). As shown in the overlay (image r), redistributed SMN (blue arrow) did not colocalise 
with microfoci of WRAP53 (white arrow). In siSMN-treated, mock-infected cells, there was reduced 
SMN staining in the majority of cells (image j, blue arrow) whilst some cells retained SMN expression 
(image j, white arrow). WRAP53 was retained in CBs in cells depleted of SMN (image k, blue arrow) 
which appeared similar to CBs seen in cells expressing SMN (image k, white arrow). As shown by the 
yellow regions in the overlay (image s), cells expressing SMN exhibited colocalisation of WRAP53 and 
SMN in CBs (white arrow) whilst cells depleted of SMN exhibited CBs containing only WRAP53 (blue 
arrow). In siSMN-treated, Ad5-infected cells, SMN staining was reduced in the majority of cells (image 
n, arrow). WRAP53 was redistributed into microfoci in these cells (image o, arrow). As shown in the 
overlay (image t), cells devoid of SMN exhibited microfoci of WRAP53 in the nucleus (white arrow). 
Bars = 20 μm. 
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arrow); WRAP53 was also located in CBs (image c, arrow). These two proteins colocalised in 
CBs, as shown by the yellow regions in the overlay (image q, arrow). In siControl-treated, Ad5 
infected cells, SMN was redistributed into rod-shaped structures in the nucleoplasm (image f, 
arrow) and WRAP53 was redistributed into microfoci (image g, arrow). As shown in the 
overlay (image r), redistributed SMN (blue arrow) did not colocalise with WRAP53 foci (white 
arrow). In siSMN-treated, mock-infected cells, there was a loss of SMN staining in the majority 
of cells (image j, blue arrow) whilst some cells retained SMN expression (image j, white arrow). 
In SMN-depleted cells, WRAP53 was found in CBs (image k, blue arrow), which appeared 
analogous to WRAP53 staining in CBs in cells expressing SMN (image k, white arrow). This 
supports previously published data showing that whilst coilin and WRAP53 are integral for CB 
structure, SMN is not required (Lemm et al., 2006; Mahmoudi et al., 2010). As shown in the 
overlay (image s), WRAP53 and SMN colocalised in CBs in cells expressing SMN (white 
arrow), whilst in cells depleted of SMN, WRAP53 was found in CBs in the absence of SMN 
(blue arrow). In siSMN-treated, Ad5-infected cells, SMN staining was reduced in the majority 
of cells (image n, arrow) and WRAP53 was redistributed into microfoci (image o, arrow). These 
microfoci of WRAP53 appeared similar to WRAP53 microfoci seen in siControl-treated, Ad5-
infected cells (image g, arrow). As shown in the overlay, in cells depleted of SMN, WRAP53 
was found in nuclear microfoci (image t, arrow). These data indicated that there was no 
significant alteration to the subcellular distribution of WRAP53 following depletion of SMN, 
and, following Ad5 infection, WRAP53 was redistributed into rosettes in a similar manner to 
that seen in cells expressing SMN.  
5.6 Impact of SMN depletion on Ad5 virus yield 
To assess whether SMN depletion affected the production of infectious progeny viruses 
following Ad5 infection, A549 cells were subjected to siRNA transfection using siControl or 
siSMN (Chapter 2.2.5.1) and incubated for 24 hours. Cells were mock or Ad5 infected (Chapter 
2.2.6.1) and incubated for 24 hours. Cell lysates were prepared and used to infect fresh A549 
cells (Chapter 2.2.6.2). As with coilin depletion (Chapter 0), both plaque assays and flow 
cytometric assays were used to assess the impact of SMN depletion on virus yield.  
As shown in Figure 5-7A, depletion of SMN resulted in a significant decrease in the production 
of Ad5 progeny virus as assessed by plaque assay. Similar results were obtained by flow 
cytometric analysis (Figure 5-7B), where SMN depletion significantly reduced the levels of 
hexon expression following re-infection. These results strongly suggest that depletion of SMN 
significantly impairs Ad replication. This indicates that, similar to coilin, SMN is required for a 
productive Ad5 infection. 
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Figure 5-7. The impact of SMN depletion on Ad5 virus yield. 
A549 cells were treated with siControl or siSMN and incubated for 24 hours. Cells were mock or Ad5 
infected and incubated for a further 24 hours. Cells were harvested and whole cell lysates were prepared 
and used to infect fresh A549 cells. Cells were incubated for 48 hours for flow cytometric analysis or for 
six days for analysis by the plaque assay. Results are displayed as the mean fold change (± SEM) from at 
least three independent repeats. Results are shown as relative to the siControl-treated, mock infected 
sample, which was set to a value of 1. All statistics were calculated using the paired 1 sample t-test. A. 
Plaque assay analysis. Compared with Ad5 infection of siControl-treated cells, the virus yield following 
infection of siSMN-treated cells was reduced by 62%. The average virus titre following infection of A549 
cells with cell lysate from siControl-treated, Ad5-infected cells was 1.5 x 10
8
 PFU/ml. B. Flow cytometric 
analysis of hexon expression. Compared with Ad5 infection of siControl-treated cells, hexon expression 
following infection of siSMN-treated cells was reduced by 48%. * p<0.05, **p<0.01. 
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5.7 The impact of SMN depletion on Ad5 protein expression 
It was decided to investigate whether the observed decrease in virus yield following Ad5 
infection of SMN-depleted cells was due to an effect on Ad protein levels. A549 cells were 
subjected to siRNA transfection using siControl or siSMN (Chapter 2.2.5.1). Following 24 
hours incubation, cells were mock or Ad5 infected (Chapter 2.2.6.1). At 24 h.p.i, cells were 
harvested and analysed by either Western blotting (Chapter 2.2.2) or flow cytometry (Chapter 
2.2.8). 
5.7.1 Assay of Ad protein levels by Western blotting following infection of SMN-
depleted A549 cells 
The impact of SMN depletion on the expression of Ad5 proteins was analysed by Western 
blotting using antibodies raised against the Ad5 proteins E1A, DBP, IVa2, pIX, L4-100K, IIIa 
and fibre. As mentioned previously, the hexon antibody (2Hx2) cannot be used in Western 
blotting analysis, and there was an insufficient amount of the anti-IX antibody to perform 
Western blotting analysis. 
As shown by the representative Western blots in Figure 5-8A, SMN depletion resulted in a 
decrease in the levels of the late proteins IIIa and fibre whilst the levels of DBP and IVa2 were 
not significantly altered. Interestingly, L4-100K was found to be slightly increased following 
Ad5 infection of SMN-depleted cells. Whilst the E1A 289R isoform appeared to be decreased 
following SMN depletion, the level of the 243R isoform appeared to be slightly increased. 
These observations were confirmed by densitometric analysis (Figure 5-8B). These data suggest 
that depletion of SMN significantly reduced the levels of the 289R E1A, IIIa and fibre proteins 
in Ad5-infected cells, did not affect the levels of DBP or IVa2 and increased the levels of 243R 
E1A and L4-100K.  
5.7.2 Assay of protein levels by flow cytometry following SMN depletion in A549 cells 
In order to obtain quantitative data on the impact of SMN depletion on Ad5 protein expression, 
the levels of the Ad5 early proteins E1A and DBP, intermediate proteins IVa2 and pIX and late 
proteins L4-100K, IIIa, fibre and hexon were assayed by flow cytometry following SMN 
depletion and Ad5 infection. Figure 5-9A shows representative overlays from flow cytometric 
analysis of (i) E1A and (ii) hexon. For Ad E1A expression, the isotype antibody controls are 
located in the region 0-10
1
 FITC-A. The mock-infected samples incubated with the anti-E1A 
antibody show a slight shift to the right toward more positive values, indicating there is some 
non-specific binding of the E1A antibody to cellular proteins. However, the peaks for siControl-
treated, mock-infected cells and siSMN-treated, mock infected cells appeared to closely overlay, 
indicating that depletion of SMN does not alter the level of the non-specific protein(s).  
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Figure 5-8. Western blot analysis of Ad5 proteins following infection of SMN-depleted A549 cells. 
A549 cells were treated with siControl or siSMN and incubated for 24 hours. Cells were mock or Ad5 
infected and incubated for 24 hours. Whole cell lysates were prepared and equal masses of protein from 
each sample (20 µg) was separated by SDS-PAGE and analysed by Western blotting. A. Representative 
Western blots of Ad5 proteins following Ad5 infection of SMN-depleted cells. Compared with infection 
of siControl-treated cells, Ad5 infection of siSMN-treated cells resulted in decreased levels of E1A 13S, 
IIIa and fibre whilst levels of E1A 12S and L4-100K were increased. Levels of DBP and IVa2 were not 
altered. B. Densitometric analysis of signal intensities from Western blots. Signal intensities were 
calculated by densitometric analysis and were normalised to the signal intensity of the loading control, 
GAPDH. Black bars represent the siControl-treated cells, grey bars represent the siSMN-treated cells. 
Results are the mean fold change in protein level (± SEM) from at least three independent experiments. 
Results are displayed as relative to the siControl-treated, mock-infected sample, which was set to a value 
of 1. Statistics were calculated using the paired 1 sample t-test. Compared with infection of siControl-
treated cells, Ad5 infection of siSMN-treated cells resulted in significant decreases to levels of E1A 13S, 
IIIa and fibre and significant increases in the levels of E1A 12S and L4-100K. Levels of DBP and IVa2 
were not significantly affected. * p < 0.05, ** p < 0.01. 
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Figure 5-9. Flow cytometric analysis of Ad5 proteins following infection of SMN depleted cells. 
A549 cells were treated with siControl or siSMN and incubated for 24 hours. Cells were mock- or Ad5-
infected at an MOI of 5 FFU/cell and incubated for 24 hours. Cells were harvested and subject to flow 
cytometric analysis. A. Example overlays from flow cytometric analysis. (i) E1A. Compared with Ad5 
infection of siControl-treated cells, infection of siSMN-treated cells resulted in increased overall E1A 
expression (as shown by a shift of the FITC curve to the right) and also resulted in an increase in the 
number of E1A-expressing cells. (ii) Hexon. Compared with infection of siControl-treated cells, Ad5 
infection of siSMN-treated cells resulted in decreased overall hexon expression (as shown by a shift of 
the FITC curve to the left) and also resulted in a decrease in the number of hexon positive cells. B. Flow 
cytometric analysis of Ad5 proteins following infection of SMN-depleted cells. Black bars represent 
siControl-treated cells, grey bars represent siSMN-treated cells. Results are the mean fold change in 
protein level (± SEM) from at least three independent experiments. Data are shown relative to the 
siControl-treated, Ad5-infected sample, which was set to a value of 1. Statistics were calculated using the 
paired 1 sample t-test. Compared with Ad5 infection of siControl-treated cells, infection of siSMN-treated 
cells resulted in decreased expression of pIX, IIIa, hexon and fibre, increased expression of E1A and L4-
100K. Levels of DBP and IVa2 were not affected. *p<0.05, **p<0.01, ***p<0.001.  
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Therefore it seems that non-specific binding by this antibody does not vary when SMN is 
depleted, and as a result should not skew the results obtained for E1A. Both the Ad5-infected 
samples (siControl and siSMN-treated) exhibited large shifts in FITC-A to the right indicating 
high-level expression of E1A in these cells. Compared with the siControl-treated, Ad5-infected 
cells, the siSMN-treated, Ad5-infected sample revealed a greater shift of the positive cell 
population to the right. This indicated that SMN depletion increased the expression of E1A 
following Ad5 infection. In addition, a greater proportion of the cell population were fluorescent 
in the siSMN-treated, Ad5-infected cells compared with the siControl-treated, Ad5-infected 
cells, indicating that a greater proportion of the cell population were expressing E1A.  
The flow cytometry overlay for hexon showed that the isotype antibody controls and mock-
infected control samples located in the region 0-10
1
, i.e. were negative for hexon staining. 
Following Ad5 infection, there was a large shift of a proportion of the cell populations to the 
right, indicating a proportion of the cells were expressing hexon. Comparison of the siSMN-
treated, Ad5-infected cells with the siControl-treated, Ad5-infected cells revealed that the 
population shift to the left was slightly less pronounced in the siSMN-treated cells, indicating 
that SMN depletion reduced the expression of Ad5 hexon. In addition, the number of 
fluorescent cells was also decreased in the siSMN-treated, Ad5 infected population compared 
with the siControl-treated, Ad5-infected population, suggesting that depletion of SMN reduced 
the proportion of cells that were expressing hexon. 
Collated results from analysis of all Ad proteins are displayed in Figure 5-9B. Depletion of 
SMN resulted in a significant decrease in the levels of IIIa and fibre, consistent with the 
Western blotting analysis in the previous section (Chapter 5.7.1). Hexon and pIX were also 
found to be significantly decreased following SMN depletion. Levels of DBP and IVa2 were not 
significantly altered following SMN depletion, confirming the preliminary Western blotting 
analysis. Confirming the Western blotting results, L4-100K was found to be significantly 
increased following SMN depletion. Finally, levels of E1A were found to be significantly 
increased. As flow cytometric analysis cannot distinguish between protein isoforms, it is 
possible that the increase in the 289R E1A isoforms observed from Western blotting analysis is 
greater than the observed decrease in protein levels of the 243R isoform, resulting in an 
apparent small increase in total E1A levels by flow cytometric analysis.  
5.8 Impact of SMN depletion on Ad mRNA levels 
The data from the previous section (Chapter 5.7) revealed that following Ad5 infection of SMN-
depleted A549 cells, there was a significant decrease in the levels of IIIa, hexon, fibre and pIX, 
an increase in E1A and L4-100K whilst DBP and IVa2 were not significantly affected. In order 
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to establish whether the alterations observed in Ad protein levels were due to changes at the 
mRNA level, QPCR was carried out using exon-spanning primers to amplify mature, spliced 
Ad5 E1A (13S, 12S, 11S, 10S, and 9S spliceoforms), DBP (RT1 and RT2 spliceoforms), L4-
100K, IVa2, IIIa, hexon and fibre (Chapter 2.2.4.4). The unspliced Ad IX mRNA (Alestrom et 
al., 1980) was also analysed. 
5.8.1 The kinetics of Ad5 mRNA expression following SMN depletion 
As the decrease in Ad5 protein levels following SMN depletion was observed at 24 h.p.i, a time 
course of Ad5 hexon mRNA expression was performed at 18, 20, 22 and 24 h.p.i to ensure that 
any impact of SMN depletion on Ad5 mRNA levels would be observed. A549 cells were 
subjected to siRNA treatment (Chapter 2.2.5.1) and incubated for 24 hours. Cells were mock or 
Ad5 infected (Chapter 2.2.6.1) and harvested at 18, 20, 22 and 24 h.p.i. Total cellular RNA was 
extracted from cells using Trizol-chloroform extraction (Chapter 2.2.3.1) prior to reverse 
transcription (Chapter 2.2.4.2) to produce cDNA from mRNA. QPCR was performed (Chapter 
2.2.4.4) using exon-spanning hexon primers to specifically amplify mature, spliced hexon 
mRNA (Table 2-1). 
As shown in Figure 5-10A, the time course of hexon mRNA expression following SMN 
depletion revealed a decrease in hexon mRNA levels from 18 to 22 h.p.i, with an increase to 
levels equivalent to siControl-treated by 24 h.p.i. This indicated that following Ad5 infection, 
SMN depletion may abrogate the expression of hexon mRNA. As 20 h.p.i was the time point at 
which the observed decrease in hexon mRNA was most pronounced, this was chosen as the 
time point at which to study Ad mRNA expression following SMN depletion. 
5.8.2 Impact of SMN depletion on Ad5 mRNA expression 
Following the identification of a suitable time point at which to study Ad5 mRNA expression 
following SMN depletion, the qPCR analysis at 20 h.p.i was extended to include all mRNA 
isoforms described in Table 2-1. As shown in Figure 5-10B, the depletion of SMN resulted in 
significant decreases in the levels of the following mature, spliced Ad transcripts: E1A 13S, 
E1A 9S, DBP (RT2), IX, IIIa, hexon and fibre. In contrast, the following transcripts were 
unaffected by SMN depletion: E1A 12S, E1A 11S, E1A 10S, DBP (RT1), IVa2 and L4-100K. 
No Ad transcripts were increased following SMN depletion. This suggested that SMN depletion 
caused a significant reduction in the levels of certain Ad mRNA transcripts. 
Analysis of the unspliced Ad IX mRNA transcript was also performed. As shown in Figure 
5-10B, SMN depletion significantly reduced the levels of IX mRNA. Therefore SMN depletion 
may affect transcription, post-transcriptional processing or mRNA stability of Ad pIX mRNA. 
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Figure 5-10. The expression of mature Ad5 mRNAs following infection of SMN-depleted A549 cells. 
A549 cells were treated with siControl or siSMN incubated for 24 hours. Cells were infected with Ad5 at 
an MOI of 5 FFU/cell and harvested at 18, 20, 22 or 24 h.p.i. Total cellular RNA was extracted and 
subjected to reverse transcription to produce cDNA from RNA. QPCR was performed using cDNA and 
exon-spanning primers to amplify spliced Ad mRNAs. Intra-exon primers were used to amplify unspliced 
Ad pIX mRNA. Rotorgene 6000 software was used to calculate delta Ct values, which were standardised 
to levels of the ‘housekeeping’ transcript, GAPDH. Results are displayed relative to the siControl-treated, 
Ad5-infected sample, which was set to a value of 1. A. A time course of Ad5 hexon expression following 
infection of SMN-depleted cells. Compared with siControl-treated, Ad5-infected cells, levels of hexon 
were decreased at 18, 20 and 22 h.p.i in siSMN-treated, Ad5-infected cells. At 24 h.p.i, levels of hexon 
were similar in siControl-treated, Ad5-infected cells and siSMN-treated, Ad5-infected cells.  
B. Expression of spliced Ad5 mRNAs and non-spliced pIX mRNA at 20 h.p.i following infection of 
SMN-depleted cells. Results are the mean fold change in mRNA level (± SEM) from at least four 
independent experiments performed in duplicate. Statistics were calculated using the paired 1 sample t-
test. Compared with Ad5 infection of siControl-treated cells, infection of siSMN-treated cells resulted in 
decreased levels of E1A 13S, E1A 9S, DBP RT2, IX, IIIa, hexon and fibre mRNAs whilst levels of E1A 
12S, E1A 11S, E1A 10S, DBP RT1, IVa2 and L4-100K were not affected. Black bars = siControl-treated 
cells. Grey bars = siSMN-treated cells. *p<0.05, **p<0.01, ***p<0.001. 
A
B
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Figure 5-11. The expression of Ad5 pre-mRNAs following infection of SMN-depleted A549 cells. 
A549 cells were treated with siControl or siSMN and incubated for 24 hours. Cells were mock or Ad 
infected at an MOI of 5 FFU/cell and incubated for 20 hours before harvesting. Total RNA was extracted 
from cells and subjected to reverse transcription to produce cDNA from RNA. QPCR was performed on 
cDNA using intron-exon spanning primers specific for E1A, DBP, IVa2 or tripartite-leader-containing 
(TPL) pre-mRNAs. Rotorgene 6000 software was used to calculate delta Ct values, which were 
standardised to levels of the ‘housekeeping’ transcript, GAPDH . Results are the mean fold change in pre-
mRNA level (± SEM) from at least three independent experiments performed in duplicate. Results are 
displayed as relative to the siControl-treated, Ad5-infected sample, which was set to a value of 1. All 
statistics were calculated using the paired 1 tailed t-test. Compared with siControl-treated, Ad5-infected 
cells, levels of E1A and DBP pre-mRNAs were significantly decreased in siSMN-treated, Ad5-infected 
cells whilst levels of IVa2 and TPL-containing pre-mRNAs were not significantly affected. Black bars = 
siControl-treated cells. Grey bars = siSMN-treated cells. *p<0.05. 
  
 191 
 
5.8.3 Ad5 pre-mRNA expression following infection of SMN-depleted cells 
As the production of certain Ad5 mRNAs appear to be reduced following SMN depletion, it 
was decided to investigate whether this was due to effects on transcription or splicing and/or 
mRNA stability. To distinguish potential effects on transcription, qPCR analysis of pre-mRNA 
transcripts was carried out using intron-exon spanning primers (Table 2-1).  
As shown in Figure 5-11, no significant alteration was observed in the levels of IVa2 or late 
TPL-containing pre-mRNAs following Ad5 infection of siSMN-treated cells compared to 
siCoilin-treated cells. This indicated that transcription of IVa2 or late TPL-containing 
transcripts is not affected by SMN depletion. In contrast, E1A and DBP pre-mRNAs were found 
to be significantly reduced in SMN-depleted cells (Figure 5-11). This indicates that transcription 
of E1A and DBP are dependent on SMN. Therefore SMN may play a role in early Ad 
transcription but not in late phase transcription. 
5.9 Depletion of SMN and coilin in A549 cells 
In order to establish the impact of depleting both coilin and SMN on Ad5 infection, A549 cells 
were treated with siControl or siCoilin and siSMN and incubated for 24 hours. Cells were mock 
or Ad5 infected and incubated for a further 24 hours. Cells were harvested and equal masses of 
protein from whole cell lysates were separated by SDS-PAGE and analysed by Western 
blotting. 
As shown in Figure 5-12Ai, siCoilin and siSMN treatment resulted in a marked reduction in the 
protein levels of SMN and coilin in both mock- and Ad5-infected cells. Densitometric analysis 
revealed that compared to siControl-treated, mock-infected cells, siCoilin and siSMN treatment 
reduced coilin levels by 56% and 58% in mock- and Ad5-infected cells, respectively (Figure 
5-12Aii). This was similar to the level of coilin depletion achieved by siCoilin treatment alone 
(Chapter 4.1). Likewise, compared to siControl-treated, mock-infected cells, siSMN treatment 
reduced levels of SMN by 59% and 58% in mock- and Ad5-infected cells, respectively, similar 
to the level of SMN depletion as achieved by siSMN treatment alone (Chapter 5.1). Therefore it 
appeared that treatment of A549 cells with both siCoilin and siSMN achieves a similar level of 
depletion of coilin and SMN as single siRNA treatment. 
To determine whether depletion of both coilin and SMN altered the viability of A549 cells, the 
cells were subjected to ‘reverse siRNA transfection’ (Chapter 2.2.5.2) and incubated for 24 
hours. Cells were mock or Ad5 infected (Chapter 2.2.6.1) and incubated for 24 hours before 
analysis by the MTT assay (Chapter 2.2.9). As shown in Figure 5-12B, compared with 
siControl-treated, mock-infected cells, there was a significant decrease in the viability and/or  
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Figure 5-12. Impact of coilin and SMN depletion on the viability of mock- and Ad5-infected cells. 
A549 cells were treated with siControl or siCoilin and siSMN. Following 24 hours incubation, cells were 
mock or Ad5 infected at an MOI of 5 FFU/cell. Cells were incubated for 24 hours before harvesting.  
A. Western blot analysis of coilin and SMN levels following depletion of coilin and SMN. Whole cell 
lysates were prepared and equal masses of protein (20 μg) from each sample were separated by SDS-
PAGE and analysed by Western blotting. Bound antibody was detected using the ECL system and images 
were captured using a Las 3000 Imager. Signal intensities were calculated by densitometric analysis and 
were normalised to the signal intensity of the loading control, GAPDH. i. Western blots of coilin and 
SMN protein levels in coilin and SMN-depleted cells. Compared with siControl-treated cells, 
siCoilin/siSMN-treated cells showed reduced levels of coilin and SMN. N/S – non-specific cross-reacting 
protein species. ii. Densitometric analyses of coilin and SMN protein levels following depletion of coilin 
and SMN. Results are the mean fold change in protein (±SEM) from two independent repeats. Data are 
displayed as relative to the siControl-treated, mock-infected sample, which was set to a value of 1. 
Compared with siControl-treated, mock-infected cells, levels of coilin and SMN were reduced in 
siCoilin/siSMN-treated, mock-infected cells and siCoilin/siSMN-treated, Ad5-infected cells (coilin was 
reduced by 56% and 58%, respectively; SMN was reduced by 59% and 58%, respectively). B. Viability 
of coilin and SMN-depleted cells as analysed by the MTT assay. Results are the mean fold change in 
absorbance at 570 nm (±SEM) from at least three independent repeats performed in triplicate. Data are 
displayed relative to the siControl-treated, mock-infected sample, which was set to a value of 1. All 
statistics were calculated using the paired 1-sample t-test. Compared with siControl-treated, mock-
infected cells, absorbance at 570 nm was significantly reduced in siCoilin/siSMN-treated, mock-infected 
cells and siControl/siSMN-treated, Ad5-infected cells.  This indicated that the viability of the cells was 
reduced following depletion of both coilin and SMN. Black bars = siControl-treated cells. Grey bars = 
siCoilin/siSMN-treated cells.*p<0.05. 
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proliferation of siCoilin/siSMN-treated, mock-infected cells and siCoilin/siSMN-treated, Ad5-
infected cells. There was also a significant reduction in the viability of siCoilin/SMN-treated, 
Ad5-infected cells compared with siControl-treated, Ad5-infected cells. This indicated that 
depletion of coilin and SMN significantly reduced the viability of the cells. As a result, the 
investigation of the impact of depletion of both coilin and SMN on Ad5 infection was not 
continued, as any results obtained from the double depletion could be indirectly due to the 
reduced viability and/or proliferation of the cells. 
5.10 Chapter 5 Discussion 
In Chapter 3, Ad5 infection was shown to redistribute SMN from CBs to a novel nuclear 
subdomain, which was distinct from the CB microfoci containing the CB proteins coilin, 
WRAP53 and fibrillarin (Figure 3-5). However, the role of SMN during Ad5 infection was 
unknown. In this chapter, the role of SMN during Ad5 infection was investigated. SMN was 
depleted in A549 cells by siRNA transfection and the impact on Ad5 virus titre, Ad protein 
expression and Ad mRNA expression was assessed. Expression of Ad5 proteins was shown to 
be altered following Ad5 infection of SMN-depleted cells, with significant decreases observed 
for Ad capsid proteins whilst early or late non-structural proteins were either increased or were 
unaffected by SMN depletion (Figure 5-8 and Figure 5-9). The virus yield was found to be 
significantly reduced (Figure 5-7), indicating that reduced production of Ad capsid proteins 
following SMN depletion resulted in decreased production of progeny virions. Analysis of 
mature, spliced mRNAs indicated that the production of IIIa, hexon and fibre was significantly 
reduced in Ad5-infected cells (Figure 5-10). This indicated that there was decreased production 
of certain late spliced mRNAs in SMN-depleted cells, resulting in decreased production of Ad 
capsid proteins. Analysis of pre-mRNA levels revealed that the level of tripartite leader-
containing mRNAs was not altered following Ad5 infection of SMN-depleted cells (Figure 
5-11). This indicates that transcription of late Ad genes from the MLP did not require SMN. 
Therefore the observed decrease in IIIa, hexon and fibre levels following SMN depletion may 
be due to altered mRNA splicing or mRNA stability. SMN has previously been shown to 
regulate pre-mRNA splicing (Pellizzoni et al., 1998; Mourelatos et al., 2001; Zhang et al., 
2008) and play a role in assembly of the spliceosome (Meister et al., 2000; Makarov et al., 
2012). However, to date there has been no report of involvement of SMN in the splicing of viral 
transcripts. Therefore these data may be the first report of a potential role of SMN in viral 
mRNA splicing. 
In contrast to IIIa, hexon and fibre, the level of L4-100K protein was significantly increased 
following Ad5 infection of SMN-depleted cells (Figure 5-3 and Figure 5-4); however, analysis 
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of L4-100K mRNA in SMN-depleted cells was not significantly altered (Figure 5-10). A 
possible explanation for these seemingly contradictory results is that during the late phase of 
Ad5 infection, there is enhanced translation of tripartite-leader-containing mRNAs (Cuesta et 
al., 2000; Xi et al., 2004, 2005). It is possible that in the absence of competition from other 
tripartite leader mRNAs such as IIIa, hexon and fibre (whose transcript levels are reduced 
following SMN depletion), there is increased translation of L4-100K transcripts resulting in an 
increase in L4-100K protein levels, despite there being no increase at the mRNA level. 
Alternatively, as Ad proteins and mRNAs were only analysed at one time point post-infection, it 
is possible that there is enhanced L4-100K at an earlier time point than 20 h.p.i and, as the half 
life of L4-100K protein is known to be greater than 3 hours (Hayes et al., 1990), this may result 
in the accumulation of large amounts of L4-100K protein that persists even when high 
transcription levels are not maintained. A detailed analysis of Ad protein and mRNA levels at 
several points over the course of Ad infection would be required to clarify these matters.  
The levels of the intermediate protein IVa2 was unaffected by SMN depletion (Figure 5-8 and 
Figure 5-9). There were no significant alterations to the levels of IVa2 mRNA or pre-mRNA 
following SMN depletion (Figure 5-10 and Figure 5-11), indicating that SMN is not required for 
transcription, RNA splicing or mRNA stability of IVa2. DBP mRNAs form two distinct species; 
the early expressed RT1, consisting of two short leader sequences and the main body of the 
mRNA and the delayed early RT2, consisting of a single short leader sequence and the main 
body (Kruijer et al., 1981). The DBP protein is encoded within the main body, producing the 72 
kDa protein (Kruijer et al., 1981). In this study, it was found that level of the RT1 spliceoform 
of DBP was unaffected following SMN depletion, whereas the level of the RT2 spliceoform 
was significantly decreased (Figure 5-10). Similar to the results obtained with the TPL-
containing mRNAs, these results for DBP indicate a role for SMN in alternative splicing of 
DBP transcripts. However, despite the reduction in the RT2 transcript, no significant alteration 
was observed in the level of DBP protein (Figure 5-8 and Figure 5-9). As suggested for L4-
100K, a more precise kinetic analysis of Ad5 protein and mRNA levels over a number of time 
points would establish the impact of SMN depletion on Ad5 protein and mRNA levels. 
Interestingly, analysis of DBP pre-mRNA revealed that DBP pre-mRNA levels were also 
significantly reduced following SMN depletion (Figure 5-11). This indicated that SMN may be 
involved in DBP transcription. SMN has previously been implicated in transcription; SMN 
interacts with the transcriptional co-repressor mSin3A (Zou et al., 2004), an RNA helicase 
(Campbell et al., 2000) and RNA polymerase II (Pellizzoni et al., 2001b). Moreover, SMN has 
been shown to play roles in transcription during virus infection; SMN acts as a transactivator of 
the BPV E2 promoter (Strasswimmer et al., 1999) and also the EBV LMP1 promoter (Voss et 
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al., 2001). Therefore these data indicate that, in addition to BPV and EBV, SMN may also play 
a role in transactivation of the E2A promoter during Ad infection. Considering that the majority 
of Ad-splicing is believed to occur co-transcriptionally (Nevins et al., 1979), it is possible that 
SMN may play a role in integrating transcription and splicing during Ad infection.  
The levels of E1A proteins and mRNAs were also assessed following SMN depletion. There 
was an apparent decrease in the level of the 289R isoform of E1A with a concomitant increase 
in the levels of the 243R isoform as judged by Western blotting analysis (Figure 5-8). This 
indicated that there may be alterations to Ad mRNA splicing when SMN is depleted. 
Investigation of mature, spliced Ad mRNAs revealed that E1A 13S transcripts were 
significantly reduced following SMN depletion (Figure 5-10), which correlates with a resulting 
decreased production of 289R protein. Again, this indicates a role for SMN in Ad alternative 
splicing. Adding complexity is the apparent increase in protein levels of the 243R protein 
isoform, whilst levels of the mRNA encoding this isoform, 12S, did not appear to be affected. 
As suggested for L4-100K and DBP, it is possible that a more extensive analysis of Ad protein 
and mRNA levels over a number of time points during Ad5 infection may shed light on the 
regulation of E1A transcription and/or splicing.  
Finally, levels of the 9S E1A transcript was found to be significantly decreased following SMN 
depletion whilst there appeared to be no effect on the levels of the 10S or 11S E1A transcripts 
(Figure 5-10), again implying a role for SMN in alternative splicing of Ad transcripts. However, 
as the E1A antibody used did not recognise the 217R, 171R or 55R E1A isoforms, the impact of 
SMN depletion on protein levels of these isoforms could not be assayed. 
As with coilin, it was surprising that a decrease in the production of the early E1A transcript 
13S did not affect the production of the DBP transcript RT1 or the major late transcript L4-
100K, as the 289R protein is required for the subsequent transcriptional activation of the other 
Ad transcriptional units (Berk et al., 1979; Jones and Shenk, 1979; Nevins and Wilson, 1981; 
Morris et al., 2010). As suggested in Chapter 4.10, as the E1A proteins are produced in great 
excess (Barbeau et al., 1992) it is possible that a threshold decrease in E1A protein levels is 
required before a negative effect is observed on the expression of the remaining Ad transcripts. 
Further investigation would be required to confirm this. 
One consideration to be made when analysing these results is that at 24 hours post-transfection, 
SMN levels were around 60% of those in siControl-treated cells whilst at 48 hours post-
transfection, SMN levels were decreased to around 30% of siControl-treated cells (Figure 5-1). 
This indicated that the level of SMN in the siSMN-treated cells was steadily decreasing as Ad5 
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infection progressed. Therefore, it is possible that effects of SMN depletion on late mRNA 
transcripts, which were expressed late in infection when SMN levels were very low, may be 
more pronounced than the effects observed on early expressed Ad transcripts, which were 
expressed when SMN levels were higher. Further work is required to determine the effect of 
SMN depletion on early expressed transcripts.  
Although the expression of certain Ad transcripts was significantly decreased, SMN depletion 
did not completely abrogate the expression of these transcripts. This could be due to the fact that 
SMN levels were only depleted by 60-70% (Chapter 5, Figure 5-1), allowing a certain degree of 
splicing by low level SMN expression. Although it would be interesting to establish whether 
SMN is an absolute requirement for the splicing of certain Ad transcripts, unfortunately it is not 
possible to establish the ability of Ads to replicate in SMN-knockout cell lines as SMN is 
required for cell viability (Schrank et al., 1997). It is possible that further optimisation of the 
depletion procedure using a mixture of siRNAs could be used to deplete SMN to a greater 
extent and establish an absolute requirement for SMN in the splicing of certain Ad transcripts. It 
would also be interesting to investigate the impact of SMN over-expression on Ad early gene 
transcription and Ad mRNA splicing, either by transient transfection of an SMN expression 
plasmid or by production of stably-transformed SMN over-expressing cell lines. 
Taken together, the data from this Chapter indicate that SMN may play a role in the alternative 
splicing of Ad mRNA transcripts and may also facilitate early gene transcription. The 
alterations to Ad transcript levels resulted in abrogated late protein expression, leading to a 
decreased virus yield. Further work is now required to establish the mechanism by which SMN 
regulates early but not late Ad transcription, and to identify the precise role of SMN in Ad 
mRNA splicing. The role of SMN in splicing during infection with other viruses is also 
warranted. 
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Chapter 6 – General Discussion and Further Studies 
6. Chapter 6 - General Discussion and Further Studies 
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6.1 General Discussion and Further Studies 
Adenoviruses have long been known to hijack cellular proteins and compartments in order to 
efficiently complete their life cycles. One such compartment is Cajal body (CB), a sub-nuclear 
site involved in the metabolism of RNA. The disassembly of CBs during infection with Ad5 
was first described over 15 years ago (Rebelo et al., 1996; Rodrigues et al., 1996), and until 
recently the function of this disassembly remained unknown. In 2010, it was suggested that CB 
disassembly promoted the expression of Ad late proteins (James et al., 2010), however the 
mechanism remained unclear. The aim of this investigation was to investigate the role of coilin 
and other CB proteins during the life cycle of Ad5. The novel results obtained from this study 
are summarised in Table 6-1. 
In this investigation, coilin depletion was found to abrogate the trafficking of Ad mRNA from 
the nucleus to the cytoplasm, resulting in decreased production of Ad proteins and a reduced 
virus titre. This indicated that coilin plays a role in the export of Ad mRNAs. Interestingly, it 
was recently shown that early and intermediate Ad mRNAs are exported by the CRM1 export 
system whereas late mRNAs are exported via TAP (Yatherajam et al., 2011; Samad et al., 
2012). Given the apparent reliance of early, intermediate and late Ad mRNAs on coilin for 
export, this indicates that coilin may play a role in export of mRNAs through two separate 
export systems. Although CBs in mammalian cells do not appear to contain poly(A) RNA (Visa 
et al., 1993; Huang et al., 1994), CBs in larch microsporocytes were recently reported to contain 
poly(A) RNA and were suggested to function as storage site for mRNAs prior to export 
(Kolowerzo et al., 2009; Smolinski and Kolowerzo, 2012). It is possible that coilin outside of 
the CB may mediate this function in mammalian cells. Interestingly, CBs have been implicated 
in the export of snRNAs, which are exported via CRM1 (Suzuki et al., 2010) and also in the 
processing of histone mRNAs, which are exported via Nxf1/TAP (Erkmann et al., 2005). It 
would be appealing to investigate the potential interaction of coilin with elements of the cellular 
TREX export complex, or with the Ad E1B-55K/E4orf6 complex, shown to be necessary for the 
export of Ad late mRNAs (Blanchette et al., 2008; Woo and Berk, 2007). Potential interaction 
of coilin with these complexes would be investigated by co-immunoprecipitation and GST-
coilin pull-down assays. In addition, as the ubiquitin ligase activity of the E1B-55K/E4orf6 
complex is required for export of late mRNAs (Woo and Berk, 2007; Blanchette et al., 2008), it 
would also be worth investigating if coilin is ubiquitinated by this complex. In addition to 
marking proteins for degradation, ubiquitin can also be used as a post-translational modification 
to change protein activity (reviewed in Hunter, 2007). Therefore it is possible that ubiquitination 
of coilin during Ad infection might facilitate a change in the activity of coilin, somehow 
resulting in the enhanced export of Ad mRNAs. 
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Table 6-1. Novel results obtained in this investigation. 
*Previously documented in the literature (Rebelo et al., 1996; Rodrigues et al., 1996; James et al., 2010). N/A – not applicable. 
Protein  
Subcellular 
location following 
Ad5 infection 
Timepoint during 
infection at which 
redistribution 
occurs 
Effect of siRNA-mediated knockdown of the protein on: 
Ad5 virus 
titre 
Ad5 protein levels Ad mRNA levels Ad pre-mRNA levels 
Cytoplasmic: 
nuclear mRNA 
Coilin Nuclear microfoci* 
After Ad DNA 
replication and 
intermediate protein 
expression 
Decreased Decreased  
Decreased: 13S E1A, 12S 
E1A,  IX 
No effect: 11S E1A, 10S 
E1A, DBP RT1, DBP 
RT2, IVa2, L4-100K, IIIa, 
hexon, fibre 
No effect Decreased 
SMN 
Nuclear rod-shaped 
structures 
After Ad DNA 
replication and 
intermediate protein 
expression 
Decreased 
Decreased: pIX, IIIa, 
hexon, fibre 
Increased: E1A , L4-100K 
No effect: DBP, IVa2 
Decreased: 13S E1A, 9S 
E1A, DBP RT2, IX, IIIa, 
hexon, fibre 
No effect: E1A 12S, E1A 
11S, E1A 10S, DBP RT1, 
IVa2, L4-100K  
Decreased: E1A, DBP 
No effect: IVa2, 
tripartite leader-
containing pre-mRNAs 
N/A 
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In recent years it has become apparent that RNA processing and export are inextricably linked, 
such that export factors become recruited to the pre-mRNA transcript before completion of 
processing (reviewed in Palazzo and Akef, 2012). Interestingly, coilin has been shown to 
possess RNA editing activity and is required for final processing of snRNAs (Broome and 
Hebert, 2012). Furthermore, during the late stage of Ad infection, coilin colocalised with the 
late Ad splicing factor L4-33K (Figure 4-15). This indicated that during Ad5 infection, there is a 
close association of coilin with regions of late mRNA processing, suggesting that coilin may be 
required for the final processing and/or release of RNAs for export. Therefore functional 
interactions between coilin and L4-33K and/or cellular splicing factors could be investigated by 
co-immunoprecipitation and GST-coilin pull-down assays. The potential RNA editing activity 
of coilin on Ad transcripts could also be investigated. 
The role of coilin in the export of cellular mRNAs would also be worthy of further study. In this 
investigation, the housekeeping transcript GAPDH was used to normalise the Ad mRNA 
expression data, therefore it appears that the impact of coilin depletion upon Ad mRNA export 
supersedes the impact (if any) of coilin depletion on cellular mRNA export. Considering the 
mass synthesis of mRNA during Ad infection, this is not altogether surprising. Moreover, as the 
nuclear export of cellular mRNAs is inhibited during the late stages of Ad infection (Beltz and 
Flint, 1979; Babiss et al., 1985; Pilder et al., 1986), it is likely that depletion of coilin would not 
make any significant difference to the export of cellular mRNAs at late stages of Ad infection. 
Furthermore, as coilin appears to be non-essential for the viability of mammalian cells (Tucker 
et al., 2001; Walker et al., 2009), this indicates it is unlikely to be an essential factor for cellular 
mRNA export. Instead, coilin may simply act to accelerate export processes which would occur 
at a slower pace in its absence.  
In stark contrast to coilin, SMN was found to be redistributed into rod-shaped structures in the 
nucleoplasm. This was the first indication that SMN may perform a function independent of 
coilin during Ad5 infection. It was subsequently found that SMN depletion resulted in altered 
transcription and splicing of Ad transcripts. Intriguingly, SMN depletion appeared to 
differentially impact on the expression levels of alternative transcripts from the same 
transcriptional unit; the level of the RT2 spliceoform of DBP was significantly reduced whilst 
DBP RT1 was unaffected, 9S and 13S E1As were significantly reduced whilst 10S, 11S and 
12S were unaffected, and IIIa, hexon and fibre were significantly reduced whereas L4-100K 
was unaffected (Figure 5-10). This indicates that SMN may play a role in the alternative 
splicing of Ad transcripts, and that depletion of SMN results in the abrogated production of 
certain transcripts. Although SMN appears to play multiple roles in cellular splicing (Pellizzoni 
et al., 1998; Pellizzoni et al., 2001b; Boulisfane et al., 2011; Makarov et al., 2012), to date there 
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have been no reports of SMN playing a role in splicing of virus transcripts. Therefore this may 
be the first report of SMN being involved in the splicing of virus transcripts. Further 
investigation of the exact role of SMN in Ad mRNA splicing is warranted. To analyse the 
impact of SMN depletion on splicing separately from the possible effects of SMN on Ad 
transcription, the E1A, DBP, IVa2 and L1-5 coding regions would be cloned into an expression 
plasmid under the control of a constitutive promoter. These constructs could then be transfected 
into SMN-depleted cells and Ad transcript levels analysed by qPCR. This experiment could be 
repeated in SMN over-expressing cells (either cells transiently transfected with an SMN 
expression plasmid or stably-transformed SMN over-expressing cells) to determine whether 
SMN over-expression alters the production of differentially spliced transcripts. 
In addition to splicing defects, the depletion of SMN also significantly reduced the abundance 
of E1A and DBP pre-mRNA transcripts, whilst IVa2 and tripartite leader-containing pre-
mRNAs were unaffected (Figure 5-11). This indicated a role for SMN in early phase 
transcriptional activation. Interestingly, SMN has previously been shown to act as a 
transcriptional co-activator during infection with BPV and EBV (Strasswimmer et al., 1999; 
Voss et al., 2001). This suggests that SMN is hijacked during infection with multiple viruses in 
order to promote transcriptional activation. Further work is warranted to characterise the 
mechanism by which SMN induces Ad early transcriptional activation. To do this, expression 
plasmids containing the luciferase reporter gene under the control of Ad E1A, DBP, IVa2, IX 
and major late promoters would be constructed. These plasmids would be transfected into 
SMN-depleted or SMN over-expressing cells and the luciferase expression would be measured. 
Given that certain Ad proteins are also required as co-activators for certain Ad promoters (Berk 
et al., 1979; Morris and Leppard, 2009; Morris et al., 2010), this assay may also require co-
transfection with plasmids encoding the Ad proteins required for transcriptional activation. It 
would also be interesting to establish an interaction of SMN with Ad promoters and cellular and 
viral transcription factors by chromatin immunoprecipitation from Ad5-infected cells. 
Further investigations could also determine the impact of Ad infection upon protein-protein 
interactions between CB proteins. Coilin has been shown to interact with both SMN and 
WRAP53, whilst SMN and WRAP53 also mutually interact (Hebert et al., 2001; Mahmoudi et 
al., 2010). As SMN is redistributed to a separate compartment to coilin and WRAP53 following 
Ad5 infection (Figure 3-6), it would be interesting to determine whether this coincides with a 
loss of interaction between coilin and SMN and between WRAP53 and SMN. As coilin and 
WRAP53 remain colocalised in rosettes following Ad5 infection (Figure 3-5), it should also be 
determine whether the interaction between coilin and WRAP53 is maintained following Ad5 
infection. Furthermore, as both WRAP53 and fibrillarin colocalised with coilin following Ad 
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infection (Chapter 3), the potential role of WRAP53 and/or fibrillarin in mRNA export could 
also be investigated. 
The redistribution of coilin and SMN from CBs was found to occur during the late stages of 
infection, indicating that an intermediate or late phase Ad protein is likely to be responsible for 
the disassembly of CBs. Therefore further work could focus on identifying potential virus 
protein-interacting partners for both coilin and SMN. To this end, coilin and SMN could be 
immunoprecipitated from whole cell extracts and analysed by Western blotting, probing for the 
virus proteins of interest. As CB proteins have many interaction partners, any identified 
interaction from co-immunoprecipitation experiments would need to be further investigated to 
show if it was direct or indirect using GST-coilin and GST-SMN pull down assays. 
 A question that remains is how the disassembly of CB components relates to their function 
during Ad5 infection. An important fact to consider is that the bulk of SMN and coilin in the 
cell is located diffusely in the nucleoplasm outside of CBs (reviewed in Ogg and Lamond, 
2002). Therefore it is possible that it is the nucleoplasmic fraction of the proteins which are 
responsible for the effects on Ad infection, rather than the CB-associated fraction. It is tempting 
to speculate that disruption of the CB following Ad5 infection may be a strategy to release more 
coilin or SMN into the nucleoplasm to enhance mRNA export and Ad transcription and/or 
splicing, respectively. Indeed, the massive up-regulation of mRNA synthesis during the late 
stages of infection (Flint and Sharp, 1976) may increase demand for free nucleoplasmic coilin 
and SMN within the cell, thus disruption of the CB may release these factors into the 
nucleoplasm to satisfy this demand. To investigate these suggestions, the potential shift of SMN 
and coilin from CBs into the nucleoplasm would be studied. CBs from mock- and Ad5-infected 
cells would be isolated by subcellular fractionation (Lam et al., 2002) and the proportion of 
coilin and SMN protein located in CBs analysed compared to the nucleoplasmic fraction. The 
proportion of coilin and SMN in the nucleoplasm versus the CB could also be analysed by using 
time-lapse fluorescence microscopy in coilin-GFP-expressing cells over the course of Ad5 
infection (Platani et al., 2000).  
The roles of coilin and SMN during Ad infection outlined in this report may also have 
implications for understanding the interaction of other viruses with the CB. The first 
characterised interaction of a virus with the CB was reported by Kim et al, who found that the 
plant virus GRV utilised CBs to traffic the GRV movement protein ORF3 to the nucleolus. This 
was found to facilitate the formation of viral snRNPs necessary for virus spread (Kim et al., 
2007b; Canetta et al., 2008). From the data described in Chapter 4, it appears that coilin has a 
very different role during Ad infection as compared to infection with GRV. This is not 
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altogether surprising considering the lifecycle of an RNA virus is quite different to that of a 
DNA virus, with transcription and RNA processing generally occurring in the cytoplasm in 
RNA virus-infected cells. In addition to RNA viruses, other DNA viruses have also been shown 
to interact with CBs. Various herpes viruses have been shown to disrupt CBs as demarked by 
coilin staining in indirect immunofluorescence analysis (Salsman et al., 2008). However, the 
reason for CB disassembly during infection with these viruses remains unknown. As herpes 
viruses also require the export of mRNA from the nucleus following synthesis, it is possible that 
herpes viruses may also redistribute coilin in order to facilitate mRNA export. It would be 
interesting to investigate the potential role of coilin in mRNA export with other DNA viruses to 
see whether this is a common mechanism during DNA virus infection. It would also be 
appealing to determine the role of other lesser-characterised nuclear bodies during infection 
with Ads and other viruses. It is completely unknown what the impact of Ad infection has on 
the subcellular distribution of PIKAs, OPT domains, nSBs or cleavage bodies. As cleavage 
bodies are believed to be functionally associated with CBs (Li et al., 2006b), it would be 
interesting to determine whether components of cleavage bodies also play roles during Ad5 
infection. 
From a therapeutic point of view, it has become apparent that inhibition of essential cellular 
processes may be an effective mechanism of inhibiting virus infection. Indeed, the discovery of 
the dependence of HIV-1 on the nucleolus for mRNA trafficking led to the development of 
modified T-cell lines resistant to HIV-1 infection (Michienzi et al., 2002; Paul et al., 2003; 
Michienzi et al., 2006). Therefore as mRNA export is a critical function during DNA virus 
infection, the inhibition of coilin function could potentially be a new anti-viral strategy. 
Furthermore, the non-essential role of coilin in normal cellular function indicates that inhibition 
of coilin activity might specifically impair virus replication without having a negative impact on 
normal cellular activity. Further investigation of the impact of coilin depletion during infection 
with other viruses is required. 
The original aim of this work was to gain insight into the mechanisms controlling late gene 
expression for the benefit of replication-competent Ad vector development. As mentioned 
previously, E1-deleted Ad vectors appear to retain the ability to express residual late proteins, 
resulting in immune responses to the vector and reduced efficacy (Yang et al., 1994b; Yang et 
al., 1994c; Yang et al., 1995). In this investigation neither SMN nor coilin appeared to play a 
role in the transcription of late Ad transcripts from the MLP (Figure 4-12 and Figure 5-11). 
Therefore further work is warranted to determine the mechanism by which E1-deleted Ad 
vectors express residual Ad late proteins. However, SMN depletion does appear to be required 
 204 
 
for transcription of the E2 region gene DBP (Figure 5-11). Whether SMN is able to stimulate 
transcription of DBP in the absence of Ad E1 proteins would be worthy of future study.  
This work may also have implications for Ad gene therapy vector development. This 
investigation revealed that Ads require both coilin and SMN for efficient expression of late 
virus proteins and for efficient virus replication, therefore it would seem that Ads may not 
replicate well in tissues expressing low levels of coilin and/or SMN. Although all tissues are 
believed to express both coilin and SMN, levels of these proteins appear to vary between 
tissues, for example there is very low level of SMN expressed in adult skeletal muscle 
compared to brain or lung tissue (Young et al., 2000). Therefore it is possible that Ads may not 
be able to replicate efficiently in cell types expressing low levels of these proteins, which would 
reduce their efficacy as a therapy vector. In addition, not all tissues contain CBs, including 
smooth and cardiac muscle cells, dermal and epidermal skin cells and spleen parenchymal cells 
(Young et al., 2000). It would therefore be of interest to establish whether Ads are able to infect 
cells which express coilin and SMN but do not form CBs. 
Ads have previously been investigated as gene therapy vectors for SMA. These vectors were 
intended to increase SMN expression (DiDonato et al., 2003; Geib and Hertel, 2009). As the 
data presented here indicated that E1A transcription may be dependent upon SMN, it is likely 
that Ad infection of cells from an SMA patient, which would be low in SMN, would result in 
low level expression of transgenes placed under the control of E1A promoter. However, to date 
all studies investigating the ability of Ads to restore SMN expression have used vectors where 
the E1A promoter has been replaced with a high expression promoter (e.g. rous sarcoma virus 
promoter) or an inducible expression promoter (e.g. tetracycline), thus bypassing this potential 
issue. However, the potential requirement of SMN for optimal E1A transcription may be 
noteworthy for the design of future Ad vectors for SMA gene therapy.  
In summary, the data obtained from this investigation has highlighted the potential role of the 
CB protein SMN in Ad transcription and splicing, which is the first report of a role for SMN in 
splicing of virus transcripts. This study also uncovered a potential role of another CB protein, 
coilin, in Ad mRNA processing and export. This is the first suggestion for a role of the CB in 
mRNA export. This work highlights a potential new role for CB proteins in normal cellular 
function as well as during virus infection, and is thus of great interest for future virology and 
cellular biology research. 
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7.  
Appendix Figure 1. Primer design for PCR amplification of Ad5 E1A mRNAs and pre-mRNA.  
A. A schematic representation of the Ad5 E1A spliceoforms. There are 5 E1A spliceoforms (13S, 12S, 
11S, 10S and 9S). Boxes represent exons and thin lines represent introns. Nucleotide positions of the 
splice donor and acceptor sites are shown in base pairs (bp) on the Ad5 genome (not to scale). B. 
Positions of exon-spanning primers on the mature Ad5 E1A mRNAs. a – E1A 13S Forward primer; b – 
E1A 13S and 11S Reverse primer; c – E1A 12S Forward primer; d – E1A 12S and 10s Reverse primer; e 
– E1A 11S and 10s Forward primer; f – E1A 9S Forward primer; g – E1A 9S Reverse primer. C. Position 
of intron-exon spanning E1A primers for amplification of pre-E1A mRNA. h - pre-E1A Forward primer; 
g - E1A 9S Reverse primer. Sequence information was obtained from NCBI Nucleotide. Splice site 
information was obtained from Perricaudet et al., 1979; Virtanen and Pettersson, 1983; Stephens and 
Harlow, 1987; Ulfendahl et al., 1987a; Ulfendahl et al., 1989. 
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Appendix Figure 2. Primer design for PCR amplification of Ad5 DBP mRNAs and pre-mRNA.  
A. A schematic representation of the Ad5 DBP spliceoforms. There are 2 spliceoforms (RT1 and RT2), 
encoded on the leftward-reading strand of the Ad5 genome. Boxes represent exons and thin lines 
represent introns. Nucleotide positions of the splice donor and acceptor sites are shown in base pairs (bp) 
(genome not to scale). B. Positions of exon-spanning primers on the mature Ad5 DBP mRNAs. a – DBP 
RT1 Forward primer; b - DBP reverse primer; c - DBP RT2 Forward primer. C. Position of intron-exon 
spanning DBP primers for amplification of pre-DBP mRNA. D - pre-DBP Forward primer; b - DBP 
Reverse primer. Sequence information was obtained from NCBI Nucleotide. Splice site information was 
obtained from Kruijer et al., 1981; Caravokyri and Leppard, 1996.  
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Appendix Figure 3. Primer design for PCR amplification of IX mRNA.  
A. The transcription pathway for IX on the rightward-reading strand of the Ad5 genome. Boxes represent 
exons. Nucleotide positions of the transcription start sites are shown in base pairs (bp) on the Ad5 
genome (genome not to scale). B. Primer design for IX primers. Primers were designed to span a region 
within the single intron of IX. a – IX Forward primer; b – IX Reverse primer. Sequence information was 
obtained from NCBI Nucleotide.  
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Appendix Figure 4. Primer design for PCR amplification of Ad5 IVa2 mRNA and pre-mRNA.  
A. A schematic representation of the Ad5 IVa2 splicing pathway. Boxes represent exons and thin lines 
represent introns. Nucleotide positions of the splice donor and acceptor sites are shown in base pairs (bp) 
on the Ad5 genome. B. Positions of exon-spanning primers on the mature Ad5 IVa2 mRNA. a - IVa2 
Forward primer; b - IVa2 reverse primer. C. Position of intron-exon spanning IVa2 primers for 
amplification of pre-IVa2 mRNA. A - pre-IVa2 Forward primer; b - pre-IVa2 Reverse primer. Sequence 
information was obtained from NCBI Nucleotide. Splice site information was obtained from Van Beveren 
et al., 1981.  
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Appendix Figure 5. Primer design for PCR amplification of the Ad5 major late mRNAs.  
A. A schematic representation of the Ad5 mRNAs expressed from the major late transcription unit. The 
mRNAs each contain a common set of 5′ -leaders (1, 2, i and 3) and are split into 5 families (L1-L5, L1, 
L3, L4 and L5 depicted above). The inclusion of the i-leader occurs only in a small proportion of the late 
mRNAs and this minor splicing pathway is represented as dashed lines. Boxes represent exons and thin 
lines represent introns. Nucleotide positions of the splice donor and acceptor sites are shown in base pairs 
(bp) on the Ad5 genome (not to scale). B. Positions of exon-spanning primers on the mature Ad5 late 
mRNAs. a – IIIa/hexon/L4-100K/Fibre Forward primer; b - IIIa/hexon/L4-100K/Fibre Reverse primer. C. 
Position of intron-exon spanning primers for amplification of Ad major late pre-mRNAs. A – Tripartite 
Leader Forward primer b) Tripartite Leader Reverse primer. Sequence information was obtained from 
NCBI Nucleotide. Splice site information was obtained from Gingeras et al., 1982; Kreivi et al., 1991. 
Figure is adapted from Kreivi et al, 1991.  
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Appendix Figure 6. Primer design for PCR amplification of human GAPDH mRNAs.  
A. A schematic representation of the GAPDH mRNA transcription pathway. Boxes represent exons and 
thin lines represent introns. Nucleotide positions of the splice donor and acceptor sites on chromosome 12 
are shown in base pairs (bp) (not to scale). B. Positions of exon-spanning primers on the mature GAPDH 
mRNAs. a – GAPDH Forward primer; b – GAPDH Reverse primer. C. Position of intron-exon spanning 
primers for amplification of GAPDH pre-mRNAs. a - pre-GAPDH Forward primer; b - pre-GAPDH 
Reverse primer. Nucleotide sequences and location of splice sites were obtained from NCBI Nucleotide.  
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Appendix Figure 7. Dilution dependent decrease in absorbance by the MTT assay. 
A549 cells were serially diluted, seeded in 96-well plates and incubated for 24 hours. Cells were 
harvested and subjected to analysis by the MTT assay. Results are the mean fold change in absorbance at 
570 nm (± SEM) from two independent repeats performed in duplicate. Data is shown as relative to the 
highest cell concentration, which was set to a value of 1. It was found that the relative absorbance at 570 
nm directly correlated with the cell density. 
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Appendix Figure 8. Validation of primer specificity by semi-quantitative PCR. 
A549 cells were mock or Ad5 infected at an MOI of 5 and incubated for 24 hours. Cells were harvested 
and total RNA was extracted followed by DNAse treatment to remove contaminant DNA. Reverse 
transcription was carried out on total RNA to produce cDNA from mRNA. A non-template control (NT) 
was included to ensure amplified product was specific to the template. Control reactions which did not 
contain reverse transcriptase (RT) were also included to verify that specific cDNA sequences were being 
amplified. Target cDNA was amplified in PCR reaction using exon-spanning or intro-exon spanning 
primers. PCR products were separated on a 2% agarose gel by electrophoresis. Images were captured 
using a Las 3000 Imager. For all primer pairs, the NT control and no RT control were negative for PCR 
product. For all primer pairs specific for Ad mRNA sequences, no product was detected in the mock-
infected samples.  
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